Fluorescence and active site engineering studies of copper-containing oxidoreductases by Kostrz, Dorota Natalia
  
 
 
 
 
 
 
 
Fluorescence and active site engineering studies 
of copper-containing oxidoreductases 
 
 
 
Dorota Natalia Kostrz 
 
 
 
A Thesis Submitted for the Degree of Doctor of Philosophy 
March 2014 
Institute for Cell and Molecular Biosciences 
Newcastle University 
 i 
Declaration 
I certify that this thesis contains my own work, except where acknowledged, and that no 
part of this work has been submitted in support of an application for other qualifications 
at this or any other institution. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ii 
Abstract 
 
Copper-containing proteins are involved in a wide range of biological processes mainly 
via oxidation and reduction reactions. The oxidation state of these proteins can be 
monitored via Förster resonance energy transfer (FRET) between a covalently attached 
fluorescent dye and the protein’s redox active centre. Consequently, changes in 
absorbance upon reduction or oxidation of the protein can be related to changes in the 
fluorescence intensity and lifetime. This FRET-based approach has been applied to 
study the catalytic activity of the copper-containing blue nitrite reductase (bNiR) from 
Alcaligenes xylosoxidans at the single molecule level by means of scanning confocal 
microscopy combined with fluorescence lifetime imaging (FLIM). bNiR catalyzes the 
reduction of nitrite to nitric oxide during denitrification. The active centre of bNiR 
consists of a type 1 (T1) Cu site, which acts as the initial port of entry for electrons, and 
a type 2 (T2) Cu site, where nitrite reduction occurs. Detailed analysis of single 
molecules of immobilized, fluorescently labeled bNiR has allowed two populations of 
molecules to be identified that turn over with different catalytic rates. Previous studies 
of the catalytic mechanism of copper-containing NiRs distinguished two possible 
reaction pathways. The single molecule results imply these occur as a consequence of 
heterogeneity in the enzyme population. 
Fluorescent labeling of laccases, which catalyze the oxidation of a range of 
substrates coupled to the four electron reduction of O2, with fluorescent dyes was 
investigated for their potential use in the development of a FRET-based biosensor.           
A novel expression system for the Trametes versicolor laccase Lcc1 in Schizophyllum 
commune was developed. The recombinant protein is similar to another native laccase 
(Laccase A) from T. versicolor and both exhibit significantly higher catalytic efficiency 
with phenolic compounds than the bacterial small laccase (SLAC) from Streptomyces 
coelicolor. Regardless, preliminary data indicate involvement of a tyrosyl radical in the 
catalytic activity of fungal laccases, similar to what is observed in SLAC.   
bNiR and SLAC are trimers, with each monomer consisting of two cupredoxin-
like domains. The structure of the catalytic site and the location of a T1 Cu site are 
different in these two enzymes. A crystal structure provides detailed insight into why an 
attempt to introduce the SLAC active site into bNiR was unsuccessful. Attempts to 
introduce T1 Cu sites into the cupredoxin-like domains of bNiR and SLAC, which 
normally lack this site, resulted in the introduction of a tetragonal thiolate-containing T2 
Cu site. 
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 viii 
SLAC Bacterial, two-domain (small) laccase from Streptomyces 
coelicolor. Also referred to as SLACtruncated 
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Aspartic acid Asp D  Proline Pro P 
Glutamic acid Glu E  Glutamine Gln Q 
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Histidine His H  Threonine Thr T 
 ix 
Isoleucine Ile I  Valine Val V 
Lysine Lys K  Tryptophan Trp W 
Leucine Leu L  Tyrosine Tyr Y 
 
Adenine A Guanine G 
Cytosine C Thymine T 
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1.1 Introduction 
 
In nature, oxidation and reduction reactions are essential for vital processes such as 
photosynthesis, respiration, redox homeostasis, and antioxidant defense mechanisms 
[1]. Many of the proteins that are involved in these reactions rely on the presence of 
redox active metal cofactors: most commonly iron (Fe) and copper (Cu). Both metals 
are transition elements, with more than one stable and biologically accessible oxidation 
state. The biological functions of these metals relate to their ability to convert between 
these oxidation states in oxidation-reduction processes. The bioavailability of iron and 
copper has changed over the geological history of the Earth [2]. While iron (as Fe(II)) 
was favored in the anaerobic Earth, the oxygenation by early photosynthetic organisms 
promoted the use of copper, particularly in systems that mediate oxygen (O2) chemistry 
[2].         
Copper is one of the most important trace elements found in living organisms, 
with functions ranging from the influence on specific gene expression [3] to serving as a 
cofactor for multiple proteins. However, free copper is highly toxic to living cells 
(particularly at high concentrations [4]), and therefore, the uptake, transport and 
incorporation of the metal into the copper requiring proteins within the cell are tightly 
regulated [5 - 8]. Cu-binding proteins account for up to 1 % of the total cellular 
proteome [9]. The metabolic roles of these proteins fall into four major categories 
including electron transfer (ET) reactions (for example azurin, Az) [1, 10 - 12], O2 
binding, transfer and activation (as in tyrosinase, Ty, and hemocyanin, Hc) [12, 13], 
transport or storage of metal itself (for example metallochaperones, which transport 
copper to their specific target proteins [5] and metallothioneins, which are cysteine-rich 
polypeptides with high affinity for Cu(I) [14]) and catalysis. Cu sites in proteins can 
exhibit oxidase activity by oxidation of substrates, which is coupled to either two or 
four electron reduction of O2 (in amine oxidases, CuAOs [15], galactose oxidases, GOs 
[16] and multicopper oxidases, MCOs [17]), oxygenase activity by incorporating one 
oxygen atom from O2 (in peptidylglycine α-hydroxylating monoxygenase, PHM [18], 
particulate methane monooxygenase, pMMO [19, 20] and ammonia monooxyganese, 
AMO [21]), act as reductases (for example in nitrite reductases, NiRs [22]), and can 
also participate in superoxide scavenging (copper/zinc superoxide dismutase,           
Cu/Zn-SOD) [23].  
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1.2 Copper coordination chemistry and copper sites in proteins 
 
The ground state of Cu has a 3d104s1 valence electronic configuration. The Cu(I) 
oxidation state occurs through the loss of the 4s electron (3d10), whilst Cu(II) has a 
singly occupied d orbital (3d9) [24]. Cu(I) is a soft Lewis acid and prefers to bind to soft 
ligands such as those containing sulfur donor atoms (Cys or Met), whereas Cu(II) as a 
hard Lewis acid preferentially binds to harder ligands containing nitrogen (His) and 
oxygen (Asp or Glu) donor atoms [2]. Depending on coordination number, Cu(I) 
predominantly forms tetrahedral and trigonal planar complexes, whilst Cu(II) prefers 
tetragonal geometries, including square planar and axially elongated octahedral [25, 26]. 
The latter geometry of Cu(II) occurs due to the partial occupancy of degenerate              
d orbitals. The resulting instability is overcome via Jahn-Teller distortion that removes 
the orbital degeneracy through a reduction in symmetry by forming an axially distorted 
octahedron [24].       
 
A) 
    
C) 
 
B) 
 
D) 
 
 
Figure 1.1 Some examples of Cu sites in proteins. (A) Type 1 (T1) Cu site of small 
laccase (SLAC) from Streptomyces coelicolor (pdb file: 3KW8 [27]), (B) type 2            
(T2) Cu site of blue NiR (bNiR) from Alcaligenes xylosoxidans (pdb file: 1OE1 [28]), 
(C) type 3 (T3) Cu site of Ty from Streptomyces castaneoglobisporus (pdb file: 1WX2 
[29]) and (D) trinuclear (T2/T3) Cu cluster from SLAC (pdb file: 3KW8 [27]).               
The T1, T2 and T3 Cus are shown as green, purple and red spheres, respectively, whilst 
O22−/OH−/H2O ligands are shown as small white spheres.  
 
The active sites of many Cu-containing proteins exhibit distinct spectral 
properties as compared to those of inorganic copper complexes [10, 11, 26, 30].              
These properties reflect the geometric and electronic structures that are imposed on the 
Cu ion by the protein coordination environment. Historically, based on their 
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spectroscopic properties, Cu sites in proteins were classified as either type 1 (T1, “blue” 
or “green”), type 2 (T2, “normal”) or type 3 (T3) [31]. In some cases T2 and T3 Cus 
form a trinuclear cluster (TNC) also referred to as a T2/T3 or T4 Cu site [10]. This 
original classification has been extended as novel Cu sites are discovered including the 
“red” Cu in nitrosocyanin [32], the binuclear “purple” CuA, for example in cytochrome 
c oxidase [33, 34] and the tetranuclear CuZ in nitrous oxide reductase (that also has a 
CuA site) [35]. Cu sites have also been created by protein engineering, including type 
zero [36], type 1.5 [37] and “yellow” thiolate-containing T2 (S(Cys)-T2) Cu [37, 38] 
(for more details see Chapter 4). 
 
1.2.1 The mononuclear T1 Cu site  
 
T1 Cu sites (Figure 1.1.A) carry out ET in a wide variety of biological systems                
[10, 11, 39, 40, 41]. The site consists of a single Cu ion protected by a protein envelope, 
which is commonly referred to as a cupredoxin fold [40, 41]. The cupredoxin fold 
consists of eight β-strands arranged into two β-sheets forming a Greek key β-barrel         
[42, 43]. Cupredoxins can occur as either single domain proteins, such as Az [42] and 
plastocyanin (Pc) [44], or as components (cupredoxin-like metal-binding domains, 
MBDs) of larger enzymes, such as NiRs [28] and MCOs, including laccases                     
[27, 45 - 48], ascorbate oxidase (AO) [49], Fet3p [50] and ceruloplasmin (Cp) [51].    
The metal ion at the T1 Cu site of cupredoxins is bound to the protein by two                 
Cu-N(His) bonds and a short Cu-S(Cys) bond [26, 39, 52]. Additionally, weaker 
interactions either from Met (for example in Pc [44]), Gln (in stellacyanin, STL [53]), 
and Met and a carbonyl oxygen from the protein’s backbone (in Az [42]) can be 
present. In some T1 Cu-containing proteins, a non-coordinating Val (in the 
plantocyanin (PLN) from tomato [54]), Leu (in PLN from lily [55], Cp [51] and Fet3p 
[50]) and Phe (fungal laccases [48]) occupy the axial position. Therefore, the geometry 
of a T1 Cu site varies from trigonal planar (as in fungal laccases [48]) via distorted 
tetrahedral (as in Pc [44]) to trigonal bipyramidal (as in Az [42]).  
The reduction potential (Em) of a T1 Cu site can vary from 190 (in STL) to           
> 1000 mV (in Cp) versus the normal hydrogen electrode [39, 40]. The single domain 
cupredoxins have Em values ranging from 190 to 370 mV [40], except for rusticyanin, 
which has an Em value of 670 mV [23]. The Em of the T1 Cu sites of MCOs covers a 
wide range of values, with the three-coordinate T1 Cu sites of fungal laccases having 
Ems of ~ 790 mV [40]. The residue in the axial position of a T1 Cu site is considered as 
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one of the factors influencing Em, as the T1 Cu sites containing Phe or Leu in the axial 
position show typically higher Em values than those containing Met. However, other 
factors such as hydrogen bonding [56], site hydrophobicity [57] and electrostatics [58] 
have been suggested to play an important role in modulation of the Em value. Lu et al. 
demonstrated the additive nature of these effects by tuning the Em of Az from 
Pseudomonas aeruginosa in the range of 80 to > 700 mV range [59]. The highest Em 
among T1 Cu sites has that of Cp (with non-coordinating Leu in the axial position) [60] 
but it has been hypothesized that this site stays permanently reduced [60].                     
The replacement of the T1 Cu axial Leu with Met resulted in a silent mutation, which 
failed to modify either the spectroscopic or catalytic properties of Cp [61]. 
T1 Cu(II) sites show unusual spectroscopic properties as a consequence of their 
coordination geometry compared to those of normal tetragonal Cu(II) complexes [26]. 
In the visible region of its absorption spectrum a T1 Cu(II) site has an intense                    
(ε ~ 2000 - 6000 M-1cm-1), low-energy S(Cys)π→Cu(II) dx2−y2 ligand to metal charge 
transfer (LMCT) transition centered at ~ 600 nm and a weak, high energy 
S(Cys)σ→Cu(II) dx2−y2 LMCT band at ~ 450 nm [10, 26, 39, 40, 52]. The electron 
paramagnetic resonance (EPR) spectrum of a T1 Cu(II) site has a small hyperfine 
coupling constant in the gz region (Az), typically < 95 × 104 cm-1 [26]. This unique 
visible spectrum and small Az value are attributed to the highly covalent Cu(II)-S(Cys) 
bond (the unpaired electron is strongly delocalized onto the Cys ligand, hence reducing 
its interaction with the nuclear spin on the Cu ion) [10, 26, 60, 61].  
The relative intensities of the two LMCT bands in the visible spectrum and the 
separation between gx and gy in the EPR spectrum of a T1 Cu(II) site vary [40, 62]. The 
classic “blue” T1 Cu sites (for example in Pc and bNiR from A. xylosoxidans) have 
lower absorbance at ~ 450 nm in their visible spectra and an axial EPR signal (similar 
gx and gy values). Upon tetragonal distortion of the ligand field (LF) of a “blue” T1 Cu 
site, the intensity of the LMCT band at ~ 600 nm decreases, whilst that at ~ 450 nm 
increases, resulting in a “green” T1 Cu site (for example the perturbed T1 Cu site in 
green NiR from Rhodobacter sphaeroides) [10, 26, 52, 60, 61]. Concomitantly, the 
separation between gx and gy increases giving rise to a rhombic EPR signal [40, 62]. 
The half-occupied Cu(II) dx2−y2 orbital is oriented perpendicular to the long                
Cu(II)-S(Met) bond and close to the plane of the short S(Cys) and two N(His) ligands. 
The lobes of the Cu(II) 3dx2−y2 orbital in a “blue” T1 Cu bisect the Cu-S(Cys) 3p orbital 
giving highly covalent π overlap with the S(Cys) ligand (in square planar Cu(II) 
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complexes the 3dx2−y2 orbital is oriented towards a ligand’s 3p orbital allowing for 
(ligand)σ→Cu(II) dx2−y2 LMCT) [10, 26, 60, 63]. The spectral changes of a “green”        
T1 Cu site are attributed to rotation of the Cu(II) dx2−y2 orbital and a shift from π to σ 
bonding with the S(Cys) ligand, and therefore, a weakening of the Cu(II)-S(Cys) bond 
that leads to strengthening of the axial Cu(II)-S(Met) interaction [10, 52, 60, 61]. 
Interestingly, the relative intensities of the two LMCT bands of the perturbed T1 Cu site 
of green NiR are temperature dependent, indicating thermodynamic equilibrium 
between “green” and “blue” T1 Cu sites [60, 61].  
 
1.2.2 The mononuclear T2 Cu site 
 
Mononuclear T2 Cu sites are found in a range of proteins including Cu/Zn-SOD, PHM, 
dopamine β-hydroxylase (DβM), NiRs, CuAOs and GOs [26, 64]. In MCOs, a T2 Cu 
site contributes to the T2/T3 Cu cluster (see below) [63]. The T2 Cu ion is usually 
coordinated by imidazole side chains of His residues, but Tyr (in GO [65]) and Met        
(in PHM [18]) can also be present. T2 Cu sites can have a range of geometries including 
square planar (as in Zn/Cu-SOD [66]), tetrahedral (as in NiRs [28], Figure 1.1.B) and 
square pyramidal (as in GO [65] and CuAO [67]). T2 Cu sites are typically catalytic and 
the substrate binds to the Cu ion in place of the exogenous ligand (such as H2O and OH− 
[22, 64]). T2 Cu can catalyze a range of reactions including the disproportionation of 
superoxide (Cu/Zn-SOD [23]), reduce NO2− to NO (NiRs [22], see Chapter 2) and have 
oxidase (as part of a T2/T3 Cu cluster in MCOs [17], see Chapter 3) and oxygenase        
(in PHM, which hydroxylates the Cα atom of a terminal Gly residue in the amidation of 
peptide hormones, neuropeptides and antimicrobials, and DβM that converts dopamine 
to norepinephrine [18]) activities.  
The spectral features of a T2 Cu(II) site are similar to those of normal tetragonal 
Cu(II) inorganic complexes [26]. Due to the absence of a thiolate ligand, the absorption 
spectrum of this site does not show any distinct features in the visible region.                 
The T2 Cu(II) site exhibits an EPR signal with an Az value of ~ (150 - 250) × 104 cm-1 
[26] and several weak LF transitions in the magnetic circular dichroism (MCD) 
spectrum [68, 69].  
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1.2.3 The binuclear T3 Cu site 
 
Binuclear T3 Cu sites (Figure 1.1.C) are found in proteins such as Hc [70], Ty [29] and 
catechol oxidase (CatOx) [71]. In Hc, the site reversibly binds O2 facilitating storage 
and transport, whilst it participates in the hydroxylation of monophenolic substrates in 
Ty and the oxidation of catechol substrates (ortho-diphenols) in both Ty and CatOx [13, 
29, 70, 71]. The binuclear T3 Cu site is composed of two Cu ions, both coordinated by 
three His ligands in a trigonal planar geometry [29, 70, 71]. The metal ions are strongly 
coupled through a bridging ligand, such as O22− and OH− [3, 26, 30]. Molecular O2 
binds to the reduced and colourless T3 Cu(I)s yielding two forms of oxygenated species 
that exhibit different spectral features [12, 13, 26, 30, 72 - 76]. The peroxide-bound 
Cu(II)-O22−-Cu(II) oxy form, in which O2 is bound in a side-on geometry (Figure 1.1.C) 
is characterized by O22−→Cu(II) dx2−y2 LMCT transition bands at ~ 350 nm                      
(ε ~ 20000 M-1cm-1) and ~ 550 nm (ε ~ 1000 M-1cm-1). The met Cu(II)-Cu(II) species, 
in which the T3 Cus are OH−-bridged, show a weak OH−→Cu(II) dx2−y2 LMCT 
transition band at ~ 330 - 360 nm. Both forms of T3 Cu(II) site do not give rise to an 
EPR signal and spectral features in the MCD spectrum owing to strong 
antiferromagnetic coupling mediated by a bridging ligand [12, 13, 26, 77]. 
 
1.2.4 The trinuclear T2/T3 Cu cluster  
 
Trinuclear T2/T3 Cu cluster consists of a T2 Cu ion and a T3 Cu pair (Figure 1.1.D), 
and is found in MCOs, which catalyze substrate oxidation coupled to the four-electron 
reduction of O2 to H2O (the reactivity of the T2/T3 Cu cluster in laccases is discussed in 
detail in Chapter 3) [30, 63]. In the resting enzyme, the T3 Cu(II)s are coupled through 
a bridging OH− ligand [12, 26, 63]. Therefore, each T3 Cu is four-coordinated (three 
His and OH− ligands) in a distorted tetrahedral geometry [27, 48 - 51, 63]. The T2 Cu is 
three-coordinated (two His and OH− ligands) in a trigonal planar geometry.  
Similar to the binuclear T3 Cu site, the T3 Cu(II)s in the T2/T3 Cu cluster are 
EPR and MCD silent due to strong antiferromagnetic coupling of the T3 Cu(II) pair 
bridged by an OH− ion [26]. The site demonstrates a bridging OH− to Cu(II) LMCT 
band at ~ 330 nm (ε ~ 4000 M-1cm-1) [39] and several LF transitions in the circular 
dichroism (CD) spectrum [77]. The T2 Cu(II) is not bridged to the T3 Cus and, 
therefore, shows an EPR signal and LF transitions in the MCD spectrum, similar to 
those observed for the mononuclear T2 Cu(II) [26, 77].   
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1.3 Structural relationship between copper-containing proteins  
 
A) 
 
B) 
 
C) 
 
 
Figure 1.2 Schematic representations of MBDs and Cu ions organization in                   
Cu-containing proteins and their hypothetical ancestors as proposed by (A) Ryden and 
Hunt [78], (B) Murphy et al. [79] and (C) Nakamura et al. [80]. Blue represents the 
two-domain monomer of trimeric proteins. The T1 Cu and IDCB (the T2 Cu and           
T2/T3 Cu cluster) sites are shown as blue and black dots, respectively.  
 
Multi-domain Cu-containing proteins consist of two (for example NiRs [28] and two-
domain laccases [27, 45 - 47]), three (for example AO [49], and three-domain laccases 
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[48]) or six (for example Cp [51]) MBDs. Only some of these MBDs bind a T1 Cu, 
some are involved in inter-domain Cu-binding (IDCB) sites, and some do not bind 
metal at all. Several NiRs with an additional MBD have been found and a crystal 
structure of a hexameric NiR (tightly associated dimer of trimers, with each monomer 
consisting of three MBDs) is available [81]. However, the function of this additional 
MBD is as yet unknown.  
Genome sequence analyses combined with structural and spectroscopic data 
suggest that the multiplication of a MBD followed by creation of the IDCB and 
substrate-binding sites led to the formation of multi-domain Cu-binding proteins. 
Several duplicated cupredoxins such as dicyanin from tomato (NCBI accession no. 
Q9M510; containing two T1 Cu sites, one in each MBD), dinodulin from Arabidopsis 
thaliana, (NCBI accession no. Q9MAK3, Q9LFI4 and Q9M135; lacking T1 Cu sites) 
and hDN from Halobacterium sp. NRC-1 (NCBI accession no. Q9HPH3; containing 
only one T1 Cu site), have been identified [80, 82]. However, Nakamura et al. 
suggested that the duplication of cupredoxins to form these proteins were separate 
events from the one that led to the creation of multi-domain Cu-binding proteins [80]. 
Ryden and Hunt [78] proposed that a pair of MBDs from the initial duplication of a 
cupredoxin domain was duplicated twice more to create a six-domain form such as Cp, 
whereas three-domain MCOs were formed by a single addition of an MBD to a two-
domain protein (Figure 1.2.A). Based on the similarities between the proteins’ structure 
and function of their IDCB sites, Murphy et al. [79] proposed (Figure 1.2.B) that either 
triplication of a two-domain protein, which led to the formation of Cp, was followed by 
the loss of three MBDs to form a three-domain MCOs, or that duplication of a three-
domain MCO led to the formation of Cp.  
Nakamura et al. hypothesized [80, 83] the presence of three types of trimeric, 
two-domain MCOs (type A, B and C) as common ancestors in the formation of three- 
and six-domain Cu-binding proteins (Figure 1.2.C). The difference between the type A, 
B and C intermediates is the distribution of T1 Cu sites. The type A MCOs contain a    
T1 Cu site in each MBD, and are considered the precursors to the type B and type C 
MCOs, which contain T1 Cu sites in the second (MBD-2) and the first (MBD-1) MBD, 
respectively (Figure 1.2.C). Trimeric NiRs evolved either from the type C MCOs with 
concomitant loss of the T3 Cus, or from the type Y ancestor (an analogue to the type A 
MCO containing a T2 Cu instead of a T2/T3 cluster) with concomitant loss of a T1 Cu 
site in MBD-2 (Figure 1.2.C). Deposition of several crystal structures of trimeric         
two-domain MCOs, such as mgLAC obtained from metagenome database [45], SLAC 
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[27, 47] and the blue copper oxidase (BCO) from Nitrosomonas europaea [46], 
supports the evolutionary scheme presented in Figure 1.2.C. However, Nakamura et al. 
did not identify sequences of any type Y proteins in genome databases [80], and 
although the sequences of three type A proteins were identified [80], no crystal 
structures are available.  
 
A) B) C) 
   
   
 
Figure 1.3 Cartoon representations of the overall structures (top) and the active sites 
(bottom) of (A) bNiR (pdb file: 1OE1 [8]) and (B) SLAC (pdb file: 3KW8 [27]) and   
(C) laccase from Trametes versicolor (pdb file: 1KYA [48]). MBD-1, MBD-2 and 
MBD-3 are coloured pink, green and blue. The T1, T2 and T3 Cus are shown as green, 
purple and red spheres, respectively, whilst OH− and H2O ligands are small white 
spheres.  
 
The core domains of characterized two-domain MCOs and NiRs are well 
conserved (Figure 1.3), with only minor structural differences [27, 28, 45 - 47]. In NiRs 
(Figure 1.3.A) [28], mgLAC [45] and BCO [46] (latter two enzymes are the type C 
MCOs), the T1 Cu site is located in MBD-1, whilst in SLAC (Figure 1.3.B) [27, 47] it 
is located in MBD-2 (type B MCO). The IDCB site of two-domain MCOs and NiRs is 
located at the interface between MBD-1 and MBD-2 of two adjacent monomers, whilst 
in three-domain MCOs (Figure 1.3.C) it is at the interface between MBD-1 and MBD-3 
[27, 28, 45 - 49]. The three-dimensional structure of the IDCB sites and their adjacent 
T1 Cu site (~ 13 Å away) is similar to some extend, in MCOs and NiRs. In NiRs, the     
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T1 Cu and the IDCB sites are connected by a Cys(T1 Cu)-His(T2 Cu) motif               
(Figure 1.3.A), whilst in MCOs by a His(T3 Cu)-Cys(T1Cu)-His(T3 Cu) (Figure 1.3.B 
and 1.3.C). The potential T1 Cu sites in the remaining MBDs (MBD-1 for SLAC and 
MBD-2 for NiRs, mgLAC and BCO) are missing, mainly due to the substitution of the 
potentially Cu-ligating Cys residue to either Asp, Asn or Glu (more details can be found 
in Chapter 4).  
 
1.4 The FluoRox principle 
 
1.4.1 General introduction to fluorescence 
 
Luminescence is a phenomenon occurring when a molecular system absorbs light and 
dissipates the energy through the emission of a photon [84]. The mechanism of 
luminescence is usually described by means of Jablonski diagram (Figure 1.4) that 
illustrates the processes that occur between the absorption and emission of light by a 
molecule. The singlet ground, first and second electronic states are depicted by S0, S1 
and S2, respectively, whilst the first triplet state is T1. Each of these states carries a 
series of vibrational energy levels, denoted by 0, 1, 2 and 3 (Figure 1.4).  
 
 
 
Figure 1.4 Jablonski diagram as adapted from [84], describing the electronic states of a 
luminescent molecule that are involved in luminescence. S0 is a ground electronic state, 
whilst S1 and S2 are first and second singlet excited electronic states and T1 is the first 
triplet state. hνA indicates absorbed photons  (S0→S1 and S0→S2 transitions), whilst hνF 
and hνP are the photons emitted in fluorescence (S1→S0 transitions) and 
phosphorescence (T1→S0 transitions), respectively. Wiggly arrows represent               
non-radiative energy dissipation. IC and ISC are internal conversion and intersystem 
crossing, respectively.  
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Depending on the nature of the excited state from which the emission occurs, 
luminescence is divided into fluorescence and phosphorescence (Figure 1.4). 
Fluorescence (10-8 s timescale) generally occurs from a thermally equilibrated excited 
state, which is the lowest vibrational level of S1. Therefore, following light absorption 
(S0→S1 and S0→S2 transitions, 10-15 s timescale), a fluorophore in the excited states 
relaxes to the lowest vibrational level in a process called internal conversion (IC, 10-12 s 
timescale) prior to decay from S1 to S0 [84]. Typically, this return occurs to a higher 
excited vibrational level of S0, which then quickly reaches thermal equilibrium (10-12 s 
timescale). Alternatively, the molecules in the S1 state undergo a spin conversion to the 
T1 in a process called intersystem crossing (ISC) [84]. The T1→S0 transition is 
forbidden, and thus, the rate constants for triplet emission are smaller than those for 
fluorescence (103 to 1 and 108 s-1, respectively), resulting in phosphorescence lifetimes 
ranging from 10-3 to 1 s [84]. The presence of heavy atoms such as bromine and iodine 
facilitates ISC and therefore, enhances phosphorescence quantum yields (number of 
emitted photons relative to the number of absorbed photons).  
The same fluorescence emission spectrum is generally independent of an 
excitation wavelength (Kasha-Vavilov rule) due to the strong overlap among numerous 
vibrational levels (of nearly equal energy) of S1 and rapid relaxation (10-12 s) to the 
lowest vibrational level of S1 [84, 85]. Exceptions exist, such as molecules emitting 
from the S2 level, but such emissions are generally not observed in biological molecules 
[84]. The fluorescence spectrum of a system is typically a mirror image of the 
absorption spectrum of the S0→S1 transition, but photon emission occurs at lower 
energies (longer wavelengths) than excitation. This red shift, also called the Stokes 
shift, is caused by the relaxation, mainly by thermal equilibration, of the excess 
vibrational energy. The fluorescence parameters that are typically measured for the 
biophysical and biochemical characterization of molecules are the fluorescence 
quantum yield, fluorescence intensity as a function of wavelength, fluorescence lifetime 
(average time that a molecule spends in the excited state prior to return to the S0 level) 
and fluorescence polarization [84].  
The main fluorescent probes used in biochemistry are classified as intrinsic 
(natural) and extrinsic fluorophores, and fluorescence indicators [84]. Intrinsic 
fluorophores include among others the indole group of Trp, oxidized flavins, reduced 
nicotinamide adenine dinucleotide (NADH), pyridoxal phosphate and chlorophyll. 
Extrinsic fluorophores, including fluorescent proteins such as GFP and YFP, and 
commercially available organic molecules such as rhodamine- (for example ATTO 532) 
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and cyanine- (for example Cy5) based dyes are used when the molecule of interest is 
not fluorescent or the intrinsic fluorescence is either inadequate or insufficient. 
Fluorescence indicators are fluorophores whose spectral features are sensitive to a 
substance of interest (such as metal ions, O2 or pH) [84]. Although relatively few 
copper-selective fluorescent probes have been reported, their use has enabled the 
detection and visualization of intracellular copper present in living cells [86 - 90]. For 
example the Cu(II)-selective Phen Green FL fluorescent probe has been used to study 
binding of metal to the full-length Alzheimer’s amyloid-β peptide [86] and to 
investigate the mechanism of Cu(II) uptake by different types of hepatopancreas 
epithelial cells and mitochondria [87, 88].  
 
1.4.2 Förster Resonance Energy Transfer 
 
Förster Resonance Energy Transfer (FRET) is a radiation-less energy transfer resulting 
from long-range dipole-dipole interactions between a donor molecule (D) in the excited 
electronic state and an acceptor molecule (A) in the ground electronic state [84]. FRET 
is widely used in biology and biochemistry as a sensitive method for measuring 
distances within or between molecules [91, 92]. The conditions required for FRET to 
occur are: sufficient spectral overlap between the emission spectrum of D and the 
absorption spectrum of A, a D to A distance of 20 to 90 Å [84], and optimal relative 
orientation of the transition dipoles of D and A.  
The dependence of FRET efficiency of energy transfer (E) on the D to A 
distance (r) is given by Equation 1.1 [84]:    
 
€ 
E = R0
6
R06 + r6
                                     (Equation 1.1), 
 
where R0 is the Förster distance, which is the distance at which E is 50 %. R0 is 
dependent on the spectral properties of D and A, and their relative orientation, as 
described by Equation 1.2 [84]: 
 
           
€ 
R0 = 0.211 κ 2n−4QDJ(λ)( )
1 6
                          (Equation 1.2), 
 
in which κ2 describes the relative orientation in space of the transition dipoles of D and 
A, n is the refractive index of the medium, QD is the quantum yield of D and J(λ) is the 
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spectral overlap integral, which expresses the degree of spectral overlap between the 
emission of D and the absorption of A as a function of wavelength, λ. J(λ) is defined as 
[84]:   
 
          
€ 
J(λ) =
FD (λ)εA (λ)λ4dλ0
∞
∫
FD (λ)dλ0
∞
∫          
                 (Equation 1.3), 
 
where FD is the fluorescence intensity of D and εA is the extinction coefficient of A as a 
function of λ. In case of a fixed D-A distance, E can be expressed in terms of 
fluorescence intensities (Equation 1.4) or lifetimes (Equation 1.5) [84]:    
 
€ 
E =1− FDAFD
             (Equation 1.4), 
€ 
E =1− τDA
τD
            (Equation 1.5), 
 
where FDA and τDA are the fluorescence intensity and lifetime respectively of D in the 
presence of A, whilst FD and τD are the fluorescence intensity and lifetime respectively 
of D in the absence of A. 
 
1.4.3 FRET as a reporter of the oxidation state of metalloproteins 
 
The FluoRox principle is a FRET-based approach that relies on the use of a surface-
conjugated fluorescent dye molecules acting as the FRET donor and the redox-active 
cofactor of a protein or enzyme acting as the FRET acceptor (Figure 1.5.A). The use of 
a fluorescent label whose emission spectrum overlaps with the absorption spectrum of 
the cofactor in one of its oxidation states results in partial quenching of the label’s 
fluorescence by that state. Upon changing the oxidation state of the cofactor the spectral 
overlap, and the R0 value of the D-A pair, changes (Figure 1.5.B). Therefore, 
fluctuations in the oxidation state of the cofactor are reflected in changes in 
fluorescence intensity (Figure 1.5.C). This FRET-based approach provides increased 
sensitivity compared to absorbance and electrochemical measurements of oxidation 
state changes, making FluoRox particularly attractive for biosensing applications [93 - 
96] and single molecule investigations (as in Chapter 2) [97 - 99].        
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A) 
      
B) 
 
             C) 
 
 
Figure 1.5 (A) Schematic depiction of the FluoRox principle, (B) spectral overlap 
(J(λ)) between absorption (red) of a T1 Cu-containing protein and emission (green) of a 
fluorescent label, and (C) fluorescence intensity changes upon oxidation and reduction 
of labeled protein. Left and right panels in (A) and (B) correspond to the Cu(II) and 
Cu(I) forms of the protein, respectively. The fluorescent label is shown as a green star, 
whilst the oxidized and reduced states of the T1 Cu are blue and gray spheres, 
respectively. 
 
The strong absorbencies at ~ 330 and ~ 600 nm of oxidized T3 (and also T2/T3) 
and T1 Cu-containing proteins (Section 1.2), which are absent in the reduced forms, 
make them particularly amenable to the FluoRox approach (Figure 1.5, scheme for the 
T1 Cu-containing protein). The fluorescence of a surface-attached fluorescent label 
(whose spectrum overlaps with ~ 600 nm absorbance of the T1 Cu(II) site) is quenched 
owing to FRET between the label and the T1 Cu(II) site, and thus the fluorescence 
intensity is low (Figure 1.5.C). Upon reduction, no FRET occurs and the fluorescence 
intensity of the label is much higher (Figure 1.5.C). The absorbance at ~ 330 nm of 
e! 
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Energy 
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oxidized T3 and T2/T3 Cu sites overlaps with the emission of Trp residues (intrinsic 
fluorescence in proteins typically occurs between ~ 308 to 355 nm [100]). This intrinsic 
fluorescence is quenched as a result of FRET between the Trp residues and the T3 and 
T2/T3 Cu(II) sites resulting in low intensity of Trp emission [101, 102]. Upon 
reduction, no FRET occurs and higher intensity of Trp fluorescence is detected. 
Intrinsic fluorescence is therefore a sensitive reporter for O2 bound to the T3 Cu center 
and, thus, the T3 Cu and T2/T3 Cu-containing enzymes can be used for O2 biosensing 
[93, 103, 104].    
 
1.5 Aims of the thesis 
 
The first aim of this research was to apply a FRET-based approach (FluoRox) to study 
the catalytic mechanism of bNiR from A. xylosoxidans at the single molecule level 
(work in collaboration with Leiden University, Chapter 2). The enzyme mechanism is 
controversial and therefore the single molecule approach was anticipated to provide a 
better understanding of this.  
The second objective was to develop an efficient over-expression system for the 
high-potential fungal laccase Lcc1 from T. versicolor (work in collaboration with 
Utrecht University) and comparison of this enzyme with native Laccase A from               
T. versicolor and low-potential bacterial SLAC from S. coelicolor. Potential application 
of these laccases in development of a laccase-based FluoRox biosensor was investigated 
(Chapter 3).  
The third aim was to explore whether it was possible to modify the cupredoxin-
like domains of bNiR and SLAC, which normally lack a T1 Cu site, to introduce metal-
binding site (Chapter 4). Additionally, owing to the high structural similarity between 
trimeric NiRs and two-domain MCOs, the possibility to transform the T2 Cu site of 
bNiR into a T2/T3 Cu cluster using protein engineering was tested (Chapter 4).  
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CHAPTER 2 
 
Studies on the mechanism of nitrite reductase from Alcaligenes 
xylosoxidans at the single molecule level a 
 
 
 
a Sections of the work presented in this chapter have been published as the following 
articles: 
 
1) Tabares L.C., Kostrz D., Elmalk A., Andreoni A., Dennison C., Aartsma T.J., 
Canters G.W., 2011, Chem. Eur. J., 17, 12015-12019, Fluorescence lifetime analysis of 
nitrite reductase from Alcaligenes xylosoxidans at the single-molecule level reveals the 
enzyme mechanism (also published in 2012 in A. Andreoni’s PhD thesis “Shedding 
light on biological redox processes - single molecule studies of Cu-containing 
oxidoreductases”)  
 
2) Goldsmith R.H., Tabares L.C., Kostrz D., Dennison C., Aartsma T.J., Canters G.W., 
Moerner W.E., 2011, Proc. Natl. Acad. Sci. USA, 108, 17269-17274, Redox cycling 
and kinetic analysis of single molecule of solution-phase nitrite reductase 
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2.1 Introduction 
 
2.1.1 Nitrite reductases in dissimilatory denitrification  
 
Dissimilatory denitrification (Figure 2.1) is a complex, four-step anaerobic process 
analogous to aerobic respiration. In this process protons are transferred from the 
cytoplasm to the periplasm of a cell during reduction of nitrate (NO3−) to dinitrogen 
(N2) to support adenosine triphosphate (ATP) synthesis [1 - 5]. Aerobic respiration is 
more energetically preferred, thus denitrification occurs only in oxygen-deprived 
environment and when sufficient quantities of NO3− are present. Microorganisms 
capable of denitrification are distributed mainly among bacteria, but also archaea [2].  
 
 
 
Figure 2.1 Schematic arrangement of dissimilatory denitrification in Gram-negative 
bacteria adapted from [1]. Nitrate reductase is depicted as NAR; nitrite reductase as 
NiR; nitric oxide reductase as NOR and nitrous oxide reductase as N2OR. AP is a 
postulated nitrate/nitrite antiporter. 
 
The enzymes, nitrate reductase (NAR), nitrite reductase (NiR), nitric oxide 
reductase (NOR) and nitrous oxide reductase (N2OR) are required to facilitate the 
sequential reduction of NO3− to N2. In Gram-negative bacteria, NAR is located at the 
cytoplasmic membrane, with its active site directed towards the cytoplasmic side. The 
product of the two-electron reduction of NO3−, nitrite (NO2−), is transported to the 
periplasm, where it is further reduced to nitric oxide (NO) by the soluble NiR. NOR is a 
membrane-bound protein localized in the cytoplasm that releases its product, nitrous 
oxide (N2O), back into the periplasmic space, where a soluble enzyme, N2OR converts 
it to N2.  
NiR catalyses the one-electron reduction of NO2− to NO (NO2− + e− + 2H+  
NO + H2O) [1, 2]. This reaction is bidirectional and at alkaline pH the catalytic rate of 
the reverse reaction is higher than that of the forward reaction [6]. Two distinct classes 
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of NiR are distinguished, those utilizing heme iron (cd1) as the prosthetic group and 
those containing copper (Cu) ions, the type 1 (T1 Cu) and the type 2 (T2 Cu) [2, 7].              
Copper-containing NiRs (CuNiRs) have been isolated from a number of bacterial 
sources, including Alcaligenes faecalis S-6 (referred herein as “green” NiR, gNiR) [8], 
Alcaligenes cycloclastes [9], Alcaligenes xylosoxidans (referred herein as “blue” NiR, 
bNiR) [10], Pseudomonas aureofaciens [11], Rhodobacter sphaeriodes [12], 
Pseudomonas chlororaphis [13] and Hyphomicrobium denitrificans (HdNiR) [14].   
Majority of CuNiRs are trimeric, with each monomer consisting of two 
cupredoxin-like domains (Chapter 1.3) [15]. These enzymes have been shown to exhibit 
high structural similarity with two-domain laccases (see Chapters 1.3 and 4) [16]. 
Trimeric CuNiRs contain one T1 Cu and one T2 Cu per monomer, and subtle 
differences at a T1 Cu(II) centre result in these proteins being either green or blue 
(Chapter 1.2.1) [17 - 22]. The T1 Cu site plays a crucial role in electron transfer (ET) 
and serves as an initial port of entry of electrons from putative physiological donors 
such as azurin (Az), pseudoazurin (Paz) or cytochrome c551 [8, 23 - 27]. The electrons 
are subsequently transferred to the T2 Cu site, in which NO2− is bound and reduced [28, 
29]. Several models of the complex formed by bNiR and Az have been proposed [27, 
30, 31] but only complexes of gNiR with Paz [32, 33] and bNiR with cytochrome c551 
[34] have been determined.  
 
2.1.2 The CuNiR from Alcaligenes xylosoxidans 
 
bNiR from A. xylosoxidans that is analyzed in this study is a homotrimeric, blue CuNiR. 
Several crystal structures reveal that the T1 Cu site is buried ~ 7 Å beneath the protein 
surface in the first domain of each monomer, with the T2 Cu site located at the interface 
between two monomers [35, 36]. The T1 Cu of bNiR (Figure 2.2.A) is coordinated by 
His89, His139, Cys130 and Met144 in a distorted tetrahedral geometry. The axial 
ligand to the T1 Cu, Met144, shows a degree of flexibility, reflected by two distinct 
conformations [36]. In the resting state, the T2 Cu is coordinated by His94, His129, 
His300 and a H2O or OH− ligand in a tetrahedral geometry (Figure 2.2.A). All three His 
ligands remain in the same orientation on removal of the T2 Cu ion [37]. Within the 
same monomer, the two Cu centers are connected by the 12.6 Å covalent bridge, which 
consists of the T1 Cu-coordinating Cys130 and the T2 Cu-coordinating His129. It has 
been suggested that this covalent bridge provides the ET pathway from the T1 Cu to the 
substrate-binding T2 Cu center [38].  
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A) B)  
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D) 
 
E) 
 
 
Figure 2.2 (A) Structure of the active site of bNiR (pdb file: 1OE1 [36]) including the 
residues involved in the electron and putative proton transfer pathways. His249, His254 
and His300, which are depicted in blue, are from the adjacent monomer. (B) Different 
modes (η2-O,O, η1-O and η1-N) of binding NO2− to Cu ion [42], where M, O and N are 
Cu, oxygen and nitrogen atoms, respectively. Crystal structures of gNiR showing                     
(C) the T2 Cu(II)−NO2− complex (pdb file: 1SJM [39]), (D) the T2 Cu(I)−NO2− 
complex (pdb file: 1AS8 [40]) and (E) the T2 Cu(I)−NO complex (pdb file: 1SNR 
[39]). The T1 and T2 Cus are large red and yellow spheres, respectively. Water 
molecule is small green, while oxygen and nitrogen from NO2− (or NO) are small red 
and blue spheres, respectively. The images were generated using PyMol [41].  
 
Within the active site pocket, a number of residues are considered relevant for 
catalysis of bNiR, in particular Asp92, His249 and Ile251 [40, 43]. Asp92 and His249 
are conserved among CuNiRs and are responsible for holding an H2O/OH− ligand in 
place, positioning NO2− and reaction intermediates, and proton donation during catalytic 
turnover [36, 44]. Ile251 is proposed to help position NO2− within the active site            
[40, 43]. Recently, it has been demonstrated that ET from the T1 Cu to T2 Cu is tightly 
coupled to protons transfer [45 - 48]. Two distinct proton channels, which are conserved 
among CuNiRs have been identified [36, 49 - 51]. One of these connects Asp92 at the 
T2 Cu site to the protein surface via His254, which is proposed to regulate the proton 
flow [50], whilst the second connects Asp92 to the surface via Ala131, Asn90 and 
Asn107 and several molecule waters [49]. Although those channels were identified at 
low (4.6) and high (8.5) pH, respectively, a crystal structure determined at pH 6.5 
shows the presence of both networks [36].  
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2.1.3 Binding modes of NO2− and NO 
 
The geometry of substrate binding to the T2 Cu of CuNiRs was characterized in detail 
by structural studies. A number of gNiR crystal structures in the presence of NO2− show 
large variations in the T2 Cu(II)−NO2− complex [35, 37, 39, 43, 52]. Typically, NO2− is 
bound asymmetrically through both oxygen atoms (bidentate coordination, η2-O,O, 
Figure 2.2.B) with T2 Cu(II)−O1 longer (2.19 to 2.4 Å) than T2 Cu(II)−O2 (1.98 to         
2.2 Å), where O1 of NO2− corresponds to the oxygen atom closest to Asp98 (gNiR 
numbering, Figure 2.2.C) [5, 39, 40, 52]. A wide range of dihedral angles between the 
planes created by the O−N−O and O−Cu−O atoms has also been observed [5, 39, 40, 
52]. A hydrogen bond is found between the O1 of NO2− and the Asp98 side chain, which 
is suggested to be involved in NO2− turnover. His255 and Ile257 (gNiR numbering) do 
not seem to change their conformation upon substrate binding [40, 43]. In the                         
T2 Cu(I)−NO2− complex (Figure 2.2.D), NO2− binds more weakly to the T2 Cu (crystals 
with lower occupancy of NO2− bound to the T2 Cu) but also in asymmetrical way, with 
T2 Cu(I)−O1 and T2 Cu(I)−O2 distances in a range from 2.4 to 2.7 Å and 2.2 to 2.3 Å, 
respectively [5, 40]. The space restrictions imposed by the side chain of Ile257 together 
with hydrogen bonding between NO2− and Asp98 limits the possibility of NO2− binding 
in the T2 Cu(I)−NO2− complex through nitrogen atom (monodentate coordination η1-N, 
Figure 2.2.B). The solvent around Asp98 at the T2 Cu(I)−NO2− appears to be less 
ordered than is found at the T2 Cu(II)−NO2− [40, 50]. Structures of gNiR containing the 
T2 Cu(II)−NO2− show additional (five) solvent molecules in the active site compared to 
gNiR containing T2 Cu(I)−NO2− (two molecules) [40, 50]. Figure 2.2.E shows NO (the 
product of NO2− reduction) bound to the T2 Cu(I) site of gNiR with a side-on geometry 
(Cu−N−O angle of 71°) and almost equal Cu−NNO and Cu−ONO distanced [39, 52]. 
Interactions with the bulky Ile257 and hydrogen bonding between NO and the Asp98 
side chain result in side-on binding of NO within the active site [53].   
Several model compounds of intermediates in the catalytic cycle of CuNiRs 
have been synthesized and extensively studied [3, 5]. Different modes of binding of 
NO2− have been identified for Cu(II)−NO2− including bidentate η2-O,O, and 
monodentate η1-O and η1-N [42, 54 - 58] (Figure 2.2.B). Most of the Cu(I)−NO2− model 
complexes shows η1-N bound nitrite, in disagreement to what is observed in CuNiR 
crystal structures [59 - 61]. In addition, a number of model complexes with unknown 
structures but capable of nitrite reduction have been published [55, 62 - 64]. Despite 
multiple possibilities in the way of binding (end-on linear, end-on bent and side-on) the 
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only structurally characterized Cu(II)−NO model complex [65] contains N-bound,        
end-on bent NO with a Cu−N−O angle of 121° and Cu−NNO length comparable to that 
observed in the Cu(I)−NO CuNiR crystal structure [39]. All structurally characterized 
Cu(I)−NO model complexes show end-on NO with Cu−N−O angles ranging from         
168 to 176° [66 - 68].    
 
2.1.4 Proposed mechanisms for NO2− reduction by CuNiRs  
 
Despite intense studies, the exact order of events of NO2− reduction by CuNiR is still 
under debate [3, 5, 51, 69 - 71]. The dispute over the mechanism revolves around 
whether NO2− binds to the T2 Cu site only after it has received an electron from the         
T1 Cu site (the “reduction first” mechanism) [1, 28, 29, 31, 34, 35], or whether an 
electron is transferred only after binding of the substrate (“substrate-binding first” 
mechanism) [37, 40, 69, 71 - 76]. However, most evidence now favor the theory 
proposed by Wijma et al. [70, 77], that the enzyme operates according to a “random 
sequential” mechanism in which either pathway is possible and the predominant route 
depends on parameters such as pH and NO2− concentration.  
The “reduction first” reaction mechanism (Figure 2.3.A) was proposed by Hulse 
and Averill and resembles the mechanism of cd1 NiRs, in which the T2 Cu(II) is 
reduced to Cu(I) before NO2− binding occurs [1, 78, 79]. NO2− displaces a water 
molecule at the T2 Cu site and a cuprous nitrosyl (Cu(I)−NO+) and its resonance form 
(Cu(II)−NO) are generated via N-bound Cu(I)−NO2− complex. The cycle is completed 
with the release of NO from unstable Cu(II)−NO complex. The observed 10-fold 
tighter binding of NO2− to the reduced rather than the oxidized protein (determined at 
pH 7.5) further supported enzyme reduction preceding the binding of NO2− [80].     
The “substrate-binding first” ordered reaction mechanism (Figure 2.3.B) was 
primarily proposed by Adman and coworkers [37, 40] and favored by groups of Suzuki 
[24, 74], Hasnain [52, 69] and Murphy [76]. The concept of an ordered mechanism has 
been extensively investigated by computational [71, 81], kinetic, spectroscopic, site-
directed mutagenesis and structural studies [36, 44, 69, 72 - 74]. It describes the ET 
from the T1 Cu(I) site to the T2 Cu(II) site, which is triggered by substrate binding to 
the T2 Cu site. NO2− binds to the T2 Cu(II) via its oxygen atoms and forms a             
η2−O,O T2 Cu(II)−NO2− intermediate. Once NO2− is bound, the T2 Cu is reduced to 
form the T2 Cu(I)−NO2− complex, leading to a quick release of NO and formation of 
the T2 Cu(II)−H2O complex. Differently to the “reduction first” mechanism, the η1−N 
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T2 Cu(I)−NO2− intermediate is not formed. It is assumed that the information about 
NO2− binding at the T2 Cu is sent to the T1 Cu site through the so-called substrate 
“sensor loop” (consisting of His89, Asp92 and His94, bNiR numbering), thereby 
triggering ET [36, 44, 50, 69, 73]. Further support for this mechanism is provided by 
combined crystallographic and single-crystal spectroscopic studies, which showed that 
ET could only be detected when NO2− was bound to the T2 Cu site [72]. In contrary, 
pulse radiolysis results at pH 7.0 show that ET occurs without NO2−, with the rate 
sharply decreasing upon substrate binding [82 - 85]. In the presence of NO2−, the pH 
dependence of this ET rates matches that of enzyme activity however, in the absence of 
substrate, the rate is not influenced by pH [79]. 
 
A) B) 
  
C) 
       
 
Figure 2.3 Schemes of catalytic mechanism of CuNiRs proposed by the groups of         
(A) Averill (“reduction first” mechanism) [1], (B) Suzuki and Hasnain (“substrate-
binding first” mechanism) [52, 74] and (C) Canters (“random sequential” mechanism) 
[70]. Figures taken from [5] and [70]. 
 
Activity assays and electrochemical measurements on gNiR suggest that the 
enzyme can operate using both pathways in a “random sequential” mechanism           
(Figure 2.3.C). The velocity of the ET between the T1 Cu and T2 Cu depends on the 
ligand coordinated at the T2 Cu site and decreases in the order: H2O > NO2− > OH− 
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[70]. In addition, it has been shown that the binding of substrate does not effect the 
midpoint potential of the T1 Cu site, thus excluding the cooperativity between the two 
sites during the catalytic cycle that is postulated in the “ordered” mechanism [77]. 
Random sequential mechanism received further support from electrochemical [86] and 
single molecule studies on gNiR [87], and from Scrutton and coworkers [45, 47], who 
postulated the possible existence of two substrate-binding sites or two different 
substrate-binding affinities for bNiR. 
 
2.1.5 Single molecule studies 
  
Biochemical research uses a range of tools, including X-ray crystallography, UV-Vis, 
circular dichroism, electron paramagnetic resonance (EPR), resonance Raman (RR), 
NMR, X-ray absorption, fluorescence spectroscopy and many more to investigate 
structure and function of proteins. These techniques are used for so-called “in bulk” 
investigations, in which the properties of ensemble of molecules is sampled at the same 
time and averaged. Recent advances in single molecule spectroscopy allow for 
manipulation of individual molecules and study their behavior in the course of a 
chemical reaction. The ability to resolve microscopic catalytic states during turnover 
and observe their subsequent conversion provides unique information that is normally 
hidden in ensemble experiments due to averaging. The groups of Xie, Rigler, De 
Schryver, and others have shown that the intensity time traces of single molecules 
contain detailed information about enzyme dynamics by providing novel evidence for 
static and dynamic heterogeneity, and have enabled the observation of transient 
intermediates and the determination of microscopic rate constants for catalytic cycles 
[88 - 92]. 
 Single molecule fluorescence data can be collected using an inverted confocal 
microscope (Figure 2.4.A). Typically, the sample is mounted on a precisely moving 
piezoelectrical scanning (translation) stage that allows for sub-micrometer movements. 
Using this scanning stage, the sample is moved across the confocal volume. Pulsed laser 
light at particular wavelength is reflected on a dichroic mirror and is focused by an 
objective on a glass slide coated with sample. Fluorescence is collected by the same 
objective, transmitted by the dichroic mirror and imaged onto a pinhole oriented in front 
of the detector, e.g. a single-photon avalanche photodiode. To generate fluorescence 
lifetime imaging microscopy (FLIM) images, the signal from the detector is fed into a 
Time-Correlated Single Photon Counting (TCSPC) unit, which allows for the repetitive 
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precisely timed registration of single photons using the excitation pulse as the timing 
reference [93, 94].  
 
A) 
 
B) 
   
 
Figure 2.4 Experimental setups for single molecule measurements using (A) a confocal 
scanning microscope and (B) an anti-Brownian electrokinetic (ABEL) trap [95].          
The insets: schematic overview on (A) an immobilized fluorescently labeled protein and 
(B) microfluidic cell of an ABEL trap with fluorescently labeled protein in the confocal 
beam under turnover conditions. The green and orange paths are an excitation and 
emission beams, respectively. The electron donor in its oxidized and reduced states is 
depicted as Xoxy and Xred, respectively. The reaction substrate and product are depicted 
as S and P, respectively. 
 
Activity measurements of single enzymes require the observation of multiple 
turnovers for several seconds or more. The observation window is several orders of 
magnitude longer than the typical diffusion time of solution-phase molecules through 
confocal volume, and therefore molecules are typically immobilized on a solid support 
(Figure 2.4.A) [88 - 90, 96]. A fundamental problem with this approach is to avoid 
perturbations to the system resulting from protein immobilization. In most cases, 
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measured properties of the freely diffusing and immobilized biomolecules tend to show 
good agreement [88, 90, 97]. However, immobilization is suspected of contributing to 
observed enzyme behavioral heterogeneity [91, 98 - 100]. Recently, an alternative way 
for prolonged solution-phase measurements without protein immobilization but via a 
specialized microfluidic trapping device has been developed [95, 101]. The anti-
Brownian electrokinetic (ABEL) trap (Figure 2.4.B) estimates the position of 
fluorescent molecule in real time using a laser spot revolving in a circular pattern             
(at 40 kHz). This laser spot is phase-locked in an analogue circuit to a feedback force 
that is gated by photon detection and applied via two orthogonal pairs of electrodes to 
cancel Brownian displacements of the molecule. The molecule is therefore held near the 
center of the trap that enables prolonged solution-phase measurements. This ABEL trap 
has been successfully applied in a number of studies, including conformational 
dynamics of single photosynthetic antenna proteins and ATP binding stoichiometry of 
the multi-subunit chaperonin [102]. 
 One of the common methods of determining the oxidation state of cofactor of 
metalloproteins is via its optical absorption spectrum. Recently, a new method for 
sensing the changes in protein absorption spectra, and therefore in the oxidation state of 
cofactor, based on fluorescence by means of Förster Resonance Energy Transfer 
(FRET) have been developed (FluoRox principle, for details see Chapter 1.4.3) [103, 
104]. This approach relies on FRET from a surface-conjugated fluorescent dye (FRET 
donor) to the cofactor of the protein or enzyme (FRET acceptor). In the present work, 
the T1 Cu(II) site of bNiR possesses a strong absorption band at approximately 600 nm 
(see Chapter 1.2.1), which disappears upon reduction [22]. The emission spectrum of a 
surface-conjugated fluorescent dye overlaps with the absorption spectrum of the              
T1 Cu(II) site what results in partial quenching of the label’s fluorescence when the 
protein is in its oxidized state. Therefore, fluctuations in the oxidation state of the T1 Cu 
site during turnover are reflected in changes in fluorescence intensity. It has been shown 
that the occurrence of FRET between the donor and acceptor also influences the 
fluorescence lifetime of the donor. Therefore, both intensity and fluorescence lifetime 
time traces may be used to reveal related information about enzyme kinetics [105 - 
107]. Although lifetime measurements are not sensitive to instrument-derived or photo-
physically induced variations in intensity, the intensity-based technique has the 
advantage that fewer photons are needed to obtain useful data [108]. FluoRox approach 
has been successfully applied in biosensor development [109 - 112] and studies of the 
electrochemical behavior of metalloproteins [86, 113 - 115]. Additionally, this approach 
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was used for single molecule studies on gNiR [87], in which the fluorescence intensity 
distributions in time traces of immobilized single molecules during NO2− turnover were 
analyzed by means of autocorrelation analysis. The approach was based on the pioneer 
single molecule fluorescence spectroscopy studies on cholesterol oxidase [85], but did 
not require an intrinsically fluorescent enzyme. 
 
2.2 Scope of the chapter 
 
The aim of the research described in this chapter is to study the catalytic mechanism of 
bNiR at the single molecule level, using a FRET-based approach. This research deals 
with the development of a new method for data collection and analysis of individual 
fluorescently labeled bNiR molecules using scanning confocal fluorescence microscopy 
combined with FLIM of the sample. M87C bNiR and K329C bNiR, with surface-
exposed Cys residues introduced have been prepared to allow labeling with fluorescent 
dyes and protein immobilization. The Cys variants are characterized and labeled with 
fluorescent ATTO 532 and ATTO 647N maleimide labels. To determine the optimal 
approach for immobilization of labeled enzymes on a glass surface, several methods are 
described. FLIM images are collected from an area of the sample containing 
immobilized enzyme molecules, which is scanned in steps and the fluorescence is 
collected for few milliseconds between the steps. The analysis of FLIM images 
provides the information about the oxidation state of the molecules at each sampling 
point, which is then transformed into information on behavior of a single molecule and 
gives a new insight into the catalytic mechanism of immobilized enzyme. The results 
are compared to those from single molecule solution-phase measurements using the 
ABEL trap.  
 
2.3 Materials and methods 
 
2.3.1 Site-directed mutagenesis 
 
The M87C and K329C variants of bNiR from A. xylosoxidans were created using 
QuickChange mutagenesis (Stratagene) as described in Chapter 5.7.2. The plasmid 
pET22b-bNiR [22] was used as a template along with the following pairs of primers: 
5’–CAACCCGGCCACCAACGCCTGCCCGCACAACGTCGACTTCC–3’ (forward) 
and 5’−GGAAGTCGACGTTGTGCGGGCAGGCGTTGGTGGCCGGGTTG−3’ 
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(reverse), 5’–CTGATGAAGCAGATCTGCGCGCCCGCGCCGATTCC–3’ (forward) 
and 5’–GGAATCGGCGCGGGCGCGCAGATCTGCTTCATCAG−3’ (reverse) for 
M87C bNiR and K329C bNiR, respectively. The sequences of both strands of the 
mutated plasmids (pET22b-bNiRM87C and pET22b-bNiRK329C) were verified. 
 
2.3.2 Over-expression, isolation and purification of wild type, M87C and K329C bNiR 
 
Wild type (WT), M87C and K329C variants were over-expressed in Escherichia coli 
BL21 (DE3), isolated and purified as described in Chapter 5.10.3 [22]. Purity was 
confirmed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE, 
12.5 % gel) and the protein concentrations were determined using an extinction 
coefficient (ε) of 5200 M-1cm-1 at 594 nm [22]. Purified Az from Pseudomonas 
aeruginosa was kindly provided by Prof. C. Dennison. 
 
2.3.3 Determination of proteins’ apparent molecular weight by gel-filtration 
 
The apparent molecular weight (MWapp) of proteins was determined, as described in 
Chapter 5.13.4, using a HiLoad Superdex 200 16/60 (GE Healthcare) gel-filtration 
column in 20 mM tris(hydroxymethyl)aminomethane (Tris) pH 7.5 containing 200 mM 
NaCl [22]. 
 
2.3.4 Determination of proteins’ molecular weight by mass spectrometry 
 
The molecular weight (MW) of proteins was determined as described in Chapter 5.12.1 
by matrix-assisted laser desorption ionization time-of-flight mass spectrometry, 
MALDI-TOF-MS [22]. MALDI-TOF-MS was also performed on a K329C bNiR 
sample that had been incubated with 300 equivalents of tris(2-carboxyethyl)phosphine 
hydrochloride (TCEP) for 1 h at room temperature (RT) prior to measurements. 
 
2.3.5 Activity assay for nitrite reduction by WT, M87C and K329C bNiR 
 
The catalytic activity of WT bNiR and the variants was determined as previously 
described [70]. Measurements were performed in 50 mM phosphate pH 7.0 at 21 °C 
following the rate of oxidation of dithionite-reduced 1,1’-dibenzyl-4,4’-bipyridinium 
dichloride (benzyl viologen, BV). The reaction mixture was prepared in an anaerobic 
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chamber (Belle Technology, [O2] << 2 ppm) in a 3 mL sealed cuvette, and routinely 
contained 200 µM BV, 100 µM dithionite and NaNO2 (7 - 400 µM). The reaction was 
started by the addition of enzyme (1.0 - 3.7 nM final concentration), and the oxidation 
of BV was measured from the absorbance decrease at 603 nm (ε603 = 14500 M-1cm-1), 
with the data corrected for any baseline drift. The kinetic parameters, KM and kcat were 
obtained from fitting of the initial velocities for each substrate concentration to the 
nonlinear Michaelis-Menten equation (Equation 2.1).  
 
€ 
ν0 =
d P[ ]
dt =
νmax S[ ]
KM + S[ ]
= kcat E[ ]
S[ ]
KM + S[ ]
           (Equation 2.1), 
 
where ν0 is the initial velocity of the reaction, νmax is the maximal velocity of the 
reaction, [P] is the product concentration, [S] the substrate concentration, and [E] is 
enzyme concentration. 
 
2.3.6 UV-Vis spectroscopy 
 
UV-Vis spectra were acquired with a Perkin Elmer λ 35 spectrophotometer at RT as 
described in Chapter 5.12.2.  
 
2.3.7 Continuous wave electron paramagnetic resonance spectroscopy  
 
Continuous wave (cw), X-band (9.48 GHz) EPR spectra of oxidized WT, M87C and 
K329C bNiR were acquired at ~ 80 K with a Bruker EMX EPR spectrometer equipped 
with an ESR900 cryostat (Oxford Instruments) as described in Chapter 5.12.5.  
 
2.3.8 Fluorescence spectroscopy 
 
Fluorescence spectra and time course measurements were performed on a Cary Eclipse 
Fluorescence Spectrophotometer (Varian Inc., Agilent Technologies), as described in 
Chapter 5.12.6. ATTO 647N and ATTO 532 labeled proteins were excited at 630 and 
520 nm, respectively, and the emission was measured at 657 and 550 nm, respectively. 
The protein samples were prepared in 50 mM phosphate pH 7.5 at 20 °C. 
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2.3.9 Protein labeling with fluorescent dyes 
 
The proteins were labeled using modified versions of published protocols [105, 106] as 
described in Chapter 5.11. Structure of ATTO 532 label (ATTO-TEC GmbH) is shown 
in Appendix A, whereas structure of ATTO 647N (ATTO-TEC GmbH) is not available. 
WT protein was labeled at the surface-exposed amine groups (including N-terminus), 
whilst K329C bNiR was labeled at the free thiol group of the introduced Cys residue. 
M87C bNiR was labeled either at the free thiol group (for ‘in bulk’ measurements) or at 
the amine groups (for protein immobilization studies). Prior to labeling with ATTO 532 
or ATTO 647N N-hydroxysuccinimide (NHS) ester, WT and M87C bNiR were 
exchanged into 100 mM 4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid (Hepes) 
pH 8.3, and then incubated with 0.25 equivalents of appropriate dye for 30 min at 4 °C. 
Prior to labeling with ATTO 647N maleimide, M87C bNiR was exchanged into            
100 mM phosphate pH 7.5, and then incubated with 0.5 equivalents of a dye for 1 h at     
4 °C in 100 mM phosphate pH 7.5. Prior to labeling, K329C bNiR was incubated for        
2 h at 4 °C with 25-equivalents of TCEP and desalted on a Superdex 200 10/300 GL 
column (GE Healthcare) equilibrated in 20 mM Tris pH 7.5 containing 200 mM NaCl. 
Following this procedure, which removed some of the glutathione bound to Cys329, the 
protein was exchanged into 100 mM phosphate pH 7.5 and incubated with an excess    
(in this case the exact amount of dye used was less important as the labeling ratio was 
dependent upon the amount of glutathione that had been removed from Cys329) of 
ATTO 647N maleimide for 1 h at 4 °C.  
The excess of unlabeled dye was removed by desalting on a PD10 column         
(GE Healthcare) and the labeling ratios (DOL) were determined according to the 
manufacturer’s protocol as described in Chapter 5.11. To observe the activity of only 
one monomer in the trimer a low DOL was maintained of ~ 11 % for the WT and M87C 
bNiR and ~ 13 % for the K329C variant. 
 
2.3.10 ‘In bulk’ fluorescence spectroscopy measurements and determination of the 
fluorescence switching ratios 
 
Labeled proteins were routinely reduced with sodium ascorbate containing phenazine 
ethosulfate (PES) (stock solution of 1 M ascorbate plus 50 µM PES) and oxidized with 
potassium ferricyanide (0.5 M stock solution). Enzyme turnover was studied by 
addition of 250, 500, 1000 and 5000 µM NaNO2.  
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Alternatively, the proteins were reduced with dithionite-reduced Az. Prior to 
reaction, Az was incubated in an anaerobic chamber with 5-equivalents of sodium 
dithionite for 30 min at RT, after which the reductant was removed by ultrafiltration 
(Vivaspin, 3 kDa cut off). The reaction mixture was prepared anaerobically and 
consisted of 145 nM of WT bNiR and the variants (28 - 36 nM of ATTO 647N labeled 
enzyme) in 50 mM phosphate pH 7.5. The reaction was initiated by the addition of          
15 µM of anaerobic dithionite-reduced Az. Enzyme turnover was studied by addition of 
66, 265, 530 and 5300 µM of anaerobic NaNO2. The switching ratio (SR) is defined as 
described in Chapter 5.12.6.  
 
2.3.11 Protein immobilization via 1-11-bis-maleimidotetraethyleneglycol linker on a 
silanised glass slide 
 
ATTO 532 labeled WT and M87C bNiR were immobilized on a surface modified glass 
slide (MENZEL GLÄSER Nr. 1, Gerhard Menzel GmbH) using previously described, 
modified, methods [87]. Prior to protein immobilization, the glass slides were sonicated 
sequentially for 30 min in acetone and 10 % NaOH (twice), and stored in methanol. 
Between the sonication steps the glass slides were rinsed and sonicated for 5 min in 
deionised water. The glass slides were nitrogen-dried and ozone-cleaned (UVP PR-100 
UV-ozone photoreactor) for 1 hour on each side immediately prior to silanisation.           
To generate a hydrophobic layer the glass slides were sonicated for 30 min in a mixture 
of 10 % triethoxysilane (TES) and 0.1 % 3-mercaptopropyl-trimethoxysilane (MPTS) in 
toluene, rinsed with toluene and dried with nitrogen. To generate a hydrophilic surface, 
the glass slides were treated with a mixture of 10 % 3-aminopropyl-trimethoxysilane 
(APTS) and 0.1 % MPTS in toluene.  
N-terminally ATTO 532 labeled M87C bNiR was conjugated via the thiol group 
of Cys87 with the linker 1-11-bis-maleimidotetraethyleneglycol (BM(PEO)3). Prior to 
deposition on a modified glass slide, typically, 50 - 100 pM of the labeled protein was 
incubated with 50-equivalents of the linker in 0.1 M phosphate pH 7.5 for 
approximately 1.5 h on ice. The unbound linker was removed using a Centrispin-10 
size-exclusion chromatography spin column (Princeton Separations, Adelphia). Since 
an excess of linker was used the protein can have two or three linkers attached, and as 
these are bi-functional either dimerization or aggregation can occur. However, the 
protein conjugates were not further purified to separate the various species. The 
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modified protein was deposited on a modified glass slide and incubated overnight at 4 
°C. Any unbound protein was removed with 0.1 M phosphate pH 7.5. 
 
2.3.12 Protein immobilization via biotin/streptavidin interactions on a silanised glass 
slide 
 
ATTO 647N labeled K329C bNiR was immobilized on a surface modified glass slide 
using a previously described, modified, method [116]. Prior to protein immobilization, 
the glass slides were cleaned and modified as described in Section 2.3.11. To generate a 
hydrophilic surface, the glass slides were sonicated with a 10 % APTS in toluene, rinsed 
with toluene and dried with nitrogen. Surface-modified glass slides were incubated 
overnight at 4 °C with NHS ester-modified polyethylene glycol (PEG) polymers              
(10 % methyl-PEG-NHS (MW 2000) and 0.1 % biotin-PEG-NHS (MW 3400), Laysan 
Bio) in 0.1 M sodium bicarbonate pH 8.3. The incubation mixture was washed away 
with deionised water and the glass slides were incubated for 10 min with 0.2 mg/mL 
streptavidin (Pierce) in 0.1 M phosphate pH 7.5. Any unbound streptavidin was washed 
away with 0.1 M phosphate pH 7.5.  
Cys329 ATTO 647N labeled K329C bNiR was conjugated via exposed amine 
groups with an NHS-PEG-biotin linker (conjugation via maleimide-PEG-biotin (MW 
3400) linker was not successful). Prior to deposition on a modified glass slide, the NHS-
PEG-biotin linker was added in excess (50-equivalents) to the labeled protein (300 pM 
in 0.1 M phosphate pH 7.5), followed by incubation for approximately 1.5 h on ice 
before the unbound linker was removed using a Centrispin-10 size-exclusion 
chromatography spin column. Since a biotin group (for reaction with streptavidin) is 
present at one of the ends of the linker, the possibility of proteins aggregating via the 
linker is eliminated. Protein conjugates were not further purified to separate the various 
species that could form. The modified protein was deposited on a modified glass slide 
and incubated for 10 min at RT. Any unbound protein was removed with 0.1 M 
phosphate pH 7.5.        
 
2.3.13 Protein immobilization in a layer of agarose gel 
 
ATTO 647N labeled K329C bNiR was immobilized on a glass slide in high purity 
agarose IV (Sigma) with a gelling point of 36 ± 1.5 °C using a previously described 
procedure [117] with some modifications. Prior to agarose deposition, the glass slides 
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were incubated overnight in 10 % TritonX-100 and sonicated sequentially for 30 min in         
10 % TritonX-100, acetone, 3 M KOH and methanol. Between these sonication steps 
the glass slides were rinsed and sonicated for 5 min in deionised water. Subsequently, 
the glass slides were incubated for 15 min in a 3:1 mixture of hydrochloric acid and 
nitric acid, sonicated for an additional 30 min, extensively rinsed with deionised water 
and spin-dried at 6000 rpm for 25 s. The agarose (1 %) was melted in 0.1 M phosphate          
pH 7.5 and cooled to ~ 50 °C. ATTO 647N labeled K329C bNiR was added to give a 
final concentration of labeled protein of 300 pM. Bovine liver catalase (final 
concentration of 100 µg/mL) was added to the agarose to remove hydrogen peroxide 
that is produced by the slow reaction of reduced NiR with O2 and leads to the 
inactivation of enzyme [118]. ATTO 647N labeled K329C bNiR-containing agarose 
was spin-coated onto a cleaned glass slide at 2000 rpm for 10 s yielding a thin layer of 
gel. The coated glass slide was immediately put into a holder and covered with 1 mL of 
buffer containing 100 µg/mL bovine liver catalase in 0.1 M phosphate pH 7.5 or               
0.1 M ammonium acetate pH 5.0 or 0.1 M sodium borate pH 9.0, as indicated in 
experiment.  
 
2.3.14 Single molecule setup for FLIM measurements  
 
Single molecule fluorescence measurements were performed with a home-built 
scanning confocal microscope with TCSPC capabilities that was built by                         
Dr. Abdulmohsen Elmalk and optimized by Dr. Leandro C. Tabares. Excitation was 
achieved with a pulsed picosecond diode laser (PDL 800-B, PicoQuant GmbH) emitting 
at 639 nm with a 40 MHz repetition rate. The excitation beam was coupled into a 
single-mode fibre, passed through a narrow band clean-up filter (LD01-640/8-25, 
Semrock) and reflected by a dichroic mirror (Z 532/633 M) to a high numerical aperture 
(NA) oil objective (100×oil, NA 1.4, Zeiss) and onto the sample surface. The power 
density at the sample was 0.5-1 kW/cm2. The emitted fluorescence was filtered with an 
emission filter (D 675/50 M) and imaged onto the active area of a single photon 
counting avalanche photodiode (Perkin-Elmer SPCM-AQR-14) using a +4.5 mm 
achromatic lens. Data acquisition was performed using a TimeHarp 200 TCSPC            
PC-board (PicoQuant, GmbH) working in the Time-Tagged Time-Resolved Mode 
(Benda, 2005 311). Samples were mounted onto a Physik Instrumente P-517 
nanopositioner. The control of the equipment and data acquisition was performed using 
a SymPho Time software (PicoQuant, GmbH). 
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2.3.15 Sample preparation for FLIM measurements and data collection 
 
Agarose-immobilized ATTO 647N labeled K329C bNiR was reduced using 10 mM 
sodium ascorbate and 100 nM PES and oxidized using either 1.5 mM potassium 
ferricyanide or 5 mM NaNO2. Enzyme turnover was studied in the presence of 10 mM 
sodium ascorbate, 100 nM PES and NaNO2 (5 µM - 5 mM). Although the diffusion of 
chemicals through the thin agarose layer is very fast, a minimum of 10 minutes was 
allowed for equilibration. A fresh sample was used for each condition and measured for 
no more than one hour before discarding.  
FLIM images were taken by scanning a 15×15 µm area of the immobilized 
sample, with a step size of 75 nm and a dwell time of 4 ms per point. The samples were 
scanned row by row from the top to the bottom and from left to the right. To determine 
the fluorescence lifetimes of the reduced and oxidized states, a decay histogram of the 
photons collected over the whole image was constructed. Deconvolution with the 
instrumental response function (IRF) and a fit to a single and double exponential decay 
was carried out using the SymPhoTime software (PicoQuant GmbH).  
 
2.3.16 FLIM data analysis  
 
To generate the FLIM images the fluorescence decay observed for each pixel was fit to 
a double exponential decay with fluorescence decay times (τ), τ1 and τ2, fixed                     
(τ1 = 1.1 ns and τ2 = 3.7 ns), and using the maximum likelihood algorithm as 
implemented by a SymPhoTime software. Each pixel was false coloured either blue or 
red depending on whether the resulting average lifetime was smaller or larger than            
2.5 ns, respectively. Pixels with signal strength of less than 10 photons were discarded 
to reduce the noise. A minimum of six FLIM images (15×15 µm) from at least two 
independent measurements and containing an average of 50 spots per image were 
analyzed for each condition.  
To obtain the time-averaged degree of oxidation, Pox, for a spot, a circular area 
around the center of the spot with a 15 pixel diameter (1.125 µm) was selected. Pox and 
Pred values were calculated using Equations 2.2 and 2.3, respectively.  
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where, pi,red and pj,blue are the i-th and j-th red and blue pixel, respectively. n and m are 
the total number of blue and red pixels in a single spot, respectively.  
 
The total numbers of spots used for the histograms were: 357, 274, 298, 340 and 
388 for turnover conditions at 5, 50, 500, 1000 and 5000 µM NO2− concentration, and 
308, 289 and 269 in buffer (in the absence of reductant, oxidant and substrate), reduced 
and oxidized conditions, respectively. Pox histograms were fit to a double Gaussian 
distribution except for the completely reduced and oxidized samples that were fit to a 
single Gaussian. Waiting time histograms were constructed as follows. The rows of 
pixels of a 15 pixel diameter spot represent a window with a 4 ms time resolution 
varying in length from 20 to 60 ms (12 - 52 ms for 12 pixel diameter spot). The times 
that the enzyme molecule stayed in the reduced (τon) and the oxidized (τoff) states were 
collected into two histograms and fit to single exponentials allowed exponential time 
constants, τred and τox to be extracted.   
 
2.4 Results 
 
2.4.1 Protein purification and characterization 
 
WT bNiR and the variants were pure, giving apparent single bands on SDS-PAGE gels 
at ~ 35 kDa. The elution volumes of the M87C and K329C bNiR variants (74.0 and 
73.9 ml) on the gel-filtration column correspond to an MWapp of 113.2 and 114.3 kDa 
respectively (Table 2.1), indicative of the proteins being stable trimers in solution, 
which is also the case for WT protein (elution volume of 73.8 ml corresponding to an 
MWapp of 115.2 kDa). MALDI-TOF-MS gives MWs of 36653.3 Da for the monomer of 
WT bNiR (Table 2.1), which is close to the theoretical value (36654.8 Da).                    
The experimental MWs for the M87C and K329C variants are 36638.7 and 36928.0 Da, 
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respectively. The MW of M87C bNiR is within 12.0 Da of the expected value 
(theoretical MW of 36626.7 Da), whilst the MW for K329C bNiR monomer is 298.2 Da 
heavier than the theoretical value (36629.8 Da). This mass difference indicates that a 
small molecule, most likely glutathione (MW = 307.3 Da), attaches to the mutated 
protein via the introduced Cys residue during over-expression in the cytosol of E. coli. 
Consistent with this, K329C bNiR reduced with TCEP gives an MW of 36618.4 Da, 
which is within 11.4 Da of the expected value. 
The UV-Vis spectra of WT bNiR and the M87C and K329C variants (Figure 
2.5.A) are very similar and are dominated by an intense S(Cys)π→Cu(II) dx2−y2 ligand 
to metal charge transfer (LMCT) transition band from the T1 Cu(II) site at 594 nm [22], 
which is absent in the reduced form. The relative absorbance at 280 and 594 nm 
(A280/A594 ratio) of WT bNiR and the variants is ~ 11 for the fully oxidized forms 
(Table 2.2). Contribution of the T2 Cu site to the absorption spectra in the visible region 
is negligible [119]. Differently to bNiR, gNiR, which was previously studied at the 
single molecule level, exhibits much weaker LMCT absorption band at ~ 600 nm, but 
more pronounced at ~ 460 nm, responsible for green colour of the protein (Figure 
2.5.B). The EPR spectra of WT bNiR and the M87C and K329C variants are 
comparable (Figure 2.5.C and Table 2.2), indicating that the structures of the T1 Cu and 
the T2 Cu sites in the Cys variants are very similar to those in WT protein. Removal of 
glutathione from K329C bNiR did not influence the spectral properties of the variant 
(data not shown).  
The kinetic parameters of NO2− reduction by WT bNiR and the M87C and 
K329C variants were determined in 50 mM phosphate pH 7.0 with dithionite-reduced 
BV as an electron donor (Figure 2.5.D), and the values are listed in Table 2.2.                   
An obtained KM of 32 µM and kcat of 378 s-1 of WT bNiR are in good agreement with 
previously published results for native bNiR [74]. The affinities (KM) towards NO2− of 
M87C and K329C variants are comparable to that of WT bNiR, but kcat value of M87C 
bNiR (kcat of 279 s-1) is significantly lower to those of WT and K329C bNiR (kcat of     
373 s-1).   
 
2.4.2 Protein fluorescent labeling 
 
The emission spectra of ATTO 647N and ATTO 532 show significant overlap with the 
LMCT absorption band at 594 nm of the T1 Cu(II) site of WT bNiR and the variants. 
Therefore, the fluorescence intensity of the label attached to the protein’s surface is 
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partially quenched as a result of a FRET process from the fluorescent donor to the          
T1 Cu(II) site, which acts as an acceptor. The FLIM measurements were performed 
using the ATTO 647N label, as a compromise for several considerations. On one hand, 
too small spectral overlap lowers the SR, thus the contrast between the oxidized and 
reduced state’s intensities and lifetimes is reduced. However, a large spectral overlap 
between the emission band of this label and the absorption band of the T1 Cu(II) site 
(resulting in a high quenching efficiency) hampers the intensity and lifetime 
determination in the oxidized state due to the lack of photons. 
The maleimide active groups of fluorescent dyes allow more specific (in terms 
of dye positioning) labeling to a surface exposed thiol group (provided by a Cys 
residue), compared to that of NHS active groups, which react with the surface-exposed 
amine groups [104, 120]. Previous single molecule studies on the catalytic mechanism 
of CuNiR were performed using the amine group-labeled ATTO 655 L93C gNiR, 
whilst engineered Cys93 was used for protein immobilization [87]. This engineered 
Cys93 corresponds to Met87 in bNiR and the distances between Met87 and the T1 Cu 
sites within the trimer are 8, 45 and 47 Å, all estimated from the crystal structure           
(pdb file: 1OE1, [36]). The corresponding distances in the second variant, K329C bNiR, 
between Cys329 and the T1 Cu sites are 18, 54 and 58 Å.  
The amine group-labeled ATTO 647N WT bNiR shows almost 2-fold higher SR 
than amine group-labeled ATTO 655 L93C gNiR (0.84 and 0.49 [87], respectively, 
Figure 2.6.A, i). The SR of Cys329-labeled ATTO 647N K329C bNiR (Figure 2.6.A, ii) 
is very similar to that of ATTO 647N labeled WT bNiR (0.86 and 0.84, respectively) 
but lower than that of Cys87-labeled ATTO 647N M87C bNiR (0.95, data not shown). 
The SR is higher, probably due to the shorter distance between the label and the T1 Cu 
site in the monomer of M87C bNiR (~ 8 Å). When dithionite-reduced Az is used as 
electron donor, the SRs are lower than those obtained with an artificial electron donor 
(ascorbate/PES mixture). The SRs of ATTO 647N labeled WT bNiR (Figure 2.6.B, i) 
and ATTO 647N labeled K329C bNiR (Figure 2.6.B, ii) are almost identical (0.71 and 
0.70, respectively), whilst the SR of ATTO 647N labeled M87C bNiR is very low (0.12, 
data not shown), indicative of labeled protein not being reduced with a protein electron 
donor, such as Az.  
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2.4.3 Strategies for immobilization of labeled proteins 
 
The schematic overview of the different strategies used for immobilization of labeled 
WT bNiR and the variants is shown in Figure 2.7, whilst the fluorescence images from 
confocal microscope are shown in Figure 2.8. Initially, ATTO 532 labeled M87C bNiR 
was immobilized via a homo bis-functional linker on both hydrophilic (APTS/MPTS 
coated) and hydrophobic (TES/MPTS-coated) glass slides (Figure 2.7.A) using the 
modified protocol optimized for ATTO 655 L93C gNiR [87]. In the absence of a linker 
the labeled protein was found to react non-specifically with the hydrophobic             
(Figure 2.8.A, i, upper panel) but not with the hydrophilic surface (Figure 2.8.A, ii, 
upper panel). This surface-protein interaction was also observed using tapping mode 
atomic force microscopy (AFM). Distinct AFM features resembling aggregates were 
observed, also when ATTO 532 labeled M87C bNiR was immobilized via linker on the 
hydrophilic glass slide (data not shown, measurements performed by Dr. Razvan Stan, 
Leiden University).     
To prevent non-specific protein interactions, the hydrophilic glass slide was 
coated with an additional layer of a PEG-based blunt linker. ATTO 647N labeled 
K329C bNiR was immobilized on the hydrophilic, PEG-coated glass surface via 
biotin/streptavidin interactions using an NHS-PEG-biotin linker to the protein’s surface 
exposed amine groups (Figure 2.7.B). Additionally, the high affinity of the 
biotin/streptavidin interaction increases the efficiency of the immobilization process. 
Although the labeled protein could be successfully immobilized (Figure 2.8.B, bottom 
panel), the results were less reliable as the streptavidin that was used for the 
experiments was either fluorescent or contaminated (Figure 2.8.B, upper panel).   
ATTO 647N labeled K329C bNiR was successfully trapped in a high purity, 
low-gelling point, 1 % agarose gel (Figure 2.7.C). This method of immobilization is the 
least intrusive, but the protein has to be stable at elevated temperatures, higher than the 
gelling point of agarose. The melting temperature (Tm) of CuNiRs is ~ 100 °C [121] and 
ATTO 647N labeled K329 bNiR was found equally active before and after incubation 
for 10 min at 50 °C (data not shown). The immobilization procedure is simple, resulting 
in high-quality images (Figure 2.8.C). The molecules of ATTO 647N labeled K329C 
bNiR are not mobile within the agarose gel and the diffusion of chemicals does not 
seem to be restricted.  
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2.4.4 Single molecule lifetime imaging of ATTO 647N labeled K329C bNiR 
 
FLIM images of agarose-trapped single molecules of ATTO 647N labeled K329C bNiR 
were recorded at pH 7.5 in buffer (fresh sample without reductant or oxidant present), 
under oxidizing (in the presence of 5 mM NO2−), reducing (in the presence of ascorbate 
and PES), and turnover (in the presence of five different concentration of NO2−, varying 
from 5 µM to 5 mM) conditions. Figure 2.9 shows a 15×15 µm area of a glass slide with 
ATTO 647N labeled K329C bNiR (300 pM) immobilized in an agarose gel as observed 
under a fluorescence microscope at RT. The size of the spots is slightly larger                    
(≈ 600 nm, full width at half maximum, FWHM) than the diffraction limit                           
(≈ 300 nm FWHM). Bleaching was occasionally observed, which appears to happen as 
a single step event, in which intensity is reduced to background level, meaning that each 
spot corresponds to a singly labeled K329C bNiR molecule. The fluorescence 
intensities and lifetimes could be correlated for individual ATTO 647N K329C bNiR 
molecules for prolonged periods of time (Figure 2.10). The correlograms indicate that 
either the fluorescence intensity (number of photons per ms) or lifetime (ns) can be used 
to distinguish between the reduced and oxidized states when using thresholds (yellow 
dashed line in Figure 2.10) of 15 photons per ms for the intensity and 2.5 ns for the 
lifetime.  
 Figure 2.11 shows examples of fluorescence decay curves obtained by creating 
histograms of all the photon arrival times collected during a 15×15 µm image scan 
(such as Figure 2.9.B) together with the histograms of pixel-averaged lifetimes 
observed for the ensemble of pixels in the same area. The fluorescence decay of 
oxidized and reduced ATTO 647N labeled K329C bNiR averaged to τ1 = 1.1 ± 0.1 ns 
and τ2 = 3.7 ± 0.1 ns, respectively, whilst these values obtained from the Gaussian 
distribution fit of the histograms of pixel-averaged lifetimes per pixel amount to 1.5 ns 
and 3.7 ns, respectively. For ATTO 647N labeled K329C bNiR under turnover 
conditions a sum of two exponentials (or two Gaussians) was needed to obtain                   
a satisfactory fit, which demonstrates that the sample contained a mixture of reduced 
and oxidized enzyme molecules. The SR calculated from the decay times corresponds to 
a FRET efficiency of 0.70 ± 0.01, which is in a good agreement with the “in bulk” value 
of 0.86 (Figure 2.6).  
Figures 2.9.C and 2.12 show FLIM images of a 15×15 µm scanned area in 
which the fluorescence decay observed for each pixel was fit to a double exponential 
decay with fixed τ1 of 1.1 ns and τ2 of 3.7 ns, and falsely coloured in red and blue. 
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Pixels for which the observed lifetime is longer than 2.5 ns (red) are assigned to the 
reduced state of the T1 Cu site, whilst pixels for which the observed lifetime is shorter 
than 2.5 ns (blue) are assigned to the oxidized state. Under reducing (inset, Figure 
2.12.A, i) and oxidizing (inset, Figure 2.12.A, iii) conditions, the enzyme molecules are 
overwhelmingly in the reduced and oxidized state, respectively. Under turnover 
conditions (inset, Figure 2.12.A, ii) the spots consist of a mixture of red and blue pixels, 
which clearly indicates that the oxidation state of the T1 Cu site of ATTO 647N labeled 
K329C bNiR alternates over time between the reduced and oxidized states during 
scanning of a particular spot.  
Changing the threshold for the observed fluorescence lifetime from 2.5 to 2.3 or 
2.7 ns modified the assignment of oxidized and reduced pixels in less than 10 % of 
cases. To address the possibility of under-estimation of pixels, in which the T1 Cu site 
is oxidized, the background intensity level was compared to the number of photons 
across randomly selected spots (Figure 2.12.B). A threshold of 10 photons per pixel, 
which was used for the analysis, provides good discrimination between the background 
and signal, even at the edges of the spot.  
 
2.4.5 Time-averaged degree of oxidation of ATTO 647N labeled K329C bNiR  
 
The histograms of the time-averaged degree of oxidation of single spots, Pox (which 
describes the fraction of time that a single molecule is in the oxidized form during the 
scan of a single spot), for few hundreds spots at pH 7.5 as a function of NO2− 
concentration are shown in Figure 2.13. Under reducing and oxidizing conditions 
(Figure 2.13.A; ii, viii) the distribution centers at Pox values close to 0 and 1, 
respectively, whilst without reductant or oxidant present (Figure 2.13.A; i), two 
concomitant distributions are observed, one centered close to 0 and second close to 1. 
Under turnover conditions (Figure 2.13.A; iii - vii) a much broader distribution of Pox 
values is observed and can be fit to two populations: one (labeled A) remains centered 
close to Pox = 0, and the other (labeled B) progressively moves towards larger values of 
Pox as the concentration of substrate (NO2−) increases (Figure 2.13.A and B). The width 
of the distributions, particularly for population B, increases considerably as the NO2− 
concentration increases. At the same time, the fraction of molecules in population A 
decreases with respect to population B (Figure 2.13.C). The weighted mean of Pox 
values of the populations A and B for the different turnover conditions match the degree 
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of oxidation encountered for “in bulk” measurements under the same conditions    
(Figure 2.14). 
Preliminary experiments show that ATTO 647N labeled K329C bNiR molecules 
belong either to the population A or B (Figure 2.15), with the transitions between the 
two populations occurring, but at a relatively infrequent rate. Additionally, experiments 
carried out at low (5.0) and high (9.0) pH showed that the population distribution for 
samples measured under turnover conditions are significantly affected by pH             
(Figure 2.16). At higher pH, the distribution centers close to 0 indicating that population 
A is more dominant than B and most of the molecules are in the reduced state. 
Population B increases at the expense of population A on moving towards lower pH.  
 
2.4.6 Time-dependent behavior of ATTO 647N labeled K329C bNiR  
 
To obtain information about the time-dependent behavior of single molecules, the 
waiting time distributions of the populations A and B were extracted. The schematic 
overview of histogram creation and data analysis is shown in Figure 2.17, whilst the 
histograms are shown in Figure 2.18. A 4 ms-binned (“ON”/”OFF”) time trace was 
created from each spot of population A and B of ATTO 647N labeled K329C bNiR 
(Figure 2.17.D). The occurrences of dwell times in the upper, τon (T1 Cu reduced), and 
in the lower, τoff (T1 Cu oxidized), state were plotted and these waiting times 
histograms (Figures 2.17.E and 2.18) were fit to single exponential decays. Obtained 
τred and τox lifetime values for the reduced and oxidized states of the enzyme, 
respectively, are summarized in Figure 2.19. During turnover, molecules in population 
A stay in the reduced state for approximately 20 to 30 ms, whereas for molecules in 
population B this period is approximately 10 ms (Figure 2.19, circles). The time that 
molecules from population A and B stay in the oxidized state amounts to a few ms 
(Figure 2.19, triangles). In buffer, in which a mixture of oxidized and reduced 
molecules are present and some switching of the T1 Cu site can be observed due to 
internal ET between the T1 and T2 Cu sites, the molecules in population A spend a 
longer time in the reduced form, whereas the opposite happens for population B (Figure 
2.19).  
The effect of the dwell time per pixels and time resolution on the accuracy in 
which τred and τox can be determined was analyzed using a series of simulated 
“ON”/”OFF” time traces (for more information see Appendix B). The biggest deviation 
of the experimental τred from the theoretical τred is seen only when the latter is much 
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shorter then the dwell time per pixel (“bin size”, 1 or 4 ms) or much larger than the time 
windows used for the analysis (typically 20 - 60 ms). Additionally, the effect of the spot 
shape on the waiting time results was investigated using different shapes for the 
selected area of the same spot (Appendix B). Analysis of the whole spot, a rectangular 
area (5×15 pixels) or a square (7×7 pixels) produced similar trends in τred and τox.            
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MW, Da 
Protein Theoretical 
mass a, b 
Experimental 
mass b 
Δ MWtheo-exp, 
Da 
Ve, 
mL 
MWapp, 
kDa c 
WT bNiR 36654.8 36653.3 1.5 73.8  115.2 
M87C bNiR 36626.7 36638.7 12.0 74.0 113.2 
K329C bNiR 36629.8 
36928.0, 
 36618.4 d   
298.2 
11.4 
73.9  114.3 
a MW including the N-terminal Met residue. b MW corresponds to the monomeric form 
of the protein. c MWapp corresponds to the trimeric form of the protein. d The 
experimental MWs correspond to the K329C bNiR reduced with TCEP.  
 
Table 2.1 MALDI-TOF-MS the gel-filtration data for WT, M87C and K329C bNiR. 
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Protein 
Properties 
WT bNiR M87C bNiR K329C bNiR 
 UV-Vis a 
λ1,max, nm ~ 470 ~ 470 ~ 470 
λ2,max, nm 594 594 594 
εmax (1), M-1cm-1 1040 b 1040 1040  
εmax (2), M-1cm-1 5200 b 5200 5200 
A280/Amax(2) ~ 11 ~ 11 ~ 11 
 T1 Cu (T2 Cu) EPR parameters c 
gx  2.038 (2.017) 2.038 (2.017) 2.038 (2.017) 
gy  2.058 (2.122) 2.058 (2.119) 2.058 (2.122) 
gz  2.221 (2.372) 2.221 (2.359) 2.221 (2.359) 
Az, 10-4 cm-1 10.3 (0) 10.3 (0) 10.3 (0) 
Az, 10-4 cm-1 8.3 (0) 8.3 (0) 8.3 (0) 
Az, 10-4 cm-1 66 (110) 66 (110) 66 (110) 
 ATTO 647N labeled WT, M87C and K329C bNiR d 
SR, with 
ascorbate/PES 
0.84 0.95 0.86 
SR, with dithionite 
reduced Az 
0.71 0.12 0.71 
 Activity with NaNO2 e 
KM, µM 32 ± 1 30 ± 4 36 ± 1 
kcat, s-1 387 ± 2 279 ± 8 373 ± 1 
kcat/KM, s-1µM-1 12.1 ± 0.3 9.3 ± 0.9 10.4 ± 0.3 
a In 20 mM MES pH 6.0 at RT.  b Taken from [22]. c In 24 mM Tris pH 7.5 plus 40 % 
glycerol at ~ 80 K.  d In 50 mM phosphate pH 7.0 at 20 °C. e In 50 mM phosphate           
pH 7.0 at 21 °C with 200 µM dithionite-reduced BV as electron donor.   
 
Table 2.2 Comparison of spectral properties of WT, M87C and K329C bNiR and 
kinetic parameters for NO2− reduction.  
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A) B) 
  
C) D) 
 
 
 
Figure 2.5 (A) Absorption spectra of oxidized WT ( ), M87C ( ) and K329C           
( ) bNiR and reduced WT bNiR ( ) in 20 mM MES pH 6.0 at RT. The optical 
spectra of the species coincide. (B) Absorption spectra of oxidized WT bNiR ( ) and 
WT gNiR ( ) with the emission spectrum of ATTO 647N dye ( ). (C) EPR 
spectra of oxidized WT ( ), M87C ( ) and K329C ( ) bNiR in 24 mM Tris       
pH 7.6 (40 % glycerol) at ~ 80 K. (D) The Michaelis-Menten plots of WT (), M87C 
() and K329C () bNiR (each of 1.0 nM final concentration) activity with NaNO2 
using an artificial electron donor (BV) in 50 mM phosphate pH 7.0 at 21 °C.  
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A) 
 
B)  
  
 
Figure 2.6 Fluorescence intensity changes of ATTO 647N labeled WT (i) and K329C 
bNiR (ii) reduced with (A) an excess of sodium ascorbate with PES and (B) 15 µM 
dithionite-reduced Az. (A) The concentrations of labeled enzymes are (i) 31 nM and    
(ii) 48 nM, and (i) 30 nM and (ii) 28 nM for (A) and (B), respectively. The addition of 
reductant, oxidant (potassium ferricyanide) and NaNO2 (1: 66 µM, 2: 265 µM and            
3: 5300 µM) is indicated with red, blue and black arrows, respectively.                           
The fluorescence intensity was followed at 657 nm using an excitation wavelength of 
630 nm ( ). ATTO 647N bleaching-corrected experimental traces ( ) in (A) were 
obtained by constructing the exponential bleaching curves ( ) that run through the 
experimental points at 21, 41 and 58 min (i), and 18, 36 and 54 min (ii). In the similar 
way the low intensity parts of experimental traces were corrected for bleaching.  
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A) B) 
  
              C) 
 
Legend: 
 
 
Figure 2.7 Protein immobilization schemes. (A) Covalent immobilization via a bis-
functional linker on a TES/MPTS or an APTS/MPTS-coated glass slide. (B) Affinity-
based immobilization on an APTS/streptavidin-coated glass slide via biotin/streptavidin 
interactions. (C) Trapping of molecules in a spin-coated agarose gel on a glass slide.
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A) Covalent immobilization B) Affinity-based immobilization C) Trapping in agarose gel 
i) TES/MPTS coating ii) APTS/MPTS coating APTS/streptavidin coating  
    
 
 
Figure 2.8 (A) Fluorescence intensity images (10×10 µm) of ATTO 532 labeled M87C bNiR immobilized on a silanized glass slide on (i) a 
TES/MPTS-coated and (ii) an APTS/MPTS-coated glass slides without (top) and with a bis-functional BM(PEO)3 linker (bottom). (B) Fluorescence 
intensity images (20×20 µm) of an APTS/streptavidin-coated glass slides without (top) and with ATTO 647N labeled K329C bNiR with an                    
NHS-PEG-biotin linker (bottom). (C) Fluorescence intensity images (15×15 µm) of 1 % agarose IV gel with (bottom) and without (top) ATTO 647N 
labeled K329C bNiR. All images: pixel size: 75-100 nm; dwell time per pixel: 4 ms. 
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A) B) C) 
 
 
Figure 2.9 (A) Fluorescence intensity, (B) fluorescence average lifetime (so-called fast 
FLIM) and (C) false coloured lifetime confocal images (15×15 µm) after a double 
exponential fit of ATTO 647N labeled K329C bNiR molecules immobilized in agarose 
gel on a glass surface. The brightness in (A) reflects fluorescence intensity while the 
colour in (B) indicates the mean arrival times of fluorescence photons after the 
excitation laser pulse as a measure for the average lifetime, as implemented by 
SymPhoTime. The intensity range in (A) and colour scale range in (B) are from the 
minimum to maximum values. Lifetime images in (C) were generated by fitting the 
fluorescence decay observed for each pixel to a double exponential decay with fixed τ1 
= 1.1 ns and τ2 = 3.7 ns, and using the maximum likelihood algorithm as implemented 
by SymPhoTime as described in Sections 2.3.15 and 2.3.16. Each pixel was false 
coloured either blue or red depending on whether the resulting average lifetime was 
smaller or larger than 2.5 ns, respectively. The surface was scanned from top to the 
bottom and from left to the right with a resolution of 75 nm per pixel and dwell time of 
4 ms per pixel. Each spot corresponds to a single ATTO 647N labeled K329C bNiR 
molecule. 
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Figure 2.10 Correlograms linking the fluorescence intensity and fluorescence lifetime 
observed when monitoring individual ATTO 647N labeled K329C bNiR molecules in 
agarose gel for prolonged periods varying from 0.5 s to a few seconds. The examples 
displayed in the panels are from the 4 ms-binned time traces of individual molecules 
under (A) oxidizing (Pox = 1.0), (B) reducing (Pox = 0.02) and turnover, (C) Pox = 0.15 
and (D) Pox = 0.7, conditions. The colour is indicative of the frequency of events 
occurring in the correlogram, with a colour change from green to red corresponding to 
an increase in occurrence. Yellow dashed lines depict the threshold of 15 photons per 
ms for the fluorescence intensity and 2.5 ns for the lifetime (Result from Dr. Leandro C. 
Tabares).  
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A) B) 
  
 
Figure 2.11 Fluorescence decay curves and lifetimes for ATTO 647N labeled K329C 
bNiR immobilized in agarose gel. Data correspond to an area (15×15 µm) containing 
around 40 spots. (A) Histograms of photon arrival times () for all the photons acquired 
during a full image scan in the presence of: (i) 10 mM ascorbate and 100 nM PES 
(reduced, τ = 3.7 ns); (ii) 10 mM ascorbate, 100 nM PES and 500 µM NaNO2 (turnover, 
τ1 = 1.1 ns, a1 = 16 %, τ2 = 3.7 ns, a2 = 84 %); and (iii) 5 mM NaNO2 (oxidized,                 
τ = 1.1 ns). The gray lines represent IRF whilst the black lines represent the fits to the 
single (i and iii) and double (ii) exponential decays. Total number of detected photons 
after background correction: (i) 389254; (ii) 168705; (iii) 71725. (B) Histogram of 
fluorescence lifetimes per pixel (i.e. the frequency of photon counts corresponding to 
the individual mean lifetimes) in the presence of: (i) 10 mM ascorbate and 100 nM PES 
(reduced, τ = 3.7 ns); (ii) 10 mM ascorbate, 100 nM PES and 500 µM NaNO2 (turnover, 
τ1 = 1.2 ns, a1 = 20 %, τ2 = 3.7 ns, a2 = 80 %); and (iii) 5 mM NaNO2 (oxidized, τ =       
1.5 ns). Black lines represent the fits to a single (i and iii) and double (ii) Gaussian 
distributions.  
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        i) Reduced  ii) Turnover  iii) Oxidized A) 
   
B) 
  
 
Figure 2.12 (A) FLIM images (15×15 µm, coloured as in Figure 2.9.C) of ATTO 647N 
labeled K329C bNiR immobilized in agarose gel in the presence of (i) 10 mM ascorbate 
and 100 nM PES, (ii) 10 mM ascorbate, 100 nM PES and 500 µM NaNO2, and               
(iii) 5 mM NaNO2; pixel size 75 nm, dwell time per pixel 4 ms. Fluorescence lifetimes:        
> 2.5 ns, < 2.5 ns. The insets: amplifications of the selected spots are shown for each 
FLIM image. For clarity and ease of comparison, brightness of the images was set from 
0 to 20 counts per pixel, thus pixels with a signal stronger than 20 counts have been 
given the same (maximum) brightness. (B) Cross-section of the four randomly selected 
oxidized (i) and reduced (ii) spots from a FLIM image. The dotted lines indicate the 
threshold of 10 photons that was used as a cut-off for the analysis described in the main 
text. The coloured areas indicate the parts of the cross-sections that fall below the 
threshold or outside the 15 pixel diameter circle used for the spots selection. 
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A) 
 
C) 
 
 
Figure 2.13 (A) Histograms of Pox values for ATTO 647N labeled K329C bNiR 
immobilized in agarose gel: (i) in buffer (pH 7.5) with no reductant and oxidant present; 
(ii) under reducing conditions with 10 mM ascorbate and 100 nM PES; (iii) - (vii) 
turnover conditions with 10 mM ascorbate and 100 nM PES and varying amounts of 
NaNO2: (iii) 5 µM, (iv) 50 µM, (v) 500 µM, (vi) 1 mM and (vii) 5 mM; (viii) under 
oxidizing conditions with 5 mM NaNO2. The histograms in (ii) and (viii) were fit to a 
single Gaussian ( ). For panel (i), the left and right distributions in the histogram 
were fit separately to a single Gaussian ( ). In the panels (iii) - (vii), the fits ( ) 
are the sum of two Gaussian distributions ( ). (B) Centers of the Gaussian 
distributions for populations A ( ) and B () as a function of NaNO2 concentration 
during turnover. The values for completely reduced ( ) and oxidized ( ) enzyme are 
also shown. (C) Ratio between the number of molecules in populations A and B during 
turnover as a function of NaNO2 concentration. 
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A) B) 
 
 
 
Figure 2.14 A) Normalized “in bulk” fluorescence intensity time trace of ATTO 647N 
labeled K329C bNiR, corrected for bleaching. Arrows indicate the addition of reductant 
(red arrow; 10 mM ascorbate and 100 nM PES), NaNO2 (dashed, black arrows;                
1: 250 µM, 2: 500 µM, 3: 1000 µM, 4: 5000 µM, final concentrations) and oxidant (blue 
arrow; 20 mM K3[Fe(CN)6]). B) Comparison of the mean Pox values for population        
A ( ), B ( ) and A + B ( ) with the “in bulk” ( ) percentage of oxidation 
calculated from (A).  
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Figure 2.15 FLIM images (15×15 µm, pixel size 75 nm, dwell time per pixel 4 ms, 
coloured as in Figure 2.9.C) of ATTO 647N labeled K329C bNiR immobilized in 
agarose gel showing the switch between populations in the presence of 10 mM 
ascorbate, 100 nM PES and 500 µM NaNO2 in 100 mM phosphate pH 7.5. 
Fluorescence lifetimes: > 2.5 ns, < 2.5 ns. The two images were taken of the same 
area 10 min apart (image on the left is the first one). The green grid was added to help 
to compare the position of molecules. The molecule marked as 1 switches from 
population A to B while the opposite happens for molecule 2. A few molecules 
disappear when comparing the two images due to dye bleaching. In the left image a 
single step photo bleaching can be observed for molecule 3. (Results from Dr. Leandro 
C. Tabares)   
 
       
 
Figure 2.16 Histograms of Pox values of ATTO 647N labeled K329C bNiR 
immobilized in agarose gel at (A) pH 5.0, (B) pH 7.5 and (C) pH 9.0 under turnover 
conditions: 10 mM ascorbate, 100 nM PES and 500 µM NaNO2. The samples were 
measured in 100 mM ammonium acetate pH 5.0, 100 mM phosphate pH 7.5 and           
100 mM sodium borate pH 9.0. (Results from Dr. Leandro C. Tabares).  
A) 
B) 
C) 
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Figure 2.17 Analysis of the time dependent behavior of a single enzyme molecule 
represented as a spot with a diameter of 15 pixels. (A) The 75×75 nm pixels of the 
image are scanned sequentially from top to bottom row by row, left to right, with a 
dwell time of 4 ms per pixel. (B) A pixel is assigned a value of 0 or 1 depending on 
whether the fluorescence lifetime is shorter () or longer () than 2.5 ns, respectively. 
The values are collected in a table (C) and pixels below the set threshold were omitted. 
The pixel values were then plotted on a time axis (D), from which the occurrence of the 
“ON” and “OFF” waiting times (τon and τoff) was plotted (E).   
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Figure 2.18 Histograms of the “ON” times, τon (A) and (C), and “OFF” times, τoff (B) 
and (D), for the molecules from population A (A) and (B), and B (C) and (D). To limit 
cross contamination between the populations, for each condition, the crossing point of 
the Gaussian fit was determined (Pc) and populations A and B were defined as the 
collections of spots with Pox ≤ Pc – 0.025 and Pox ≥ Pc + 0.025, respectively.                   
All histograms are fit to a single exponential function ( ). 
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A)           Population A B)            Population B 
 
 
 
 
 
Figure 2.19 Lifetimes in the reduced (τred, ) and the oxidized (τox, ) states for (A) 
population A and (B) population B as determined from the single exponential fits of the 
histograms of waiting times (see Figure 2.18). Error bars represent the standard error of 
the fit (in cases where the error bars are not shown, the standard error is smaller than the 
symbol size).   
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2.5 Discussion 
 
2.5.1 Fluorescent labeling and “in-bulk” studies of bNiR 
 
The UV-Vis and EPR spectra of WT, M87C and K329C bNiR are very similar and 
therefore M87C and K329C mutations have little effect on the structure of the T1 or the 
T2 Cu sites of the enzyme. However, at pH 7.0, the activity of the M87C variant using 
BV as an artificial electron donor is lower than that of WT protein and the K329C 
variant. Additionally, Cys87-labeled ATTO 647N M87C bNiR could not be reduced 
with dithionite-reduced Az (data not shown), what is in agreement with previous 
findings that Met87 is involved in formation of the bNiR-Az complex [31]. Independent 
of the nature of electron donor, the K329C mutation has a limited effect on enzyme 
activity (Figure 2.5.D and Figure 2.6.B).  
The contrast between reduced and oxidized states of the T1 Cu site of bNiR, 
which is reflected in SR values of fluorescence intensity and lifetime, is greater than that 
of labeled gNiR. K329C bNiR variant was chosen over M87C bNiR for studies on the 
mechanism of bNiR at the single molecule level, owing to the lower activity in NO2− 
reduction of the latter variant. The distance between the introduced Cys and the T1 Cu 
site within the monomer of K329C bNiR gave the optimal FRET and limited the 
concomitant detection of redox changes at the two other T1 Cu sites of the trimer.         
The SR values derived from fluorescence decay times for immobilized ATTO 647N 
labeled K329C bNiR (0.70), is in reasonable agreement with fluorescence intensity 
switching ratios observed for ABEL-trapped molecules (0.77) [122] and “in-bulk” 
measurements (0.86).    
 
2.5.2 Single molecule measurements of ATTO 647N labeled K329C bNiR 
 
The novel method of analyzing FLIM images of immobilized ATTO 647N labeled 
K329C bNiR revealed the existence of two populations (depicted as A and B,             
Figure 2.13), characterized by different lifetimes, τred and τox (Figure 2.19), in the 
reduced (RO and ROs, bright part of manifold) and oxidized (OO, OR and ORs, dark 
part of manifold) states of the T1 Cu (Figure 2.20). The values for the ET rate between 
the T1 Cu and T2 Cu (corresponding to the RO OR and ROs ORs transitions in 
Figure 2.20.A) determined by pulse radiolysis or flash photolysis are in range of             
180 - 330 s-1 and 265 - 770 s-1 for the forward and backward reaction, respectively [82, 
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83]. Therefore, for the single molecule experiments, the τred are estimated in order of     
~ 3 - 6 ms, whilst τox of ~ 1 - 4 ms. The values of τred and τox obtained from FLIM 
analysis are higher than expected (especially for population A) and seem almost 
independent of NO2− concentration for both populations within the concentration range 
5 µM to 5 mM (Figure 2.19). The comparison of τred values shows that the molecules 
from population A stay in the reduced state approximately 2 to 3-fold longer than 
molecules from population B, indicating that the ET between the T1 Cu and T2 Cu in 
population A takes longer than in population B. As the NO2− concentration increases, 
the distribution of populations A and B becomes broader (in particular for population B) 
and separation between populations is more visible, suggesting more pronounced 
heterogeneity between molecules. This has been observed before for gNiR and may 
reflect a distribution in rate of ET between the T1 Cu and T2 Cu related to structural 
disorder of the T1 and the T2 Cu sites [87]. Upon addition of NO2−, population B moves 
towards larger values of Pox, which correlates with the increase in number of molecules 
from population B relative to population A (Figure 2.13.B and C).  
Previous “in-bulk” activity and electrochemical measurements of gNiR have 
been interpreted according to the “random sequential” mechanism [70, 77] and modeled 
with a reaction scheme that distinguishes between a reduction-first and a substrate 
binding-first pathways, labeled as A and B, respectively, in Figure 2.20.A. The rate of 
ET between the T1 Cu and T2 Cu is known to depend on the ligand in the first 
coordination shell of the T2 Cu site, and at pH 7.5, in the absence of substrate this 
ligand is an OH− group (pathway A) whilst in the presence of substrate, NO2− is bound 
(pathway B) [70]. Longer τred values for population A of immobilized K329C bNiR 
molecules are in agreement with ET to the T2 Cu coordinated by the OH− ligand being 
slower then when NO2− binds [70, 86]. Therefore, we proposed that identified 
population A and B correspond to molecules that follow pathways A and B, 
respectively. It is important to note that the immobilized enzyme molecules seem to 
exhibit features reminiscent of an “ordered” mechanism, in the sense that once the bNiR 
molecule operates according to either pathway it will keep doing it for at least several 
turnovers [88, 123]. 
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A) B) 
 
 
C) D) E) 
     
 
 
Figure 2.20 (A) “Random sequential” mechanism of NO2− reduction by CuNiRs as 
described by Wijma et al. [70]. The letters (R and O) in each box are, from left to right, 
the T1 Cu and T2 Cu. The letters R and O are the reduced and oxidized states, 
respectively, whilst NO2− and NO is s and P, respectively. Red-coloured states are 
highly fluorescent and referred as the bright part of the manifold, whilst non-coloured 
states are low fluorescent and referred as the dark part of manifold. The reduction-first 
and the substrate-binding first pathways are A and B, respectively. (B) Population 
distribution of each kinetic microstate of ATTO 647N labeled K329C bNiR during 
reduction of NO2− as a function of substrate concentration measured by ABEL trap in 
10 mM Hepes pH 7.0 in 50 % glycerol at RT [122]. The circle area is directly 
proportional to the fractional population and each colour corresponds to a particular 
NO2− concentration, as shown on the colour bar. Population dynamics of each kinetic 
microstate in (C) bright and (D) dark manifold for each NO2− concentration, and (E) 
microscopic rate parameters for reduction of NO2− obtained for ABEL-trapped ATTO 
647N labeled K329C bNiR molecules [122]. Images adapted from [122].      
 
Substrate-binding First, pathway B 
Reduction First, pathway A 
P 
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Parallel experiments of individually ABEL-trapped molecules of ATTO 647N 
labeled K329C bNiR probed in solution (10 mM Hepes pH 7.0 with 50 % glycerol) 
allowed a complete set of the kinetic parameters for the reduction of NO2− to be 
obtained [122]. The parameters were used to calculate the equilibrium population 
distribution of each kinetic state as a function of NO2− concentration (Figure 2.20.B). 
The population dynamics are described as the probabilities of occupying a particular 
state (RO, ROs, OO, OR, and ORs) as a function of time after entering pathway A or B 
(Figure 2.20.C and D). At low NO2− concentration, the enzyme molecules in the bright 
part of the manifold, follow pathway A in RO OR reaction, whilst at high NO2− 
concentration the population shifts rapidly from RO to ROs (RO ROs reaction), 
following pathway B what is in agreement with published results at pH > 6.5 [70].        
The dark part of manifold can be entered through either OR or ORs states. At low NO2− 
concentrations, the enzyme is initially occupying the OR state (Figure 2.20.C), 
however, with increasing NO2− concentration, the probability of occupying ROs rather 
than OR states rapidly increases, with the majority of the population residing in the   
OO state (Figure 2.20.D). The 2-fold increase in the ET rates between the T1 Cu and 
T2 Cu (Figure 2.20.E) was determined between RO OR (kC, Figure 2.20.A) and 
RO ROs (kD, Figure 2.20.A) reactions, indicating that the ET to the T2 Cu site with 
coordinated OH− is slower than when NO2− is bound, which is in agreement with the 
literature [70, 77]. Similar increase has been observed before [86], but since single 
molecule measurements using ABEL trap were performed in the presence of 50 % 
glycerol, a direct comparison of the kinetic rates is not possible.   
 
2.5.3 The populations distribution 
 
The FLIM analysis of NO2− reduction by ATTO 647N labeled K329C bNiR indicates a 
clear separation between the two distinct populations of enzyme molecules in the 
absence of substrate, which disappears when NO2− is added. Up to NO2− concentration 
of 50 µM, the Pox distribution is broad and the separation becomes apparent only above 
the NO2− concentration of 500 µM. The population B separates considerably from 
population A as the substrate concentration increases. It is consistent with the change 
from the pathway A to B at NO2− concentration of ~ 520 µM that has been previously 
observed for immobilized gNiR [86]. Laser photoexcitation studies of ET between the 
T1 and T2 Cus suggest the existence of two apparent substrate-binding sites or two 
different affinities for NO2− [45, 47]. Krzeminski et al. have assigned these two 
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affinities as the different binding constants of NO2− to the reduced and oxidized T2 Cu 
site of immobilized ATTO 565 labeled L93C gNiR [86]. 
The increase in number of the individual enzyme molecules from population B 
upon increasing NO2− concentration observed during the FLIM measurements on 
immobilized bNiR (Figure 2.13.A and C) is consistent with the decrease in probability 
of finding molecules in RO state and concomitant growth of the ROs and OO 
populations observed during measurements of ABEL-trapped enzyme molecules 
(Figure 2.20.B). The molecules from population B spend less time in the reduced state 
than the molecules from population A, which suggests a faster depletion of the RO state 
from the pathway B than from the pathway A, in agreement with previously published 
results at pH > 6.5 [86, 122]. This increasing number of molecules in population B 
indicates the Michaelis-Menten constant relevant to route B (KMB) being much larger 
than the highest substrate concentration used in the experiment (5 mM), and therefore 
saturation with NO2− does not occur, in agreement with previous observations [70, 86].  
The histograms of Pox values, derived from FLIM of immobilized ATTO 647N 
labeled K329C bNiR, measured at three different pH values (pH 5.0, 7.5 and 9.0) show 
that at relatively high NO2− concentration (500 µM) at pH 5.0 molecules predominantly 
reside in population B whilst at 9.0 in population A, showing a lower degree of 
heterogeneity than at intermediate pH (pH 7.5) (Figure 2.16). At low pH and 500 µM 
NO2−, population B increases at the expense of population A what is an agreement with 
a decrease of the KMB value below pH 6.0 [70, 86]. The substrate inhibition at low pH 
(pH 5.45) and substrate activation at high pH (pH 6.85) of ET rate between the T1 Cu 
and T2 Cu has been observed by Krzeminski et al. [86]. At ~ 520 µM NO2− 
concentration, at pH 5.45, the ET rate between the T1 Cu and T2 Cu is almost 200-fold 
lower for ROs ORs than for RO OR transition [86] what is consistent with ET 
rate being slower with NO2− bound to the T2 Cu than when H2O is bound [84, 85].          
At low substrate concentration (< 520 µM), the ET rate is higher (almost 100-fold) at 
pH 5.45 than at 6.85 [86].  
Wijma et al. proposed that there is an equilibrium between two forms of the 
reduced T2 Cu site of NiR. One of these is four-coordinate and is capable of binding 
NO2− whilst the other has the H2O/OH− ligand missing and is unable to bind NO2− 
(dead-end species, Figure 2.3.C) [70, 77]. At alkaline pH the equilibrium between these 
two is shifted towards the active form but at pH 5.5 almost half of NiR was found to be 
in the inactive form [77]. The conversion of the active to inactive form is slow                
(~ 0.1 s-1) and can be reversed by the addition of NO2− [77]. The scheme discussed in 
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Figure 2.20.A does not account for the occurrence of this dead-end species. It could be 
argued that the increase in the number of molecules in population B with a concomitant 
decrease in those in population A upon increasing NO2− concentration at pH 7.5 is 
related to slow activation of the enzyme, and therefore, that population A corresponds 
to the reduced inactive species. This is unlikely as preliminary FLIM experiments at pH 
9.0 showed that NiR predominantly resides in population A and that this is independent 
of NO2− concentration. At low pH (≤ 6.0) and low NO2− concentrations (50 - 250 µM) 
population A of ATTO 647N labeled K329C bNiR is negligible and the molecules 
reside predominantly in population B (the population distribution at pH 5.0 and at a 
NO2− concentration of 500 µM is shown in Figure 2.16). Only at high substrate 
concentrations (≥ 1 mM) do the number of molecules in population A significantly 
increases at the expense of population B. 
Preliminary experiments show that ATTO 647N labeled K329C bNiR molecules 
interchange slowly between populations A and B, suggesting a large activation barrier 
between these two populations. This is possibly related to structural disorder around the 
T2 Cu site resulting in two conformations of the enzyme molecules. The fact that the 
population distribution of immobilized bNiR molecules depends on pH would suggest 
that this could be due to those residues responsible for proton delivery. Both, Asp92 and 
His249 (bNiR numbering) have been suggested to control the ET from the T1 to T2 Cu 
by delivering protons in an ET coupled protonation step [76, 124]. Proton-transfer 
coupling to the ET between the T1 and T2 Cu and NO2− reduction has been 
demonstrated [45 - 48] and at pH 7.0, the rate-limiting catalytic step is a single 
protonation event [45]. The conserved Asp92 is connected to the protein’s surface via 
Asn90 and His254, which participate in the formation of two different proton channels. 
These channels were primarily identified in the crystal structures at different pH values, 
however, both can be observed in high-resolution crystal structures at pH 6.5 [36, 49, 
50]. At pH 7.0, the Asn90 proton channel is sufficient to maintain essentially full 
enzymatic activity. Its disruption by mutating Asn90 to Ser (also in the 
Asn90Ser/His254Phe double mutant) results in an almost 70 % decrease in activity [45, 
46]. However, proton delivery can be partially restored through the movement of the 
loop connecting Cys130 and His139 (both are T1 Cu ligands) that occurs upon binding 
of NO2− [46]. Although Asn90 has been recognized as the main proton source, the 
activities of the variants were only measured at pH 7.0. The His254 channel may be 
more significant at low pH. The influence of these proton channels on the heterogeneity 
of bNiR molecules could be examined by single molecule FLIM studies at low and high 
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pH using the Asn90Ser, His254Phe and Asn90Ser/His254Phe variants. Detailed 
analyses of population distributions and the time-dependent behavior of molecules of 
bNiR variants over a wide pH range would be necessary to quantify the influence of the 
proton delivery pathways on the enzyme’s mechanism.    
 
2.5 Conclusions 
 
Single molecule measurements of bNiR provide a detailed insight into the catalytic 
mechanism of bNiR compared to previous “in-bulk” solution studies. Analysis of the 
FLIM images of agarose-immobilized ATTO 647N labeled K329C bNiR molecules 
indicate that the enzyme can follow either a substrate-binding first or a reduction first 
pathway, as described by the “random sequential” mechanism [70], consistent with 
reported results [86, 122]. The analysis of Pox of single molecules of bNiR showed the 
presence of two populations, A and B, which distribution is dependent on the substrate 
concentration and pH. At pH 7.5, each of the populations of bNiR molecules follows 
one of the pathways of the “random sequential” mechanism, however, at high NO2− 
concentration, the substrate-binding pathway (corresponding to population B) seems to 
prevail over the reduction-first pathway (corresponding to population A), and the 
opposite happens at low substrate concentration. At extreme pH values (pH 5.0 and 
9.0), in which enzyme shows different “in-bulk” behavior [70], the distinction between 
the two populations almost disappears. Population A prevails over population B at high 
pH, whilst at low pH the reverse occurs.    
The crucial advantage of the presented FLIM measurements is not only the 
possibility of quick data collection for each full image scan but also that the long-term 
behavior of a molecule can be monitored while minimizing interference by bleaching. 
The main limitation of this method is that the signal is integrated over few milliseconds, 
and therefore events faster than the integration time cannot be easily probed. To enable 
observation of these faster events, higher time resolution measurements but with a 
longer trapping-window than can be achieved with the current ABEL trap, are 
necessary.  
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3.1 Introduction 
 
3.1.1 Occurrence and physiological function of laccases 
 
Laccases (p-diphenol: dioxygen oxidoreductases, EC 1.10.3.2) are members of the 
multicopper oxidase (MCO) family of enzymes and catalyze the four-electron reduction 
of molecular oxygen (O2) to water (H2O) in four, one-electron reductions of four 
substrate molecules [1 - 5]. Laccases are widely distributed especially among plants, 
higher fungi and bacteria. While in plants they are involved in lignification, wound 
healing and iron metabolism [3, 6, 7], fungal laccases take part in lignin degradation, 
stress defense, pathogenesis and detoxification, and in development and morphogenesis 
of fungi [3 - 5, 8]. The presence of laccases was reported in larval and adult cuticles of 
several insects, where the protein is associated with the sclerotization process [9].           
In bacteria the enzymes are involved in copper (Cu) homeostasis, sporulation and 
pigmentation of spores [10, 11].   
 
3.1.2 Reactivity of laccases 
 
The catalytic center of laccases consists of type 1 (T1), type 2 (T2) and binuclear type 3 
(T3) Cu sites [12] (Chapter 1.2), and is similar to that found in ascorbate oxidase (AO) 
[13] and ceruloplasmin (Cp) [14]. The T2 and two T3 Cu ions form a trinuclear cluster 
that is commonly referred to as the T2/T3 Cu site (Chapter 1.2.4). The T1 Cu is the 
initial port of entry of electrons into the enzyme, whilst at the T2/T3 Cu site O2 is 
reduced to H2O. The T1 Cu sites of laccases posses a broad range of reduction 
potentials that has led to the classification of low (~ 430 mV versus the normal 
hydrogen electrode, NHE), mid (from 470 - 710 mV) and high (~ 800 mV) potential 
enzymes [1]. Reduction potential of the T2/T3 Cu site (determined only for several 
laccases) is usually similar that of the T1 Cu site [15, 16]. Laccases directly oxidize 
substrates with the reduction potentials lower to that of their T1 Cu site, with the rate of 
reaction being dependent on the reduction potential difference between the enzyme and 
the substrate [17, 18] (other factors such as steric hindrance of the substrate and 
size/shape of the substrate-binding pocket also affect the reaction rate [19, 20]). 
Therefore, high reduction potential of the T1 Cu site increases the range of oxidizable 
substrates. This and the broad substrate specificity make the high potential laccases 
especially promising for industrial and biotechnological purposes [3 - 5, 21 - 23].  
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Laccases catalyze the oxidation of a variety of aromatic compounds, including 
ortho- and para-substituted phenols, polyphenols, anilines, aryl diamines, methoxy-
substituted phenols, hydroxyindols, benzenethiols and also some inorganic ions such as 
[Mo(CN)8]4- and [Fe(CN)6]4- (Figure 3.1.A) [1, 5]. Laccases remove a single electron 
from a phenolic substrate generating a free radical [24]. Depending on the conditions, 
this species can be transformed into a quinone or undergo non-enzymatic reactions like 
hydratation, disproportionation and polymerization. Non-phenolic substrates, phenols 
with reduction potential exceeding that of the T1 Cu site of laccase or molecules too 
bulky to enter the substrate-binding sites (for example lignin-like substrates) are not 
directly oxidized by the enzyme. However, catalysis can be carried out by the inclusion 
of low molecular weight organic compounds called mediators [25, 26] (Figure 3.1.B). 
The most common mediators are 2,2’-azinobis-3-ethylthiazoline-6-sulfonat (ABTS, 
also used as an artificial substrate), 1-hydro-xybenzotriazole (HOBT), N-hydro-
xyphthalimide (NHPI) and 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO).   
 
A) 
 
B) 
 
 
Figure 3.1 Schematic representations of laccase-catalyzed reactions in the absence (A) 
and in the presence (B) of redox mediators.  
 
3.1.3 Potential applications of laccases 
 
A number of potential applications for laccases have been investigated in several sectors 
[21, 27 - 31] including among others pharmaceutical [32, 33], pulp and paper bleaching 
[28], food and beverages [29, 34, 35], textiles [36], and cosmetic [37, 38] industries. 
The enzymes have been applied in organic synthesis [27], degradation of dyes and 
xenobiotics, bioremediation of coloured industrial effluents [30, 31, 39, 40], and 
wastewater treatment by degradation of a variety of persistent environmental pollutants 
[21, 41].  
Laccases have been employed in the construction of biocathodes for biofuel 
cells [42 - 47]. The design involves the application of enzymes as biocatalysts for the 
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conversion of chemical energy into electrical current. Electricity that is generated from 
the oxidation of biofuels (glucose, glycerol or ethanol) coupled to concomitant 
reduction of O2 to H2O by laccases is expected to suffice for micro devices requiring 
relatively low power. To date, bioelectrodes with immobilized laccase from Trametes 
versicolor and small laccase (SLAC) from Streptomyces coelicolor [43, 46, 47] have 
great potential for successful use in biofuel cells.  
In addition, laccases have been used in the construction of biosensors for clinical 
and environmental purposes [48]. The enzymes are mainly used for the determination of 
various phenolic compounds [49 - 59], plant flavonoids [60], O2 [61], azides [62] and 
cyanides [63]. Selectivity and sensitivity of laccase-based biosensors have been 
improved by enzyme co-immobilization either with tyrosinase [64, 65], glucose 
dehydrogenase (GDH) [66 - 68] or peroxidases [69]. Biosensors based on the dual 
enzyme coupled system of laccase and GDH have been used for selective detection of 
morphine [66] and catecholamines [67, 68]. Detection of catecholamines at 
submicromolar detection limits has also been achieved using a laccase/peroxidase dual 
enzyme coupled system [69], laccase co-immobilized with an osmium redox polymer 
[70] and recently, using a laccase-based optical fiber biosensor [71].  
 
3.1.4 Heterologous expression of laccase from Trametes versicolor  
 
Production of laccases from native sources cannot meet the increasing demands for the 
enzyme, mainly due to low yields and long and expensive cultivation. Recombinant 
protein over-expression offers higher productivity at lower cost, and therefore, it is of 
importance for both industrial and biotechnological applications [72]. Additionally, 
protein engineering that requires a good over-expression system is often used to 
improve the biochemical (such as stability or substrate specificity) and catalytic 
efficiency of the enzyme [17, 72].  
Among the best-characterized high potential laccases is that from the white-rot 
fungus T. versicolor. The fungus secretes several iso-forms [73, 74] that also differ in 
their glycosylation pattern. Hence the exact number of different laccases produced is 
not known [75, 76]. The difference in isoelectric point (pI values) of laccases has 
commonly been used as a criterion to identify these different iso-forms, and using this, 
two chromatographic fractions (A and B) have been separated by ion-exchange 
chromatography [77]. Isoelectric focusing has revealed that fraction A contains two 
components (pI 3.07 - 3.27), whilst fraction B has ten components (pI 4.64 - 6.76) [78, 
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79]. The production of active recombinant laccases from T. versicolor has previously 
been reported in plants [80, 81], yeast [73, 79, 82 - 94] and filamentous fungi [90, 95 - 
98]. Filamentous fungi are generally good hosts for production of proteins but are more 
time consuming to work with compared to yeast [72]. No bacterial over-expression 
system producing an active T. versicolor laccase has been reported. However, laccases 
from Cyathus bulleri and Ridigoporus lignosus has been expressed in Escherichia coli, 
making them the first fungal laccases expressed in a bacterial host [99, 100].  
 
3.1.5 Characterization of the two- and three-domain MCOs 
 
The crystal structures of only fungal and bacterial laccases have been published.              
A structural model of the plant laccase from Populus trichocarpa is available [101].       
The first crystal structure of a fungal laccase was solved for the T2 Cu depleted form of 
the enzyme from Coprinus cinereus [102]. Since then, a number of crystal structures of 
fungal laccases have been solved, including those from T. versicolor (TvL1KYA [75] 
and TvL1GYC [103]), Pycnoporus cinnabarinus [76], Melanocarpus albomyces [104], 
Cerrena maxima [105] and R. lignosus [106], all with a full complement of Cu ions. 
The enzymes are monomeric with three cupredoxin-like, metal-binding domains   
(MBD-1, MBD-2 and MBD-3, Chapter 1.3) The amino-acid sequences of the two 
crystallized iso-forms of T. versicolor laccases share ~ 80 % similarity, however, the 
crystal structures of TvL1KYA and TvL1GYC, superimpose with a root-mean square 
deviation (RMSD) of 0.343 Å for Cα atoms. A number of crystal structures of bacterial 
laccases have been determined. These include the monomeric, three-domain CotA from 
Bacillus subtilis [107] and the trimeric, two-domain laccases such as SLAC from              
S. coelicolor [108 - 110], mgLAC from metagenome database [111] and blue copper 
oxidase (BCO) from Nitrosomonas europaea [112].  
Compared to three-domain laccases, two-domain laccases lack the second 
domain, however, a trimeric arrangement of those enzymes ensures stability and 
enables the same enzymatic function using different quaternary structure. Superposition 
of the structure of SLAC [108] with those of TvL1KYA and TvL1GYC gives RMSDs 
of 5.50 Å and 6.91 Å, respectively, for Cα atoms. Nakamura et al. suggested that the 
three-domain AO, three-domain laccases and six-domain Cp have evolved from 
cupredoxins via formation of trimeric two-domain MCOs [113] (for more details see 
Chapter 1.3). Three types (A, B and C) of these trimeric forms have been predicted and 
classified according to the location of T1 Cu sites [113]. Type A two-domain MCOs 
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contain a T1 Cu site in each domain, whereas type B (e.g. SLAC) and type C              
(e.g. mgLAC and BCO) house the T1 Cu site in MBD-2 and MBD-1, respectively.           
In three-domain laccases, the T1 Cu is located in MBD-3. The T2/T3 Cu cluster is 
located either between MBD-1 and MBD-2 of each two-neighboring chains of the 
trimer of the two-domain MCOs or at the interface of MBD-1 and MBD-3 of the three-
domain MCOs.  
 
3.1.6 Structure of the active sites 
 
Crystallographic and spectroscopic studies of laccases have generated a detailed 
description of their active sites [1, 12, 75, 76, 102 - 106, 114 - 119] (Chapter 1.2).             
The three types of Cu sites in laccases differ in their spectroscopic properties [1, 116, 
117, 120, 121]. The T1 Cu of TvL1KYA (and TvL1GYC) and SLAC is coordinated to 
two His and Cys in a trigonal planar [75, 103] and trigonal pyramidal [108] geometry, 
respectively (Chapter 1.3). A non-coordinating Phe in T. versicolor laccases is 
homologous to the axial Met ligand to the T1 Cu in SLAC. In some laccases (such as 
laccases from M. albomyces [104] or R. lignosus [106]), a non-coordinating axial Leu is 
present (Chapter 1.2.1). The T1 and the T2/3 Cus are 12 - 13 Å apart connected by a 
His(T3 Cu)-Cys(T1 Cu)-His(T3 Cu) motif, which is highly conserved among MCOs 
and is suggested to facilitate fast electron transfer (ET) between the Cu centers [1].       
The T2 Cu, which is coordinated by two His residues and OH−/H2O, has a trigonal 
planar geometry, whereas both T3 Cus are coordinated by three His residues and a 
bridging oxygen ligand (OH− or O2−) in distorted tetrahedral geometries (Chapters 1.2.4 
and 1.3).  
 
3.1.7 Catalytic mechanism of laccases 
 
Even though much effort has been devoted to describe the reduction of O2 into H2O by 
MCOs, the mechanism is still the subject of considerable debate. Solomon and 
coworkers have investigated in detail the kinetic and spectral features of intermediates 
present during O2 reduction by MCOs [114, 122 - 126], mainly Rhus vernificera 
(Japanese lacquer tree) laccase [122, 126 - 128], and more recently Fet3p from 
Saccharomyces cerevisiae [128, 129]. Reduced laccase (4 Cu(I)) reacts with O2 via two 
sequential two-electron transfer steps generating first a “peroxy” intermediate (PI,          
2 Cu(I), 2 Cu(II)) [122, 130 - 133] followed by a “native” intermediate (NI, 4 Cu(II)) 
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[122, 124] (Figure 3.2.A). The NI is structurally distinct from the fully oxidized resting 
form of the enzyme (RO) [124, 131 - 136]. The T2/T3 Cus in NI are bridged by µ3-oxo 
ligand and the T3 Cus are additionally bridged by a µ2-hydroxo moiety, whilst in RO 
only the µ2-hydroxo between the T3 Cu is present (Figure 3.2.A). Rapid reduction of the 
NI indicates that NI rather than RO is the catalytically relevant fully oxidized form of 
the enzyme [122, 124, 137]. The formation of NI has been observed in native laccases 
[138, 139] (NI was also identified in the crystal structure of laccase from Lentinus 
tigrinus [140]), whilst PI has been trapped and characterized using the T1 Hg(II) 
derivative [122, 130, 131] and a C484S (T1 depleted, T1D) Fet3p variant [141, 142]. 
The NI and PI species are formed at similar rates (1.7×106 and 2.2×106 M-1s-1, 
respectively [130]) and the transition from PI to NI is very fast in the native enzyme        
(k > 350 s-1) [126]. Multiple studies indicate that PI is a kinetically competent precursor 
to NI [122, 143, 144].  
 
A) B) 
 
 
 
Figure 3.2 (A) Mechanism of O2 reduction by Fet3p. Black solid arrows indicate the 
steps that take place in the catalytic cycle of the MCOs. Dashed arrows indicate steps 
that can be experimentally observed but are not part of the catalytic cycle. Dotted 
arrows indicate the transfer of an electron from the T1 Cu to the T2 Cu to create PI+e− 
that occurs on going from NI to PI but is not experimentally observed in the native 
enzyme (adapted from [125, 145]). (B) Structure of the active site of a resting oxidized 
AO [13] with the side chains numbered as in Fet3p [146]. The side chains of Asp94 and 
Glu487 are shown as green sticks. The T2 and T3 Cus are brown, H2O/OH− ligands are 
red and waters are gray spheres.    
 
Figure 3.2.A shows the current understanding of the mechanism based on 
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contribute differently to O2 reactivity [147]. Mutation of the T3β Cu His483, but not of 
T3α Cu His126 ligand (Figure 3.2.B), strongly affects the electronic structure of the 
reduced enzyme, disabling fast two-electron reduction of O2 to form PI [145, 147]. 
Formation of PI is a rate-determining step in O2 reduction [114, 125], and the 
computational model of PI (Figure 3.2.A), in which O2 is bound as peroxide bridge to 
the T2/T3 Cus, implicates the involvement of anionic Asp (Asp94 in Fet3p 
corresponding to the Asp77 in TvL1KYA), nearby the T2 Cu and the T3β Cu, in the 
stabilization of this intermediate [123, 126, 132, 144, 148]. In Fet3p, the carboxylate 
moiety of Asp94 is suggested to be involved in hydrogen bonding with the T2 Cu 
water-derived ligand (mediated by H2O) and a T3β Cu His418 ligand (Figure 3.2.B), 
whereas the backbone carbonyl group hydrogen bonds with the T2 His81 ligand. The 
negative charge of Asp94 is suggested to stabilize the PI structure leading to the 
oxidation of the T2 Cu and the T3β Cu by lowering their reduction potentials. The 
computational model of PI is supported by experimental data on Fet3p, in which the 
D94A and D94N mutations result in complete loss of O2 reactivity, but the D95E 
variant is still active [129, 149]. The T3α Cu is reduced first, followed by the reduction 
of the T2 Cu. Consequently T2 Cu-peroxide bonding is lost and PI adapts a transition 
structure (PI+e−) with peroxide bound in between the T3α Cu(I) and T3β Cu(II). Fast 
ET from the T1 Cu to the T2 Cu promotes reductive cleavage of O−O peroxide bond 
accompanied by protonation (proton donated by Glu487 near the T3 Cus [129, 147], 
Asp456 in TvL1KYA) of one of the oxygens to produce NI [123, 125]. This 
intermediate is either rapidly reduced by substrate in the catalytic reaction, or, in the 
absence of a reducing substrate, very slowly decays to RO [122, 124, 137].    
 
3.2 Scope of the chapter 
 
The research described in this chapter deals with the development and characterization 
of laccase-based constructs, which utilize fluorescence detection for biosensing 
applications. This so-called FluoRox concept (Chapter 1.4.3) consists of a redox 
enzyme (herein laccase) with a fluorophore covalently attached to the protein’s surface. 
This method not only permits the oxidized and the reduced states of the active site to be 
distinguished during redox reactions [150, 151], but also holds promise for improved 
sensitivity as compared to conventional electrochemical sensing techniques.  
Primarily, work focused on the expression of the lcc1 gene from T. versicolor in 
bacteria, yeast and filamentous fungi. A novel fungal expression system of active Lcc1 
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in Schizophyllum commune is presented. Recombinant protein has been isolated and 
spectrally characterized and a comparison made with native Laccase A from                 
T. versicolor and the two-domain SLAC. The oxidation capacity of fungal laccases 
using phenolic and non-phenolic compounds has been evaluated. Preliminary studies on 
the relationship between the two- and three-domain laccases, in terms of the kinetics of 
the O2 reduction, were performed. Furthermore, Lcc1, Laccase A and SLAC were 
fluorescently labeled with rhodamine dyes and these constructs were characterized.  
 
3.3 Materials and methods 
 
3.3.1 Molecular cloning 
 
3.3.1.1 Cloning for expression of Lcc1 in Escherichia coli 
 
The gene encoding Lcc1 (NCBI accession no. X84683) was amplified by polymerase 
chain reaction (PCR) using lcc1_pUC19 (kindly provided by Dr. M. Guo from Tianjin 
Agriculture College, People’s Republic of China) as the template and the primers listed 
in Table 3.1. The PCR products were cloned into the NdeI and BamHI sites of pET29a 
(lcc1_pET29a construct; the gene subcloned from lcc1_pGEMT by Dr. Katsuko Sato 
and Rafal Zur), the NdeI and BamHI sites of pET44a (lcc1_pET44a construct encoding 
for Lcc1 fused N-terminally with N-utilization substance A (NusA) protein) and the 
NcoI and BamHI sites of pET22b (lcc1_pET22b construct with lcc1 gene cloned 
upstream of the periplasmic PelB leader sequence). All constructs were verified by 
sequencing both strands. 
 
3.3.1.2 Cloning for expression of Lcc1 in Pichia methanolica and Pichia pastoris 
 
The gene encoding Lcc1 was amplified by PCR using lcc1_pE29a as the template and 
the primers listed in Table 3.1. The PCR product was cloned into the pGEMT and 
subcloned into the EcoRI and NotI sites of pMETαA (lcc1_pMETαA) and pPICZαA 
(lcc1_pPICZαA) upstream of the secretion α-factor signal peptide from S. cerevisiae 
(signal peptide was used to direct the secretion of the recombinant protein into the 
media). The constructs were verified by sequencing both strands. 
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3.3.1.3 Cloning for expression of Lcc1 in Schizophyllum commune 
 
The circular (lcc1-cDNA) and genomic (lcc1-gDNA) genes encoding Lcc1 were 
amplified by PCR using lcc1_pET29a and T. versicolor genomic DNA as the templates, 
respectively, and the primers listed in Table 3.1. The full sequences of clcc1 and glcc1 
can be found in Appendix C. The extraction and purification of genomic DNA from      
T. versicolor is described in Chapter 5.6. The 1497 bp (lcc1-cDNA) and 2052 bp-long 
(lcc1-gDNA) PCR products were cloned between the β-tubulin 2 promoter gene tub 2 
and the transcription termination signal, upstream of the SC3 signal sequence (the 
signal sequence was used for exporting the recombinant protein into the media), using 
the SmaI and BamHI sites of pKSPTubiT3 (unpublished results, kindly provided by   
Dr. Karin Scholtmeijer from Utrecht University, The Netherlands) to generate 
clcc1_pKSPTubiT3 and glcc1_pKSPTubiT3, respectively. The nourseothricin 
resistance cassette [152] was cloned into the EcoRI site of clcc1_pKSPTubiT3 
(clcc1_pESCT) and glcc1_pKSPTubiT3 (glcc1_pESCT) to grant the selectivity of 
transformants in S. commune. All constructs were verified by sequencing both strands.  
 
3.3.1.4 Cloning for expression of Lcc1_cMYC and C452S_Lcc1_cMYC variants in 
Schizophyllum commune 
 
The gene encoding C-terminally fused Lcc1 was amplified by PCR using 
glcc1_pKSPTubiT3 as the template and the primers listed in Table 3.1. The PCR 
product was cloned into the SmaI and BamHI sites of pKSPTubiT3 
(glcc1_cMYC_pKSPTubiT3), as described in Section 3.3.1.3. The C452S variant of 
Lcc1_cMYC was synthesized with QuickChange Mutagenesis Kit (Stratagene) using 
glcc1_cMYC_ pKSPTubiT3 as the template and the primers listed in Table 3.1 
(C452S_glcc1_cMYC_pKSPTubiT3). The nourseothricin resistance cassette [152] was 
cloned into the EcoRI sites of glcc1_cMYC_pKSPTubiT3 and 
C452S_glcc1_cMYC_pKSPTubiT3, resulting in glcc1_cMYC_pESCT and 
C452S_glcc1_cMYC_pESCT, respectively. All constructs were verified by sequencing 
both strands. 
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Construct Primer sequence 5’ to 3’  Function 
GTTCCATGGCTATCGGGCCTGTGAC Forward primer; Lcc1 periplasmic expression in E. coli.  
lcc1_pET22b 
GTTGGATCCTTAGAGGTCGGATGAGTCAAGAG Reverse primer; Lcc1 periplasmic expression in E. coli. 
GAACATATGGCTATCGGGCCTGTGACCGAC Forward primer; Lcc1 cytosolic expression in E. coli. 
lcc1_pET29a a 
GAAGGATCCTTAGAGGTCGGATGA Reverse primer; Lcc1 cytosolic expression in E. coli. 
GTTCACGTGGCAGCGCTATCGGGCCTGTGACC 
Forward primer; NusA-fused Lcc1 cytosolic expression in 
E. coli. 
lcc1_pET44a 
GTTGGATCCTTAGAGGTCGGATGAGTCAAGAG 
Reverse primer; NusA-fused Lcc1 cytosolic expression in 
E. coli. 
CAAGAATTCGCTATCGGGCCTGTGACCGACCTC
ACC 
Forward primer; Lcc1 expression in P. methanolica and       
P. pastoris 
lcc1_pMETαA, 
lcc1_pPICZαA 
 
CAAGCGGCCGCTTAGAGGTCGGATGAGTCAAG
AGC 
Reverse primer; Lcc1 expression in P. methanolica and        
P. pastoris 
GGAGCTATCGGGCCTGTGACCGACCTCACCATC 
Forward primer; lcc1-cDNA and lcc1-gDNA cloning into 
pKSPTubiT3 vector for expression in S. commune. clcc1_pKSPTubiT3 
glcc1_pKSPTubiT3 
GTTGGATCCTTAGAGGTCGGATGAGTCAAGAG 
Reverse primer; lcc1-cDNA and lcc1-gDNA cloning into 
pKSPTubiT3 vector for expression in S. commune. 
a Primers designed by Rafal Zur 
 
Table 3.1 List of primers used for cloning of Lcc1, Lcc1_cMYC, SLAClong, SLACtruncated and preparation of the C452S_Lcc1_cMYC variant. 
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Construct Primer sequence 5’ to 3’  Function 
GGAGCTATCGGGCCTGTGACCGACCTCACCATC Forward primer for C-terminal cMYC tagging of Lcc1 
glcc1_cMYC_ 
pKSPTubiT3 
GTTTCTTGGATCCTCAGAGGTCCTCCTCGCTGAT
GAGCTTCTGCTCGAGGTCGGATGAGTCAAGAGC
GTTGTACG 
Reverse primer for C-terminal cMYC tagging of Lcc1 
CAACCCCGGCCCCTGGTTCCTCCACTCTCACAT
CGACTTCCACTTG 
Forward primer; C452S mutagenesis of Lcc1_cMYC  
C452S_glcc1_ 
cMYC_pKSPTubiT3 CAAGTGGAAGTCGATGTGAGAGTGGAGGAACC
AGGGGCCGGGGTTG 
Reverse primer; C452S mutagenesis of Lcc1_cMYC 
GTTGGAGTCTCATATGGACAGGCGAGGCTTTAA
CC 
Forward primer; SLAClong expression in E. coli 
SLAC(long)_pET22b 
GTTGGCCATCTCGAGTCAGTGCTCGTGTTCGTG
TG 
Reverse primer; SLAClong expression in E. coli 
GTTGGAGTCTCATATGGGGGGCGAGGTGAGAC
ACCTCAAG 
Forward primer; SLACtruncated expression in E. coli 
SLAC(truncated)_  
pET22b GTTGGCCATCTCGAGTCAGTGCTCGTGTTCGTG
TG 
Reverse primer; SLACtruncated expression in E. coli 
 
Table 3.1 List of primers used for cloning of Lcc1, Lcc1_cMYC, SLAClong, SLACtruncated and preparation of the C452S_Lcc1_cMYC variant - 
continued.  
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3.3.1.5 Cloning for expression of SLAC in Escherichia coli 
 
The gene encoding SLAClong (NCBI accession no. Q9XAL8) including the twin-
arginine translocation (TAT) leader peptide (first 30 residues) was amplified by PCR as 
previously described [153] using S. coelicolor genomic DNA (kindly provided by Dr J. 
Stach from Newcastle University, UK) as the template and the primers listed in Table 
3.1. The PCR product was cloned into the NdeI and XhoI sites of pET22b 
(SLAC(long)_pET22b). The leader sequence was removed by PCR using 
SLAC(long)_pET22b as the template and the primers listed in Table 3.1, and was also 
cloned into the NdeI and XhoI sites of pET22b (SLAC(truncated)_pET22b encoding for 
SLACtruncated that lacks the N-terminal 44 residues compared to SLAClong). All the 
constructs were verified by sequencing both strands. 
 
3.3.2 Organisms used for over-expression of Lcc1, SLAClong, SLACtruncated 
 
The BL21 (DE3), Tuner (DE3) and Rosetta (DE3) strains were used for over-expression 
of Lcc1, SLAClong, SLACtruncated in E. coli. P. methanolica PMAD11 (genotype: ade2-
11) and P. pastoris X33 (genotype: wild type (WT)) strains were used for expression of 
Lcc1 in yeast. The competent cells were prepared as described in Chapters 5.3.2            
(E. coli), 5.4.2 (P. methanolica) and 5.4.4 (P. pastoris). The S. commune WT 4-8 [154, 
155] and KS8 [156, 157] strains were used for expression of Lcc1 and the variants.          
S. commune KS8 was obtained through a spontaneous event during cultivation of strain 
72-3 which contains a deletion of the SC3 gene [156, 157]. Mutation in the thn gene 
results in several morphological changes in KS8 strain such as production of a pungent 
smell, a higher radial growth rate and a lower biomass [158]. Protoplasts of S. commune 
WT and KS8 strains were prepared as described in Chapter 5.5.2.  
 
3.3.3 Expression studies of Lcc1  
 
3.3.3.1 Lcc1 expression studies in Escherichia coli  
 
Small-scale expression of Lcc1 in the cytoplasm of E. coli was performed in Luria-
Bertani (LB) media (Chapter 5.2.1) using BL21 (DE3), Rosetta (DE3) and Tuner (DE3) 
strains as described in Chapter 5.9.1. BL21 (DE3) cells transformed with lcc1_pET29a 
plasmid were grown at 30, 20, 10 and 4 °C; transformed Rosetta (DE3) cells at 30, 20 
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and 10 °C, whilst transformed Tuner (DE3) cells at 16 and 10 ºC. E. coli cells were 
grown in LB media at 37 oC until an OD600 of ~ 0.8 - 1.2 was reached. The cultures 
were cooled and 0.1 mM Cu(NO3)2 and/or 25 mM proline were added when necessary. 
Protein expression was induced with isopropyl β-D-1-thiogalactopyranoside (IPTG;      
0.5 mM in BL21 (DE3) and Rosetta (DE3) and 0.05 - 0.2 mM in Tuner (DE3)). Cells 
were incubated at designated temperatures and 4 mL samples of the cultures were 
collected every few hours, sonicated and centrifuged for 10 minutes at 5000 g. 50 µL 
samples of sonicated cultures (representing all expressed proteins) and 50 µL of 
supernatant (representing soluble proteins) were lysed and analyzed using sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (Chapter 5.8.2). 
E. coli BL21 (DE3) transformed with lcc1_pET44a and lcc1_pET22b were 
grown as described above for lcc1_pET29a. Over-expression of Lcc1_NusA was 
induced with 0.5 mM IPTG at an OD600 of ~ 0.9 - 1.4. Cells were incubated at 30 and 
20 °C, and samples were collected and processed as previously. Periplasmic                   
over-expression of Lcc1 was induced with 0.5 mM IPTG at an OD600 of ~ 0.6 - 0.8. 
Cells were incubated at 30 and 20 °C, and the samples were collected every few hours. 
Cells were spun down at 5000 g and the periplasmic fraction was isolated using osmotic 
shock-based method (Chapter 5.9.1). Samples (50 µL) were collected and processed as 
previously. 
 
3.3.3.2 Refolding of Lcc1 from Escherichia coli inclusion bodies 
 
E. coli BL21 (DE3) cells transformed with lcc1_pET29a were grown in LB at 37 °C 
until an OD600 of ~ 1.0 was reached. The Lcc1 over-expression was induced with          
1.0 mM IPTG and the cells were incubated at 30 °C for 22 h. After harvesting, the cell 
pellet was re-suspended in 25 mM tris(hydroxymethyl)aminomethane (Tris) pH 7.5 and 
disrupted by sonication. The inclusion bodies (IB) containing the majority of Lcc1 were 
collected by centrifugation at 13500 g and subsequently stored at -20 °C. Lcc1 was 
refolded from IB in slow [159] and rapid [160] fashion using previously published 
procedures, with modifications, as described in Chapter 5.10.5.1. Different approaches 
used for the fast refolding of Lcc1 are summarized in Table 3.2. 
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3.3.3.3 Studies on expression of Lcc1 in Pichia methanolica and Pichia pastoris 
 
The P. methanolica PMAD11 and P. pastoris X33 strains were transformed with 
lcc1_pMETαA and lcc1_pPICZαA, respectively, as described in Chapters 5.4.3 and 
5.4.5. The P. methanolica PMAD11 and P. pastoris X33 transformants were screened 
for production of Lcc1 on minimal media plates containing 5 g/L of methanol           
(MtM-agar, Chapter 5.2.6) supplemented with 0.2 mM Cu(NO3)2 and 0.2 mM ABTS as 
described in Section 3.3.17. Transformants of P. methanolica PMAD11 with the highest 
laccase production identified by the largest green halo around the colonies 
(transformants of P. pastoris X33 did not develop the green halo) were used for Lcc1 
expression, as previously described [94].    
 
3.3.3.4 Studies on expression of Lcc1 in Schizophyllum commune   
 
Small-scale expression of Lcc1 in S. commune (Chapter 5.9.2) was performed using 
WT and KS8 strains transformed with either clcc1_pESCT or glcc1_pESCT as 
described in Chapter 5.5.3. Lcc1-secreting transformants were selected on minimal 
media (MM, Chapter 5.2.7) agar supplemented with 0.2 mM Cu(NO3)2 and 0.2 mM 
ABTS, as described in Section 3.3.17. Transformant with the highest laccase production 
identified by the largest green halo around colonies was used for Lcc1 expression 
studies. To examine the effect of media composition on secretion of Lcc1, the KS8 
strain containing glcc1_pESCT was grown in 25 mL liquid standing cultures using 
MM, complete medium (CM, Chapter 5.2.8) and production media (PM, Chapter 5.2.9). 
The effect of cultivation temperature (23 and 30 °C), pH (6.6, 7.0, 7.4 and 8.0) and 
Cu(NO3)2 concentration (0 - 4 mM) in the media on Lcc1 secretion was also 
investigated. Samples (1 mL) were taken daily for measurements of protein expression 
(as in Section 3.3.17).     
 
3.3.3.5 Studies on expression of cMYC tagged Lcc1 and the C452S variant in 
Schizophyllum commune   
 
The S. commune KS8 strain was transformed with glcc1_cMYC_pESCT and 
C452S_glcc1_cMYC_pESCT encoding for cMYC tagged variants of Lcc1 and        
C452S (T1D) Lcc1, as described in Chapter 5.5.3. The S. commune KS8 strains 
containing glcc1_cMYC_pESCT and C452S_glcc1_cMYC_pESCT were selected by 
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sandwich immunodetection (experiment carried out by Dr. Karin Scholtmeijer) using 
anti-cMYC antibody conjugated with alkaline phosphatase (Acris SM1863AP), as 
described in Chapter 5.8.4. Selected S. commune KS8 strains containing 
glcc1_cMYC_pESCT and C452S_glcc1_cMYC_pESCT were cultured at 30 °C in CM 
medium, pH 7.0, containing 2.0 mM Cu(NO3)2, as described in Chapter 5.10.7. After 12 
days of growth, the supernatant was collected and incubated overnight at 4 °C with a 
diethylaminoethyl (DEAE) Fast Flow Sepharose (GE Healthcare) equilibrated in              
20 mM phosphate pH 7.0. The next day, the supernatant was filtered out, the DEAE 
Fast Flow Sepharose was washed with 20 mM phosphate pH 7.0 and the bound proteins 
were eluted with 50 mL of 0.5 M NaCl. The eluents were subsequently concentrated by 
ultrafiltration (Amicon ultra 4, 30 kDa molecular weight cut off (MWCO) membrane, 
Chapter 5.14.2) and separated by SDS-PAGE. The proteins were electrotransfered to a 
cellulose membrane as described in Chapter 5.8.3 and detected using mouse anti-cMYC 
antibody (Sigma) in combination with rabbit anti-mouse Ig conjugated with alkaline 
phosphatase (Promega).   
 
3.3.4 Expression and purification of proteins 
 
The proteins SLAClong and SLACtruncated were expressed in E. coli and purified using 
previously published procedure [153], with modifications, as described in              
Chapter 5.10.1. Laccase A was isolated from crude acetone powder from T. versicolor, 
as described in Chapter 5.10.4. Lcc1 was expressed in E. coli, P. methanolica PMAD11 
[94] and S. commune KS8 and purified, as described in Chapters 5.10.5, 5.10.6 and 
5.10.7 respectively. SLAClong, SLACtruncated concentrations were estimated using 
extinction coefficient (ε) of 4400 M-1cm-1 at 590 nm [153], whilst concentration of Lcc1 
and Laccase A was estimated using ε of 4900 M-1cm-1 at 610 nm (at pH 6.0) [107].  
 
3.3.5 Determination of proteins’ apparent molecular weight by gel-filtration 
 
The apparent molecular weight (MWapp) of proteins was determined as described in 
Chapter 5.13.4 using a HiLoad Superdex 200 16/60 (GE Healthcare) gel-filtration 
column in 20 mM Tris pH 7.5 containing 200 mM NaCl (SLAClong, SLACtruncated) or a 
HiLoad Superdex 75 16/60 (GE Healthcare) gel-filtration column in 50 mM phosphate 
buffer pH 6.0 containing 200 mM NaCl (Lcc1 and Laccase A).  
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3.3.6 Determination of proteins’ molecular weight by mass spectrometry 
 
The molecular weights (MW) of SLAClong, SLACtruncated and Lcc1 were determined by 
matrix-assisted laser desorption ionization time-of-flight mass spectrometry, MALDI-
TOF-MS, as described in Chapter 5.12.1.  
 
3.3.7 Metal content determination 
 
The metal (Cu and Zn) content of purified proteins was determined with a Thermo 
Electron M Series Atomic Absorption Spectrometer (AAS), as described in             
Chapter 5.12.4.  
 
3.3.8 N-terminal sequencing of Laccase A from Trametes versicolor 
 
The N-terminal sequencing of Laccase A was performed by Dr. Joe Gray (Pinnacle, 
Newcastle University) using a Beckman LF3000 gas-phase protein micro-sequencer. 
 
3.3.9 Fluorescence spectroscopy 
 
Fluorescence spectra and time course measurements were performed on a Cary Eclipse 
Fluorescence Spectrophotometer (Varian Inc., Agilent Technologies), as described in 
Chapter 5.12.6. ATTO 647N and ATTO 532 were excited at 630 and 520 nm, 
respectively, and the emission was measured at 657 and 550 nm, respectively.              
Trp residues were excited at 285 nm, with emission monitored at 334 nm. The protein 
samples were prepared in 50 mM phosphate pH 6.0 (Lcc1 and Laccase A) or pH 7.5 
(SLACtruncated) in the anaerobic chamber (Belle Technology, [O2] << 2 ppm) in septum 
sealed gas tight 3 mL cuvette. The proteins were reduced with anaerobic 1 mM (final 
concentration) hydroxylamine, injected using a gas tight syringe (Hamilton).  
 
3.3.10 Circular dichroism spectroscopy 
 
Far-UV (190 - 260 nm) and visible (300 - 700 nm) circular dichroism (CD) spectra of 
proteins were acquired on a Jasco J-810 spectrometer, as described in Chapter 5.12.3. 
For far-UV CD measurements, the SLACtruncated, Laccase A and Lcc1 concentrations 
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were 1.0, 1.0 and 0.64 mg/mL, respectively, whilst for visible CD they were 9.1, 5.5 
and 5.8 mg/mL, respectively.  
 
3.3.11 UV-Vis absorption spectroscopy 
 
UV-Vis spectra were acquired on a Perkin Elmer λ 35 spectrophotometer equipped with 
a Parkin Elmer PTP-1 peltier or a Varian Cary 50 spectrophotometer (Varian Inc., 
Agilent Technologies), as described in Chapter 5.12.2.  
  
3.3.12 Continuous wave electron paramagnetic resonance spectroscopy  
 
Continuous wave (cw), X-band (9.48 GHz) electron paramagnetic resonance (EPR) 
spectra of SLACtruncated, Laccase A and Lcc1 were acquired at ~ 40 or ~ 80 K with a 
Bruker EMX EPR spectrometer equipped with a TE102 cavity and an ESR900 cryostat 
(Oxford Instruments), as described in Chapter 5.12.5.  
 
3.3.13 Detection of the transient intermediate in Laccase A 
 
The intermediate formed during anaerobic reduction of Laccase A and Lcc1 by 
hydroxylamine was detected at RT using a Varian Cary 50 spectrophotometer in O2-free 
Ar-degassed 50 mM phosphate pH 6.0 in a 3 mL septum sealed gas tight cuvette. 
Concentrated protein was diluted into an anaerobic buffer to give a final concentration 
of 14 - 27 µM. A gentle flow of O2-free Ar was passed over the solution for additional 
15 min. The reaction was initiated by injecting an anaerobic hydroxylamine (1 mM), 
using a gas tight syringe. The optical spectra were acquired every 6.7 s until total 
reduction of the protein had been achieved. For the detection of the intermediate during 
aerobic turnover of hydroxylamine by Laccase A, a similar procedure was followed, but 
the reaction was carried out in air-saturated, 100 mM phosphate pH 6.0. 
For detection of the intermediate using cw X-band EPR, ~ 1 mM of anaerobic 
Laccase A in 42 mM phosphate pH 6.0 plus 15 % glycerol was incubated for around 2 h 
in the anaerobic chamber with an excess of hydroxylamine to afford complete reduction 
of the Cu centers. The enzyme was re-oxidized with an excess of O2, after which it was 
immediately frozen in liquid N2. The whole procedure was completed within 10 s from 
the start of the incubation with O2. After acquisition of the first EPR spectrum at               
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~ 40 K, the sample was then warmed up to RT and, after a certain time interval (30 s,        
1 and 5 min), frozen in liquid N2 and its spectrum re-measured.  
 
3.3.14 Protein labeling with fluorescent dyes 
 
Prior to labeling with ATTO 647N or ATTO 532 N-hydroxysuccinimide (NHS) ester 
modified fluorescent dyes, Laccase A and Lcc1 were exchanged into 100 mM 
phosphate pH 6.0, whilst SLACtruncated was exchanged into 100 mM phosphate pH 7.5. 
The proteins were labeled anaerobically using modified versions of published protocols 
[150, 151], as described in Chapter 5.11. Typically, the dye to protein labeling ratios 
were kept in the range of 40 to 80 % per protein’s monomer.    
 
3.3.15 Creation of structural model of Lcc1 
 
Structure modeling of Lcc1 was performed with I-TASSER software [161] using the 
crystal structure of TvL1KYA (pdb file: 1KYA) as the template. The template modeling 
(TM) score of 0.99 ± 0.04 and an RMSD between the main chain atoms of the modeled 
structure and the template of 3.1 ± 2.2 Å were calculated. The TM-score indicates the 
difference between the modeled structure and the template by a score of 0 to 1, where 1 
indicates a perfect match between two structures. To predict the substrate-binding sites 
of Lcc1, the model was overlaid onto the crystal structure of TvL1KYA containing one 
molecule of 2,5-xylidine. PyMol software was used to calculate qualitative electrostatic 
surface representations and to visualize the structural model [162]. 
 
3.3.16 Kinetic measurements on ATTO 532 labeled Laccase A using stopped flow 
spectrophotometer 
 
Stopped flow experiments were performed as previously described [163] using an 
SX18MV Applied Photophysics stopped flow spectrophotometer with fluorescence 
detection. An increase in fluorescence intensity at 340 and 550 nm, in parallel with a 
disappearance of the absorbance at 330 and 610 nm of N-terminally ATTO 532 labeled 
Laccase A, respectively, was followed. An optical cut off filter of 304 nm and a notch 
filter (which blocks 532 nm laser light) were used for detection of the emission from 
Trp (λexcitation = 280 nm, λemission = 340 nm) and ATTO 532 (λexcitation = 532 nm,           
λemission = 550 nm), respectively. Prior to the measurements, O2 was removed from the 
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internal flow lines of the apparatus by flushing with an anaerobic solution of sodium 
dithionite. The sample syringes were sealed with septa and gentle flow of O2-free Ar 
was passed over the system for additional 45 min. Anaerobic, concentrated Laccase A 
and ATTO 532 labeled Laccase A were mixed and diluted into 100 mM phosphate         
pH 6.0 to provide the final concentrations (in the syringe) of 3.56 µM and 0.14 µM, 
respectively. The other syringe contained an anaerobic solution of sodium ascorbate 
(600 µM) in 100 mM phosphate pH 6.0. To maintain anaerobic conditions, O2-free Ar 
was gently bubble through the samples during the experiments.  
 
3.3.17 Laccase activity assays 
  
The initial selection of Lcc1 secreting transformants was performed using an on-plate 
activity assay. Transformed P. methanolica PMAD11, P. pastoris X33 and S. commune 
WT and KS8 strains were grown for 3 days at 30 °C on MtM-agar (expression in yeast) 
or MM-agar (expression in S. commune) plates containing 0.2 mM Cu(NO3)2 and           
0.2 mM ABTS. After additional 10 - 24 h incubation at 4 °C the colonies were checked 
for the development of a green halo.  
Laccase activity in culture supernatant was determined using ABTS as the 
substrate. 1 mL aliquots of culture were collected every 1 - 3 days and centrifuged.       
The reaction mixture consisted of 100 µL of 10 mM ABTS added to 900 µL of 
McIlvaine buffer (0.1 M citric acid/0.2 M K2HPO4) pH 4.0. The reaction was initiated 
by addition of 100 µL of filtered culture. Oxidation of ABTS was followed at 420 nm                         
(ε420 = 36000 M-1cm-1 [164]). The activity is expressed as nanokatal×mL-1 (nkat×mL-1), 
which is defined as the amount of enzyme catalyzing the oxidation of 1 nmol ABTS per 
second (10-9 mol×s-1×mL-1) [165]. 
The influences of pH (McIlvaine buffer pH 2.2 - 7.0, and 100 mM phosphate     
pH 7.4 and 7.8) and temperature (15 to 70 °C) on the activity of laccases were 
determined using 2 mM of both 2,6-dimethylphenol (2,6-DMP) and ABTS (the effect of 
temperature was measured at pH 4.0 (Laccase A) and pH 5.4 (Lcc1)). Prior to 
measurements at different temperatures, the reaction mixture was incubated for 15 min 
at the designated temperature and the reaction was initiated by the addition of protein. 
The relative activity was calculated from the initial rates of product formation, which 
was determined spectrophotometrically by following the conversion of 2,6-DMP to                          
3,5,3’,5’-tetramethoxydiphenoquinone at 468 nm (ε468 = 14800 M-1cm-1 [166]) and 
ABTS to ABTS radical at 420 nm (Appendix A). 
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Enzyme kinetics was investigated by assaying laccase activity at a range of 
substrate concentrations. The initial rates of product formation were used to determine 
the substrate-dependent reaction velocities. The Michaelis-Menten constant (KM) and 
catalytic rate constant (kcat) were derived from the nonlinear fit of the data to the 
Michaelis-Menten equation (Equation 3.1).  
 
€ 
ν0 =
d[P]
dt =
νmax[S]
KM + [S]
= kcat[E]
[S]
KM + [S]
           (Equation 3.1), 
 
where ν0 is the initial velocity of the reaction, νmax is the maximal velocity of the 
reaction, [P] is the product concentration, [S] the substrate concentration, and [E] is 
enzyme concentration. 
 
3.4 Results 
 
3.4.1 Over-expression studies of Lcc1 
 
3.4.1.1 Lcc1 over-expression in Escherichia coli  
 
The expression level of Lcc1 (band with an MWapp of 55 kDa on an SDS-PAGE gel) in 
the cytoplasm of E. coli BL21 (DE3) was high (Figure 3.3), however, most of the 
protein was found in an insoluble form. All attempts to obtain active Lcc1 from IB were 
unsuccessful (Table 3.2). The refolded enzyme contained negligible Cu and did not 
show spectral features and activity typical of laccase (Figure 3.4). Higher expression 
levels seem to result in the presence of a greater proportion of insoluble protein. Tuning 
protein expression by adjusting IPTG concentration did not improve expression of 
soluble Lcc1 (Figure 3.3.C). Although lower expression was obtained in E. coli Rosetta 
(DE3), which enhances the expression of proteins containing rare codons, most of Lcc1 
was still found in IB (Figure 3.3.D). A small increase in the production of soluble Lcc1 
in E. coli BL21 (DE3) was obtained by the addition of 0.1 mM Cu(NO3)2 and 25 mM 
proline to the media and decreasing the growth temperature to 10 °C (Figure 3.3.A).        
A significant improvement was obtained by expressing the enzyme as an N-terminal 
fusion to the NusA protein (Figure 3.3.E). The NusA tag has previously been reported 
to promote cytoplasmic solubility of its fusion partners [167]. Export of Lcc1 to the 
periplasm of E. coli failed, but a higher percentage of expressed soluble protein was 
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observed (Figure 3.3.F). In all cases, however, the purified enzyme did not show any 
laccase activity and spectral features typical of laccases.  
 
3.4.1.2 Lcc1 over-expression in Pichia methanolica and Picha pastoris 
 
The majority of P. methanolica PMAD11 colonies transformed with lcc1 showed 
laccase activity using an on-plate assay (in the presence of methanol as inducer), whilst 
none of the P. pastoris X33 colonies carrying the lcc1 gene did (data not shown). 
Strains transformed with the empty vectors did not show laccase activity. A shaken 
culture of P. methanolica PMAD11 colony transformed with lcc1 had a maximal 
activity of ~ 7.3 nkat/mL on the day of harvest, which is significantly lower than 
reported values [94]. This very low expression level hampered efficient Lcc1 
purification and the protein could only be partially purified from P. methanolica 
cultures (data not shown). The MWapp of the enzyme is ~ 80 kDa from an SDS-PAGE 
gel and ~ 100 kDa from gel-filtration column, both of which are significantly heavier 
than the reported value (64 kDa) [94].       
 
3.4.1.3 Lcc1 over-expression in Schizophyllum commune 
 
Lcc1 secretion from transformed S. commune was detected using an on-plate assay. 
Around 50 % of stable WT and KS8 strains transformed with clcc1_pESCT developed 
green halos around colonies (Figure 3.5.A), whilst empty WT and KS8 strains, which 
were grown as controls, showed no laccase activity (data not shown). This result 
confirms that the SC3 signal peptide is functional for Lcc1 secretion in S. commune. 
The average ratio of the halo and the colony diameters is 0.91 ± 0.07 for the WT strains 
and 0.87 ± 0.08 for KS8 strains (Figure 3.5.A and 3.5.B), indicating that the expression 
of Lcc1 is similar in both strains. However, based on activity assays in media, Lcc1 
expression was approximately 40 % higher in the KS8 compared to the WT strain 
(Figure 3.5.C). Expression levels reached maximum values after 8 - 9 days of growth 
for the WT strain (~ 25 nkat/mL) and 11 - 13 days for KS8 strain (~ 40 nkat/mL) and 
remained constant when cultivation was continued further. S. commune WT secretes 
around 2.9 g/L of the polysaccharide schizophyllan (SPG) (unpublished results,             
Dr. Karin Scholtmeijer), which dramatically increases the viscosity of the medium, 
whilst Lcc1-expressing KS8 does not produce SPG. Although the presence of SPG is 
	   100	  
probably not responsible for the lower expression of Lcc1 (unpublished results,              
Dr. Karin Scholtmeijer), increased viscosity hampers efficient protein purification.  
It has been reported that the presence of introns in the coding gene improves 
heterologous expression of proteins in S. commune [168]. 68 % of stable S. commune 
KS8 strains transformed with glcc1_pESCT secreted Lcc1, as determined using an         
on-plate assay. Figures 3.5.A and 3.5.B show higher halo to colony ratios (1.75 ± 0.95) 
for these KS8 strains compared to the KS8 strains transformed with clcc1_pESCT, 
indicating that the presence of introns indeed increases the expression of Lcc1. In the 
liquid cultures these transformants showed an almost 4-fold increase in activity 
compared to KS8 strains transformed with clcc1_pESCT (Figure 3.5.D).  
 Similar activity levels of cultures grown in CM and MM suggest that the 
composition of media has limited influence on KS8 strain growth and Lcc1 expression 
(Figure 3.6.A). However, the level of contaminants present in MM hampered Lcc1 
purification (data not shown). The addition of ethanol (PM medium) inhibited the 
growth of KS8 strain (data not shown). The presence of Cu(NO3)2 is essential for the 
expression of active Lcc1, however, the elevated concentration (4 mM) adversely 
affects the growth of KS8 strain (Figure 3.6.B). The initial pH of the media has very 
little effect on Lcc1 expression in the 6.6 to 8.0 range (Figure 3.6.C). Almost 2-fold 
higher production of active Lcc1 was observed for the fungus grown at 30 °C than at    
23 °C (Figure 3.6.D).  
 
3.4.1.4 Over-expression of cMYC tagged Lcc1 and T1D Lcc1 in Schizophyllum 
commune 
 
S. commune KS8 transformants expressing the C452S (T1D) Lcc1 variant were selected 
using sandwich immunodetection (Figure 3.7.A). The C452S mutation disrupts the        
T1 Cu site, thus inactivates the protein. To facilitate immunodetection, Lcc1 and 
C452S_Lcc1 were tagged C-terminally with a single cMYC peptide (sequence:             
N’-EQKLISSEEDL-‘C). The western blot analysis (Figure 3.7.B) showed that                
S. commune KS8 strains transformed with glcc1_cMYC_pESCT or 
C452S_glcc1_cMYC_pESCT successfully selected by sandwich immunodetection 
using anti-cMYC antibody (Figure 3.7.A), secrete Lcc1_cMYC and T1D Lcc1_cMYC 
as full-length forms (~ 65 kDa). However, the proteins do not show any activity when 
grown on either the Cu(NO3)2 and ABTS containing MM-agar (Figure 3.7.C) or in 
liquid cultures (data not shown).  
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3.4.2 Purification of Lcc1, Laccase A, SLAClong and SLACtruncated 
 
Typically, around 5 mg of purified Lcc1 per one litre of media was obtained from 
expression in S. commune KS8 strain, whilst approximately 35 mg of pure Laccase A 
was obtained from 1 g of crude T. versicolor acetone powder. Lcc1 and Laccase A were 
pure, giving single bands on SDS-PAGE gels at ~ 64 kDa (Figure 3.8.A and 3.8.B).  
The elution volumes of Lcc1 and Laccase A (65.8 and 68.0 ml) on the gel-filtration 
column correspond to MWapps of ~ 50 and ~ 43 kDa, respectively, indicative of the 
proteins being stable monomers in solution (Table 3.3). MALDI-TOF-MS of Lcc1 
gives a range of masses, with a mean value of ~ 60.3 kDa (Laccase A was not 
analyzed). The calculated MW of the lcc1 gene translation product is 53350.9 Da (Table 
3.3), indicating an average glycosylation level of ~ 12 %, similar to that of TvL1KYA 
[75] and TvL1GYC [103]. Lcc1 and Laccase A were isolated with 3.53 ± 0.29 and        
3.81 ± 0.19 equivalents of Cu per monomer and negligible Zn (Table 3.4).  
Purified SLAClong (SLAC variant containing the 30 residues-long TAT-leader 
sequence, ~ 100 mg/L of culture) has an MWapp of ~ 40 kDa by SDS-PAGE gel and 
elutes at 68.9 ml on the gel-filtration column, corresponding to an MWapp of 147 kDa, 
indicative of the protein being a stable oligomer in solution. However, the observed 
apparent masses of both the monomer and the oligomer are significantly heavier than 
reported values of 32 and 81 kDa, respectively [108, 153]. MALDI-TOF-MS gives 
several peaks for SLAClong, with the heaviest form having a mass of 36919.9 Da (Table 
3.3). The calculated MW of SLAClong is 36875.0 Da, indicating that its TAT-leader 
peptide is not cleaved during expression, resulting in heterogeneity. This finding is 
contrary to what was observed by Machczynski et al. and Skalova et al., who reported 
that the TAT-leader sequence is cleaved during protein expression in E. coli [153] and 
A. oryzae [108], respectively. The N-terminal and C-terminal sequencing showed that 
SLAC expressed in E. coli [153] lacks the first 34 - 42 residues and the ending                  
7 residues, respectively. Similar truncations were observed for SLAC expressed in          
A. oryzae [108].  
Expression of SLACtruncated, lacking the N-terminal 44 residues (this truncation 
point was based on the crystal structure of SLAC (pdb file: 3CG8, [108]), which starts 
at residue 45), yielded a protein (~ 100 mg/L of culture), which gives a single band on                    
an SDS-PAGE gel with an MWapp of ~ 37 kDa (Figure 3.8.C). MALDI-TOF-MS gives 
a single peak of 32591.6 Da (Table 3.3), which is very close to the theoretical value 
(32587.0 Da). The gel-filtration elution volume of 74.3 mL (MWapp of 104.3 kDa) 
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indicates that SLACtruncated is a stable trimer in solution. AAS quantifies 3.38 ± 0.16 
equivalents of Cu per monomer of SLACtruncated and negligible Zn (Table 3.4). 
 
3.4.3 Structural comparison and stability of Lcc1, Laccase A and SLACtruncated 
 
Edman degradation data from the N-terminus of Laccase A identifies the first six 
residues as G I G P V A. This fragment is identical to the N-terminal sequence in 
TvL1KYA [75], which is different to that of TvL1GYC (A I G P A A) [103]. Lcc1 
shares only 71.7 % sequence similarity with TvL1KYA and 70.1 % with TvL1GYC 
(Figure 3.9). The structural model of Lcc1 predicts that His396, His457 and Cys452 
coordinate the T1 Cu. Similar to TvL1KYA and TvL1GYC, Lcc1 has                                 
a non-coordinating Phe462 residue in the axial position of the T1 Cu site, and therefore, 
is expected to exhibit a reduction potential higher than 700 mV versus NHE.                 
The T2/T3 Cu ions are coordinated by His64, His66, His109, His111, His399, His401, 
His451 and His453. The T1 Cu is linked with the T2/T3 Cu cluster by the conserved 
His451(T3 Cu)-Cys452(T1 Cu)-His453(T3 Cu) motif.  
Secondary structure compositions of purified Laccase A, Lcc1 and SLACtruncated 
have been estimated using far-UV CD spectroscopy. The far-UV CD spectrum of Lcc1 
resembles that of Laccase A and shows a maximum (+) at 196 nm and the minimum (-) 
at ~ 216 nm (Figure 3.8.D). The spectrum of SLACtruncated exhibits three bands at 201 
nm (+), 222 nm (−) and 230 nm (+) (Figure 3.8.D). The obtained secondary structure 
composition of Laccase A, SLACtruncated and Lcc1 are in relatively good agreement with 
those calculated from the structures of TvL1KYA [75], SLAC [109] and the structural 
model of Lcc1 (Table 3.5). While Lcc1 and Laccase A have similar secondary structure 
composition, SLACtruncated shows significant increase in the percentage of β-strand and a 
lowered α-helical content.  
Laccase A and Lcc1 are relatively stable (based on activity measurements with 
ABTS and 2,6-DMP) in the 4.0 to 7.0 pH range for at least 60 min (at 21 °C), however, 
this stability decreased with pH. After 60 min incubation at pH 2.2 Laccase A still 
retained ~ 50 % of the initial activity (Figure 3.8.E), whilst Lcc1 activity was 
completely abolished (Figure 3.8.F).  
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3.4.4 Spectroscopic characterization of Lcc1, Laccase A and SLACtruncated 
 
The UV-Vis spectra are dominated by the T1 Cu S(Cys)π→Cu(II) dx2−y2 LMCT bands 
at 610 nm for Lcc1 and Laccase A and 590 nm for SLACtruncated (Figure 3.10.A and             
Table 3.4). The relative absorption at 280 and 610 nm (A280/A610 ratio) is ~ 17 for Lcc1 
and Laccase A (at pH 6.0). The A280/A590 ratio of SLACtruncated is ~ 12 (pH 7.5), which 
is in good agreement with the reported value [153]. The binuclear T3 Cu site of laccases 
demonstrates an intense bridging OH− to Cu(II) LMCT transition band at ~ 330 nm.   
The A280/A330 ratio for Lcc1 is ~ 24, which is higher than that for Laccase A (~ 10) and 
SLACtruncated (~ 15) and it does not change after additional incubation of Lcc1 with 
copper. 
The visible CD spectra contain transitions mainly involving the T1 Cu 
(transitions involving T3 Cus are of low intensity). The spectra of Laccase A and Lcc1 
(Figure 3.10.B) are similar and in good agreement with those reported earlier for fungal 
laccases [117, 169, 170]. Three intense bands at 438 nm (22830 cm-1; −), 530 nm 
(18870 cm-1; +) and 630 nm (15870 cm-1; −) can be distinguished. The visible CD 
spectrum of SLACtruncated (Figure 3.10.B) is decidedly different to those of the fungal 
laccases and resembles that of plastocyanin [171]. In particular, between 450 and 700 
nm SLACtruncated shows a broad asymmetric positive maximum, whereas Laccase A and 
Lcc1 display two oppositely signed bands. The visible CD spectrum of SLACtruncated is 
characterized by intense bands at 438 nm (22830 cm-1; −), 540 nm (18520 cm-1; +) and 
700 nm (14280 cm-1; −). By comparison with the well-characterized spectra of 
plastocyanin [172], fungal laccase from Polyporus pinsitis [169] and its F463M variant 
(containing Met instead of Phe residue in the axial position, [169]), the bands at 438 and 
530 nm (and 540 nm for SLACtruncated) can been assigned as N(His)π→Cu(II) dx2−y2 and 
a S(Cys)pseudo-σ→Cu(II) dx2−y2 LMCT transitions at the T1 Cu site, respectively        
(Table 3.6). Although the S(Cys)π→Cu(II) dx2−y2 LMCT transition dominates the          
UV-Vis absorption spectrum, this band cannot be resolved in the visible CD spectrum. 
The low-energy bands at 630 nm observed in Lcc1 and Laccase A spectra, and at          
700 nm (14280 cm-1) in the SLACtruncated spectrum, can be assigned to dxz→dx2−y2 
(fungal laccases) and dyz→dx2−y2 (SLACtruncated) ligand field (LF) transitions at the           
T1 Cu site [169, 170, 173]. The LF transition in T. versicolor laccases, which is shifted 
to higher energy, indicates increased ligand field strength relative to plastocyanin and 
F463M laccases. This has previously been interpreted as being due to the lack of an 
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axial Met ligand and a more trigonal planar geometry in the T1 Cu sites of fungal 
laccases [169] and Fet3p [173]. 
The T1 Cu site of Laccase A, Lcc1 demonstrate an axial EPR spectrum         
(Figure 3.10.C) similar to those reported earlier for fungal laccases [169]. The T2 Cu 
site is also axial, but its overlap with the T1 Cu signal prevents from accurate 
deconvolution. The T1 and T2 Cu sites of SLACtruncated (Figure 3.10.C) also 
demonstrate the axial EPR signals with hyperfine coupling (Az) in the gz region of 76 × 
10-4 and 107 × 10-4 cm-1, respectively, consistent with previously reported values [153]            
(Table 3.4).   
 
3.4.5 Kinetic parameters for the reactions of Laccase A, Lcc1, SLAClong and 
SLACtruncated with 2,6-DMP and ABTS 
 
The influence of pH on the activity of Laccase A and Lcc1 was determined for phenolic 
(2,6-DMP) and nonphenolic (ABTS) substrates (structures available in Appendix A). 
Both enzymes oxidise 2,6-DMP in a pH-dependent manner showing the highest activity 
between pH 4.0 and 6.0 (Figures 3.11.A), which is slightly higher than the average for 
fungal laccases (pH 4.0) [174]. At alkaline pH the activity of laccases is negatively 
influenced by the OH− ion inhibition (at the T2/T3 Cu cluster), but positively affected 
by the lower reduction potential of the phenolic substrates [18]. The combination of 
these two effects contributes to the bell-shaped dependence of activity on pH. Both 
enzymes show maximum catalytic efficiency (expressed as kcat/KM) at pH 5.4, but the 
value is 2-fold higher for Laccase A than for Lcc1 (Figures 3.12.A and 3.12.B).            
The affinity of Laccase A and Lcc1 for 2,6-DMP increases with pH but does not reach 
the maximum at the optimal pH (Figures 3.12.C and 3.12.D). kcat shows the standard         
bell-shaped dependence on pH reaching a maximum at approximately pH 3.0 for 
Laccase A (Figure 3.12.E), and a plateau at ~ pH 4.0 for Lcc1 (Figure 3.12.F). When 
ABTS is used as the substrate (Figure 3.11.B), both enzymes show a linear dependence 
of activity on pH (decreasing as the pH becomes more alkaline due to the OH− ion 
binding at the T2/T3 Cu cluster [18]), which is similar to other fungal laccases [174].  
The oxidation of both 2,6-DMP and ABTS is optimal at 45 °C for Laccase A, 
but is at 45 and 35 °C for Lcc1 (Figures 3.11.C and 3.11.D), somewhat lower than the 
optimum temperature range (50 - 70 °C) of the majority of fungal laccases [5, 174].   
The kinetic parameters (KM and kcat) for the Laccase A-catalyzed oxidation of both 
ABTS and 2,6-DMP were determined at pH 4.0 at 21 and 45 °C, whereas for Lcc1 
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reactivity with ABTS (at 21 and 35 °C) and 2,6-DMP  (at 21 and 45 °C) was measured 
at pH 4.0 and 5.4, respectively (Figure 3.13). Laccase A shows similar affinity for both 
substrates that decreases when the temperature increases. However, kcat/KM is almost 
unaffected by temperature (Table 3.7). The affinity of Lcc1 for ABTS increases 1.4-fold 
at higher temperature, whereas for 2,6-DMP it is unaffected by temperature. At 35 °C, 
kcat/KM for Lcc1 with ABTS increases 2-fold compared to that at 21 °C but is still lower 
than that of Laccase A. A 2-fold increase with temperature of the kcat/KM with 2,6-DMP 
results in Lcc1 being more efficient in the oxidation of this substrate than Laccase A 
(Table 3.7).  
The kinetic parameters of SLAClong and SLACtruncated were determined with 2,6-
DMP at pH 8.0 (Figure 3.13.E). SLACtruncated has substantially lower affinity (~ 30 and 
220-fold higher KM and ~ 40 and 230-fold lower kcat) towards 2,6-DMP than Lcc1 and 
Laccase A (Table 3.7). Removal of the N-terminal 44 residues appears to change the 
activity of the enzyme. The KM (6.6 mM) and kcat/KM (0.97 mM-1s-1) values for 
SLACtruncated are ~ 2 to 6-fold and ~ 0.9 to 7-fold higher respectively than previously 
reported [153, 175, 176]. The KM of SLAC is almost 2-fold higher than for SLAClong 
(3.75 mM, data not shown), however kcat/KM remains almost unaffected. The role of the 
missing residues is unknown. The N-terminus points to the opposite direction of the 
T2/T3 Cu cluster and predicted shallow substrate-binding cavity (center of the trimer), 
making it unlikely for the TAT-signal peptide to approach the substrate-binding pocket 
[108].  
 
3.4.6 Preliminary studies on transient species present during the catalytic cycle of 
Laccase A  
 
Reduction of Laccase A with hydroxylamine in O2-containing buffer resulted in the 
gradual disappearance of absorption bands at 330 and 610 nm (Figure 3.14.A).             
The reduction process was complete within 90 min (Figure 3.14.B). Reaction of the 
reduced sample with O2 resulted in full recovery of absorption at 330 nm and only 
partial recovery of the 610 nm band (data not shown). However, reduction of the protein 
in anaerobic buffer resulted in the initial formation of a band at 420 nm (within a dead 
time of the measurement), which subsequently disappeared within a few minutes along 
with (but slower) the 330 and 610 nm bands (Figures 3.14.C and 3.14.D). After the 
addition of O2-containing buffer to the fully reduced sample, the 420 nm band                
re-appeared together with the partial recovery of the 330 and 610 nm bands (data not 
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shown). A similar band at ~ 420 nm was also been observed during anaerobic reduction 
of Lcc1 and subsequent oxidation (data not shown).  
To investigate whether this transient species (giving rise to the 420 nm band) is 
paramagnetic, X-band EPR spectra were obtained during the oxidation of 
hydroxylamine-reduced Laccase A. Reduced Laccase A was mixed (under anaerobic 
conditions) with an excess of O2 and frozen in liquid nitrogen. The results are 
inconclusive as the EPR spectra in the g = 2 region are complex and consists of several 
intense overlapping signals that can be attributed to the T1 and T2 Cu(II)s (data not 
shown).  
 
3.4.7 Preliminary studies on fluorescently labeled laccases  
 
The absorption bands of Laccase A (Figure 3.15.A), Lcc1 and SLACtruncated at ~ 600 nm         
(T1 Cu(II)) and ~ 330 nm (T2/T3 Cu(II)) are absent when the proteins are reduced.                
The emission spectra of Laccase A (Figure 3.15.B), Lcc1 and SLACtruncated are 
dominated by fluorescence from Trp residues (7, 6 and 5 Trp residues in Laccase A, 
Lcc1 and SLACtruncated respectively) showing a maximum at around 333 nm. This 
emission overlaps significantly with the 330 nm absorption band of the T2/T3 Cu(II) 
cluster. Therefore, in the oxidized state of the protein, this fluorescence is quenched by 
Förster Resonance Energy Transfer (FRET, Chapter 1.4.3) to the 330 nm absorption 
band. In the reduced state, the absorption band at 330 nm is absent, and therefore, the 
quenching of fluorescence is limited. This change is reflected in an increase in 
fluorescence intensity. (Figure 3.15.C). The switching ratios (SRs, Chapter 5.12.6) 
under anaerobic conditions are 0.48 for Laccase A, 0.30 for Lcc1 and 0.36 for 
SLACtruncated.  
To monitor redox changes at the T1 Cu site via fluorescence, Lcc1 and Laccase 
A were N-terminally labeled with ATTO 532 or ATTO 647N dyes, whereas 
SLACtruncated was N-terminally labeled with ATTO 590 (structures of dyes are shown in 
Appendix A). The emission spectra of the dyes (maxima at 553, 624 and 669 nm for 
ATTO 532, ATTO 590 and ATTO 647N, respectively) overlap with the absorption 
band of the T1 Cu site of Lcc1, Laccase A and SLACtruncated at ~ 600 nm. In the 
oxidized state of the proteins, the fluorescence of the dye is quenched by FRET to the 
600 nm absorption band, whilst in the reduced state this quenching is limited. The two-
phase increase in Trp and ATTO 647N fluorescence emission observed for ATTO 647N 
labeled Laccase A and Lcc1 upon reduction is different to the one-phase increase for 
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ATTO 590 labeled SLAC (and other fluorescently labeled T1 Cu-containing proteins, 
see Chapter 1.3 and Chapter 2). These unusual reduction kinetics for the fungal laccases 
are probably due to trace amounts of oxygen present in the reaction mixture. The 
reduction kinetics are sensitive to the oxygen concentration, which is hard to contol, 
even for experiments performed in an anaerobic chamber. The fluorescence SRs are 
0.44 for ATTO 647N labeled Lcc1, 0.64 for ATTO 647N labeled Laccase A and 0.63 
for ATTO 590 labeled SLACtruncated (Figure 3.16.A). Labeled SLACtruncated is stable, 
whereas labeled Lcc1 and Laccase A are not and their SRs decrease within hours (this 
decrease is faster for labeled Lcc1 than for Laccase A, data not shown). The kinetics of 
reduction of ATTO 532 labeled Laccase A was studied using stopped-flow 
spectrophotometry. ATTO 532 and Trp emission traces superimpose with the 
corresponding absorbance traces (values multiplied by -1) and follow the same kinetics, 
showing that reduction of the T1 Cu site and T2/T3 Cu cluster can be monitored 
simultaneously and independent of each other using FRET-based approach (Figure 
3.16.B). 
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Denaturating mixture Refolding mixture Observations 
6 M Gdn a, 50 mM EDTA b, 2 mM DTT c in 0.1 M Hepes d, pH 8.0 
6 M Urea, 50 mM EDTA, 2 mM DTT in 0.1 M Hepes, pH 8.0 
10 mM Hepes, pH 8.0, 
5 mM DTT 
Protein exchanged into 250 mM NH4Ac e pH 8.0 by 
ultrafiltration and incubated with 5 mM CuSO4. 
Protein precipitated. 
10 mM Hepes, pH 8.0,  
5 mM DTT 
Protein dialysed against 125 mM NH4Ac pH 8.0 
and incubated with CuSO4: (a) 5 mM (protein 
precipitated), (b) 2.5 mM (no Cu incorporation, 
Lcc1 inactive with ABTS), (c) 1 mM (no Cu 
incorporation, Lcc1 inactive with ABTS). 
6 M Urea, 50 mM EDTA, 2 mM DTT in 0.1 M Hepes,  
pH 8.0 
10 mM Hepes, pH 8.0;  Protein precipitated. 
6 M Urea, 10 or 30 mM EDTA, 2 mM DTT in 0.1 M Hepes,  
pH 8.0 
10 mM Hepes, pH 8.0,  
2 mM DTT 
Protein dialysed against 125 mM NH4Ac pH 8.0 
and incubated with 1 and 2.5 mM CuSO4. Protein 
inactive with ABTS. 
6 M Urea, 10 or 30 mM EDTA, 2 mM DTT in 0.1 M Hepes,  
pH 8.0 
10 mM Hepes, pH 8.0,  
2 mM DTT, 1 or 2 mM 
CuSO4 
Protein inactive with ABTS. 
a Guanidinium chloride b Ethylenediaminetetraacetic acid. c Dithiothreitol. d 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid. e Ammonium acetate.  
 
Table 3.2 Experimental conditions for fast refolding of Lcc1 from IB. 
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MW, Da 
Protein Experimental 
mass 
Theoretical 
mass 
Ve, mL  MWapp, kDa  
Lcc1 60226.4 53350.9 a 65.8  49.6 
Laccase A b b 68.0 42.7 
SLAClong 
36919.9 
35138.4 
34597.1 
36875.0 a 68.9  147  
SLACtruncated 32591.6 32587.0 a 74.3  104 c 
a MW excluding the N-terminal Met residue. b Not determined. c MWapp corresponds to 
the trimeric form of the protein.  
 
Table 3.3 MALDI-TOF-MS and the gel-filtration data for Lcc1, Laccase A, SLAClong 
and SLACtruncated.  
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Protein Spectral  
properties Laccase A Lcc1 SLACtruncated 
 UV-Vis a 
λmax (1), nm 330 330 330 
λmax (2), nm 610 610 590 
εmax (2), M-1cm-1 4900 b 4900 4400 c 
A280/Amax(1) ~ 10 ~ 24 ~ 15 
A280/Amax(2) ~ 17 ~ 17 ~ 12 
 T1 Cu (T2 Cu) EPR parameters d 
gx  2.042 2.042 2.032 (2.048) 
gy  2.042 2.042 2.049 (2.055) 
gz  2.191 (2.227) e 2.191 (2.244) e 2.233 (2.362) 
Ax, 10-4 cm-1 9.3 9.3 9.3 (0.0) 
Ay, 10-4 cm-1 9.6 9.6 9.6 (0.0) 
Az, 10-4 cm-1  80 (199) e 80 (178) e 77 (107) 
 Metal content per monomer 
Cu/monomer 3.81 ± 0.19 3.53 ± 0.29 3.38 ± 0.16 
Zn/monomer Negligible Negligible Negligible 
 Intrinsic fluorescence a 
λ excitation, nm 280 278 280  
λ emission, nm 332 333 333 
SR 0.48 0.30 0.36 
 
ATTO 647N labeled Laccase A and Lcc1  
or ATTO 590 labeled SLAC a 
SR 0.64 0.44 0.63 
a In 50 mM phosphate pH 6.0 (Lcc1 and Laccase A) and 20 mM Tris pH 7.5 
(SLACtruncated) at room temperature (RT). b Taken from [117]. c Taken from [153].   d In 
50 mM phosphate pH 6.0 (Lcc1 and Laccase A) and 20 mM Tris pH 7.5 containing 200 
mM NaCl (SLACtruncated) at ~ 80 K. e The T1 and T2 Cu(II)s signals overlap, thus the 
parameters obtained are less precise.  
 
Table 3.4 Comparison of spectral properties of Laccase A, Lcc1 and SLACtruncated.  
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Secondary structure, % 
Protein Data analyzed 
Fitting 
NRMSD a Helix β-sheet Turn Random Coil 
Far-UV CD b 0.025 9.0 36.0 23.0 32.0 
Laccase A 
Crystal structure c  9.4 31.3 30.5 16.6 
Far-UV CD b 0.016 11.0 36.0 23.0 31.0 
Lcc1 
Homology model c  10.8 33.5 32.3 23.4 
Far-UV CD d 0.034 3.0 47.0 22.0 27.0 
SLACtruncated 
Crystal structure c  6.6 46.5 27.5 19.4 
a Normalised to 1 root-mean square deviation [177] for fitting of the far-UV CD spectra in the 190 - 240 nm range using the CDSSTR analysis method 
[178], protein reference set 4, as implemented by Dichroweb [179]. b In 10 mM phosphate pH 6.0 at 25 °C. c The crystal structures of Laccase A (pdb 
code: 1KYA) [75] and SLAC (pdb code: 3KW8) [109] and the structural model of Lcc1 created with I-TASSER [161] using 1KYA as the template 
were used. d In 10 mM phosphate pH 7.0 at 25 °C. 
 
Table 3.5 Comparison of the secondary structure content determined from available structures or a homology model, using STRIDE [180], with those 
calculated from far-UV CD spectra using Dichroweb [179]. 
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Energy, cm-1 (λ, nm) 
Transition 
Laccase A a Lcc1 a  SLACtruncated b 
P. pinsitis 
laccase a, c 
P. pinsitis 
F463M laccase b, c 
M. thermophila 
laccase c, d 
Plastocyanin b, c, e 
dz2→dx2−y2 f f f 6900 (1450) 6500 (1539) 6500 (1539) 5000 (2000) 
dxy→dx2−y2 f f f 13270 (754) 12370 (808) 13160 (760) 10800 (926) 
dyz→dx2−y2 f f ~ 14280 (~ 700) 14350 (697) 13700 (730) 14290 (700) 12800 (781) 
dxz→dx2−y2 15870 (630) 15870 (630) f 15860 (630) 14880 (672) 15470 (646) 13950 (717) 
S(Cys)π→Cu(II) dx2−y2 16390 (610) g 16390 (610) g 16950 (590) g 16450 (608) 16630 (601) 16610 (602) 16700 (599) 
S(Cys)pseudo-σ→ 
Cu(II) dx2−y2 18870 (530) 18870 (530) 18520 (540) 18860 (530) 18540 (539) 18650 (536) 18700 (535) 
N(His)π→Cu(II) dx2−y2 22830 (438) 22830 (438) 22830 (438) f f f 21390 (468) 
a Proteins containing a T1 Cu site with Phe in the axial position. b Proteins containing a T1 Cu site with Met in the axial position. c Taken from [169].    
d Proteins containing a T1 Cu site with Leu in the axial position. e Taken from [172]. f Not determined. g Values are taken from the UV-Vis spectrum. 
 
Table 3.6 Comparison of the LMCT and LF transitions from UV-Vis absorption and visible CD spectra. 
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Substrate Temperature, °C KM, µM kcat, s-1 kcat/KM, µM-1s-1 
 Laccase A 
         21  31.5 ± 4.1 404 ± 10 12.8 ± 1.2 
ABTS, pH 4.0 
         45 a 49.0 ± 4.0 817 ± 29 16.7 ± 1.0 
         21 29.7 ± 1.8 265 ± 6 8.9 ± 0.3 
2,6-DMP, pH 4.0 
         45 a 46.7 ± 1.6 483 ± 6 10.3 ± 0.2 
 Lcc1 
         21 1011 ± 7 2475 ± 148 2.4 ± 0.2 
ABTS, pH 4.0 
         35 a 743 ± 3 3796 ± 158 5.1 ± 0.2 
         21 223 ± 8 1457 ± 107 6.5 ± 0.3 
2,6-DMP, pH 5.4 
         45 a 245 ± 10 3304 ± 46 13.5 ± 0.4 
 SLACtruncated 
2,6-DMP, pH 8.0           21 6601 ± 263 6.4 ± 0.3 (9.7 ± 0.1)×10-4 
a Single measurement. 
 
Table 3.7 Turnover number (kcat), Michaelis-Menten constant (KM) and catalytic 
constant (kcat/KM) of Laccase A, Lcc1 and SLACtruncated with ABTS and 2,6-DMP.  
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A) B) 
  
C)  D) 
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Figure 3.3 SDS-PAGE gels of Lcc1 expression in E. coli. Cytoplasmic expression        
of Lcc1 in BL21 (DE3) at (A) 10 °C and (B) 20 °C; (C) Tuner at 20 °C and (D) Rosetta 
(DE3) at 20 °C. (E) Cytoplasmic expression of Lcc1 fused to NusA in BL21 (DE3) at 
30 °C. Cells were grown with or without 0.1 mM Cu(NO3)2 and 25 mM proline.            
(F) Periplasmic expression of Lcc1 in BL21 (DE3). Legend: 1 - expressed proteins,             
2 - soluble proteins, 3 - soluble proteins in periplasmic fraction, 4 - soluble proteins in 
cytoplasmic fraction, 5 - insoluble proteins (pellet).    	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B) 
 	  
Figure 3.4 Refolding of Lcc1 from IB. (A) SDS-PAGE gel of refolded Lcc1 from IB. 
Legend: 1 - expressed proteins, 2 - soluble, pure Lcc1 refolded from IB. (B) UV-Vis 
spectra of Laccase A ( ) and pure, refolded Lcc1 ( ) after attempted reconstitution 
with copper. Spectra were acquired at RT in 50 mM phosphate pH 6.0. 
 
A) 
 
B) 
 
C) 
 
D) 
 
 
Figure 3.5 (A) On-plate activity assay of S. commune WT transformed with 
clcc1_pESCT and KS8 transformed with clcc1_pESCT and glcc1_pESCT. Top row: 
front of the colony; bottom row: other side of the colony. (B) Comparison of the halo to 
colony ratio of WT and KS8-strains. Activity of Lcc1 secreted by (C) WT ( ) and KS8 
() strains transformed with clcc1_pESCT and (D) KS8 strains transformed with 
clcc1_pESCT () and glcc1_pESCT ( ) (D) grown (30 °C) in liquid cultures MM      
at pH 7.0 and in the presence of 2 mM Cu(NO3)2. Activity was determined (RT) at     
pH 4.0 with 0.91 mM ABTS as the substrate. 
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 A) B) 
  
C) D) 
  
 
Figure 3.6 The influence of (A) medium composition, (B) Cu(NO3)2 concentration,    
(C) pH and (D) temperature on activity of Lcc1 in media during 15 - 17 days of growth. 
Lcc1 was secreted by S. commune KS8 transformed with glcc1_pESCT grown (30 °C) 
in liquid standing cultures in: (A) MM () and CM ( ) pH 7.0 with 2 mM Cu(NO3)2; 
(B) in CM at pH 7.0 in the absence ( ) and presence of 1 ( ), 2 (), 3 ( ) and          
4 mM ( ) Cu(NO3)2; (C) in CM at pH 6.6 ( ), 7.0 (), 7.4 ( ) and 8.0 ( ) with      
2 mM Cu(NO3)2; (D) in CM at 23 °C ( ) and 30 °C () at pH 7.0 with 2 mM 
Cu(NO3)2. Activity was measured at pH 4.0 (RT) with 0.91 mM ABTS as the substrate. 
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Figure 3.7 (A) On-plate screen assay of S. commune KS8 transformed with 
C452S_glcc1_cMYC_pESCT and glcc1_cMYC_pESCT via sandwich 
immunodetection using the anti-MYC alkaline phosphatase conjugated antibody (results 
provided by Dr. K. Scholtmeijer). (B) Western blot of C452S_Lcc1_cMYC (selected 
transformants: iii - v) and Lcc1_cMYC (selected transformants: vi - viii) expressed in 
liquid culture. (C) On-plate activity assay of S. commune KS8 transformed with 
glcc1_pESCT (i - positive control (Figure 3.5.A) and ii - negative control), 
glcc1_cMYC_pESCT (iii - v) and C452S_glcc1_cMYC_pESCT (vi - vii). Colonies 
were grown for 3 days on MM plates in the presence of 0.2 mM ABTS and 0.2 mM 
Cu(NO3)2.  
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Figure 3.8 SDS-PAGE gels of (A) Laccase A purified from crude acetone powder of    
T. versicolor, (B) Lcc1 expressed by S. commune KS8 strain transformed with 
glcc1_cMYC_pESCT and (C) SLAC expressed in E. coli. (D) Far-UV CD spectra of 
Laccase A ( ), Lcc1 ( ) and SLAC ( ) at 25 °C. The spectra of Laccase A and 
Lcc1 were acquired in 10 mM phosphate pH 6.0, whereas SLAC is in 10 mM phosphate 
pH 7.0. Stability of (E) Laccase A and (F) Lcc1 measured using activity at pH 2.2 ( ), 
pH 3.0 ( ), pH 4.0 (), pH 5.4 ( ) and pH 7.0 ( ). Activity was measured at 21 °C 
with 2 mM 2,6-DMP (pH 7.0, 5.4 and 4.0) and 2 mM ABTS (pH 3.0 and 2.2). 
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TvL1KYA --------------------------------GIGPVADLTITNAAVSPDGFSRQAVVVN-GGTPGPLITGNMGDRFQLNVIDNLTNHTMLKSTS  62 
PcL2XYB --------------------------------AIGPVADLTLTNAQVSPDGFAREAVVVN-GITPAPLITGNKGDRFQLNVIDQLTNHTMLKTSS  62 
TvL1GYC --------------------------------AIGPAASLVVANAPVSPDGFLRDAIVVN-GVFPSPLITGKKGDRFQLNVVDTLTNHTMLKSTS  62 
Lcc1    --------------------------------AIGPVTDLTASNADVSPDGFTRAAVLAN-GVFPGPLITGNKGDNFQINVIDNLSNETMLKSTS  62 
MAL2Q9O EPTCNTPSNRACWSDGFDINTDYEVSTPDTGVTQSYVFNLTEVDNWMGPDGVVKEKVMLINGNIMGPNIVANWGDTVEVTVINNLVTN----GTS  91 
AO1AOZ  --------------------------------SQIRHYKWEVEYMFWAPN-CNENIVMGINGQFPGPTIRANAGDSVVVELTNKLHTEG----VV  58 
 
TvL1KYA IHWHGFFQKGTNWADGPAFINQCPISSGHSFLYDFQVPDQAGTFWYHSHLSTQYCDGLRGPFVVYDPNDPAADLYDVDNDDTVITLVDWYHVAAK 157 
PcL2XYB IHWHGFFQQGTNWADGPAFVNQCPIASGHSFLYDFQVPDQAGTFWYHSHLSTQYCDGLRDPFVVYDPNDPHASLYDIDNDDTVITLADWYHVAAK 157 
TvL1GYC IHWHGFFQAGTNWADGPAFVNQCPIASGHSFLYDFHVPDQAGTFWYHSHLSTQYCDGLRDPFVVYDPKDPHASRYDVDNESTVITLTDWYHTAAR 157 
Lcc1    IHWHGFFQKGTNWADGAAFVNQCPIATGNSFLYDFTATDQAGTFWYHSHLSTQYCDGLRDPMVVYDPSDPHADLYDVDDETTIITLSDWYHTAAS 157     
MAL2Q9O IHWHGIHQKDTNLHDGANGVTECPIPPKGGQRTYRWRARQYGTSWYHSHFSAQYGNGVVGTIQING---PASLPYDIDLG—-VFPITDYYYRAAD 181 
AO1AOZ  IHWHGILQRGTPWADGTASISQCAINPGETFFYNFTV-DNPGTFFYHGHLGMQRSAGLYGSL-IVDPPQGKKEPFHYDGEINLLLSDWWHQSIHK 151 
 
TvL1KYA LGPAFPLG-------ADATLINGKG-----------------RSPSTTTADLSVISVTPGKRYRFRLVSLSCDPNYTFSIDGHNMTIIETDSINT 228 
PcL2XYB LGPRFPFG-------SDSTLINGLG-----------------RTTGIAPSDLAVIKVTQGKRYRFRLVSLSCDPNHTFSIDNHTMTIIEADSINT 228 
TvL1GYC LGPRFPLG-------ADATLINGLG-----------------RSASTPTAALAVINVQHGKRYRFRLVSISCDPNYTFSIDGHNLTVIEVDGINS 228 
Lcc1    LGAAFPIG-------SDSTLINGLG-----------------RFAGGDSTDLAVITVEQGKRYRMRLLSLSCDPNYVFSIDGHNMTIIEADAVNH 228 
MAL2Q9O DLVHFTQNNAPPF--SDNVLINGTA-----------------VNPNTGEGQYANVTLTPGKRHRLRILNTSTENHFQVSLVNHTMTVIAADMVPV 257 
AO1AOZ  QEVGLSSKPIRWIGEPQTILLNGRGQFDCSIAAKYDSNLEPCKLKGSESCAPYIFHVSPKKTYRIRIASTTALAALNFAIGNHQLLVVEADGNYV 246 
 
TvL1KYA APLVVDSIQIFAAQRYSFVLEANQAV-DNYWIRANPNFGNVGFTGGIN---SAILRYDGAAAVEPTTTQTTSTAP---LNEVNLHPLVATAVPGS 316 
PcL2XYB QPLEVDSIQIFAAQRYSFVLDASQPV-DNYWIRANPAFGNTGFAGGIN---SAILRYDGAPEIEPTSVQTTPTKP---LNEVDLHPLSPMPVPGS 316 
TvL1GYC QPLLVDSIQIFAAQRYSFVLNANQTV-GNYWIRANPNFGTVGFAGGIN---SAILRYQGAPVAEPTTTQTTSVIP---LIETNLHPLARMPVPGS 316 
Lcc1    EPLTVDSIQIYAGQRYSFVLTADQDI-DNYFIRALPSAGTTSFDGGIN---SAILRYSGASEVDPTTTETTSVLP---LDEANLVPLDSPAAPGD 316 
MAL2Q9O NAMTVDSLFLAVGQRYDVVIDASRAP-DNYWFNVTFG-GQAACGGSLNPHPAAIFHYAGAPGGLPTDEGTPPVDHQC-LDTLDVRPVVPRSVPVN 349 
AO1AOZ  QPFYTSDIDIYSGESYSVLITTDQNPSENYWVSVGTRARHPNTPPGLT-----LLNYLPNSVSKLPTSPPPQTPAWDDFDRSKNFTYRITAAMGS 336 
 
TvL1KYA PVA----GGVDLAINMAFNFNG-TNFFINGASFTPPTVPVLLQIISGAQNAQDLLPSGSVYSLPSNADI----------------------EISF 384 
PcL2XYB PEP----GGVDKPLNLVFNFNG-TNFFINDHTFVPPSVPVLLQILSGAQAAQDLVPEGSVFVLPSNSSI----------------------EISF 384 
TvL1GYC PTP----GGVDKALNLAFNFNG-TNFFINNASFTPPTVPVLLQILSGAQTAQDLLPAGSVYPLPAHSTI----------------------EITL 384 
Lcc1    PNI----GGVDYALNLDFNFDG-TNFFINDVSFVSPTVPVLLQILSGTTSAADLLPSGSLFALPSNSTI----------------------EISF 384 
MAL2Q9O SFV----KRPDNTLPVALDLTG-TPLFVWKVNGSDINVDWGKPIIDYILTGNTSYPVSDNIVQVDAVDQ----------------------WTYW 417 
AO1AOZ  PKPPVKFNRRIFLLNTQNVINGYVKWAINDVSLALPPTPYLGAMKYNLLHAFDQNPPPEVFPEDYDIDTPPTNEKTRIGNGVYQFKIGEVVDVIL 431 
 
TvL1KYA PATAA---APGAPHPFHLHGHAFAVVRSAGSTVYNYDNPIFRDVVSTGTPAAGDNVTIR--------------FRTDNPGPWFLHCHIDFHLEAG 462 
PcL2XYB PATAN---APGFPHPFHLHGHAFAVVRSAGSSVYNYDNPIFRDVVSTGQP--GDNVTIR--------------FETNNPGPWFLHCHIDFHLDAG 460 
TvL1GYC PATAL---APGAPHPFHLHGHAFAVVRSAGSTTYNYNDPIFRDVVSTGTPAAGDNVTIR--------------FQTDNPGPWFLHCHIDFHLEAG 462 
Lcc1    PITATN--APGAPHPFHLHGHTFSIVRTAGSTDTNFVNPVRRDVVNTGTA--GDNVTIR--------------FTTDNPGPWFLHCHIDFHLEAG 461 
MAL2Q9O LIENDPEGPFSLPHPMHLHGHDFLVLGRSPDVPAASQQRFVFDPAVDLARLNGDNPPRRDTTMLPAGGWLLLAFRTDNPGAWLFHCHIAWHVSGG 512 
AO1AOZ  QNANMMKENLSETHPWHLHGHDFWVLG-YGDGKFSAEEESSLNLKNPPLRNTVVIFPYG---------WTAIRFVADNPGVWAFHCHIEPHLHMG 516 
 
TvL1KYA FAVVFAEDIPDVASANPVP--QAWSDLCPTYDARDPSDQ-------- 499 
PcL2XYB FAVVMAEDTPDTKAANPVP--QAWSDLCPIYDALDPSDL-------- 497 
TvL1GYC FAIVFAEDVADVKAANPVP--KAWSDLCPIYDGLSEANQ-------- 499 
Lcc1    FAIVSFEDTADVSNTTTPS--TAWEDLCPTYNALDSSDL-------- 498 
MAL2Q9O LSVDFLERPADLRQRISQEDEDDFNRVCDEWRAYWPTNPYPKIDSGL 559 
AO1AOZ  MGVVFAEGVEKVGRIPTKALACGGTAKSLINNPKNP----------- 552 
 
Figure 3.9 Sequence alignment of the three-domain laccases: TvL1KYA from             
T. versicolor [75], PcL from P. cinnabarinus (PcL2XYB [76]), TvL1GYC from           
T. versicolor [103], Lcc1 from T. versicolor, MaL from M. albomyces (MaL2Q9O 
[104]) and AO from zucchini (AO1AOZ [13]). The residues coordinating to the T1, T2 
and T3 Cus are highlighted in green, purple and red, respectively. The Phe, Leu and 
Met in the axial position at the T1 Cu site are highlighted in teal. The conserved Gln 
(Gln70 in TvL1KYA), Asp (Asp77 TvL1KYA) and Tyr (Tyr116 in TvL1KYA) are 
highlighted in gray, cyan and yellow, respectively. The Asp (Asp456 in TvL1KYA) 
corresponding to Glu487 in Fet3p is highlighted in navy blue. Domain 1, 2 and 3 are 
green, blue and black, respectively. The sequence alignment was obtained using 
ClustalX. 
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Figure 3.10 UV-Vis absorption (A) and visible CD (B) spectra of Lcc1 ( ),        
Laccase A ( ) and SLACtruncated ( ). Spectra of Lcc1 and Laccase A were acquired 
in 50 mM phosphate pH 6.0, whilst SLACtruncated was in 50 mM phosphate pH 7.0. (C) 
EPR spectra of Lcc1 (i), Laccase A (ii) and SLACtruncated (iii) at ~ 80 K. The spectra of 
Lcc1 and Laccase A were acquired in 50 mM phosphate pH 6.0, whilst SLACtruncated in 
20 mM Tris pH 7.5 containing 200 mM NaCl.  
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Figure 3.11 The effect of pH (21 °C) on the activity of Laccase A ( ) and Lcc1 ( ) 
measured with (A) 2 mM 2,6-DMP and (B) 2 mM ABTS. The effect of temperature   
(15 - 70 °C) on activity of Laccase A ( , pH 4.0) and Lcc1 ( , pH 5.4) measured with 
(C) 2 mM 2,6-DMP and (D) 2 mM ABTS.    
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Figure 3.12 Plots of kcat/KM (A and B), KM (C and D) and kcat (E, and F) versus pH for 
the reaction of Laccase A ( ) and Lcc1 () with 2,6-DMP at 21 °C. 
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Figure 3.13 Michaelis-Menten plots for the reaction of Laccase A, Lcc1 and 
SLACtruncated with 2,6-DMP and ABTS giving the parameters obtained listed in           
Table 3.7. Activity of Laccase A with 2,6-DMP (A, 2.7 nM Laccase A) and ABTS (B, 
2.1 nM Laccase A) measured in 100 mM citrate/phosphate buffer pH 4.0 at 21 ( ) 
and 45 ( ) °C. (C) Activity of Lcc1 (2.1 nM) with 2,6-DMP measured in 100 mM 
citrate/phosphate buffer pH 5.4 at 21 ( ) and 45 ( ) °C. (D) Activity of Lcc1         
(1.0 nM) with ABTS measured in 100 mM citrate/phosphate buffer pH 4.0 at 21 ( ) 
and 35 ( ) °C. (E) Activity of SLAC (504 nM) with 2,6-DMP measured in 100 mM 
phosphate pH 8.0 at 21 °C.  
 
 
 
LaccaseA (2.7 nM) activity with 2,6-DMP at pH 4.0
0 80 160 240 320
0.0
0.4
0.8
1.2
21 °C
45 °C
A)
[2,6-DMP], µM
d[
2,
6-
D
M
P]
/d
t, 
µ
M
/s
LaccaseA (2.1 nM) activity with ABTS at pH 4.0
0 50 100 150
0.0
0.3
0.6
0.9
1.2
1.5
21 °C
45 °C
[ABTS], µM
d[
AB
TS
]/d
t, 
µ
M
/s
13.04.11 Lcc1 (2.08 nM) with 2,6-DMP at pH 5.4
0 400 800 1200 1600
0.0
1.5
3.0
4.5
6.0
21 °C 45 °C
[2,6-DMP], µM
d[
2,
6-
D
M
P]
/d
t, 
µ
M
/s
Lcc1 (1.04 nM) activity with ABTS at pH 4.0
0 1000 2000 3000
0.0
0.7
1.4
2.1
2.8
3.5
21 °C35 °C
[ABTS], µM
d[
AB
TS
]/d
t, 
µ
M
/s
08.12.12 SLAC WT activity with 2,6-DMP, 
100 mM KPi pH 8.0, RT
0 5 10 15 20 25 30
0.0
1.0
2.0
3.0
0.6183
[2,6-DMP], mM
d[
2,
6-
D
M
P]
/d
t, 
µ
M
/s
	   124	  
A) B) 
 
 
C) D) 
 
 
 
Figure 3.14 Difference absorption spectra (spectrum minus that of the oxidized protein) 
of (A) Laccase A (27 µM) reduced with 2 mM hydroxylamine in O2-containing buffer 
and (C) the same protein (14 µM) reduced with 1 mM hydroxylamine in anaerobic 
buffer. Time-dependent changes in absorbance intensity at 610 nm (), 420 nm () 
and 330 nm () after addition of hydroxylamine under (B) aerobic and (D) anaerobic 
conditions are also shown. Measurements were performed at RT in 100 mM phosphate 
pH 6.0.      
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Figure 3.15 UV-Vis (A) and Trp (B) fluorescence emission spectra of oxidized ( ), 
ascorbate-reduced ( ) and oxygen re-oxidized ( ) Laccase A. (C) Intensity changes 
in the emission (divided by the initial fluorescence intensity) upon reduction and 
oxidation of Laccase A (5.37 µM). Fluorescence was followed at 334 nm using an 
excitation wavelength of 285 nm. Solid arrows in (C) and (D) indicate the addition of 
reductant (ascorbate), whereas dashed arrows indicate exposure to oxygen. 
Measurements were performed in 50 mM phosphate pH 6.0 at RT.   
 
 
 
 
 
 
 
 
 
 
 
300 400 500 600 700 800
0
2000
4000
6000
8000
10000
12000
!, nm
",
 M
-1
cm
-1
300 350 400 450
0
200
400
600
800
1000
!, nm
Flu
or
es
ce
nc
e i
nt
en
sit
y a
.u.
	   126	  
A) B) 
 
 
 
Figure 3.16 (B) Fluorescence intensity changes (divided by the initial fluorescence 
intensity) upon reduction of (i) ATTO 647N labeled Laccase A (45 nM), (ii) ATTO 
647N labeled Lcc1 (60 nM) in 50 mM phosphate pH 6.0 and (iii) ATTO 590 labeled 
SLACtruncated (38 nM) in 50 mM phosphate pH 7.5. ATTO 647N and ATTO 590 
fluorescence ( ) was followed at 657 nm (λexc = 630 nm) and 630 nm (λexc = 590 nm), 
respectively. Trp emission ( ) was followed at 334 nm (λexc = 285 nm). The arrows 
indicate when hydroxylamine (1 mM) was added. (A) A comparison of emission and 
corresponding absorbance (multiplied by -1) observed during the reduction of ATTO 
532 labeled Laccase A (70 nM) by ascorbate in 100 mM phosphate pH 6.0, under 
anaerobic conditions: (i) Trp fluorescence at 340 nm (, λex = 280 nm) compared with 
the absorbance at 330 nm ( ); (ii) ATTO 532 fluorescence at 550 nm (, λex = 532 
nm) compared with absorbance at 610 nm ( ). 
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3.5 Discussion 
 
3.5.1 Expression and characterization of laccases 
  
Industrial and biotechnological applications of laccases require large scale production of 
stable and active enzymes. High yields of low potential laccases can be obtained from 
bacterial sources and ascomycate fungi. The more desirable high potential laccases 
originate from basidiomycetes fungi, and these are generally difficult to express 
heterologously in an active form [27, 72]. So far, heterologous expression of fungal 
enzymes has only been partially successful, when evaluated in terms of yield, protein 
stability or activity. Therefore development of efficient expression system for high 
potential laccases and engineering of bacterial laccases with enhanced activity is of 
special interest [17, 72].      
The expression of Lcc1 in E. coli resulted in insoluble aggregates in IB. 
Modifications to the expression procedure led to an increase in the amount of soluble 
Lcc1, however, this protein was not active with ABTS and did not show the spectral 
features typical of laccase. Expression of active fungal laccase in E. coli is challenging, 
probably owing to the lack of post-translational modifications, and particularly 
glycosylation. These findings are consistent with previous observations on laccase from 
Coriolus versicolor, in which the protein loses activity when the sugars are selectively 
removed [181]. Several roles for carbohydrate moieties attached to laccase have been 
suggested, including stabilization of the Cu centers, directing protein secretion, 
protection against proteolysis and enhancing thermostability [182]. Glycans have also 
been shown to influence laccase activity [183].    
Yeast expression systems are economical and in most cases result in relatively 
high protein yields. The ability of yeast to perform eukaryote-specific post-translational 
modifications, particularly glycosylation is highly advantageous for expression of 
fungal laccases. However, different yeasts do not process laccases with the same 
efficiency. Johnsson et al. reported that Lcc1 could be successfully expressed in              
P. pastoris (using the pHIL expression vector) [85, 87] but not in S. cerevisae [79], 
whereas Lcc2 was expressed in both organisms [79, 83, 90]. Herein, active Lcc1 was 
successfully expressed in P. methanolica PMAD11 but not in P. pastoris X33 strain 
(using the pPICZαA expression vector). The latter system has recently been 
successfully applied for the expression of the fungal laccase from Cyathus bulleri [184]. 
Expression of Lcc1 in P. methanolica resulted in secretion of protein with an MWapp 
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much heavier than reported, most probably due to hyperglycosylation. Additionally, the 
production yield of protein was lower than expected (10 mg/L, [94]).     
Expression systems using filamentous fungi as hosts are interesting owing to 
their ability to produce proteins in high yields. For instance, homologous                     
over-expression of laccases in Trametes sp. 420 [185] and P. cinnabarinus [165] 
yielded 310 mg/L and 1.2 g/L of protein, respectively. S. commune is considered a 
model basidiomycete fungus as a full genome sequence is available [155] and genetic 
modification of this organism is relatively easy. It has a short life cycle (10 days) and 
grows on simple media that facilitates fungus cultivation and lowers costs. Purification 
of proteins expressed in S. commune WT is complicated by the production of large 
amounts of SPG in the culture media of this fungus. However, the KS8 strain does not 
produce SPG [158, 186, 187] making it a preferential host for protein production.  
Expression of Lcc1 by S. commune KS8 resulted in maximal laccase activity 
ranging from 150 - 240 nkat/mL. The expression level of purified Lcc1 (~ 5 mg/L of 
media) is lower than those reported in P. methanolica [94] and P. pastoris [67]. 
Increasing temperature and lowering aeration during cultivation as well as increasing 
Cu(NO3)2 concentration have been identified as factors affecting the level of Lcc1 
production in the KS8 strain. The expression levels of Lcc1 increased when aeration of 
media decreased, therefore liquid-standing cultures instead of shake flask cultures were 
used for the growth of S. commune expressing Lcc1. Oxygen-limited conditions have 
previously been reported to result in higher level of laccase secretion in S. cereviasae 
[83]. In contrast to expression in yeast [86, 87, 93], decreasing the temperature of 
cultivation did not result in an increase in protein production. The effect of the initial 
pH of the cultivation media on enzyme expression was lower than that observed in          
S. cereviasae [79], P. pastoris [85, 87] and P. methanolica [93, 94].  
Activity-based method of detecting successful Lcc1-secreting transformants of 
S. commune, limits the expression system to the active variants of Lcc1. The method 
can be extended to inactive variants by using antibodies directed against Lcc1 or an 
epitope tagged to the protein. Surprisingly, the C-terminal fusion of Lcc1 with a single 
cMYC epitope led to the production of Lcc1_cMYC that was inactive with ABTS and 
2,6-DMP. The ascomycate laccases such as MaL from M. albomyces [104] contain a 
conserved Asp-Ser-Gly-Leu motif at the C-terminus (so-called “C-terminal plug”) 
pointing towards the T2/T3 Cu cluster and obstructing the solvent channel.                   
The carboxylate group of this C-terminal Leu is in a hydrogen bonding contact (2.8 Å) 
with a T3 Cu coordinating Nδ1 atom of His140 [104], and its position is critical for the 
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enzyme activity [188]. Laccases from T. versicolor do not have an analogous motif and 
the C-terminus (~ 16 Å from Nδ1 atom of His111 in TvL1KYA) is nine-residue shorter 
than that of MaL. Unexpectedly therefore the 11-residue long cMYC epitope in Lcc1 
interacts with the T2/T3 Cu cluster (similar to the “C-terminal plug” in MaL) and 
results in loss of protein activity.  
The oxidation of the phenolic substrate 2,6-DMP is optimal for Lcc1 and 
Laccase A at slightly acidic pH, whilst SLAC shows maximal activity in alkaline 
solutions [153]. At RT, the affinity of Lcc1 for 2,6-DMP and ABTS is lower than that 
of Laccase A. The kcat/KM for Lcc1 with 2,6-DMP is ~ 2.6-fold lower compared to that 
of Laccase A, and almost 7000-fold higher than that of SLACtruncated. The activity for 
oxidation of ABTS by Lcc1 and Laccase A is very high (maximal at 35 and 45 °C, 
respectively), especially at low pH, however, the activity is compromised by low 
stability of the proteins at acidic pH.  
 
        A) 
 
B) 
 
C)  
 
 
Figure 3.17 (A) 2,6-dimethylbenzene-1-amine (2,5-xylidine, Cα in green) and 
neighboring interacting residues in the substrate cavity of TvL1KYA [75] (teal) 
superimposed on structural model of Lcc1 (gray). The T1 Cu is shown as a lime sphere. 
Qualitative electrostatic surface representation in the substrate-binding cavity of             
(B) TvL1KYA (1KYA crystallized with 2,5-xylidine) and (C) Lcc1 (superimposed on 
1KYA). Surface generated in PyMol using protein contact potential with negative 
charge red and positive charge blue. 
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The structure of TvL1KYA is the only structure of T. versicolor laccase that was 
co-crystallized with an organic substrate, 2,5-xylidine, in the substrate-binding cavity 
[75]. This pocket is located at the boundary between MBD-2 and MBD-3 and is paved 
with a series of hydrophobic residues, such as Phe162, Leu164, Phe265, Phe332, 
Phe337 and Pro391, which may be involved in the protein-substrate interactions.          
The superposition of the structural model of Lcc1 with the crystal structure of 
TvL1KYA shows that the conserved among laccases, catalytically essential His (His458 
and His457 for TvL1KYA and Lcc1, respectively) and Asp (Asp206 and Asp206 for 
TvL1KYA and Lcc1, respectively) are located at the rear wall of this cavity, with their 
side chains groups pointing towards the substrate-binding pocket. The imidazole Nε2 
atom of His458 in TvL1KYA is within hydrogen-bonding distance of the amino 
nitrogen of 2,5-xylidine, and is considered important for ET between the substrate and 
the T1 Cu site [75, 189]. The amino group of 2,5-xylidine also forms a hydrogen bond 
with the side chain Oδ2 atom of Asp206 (Figure 3.17.A). This residue is suggested to 
play an important role in binding and orienting the substrate molecule [75, 189].          
The shape and volume of the hydrophobic substrate-binding pocket varies between 
laccases. A comparison of the cavities of TvL1KYA and Lcc1 indicates the presence of 
three amino acid differences: Leu164/Ile164, Phe265/Ala265 and Asn264/Ser264 in 
TvL1KYA/Lcc1 (Figure 3.17.A). As a result, the cavity of TvL1KYA (Figure 3.17.B) 
is smaller than that of Lcc1 (Figure 3.17.C). Broadening of a substrate-binding pocket 
has also been observed in T. versicolor Lcc1δ that contains Val164 and Ala265               
(as found in Lcc1) and shows similar to Lcc1 low affinities and high turnover rates with 
ABTS (KM of 2262 ± 103 µM and kcat of 798 ± 44 s-1 at pH 5.0 (RT)) [190].                  
The influence of residues at positions 164 and 265 (localized ~ 4 and 5 Å from             
2,5-xylidine, respectively, in TvL1KYA [75]) on substrate binding and stabilization in 
T. versicolor laccases was previously investigated by site-directed mutagenesis [190, 
191]. Mutations to both residues have negative influence on enzyme/substrate 
interaction and reduce the oxidation ability of the enzyme with respect to bulky 
phenolic substrates such as anthracene (polycyclic aromatic hydrocarbon) [191] and 
ortho- and meta-substituted di-t-Bu phenols [190]. Replacement of Phe265 to Ala          
(as found in Lcc1) lowered 2-fold the affinity of TvL1KYA for 2,6-DMP but did not 
change the affinity for ABTS [191]. Therefore one of the reasons for decreased activity 
of Lcc1 with 2,6-DMP (KM almost 10-fold lower compared to that of TvL1KYA) could 
be a depletion of hydrophobic interaction between the smaller Ala265 and the substrate 
molecule. X-ray structural data of CotA crystallized with ABTS showed that the 
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substrate molecule is bent and only partially buried inside the substrate-binding cavity, 
with one of the sulfonate O atoms forming a hydrogen bond with Gly323 (3.5 Å) [192]. 
Assuming similar positioning of ABTS within a substrate-binding pocket of TvL1KYA, 
the molecule might be stabilized through a hydrogen bond between the O sulfonate 
atom and side chain N donor of Asn264. The absence of a similar hydrogen bond in 
Lcc1 (due to the N264S replacement) could result in decreased affinity of Lcc1 for 
ABTS compared to TvL1KYA.  
 
3.5.2 Comparison between three-domain laccases and two-domain laccases 
 
Recently, direct involvement of Tyr108 in the catalytic cycle of SLAC has been 
demonstrated [110, 193] (Figure 3.18). The exact role of the residue is not known, but 
Gupta et al. hypothesize that it provides an additional electron, therefore reducing the 
lifetime of a three electron loaded intermediate (PI+e−). In this way Tyr108 would act as 
a “kinetic buffer” of redox equivalents, which prevents the generation of reactive 
oxygen species and possible damage to the enzyme [110]. The temporary tyrosyl (Tyr) 
radical was observed during oxidation of reduced WT SLAC and the C288S (T1D) 
variant and is characterized by an absorption band at ~ 410 nm and EPR signals in the   
g = 2 and 4 regions [193]. The EPR signals are thought to arise from exchange coupling 
of two unpaired spins, one residing at the T2/T3 Cu cluster and the other on Tyr108. 
This residue is located ~ 5 Å from the T2 Cu, at the interface of two subunits of the 
trimer and its absence in the Y108F and Y108A T1D SLAC variants was found to 
disrupt enzyme activity [110].  
 
 
 
Figure 3.18 Proposed pathway of O2 reduction to H2O by SLAC, which includes the 
role of Tyr radical (adapted from [110]). Reduced and oxidized Cu sites are depicted in 
blue and black, respectively. S indicates the substrate, while P is the reaction product. 
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Preliminary results assessing a possible role of a Tyr radical in the catalytic 
cycle of fungal three-domain laccases showed that under oxygen-limited conditions 
during the reduction of resting oxidized Laccase A and Lcc1 by hydroxylamine, an 
absorption band at ~ 420 nm is observed. The presence of this band was also observed 
during re-oxidation of hydroxylamine-reduced Laccase A and Lcc1. The spectral 
fingerprint is clearly different from those of PI (peroxy intermediate, with the LMCT 
band at 340 nm) and NI (native intermediate, with the LMCT bands at 318 and 365 nm) 
described by Solomon and coworkers [114, 122 - 126, 130], and can be assigned to a 
Tyr radical. The formation of a radical during oxidation of hydroxylamine-reduced 
Laccase A was not observed by EPR as high intensity signals of the T1 and the T2 Cus 
overlap in the g = 2 region (the EPR signal in g = 4 was also not observed, data not 
shown). The attempts to prepare T1D Lcc1 variant, in which Cys452 is replaced with 
Ser were unsuccessful. Detailed experiments, including the kinetics of formation and 
decay of the intermediate are necessary to determine if the transient species indeed 
corresponds to a Tyr radical.   
 
A) 
 
B) 
 
 
Figure 3.19 Overlaid T2/T3 Cu sites of SLAC (gray, [108]), structural model of Lcc1 
(yellow) and TvL1KYA (MBD-1, -2 and -3 are pink, blue and green, respectively, [75]) 
around Tyr108 in SLAC (A) and Tyr116 in TvL1KYA and Lcc1 (B). Tyr108 and 
Ile169 of SLAC are gray sticks; Gln70, Asp77 and Tyr116 of TvL1KYA and Lcc1 are 
pink and yellow sticks, respectively. The T2 and T3 Cus of SLAC and TvL1KYA are 
purple and red spheres, respectively.  
 
Tyr108 of SLAC is conserved not only among homologous, two-domain MCOs 
but also in six-domain Cp (Tyr107, pdb file: 2J5W). Furthermore, the appearance of a 
410 nm feature was previously observed during oxidation of fully reduced Cp but the 
nature of the intermediate was not investigated further [194, 195]. The involvement of 
the Tyr radical in the catalytic cycles of SLAC and Cp would support the evolution 
postulates, in which the two-domain laccases are proposed to be ancestors to the           
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six-domain Cp [113, 196]. The superposition of crystal structures of AO, TvL1KYA, 
TvL1GYC and the homology model of Lcc1 with that of SLAC showed that Tyr108 in 
the two-domain laccase is replaced with Gln70 and Gln66 in the three-domain laccases 
(Figure 3.19.A) and AO, respectively, with the side chains of Tyr108 and Gln70/Gln66 
pointing in the opposite directions. The side chain of Tyr108 partially overlaps with 
Asp77 in the three-domain laccases (Figure 3.19.A) and Asp73 in AO that is thought to 
participate in formation of PI [122]. Structural and sequence comparisons of the two- 
and three-domain MCOs show that Tyr116 of laccases from T. versicolor                 
(Figure 3.19.B), which is located ~ 6, 8 and 10 Å from the T3α, T3β and T2 Cus, 
respectively, is conserved among three-domain laccases (Figure 3.9). The 
corresponding residue in the structurally similar three-domain AO and SLAC is not a 
Tyr but Arg111 (Figure 3.9) and Ile169 (Figure 3.19), respectively. The investigation of 
Tyr116 variants of T1D Lcc1 is required to assess if this residue is involved in activity 
of this enzyme.  
 
3.5.3 Preliminary fluorescence studies on laccases  
 
Sensitive fluorescence-based biosensors for the detection of O2 [197 - 199], histamine 
[200], nitric oxide [201] and phenols [202] have recently been developed. These 
biosensors belong to a new generation of devices, which combine the substrate 
selectivity of proteins and the high sensitivity of fluorescence detection. In this 
approach the detection of a protein’s oxidation state is based on radiationless FRET 
from the attached fluorescent label to the prosthetic group of the redox protein                 
(Chapter 1.4.3). Redox-induced changes in the spectral features of the prosthetic group 
are therefore translated into changes in emission [150, 151]. The FluoRox principle can 
be adapted to all redox proteins, including laccases, whose absorption spectrum changes 
upon redox interconversion. In laccases, this method allows for individual assessment 
of the oxidation state of the T1 Cu and the T2/T3 Cu cluster and can be applied to study 
enzyme catalysis. The method also has great potential for the development of novel 
laccase-based biosensors (Figure 3.20) to measure the conversion of various compounds 
such as chlorinated phenols, synthetic dyes and polycyclic aromatic hydrocarbons [3, 
21, 174]. The determination of trace amounts of these compounds and their derivatives 
is of environmental importance as they are released by numerous industries, in 
particular during the manufacture of drugs and dyes, fuel burning, and are present in 
wastewaters from pulp and paper production. 
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Figure 3.20 Schematic representation of a biosensor using laccase and the FluoRox 
principle. A fluorescently labeled enzyme is immobilized on a transparent or semi-
transparent electrode surface. The fluorescence intensity depends on the oxidation state 
of the active centre, which changes upon reactions with the electrode or analytes.         
The T1, T2 and T3 Cus are green, magenta and red spheres, respectively.                      
The fluorescent label is depicted as a green star. 
 
The detection unit of FluoRox biosensor (a fluorescently labeled enzyme) ought 
to have increased sensitivity by exhibiting a high fluorescence SR in order to enhance 
the contrast between the reduced and oxidized forms of the enzyme. Föster theory 
(Chapter 1.4.2) predicts that the quenching efficiency (and SR of the label) will depend 
on the distance, the orientation and the spectral overlap between the electron donor     
(e.g. fluorescent dye and Trp) and the acceptor (e.g. the T1 and T2/T3 Cus).                   
The relatively low fluorescence SR of N-terminally labeled Lcc1 (0.30) and 
SLACtruncated (0.36) can be improved by changing the attachment point of the dye. This 
can be achieved by introducing surface exposed Cys residues as targets for maleimide-
modified fluorescence dyes, permitting more specific labeling (as in Chapter 2). Gly433 
or Ala325 located 16 and 20 Å respectively from the T1 Cu are possibilities for 
introducing Cys residues in Lcc1. Due to the trimeric arrangement of SLAC, the 
location of the introduced Cys needs to be chosen so that the distance between the label 
and the T1 Cu site within the same monomer is optimal for FRET, whilst limiting the 
influence of redox changes at the two other T1 Cu sites of the trimer (as in Chapter 2). 
The ATTO 647N maleimide conjugated K204C SLAC variant (Lys204 is located 16 Å 
from the T1 Cu within the same monomer and 26/30 Å from the T1 Cus in the other 
monomers), which was recently used for the measurements at the single molecule level, 
showed the increased SR value to ~ 0.8 [203]. Increasing the spectral overlap between 
the emission spectrum of the dye and the absorption spectrum of the T1 Cu site could 
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further enhance the fluorescence SR. However, using various different rhodamine-based 
dyes for the labeling of Lcc1, Laccase A and SLACtruncated resulted in little improvement 
of the SR values.   
Major challenges for the development of FluoRox-based biosensors for 
industrial applications are shelf life of the fluorescently labeled enzymes and 
immobilization of the labeled proteins in a stable and active form on conducting 
surfaces (transparent or semi-transparent). The stability of SLACtruncated, which is N-
terminally labeled with rhodamine-based fluorescent dyes, is relatively good, with the 
construct retaining its SR value for several days at 4 °C. However, the stability of 
labeled Laccase A and Lcc1 is very poor, with the SR decaying after ~ 24 h for Laccase 
A and within a few hours for Lcc1. The ability of fungal laccases to catalyze the 
conversion of aromatic compounds with high efficiency indicates that the rhodamine-
based fluorescent dyes are probably degraded by the enzymes (broader substrate-
binding pocket of Lcc1 might enable a better binding and faster conversion of dyes), 
and therefore cannot be used for labeling. This problem would be overcome by using an 
alternative donor such as quantum dots. 
 
3.6 Conclusions 
 
Lcc1 from T. versicolor has been successfully expressed in S. commune KS8.               
The production of laccase was found to depend on several factors, including cultivation 
temperature, Cu(NO3)2 concentration, and culture aeration. The expression level 
obtained so far is sufficient for biochemical characterization and preliminary 
measurements on the catalytic activity of the enzyme, but it is too low to be useful for 
industrial purposes. Further optimization of the expression protocol (on both protein 
expression and purification efficiency levels) is necessary to enhance the production of 
Lcc1.  
Fluorescence-based tracking of redox events independently at the T1 and the 
T2/T3 Cu sites of laccases is possible. Therefore, a laccase-based FluoRox construct 
can be used not only for biosensing but also to provide detailed insight into the kinetics 
of the internal ET processes between the Cu centers in the enzyme. In contrast to 
SLACtruncated, fungal laccases exhibit a very high conversion rate of organic compounds 
(including dyes), and therefore, the preparation of a stable FluoRox device requires 
labeling with different than rhodamine-based fluorophores.   
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Engineering copper sites using cupredoxin-like domains in SLAC from 
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4.1 Introduction 
 
The ultimate goal of protein design is the creation of new proteins with specific and 
predictable structure and function. The de novo design and the modification of existing 
sites in natural metal-binding proteins, not only deepens the understanding of protein 
structure/function relationship, but also is important for engineering proteins for 
industrial applications. Site- and loop-directed mutagenesis has been especially 
successful in evaluating the role of the first and second coordination spheres of mainly 
cupredoxins such as azurin (Az), pseudoazurin (Paz) and plastocyanin (Pc) [1 - 17]. Az 
scaffold has been successfully applied in engineering of binuclear copper (Cu) site, CuA 
[18], mononuclear type zero Cu site [19 - 21] and nonheme Fe(II) site [22]. 
 
A) 
 
B)  
 
C) 
 
 
Figure 4.1 Variations in the geometry of four-coordinate Cu sites, with a His2Cys 
ligand set and a variable fourth ligand depicted as L. The Cu ion is a gray sphere.           
(A) A trigonal pyramidal type 1 (T1) Cu site, (B) a planar, thiolate-containing type 2 
(S(Cys)-T2) Cu site and (C) a tetrahedral type 1.5 (T1.5) Cu site. Image adapted from 
[23]. 
 
Historically, the Cu sites in proteins have been classified into three types, 
mononuclear type 1 (T1 Cu, so-called ‘blue Cu site’), mononuclear type 2 (T2 Cu, so-
called ‘normal Cu site’) and the binuclear type 3 (T3 Cu) [24 - 27] (Chapter 1.2). The 
T2 Cu and the T3 Cus form a trinuclear cluster (T2/T3 Cu site, Chapter 1.2.4).          
The T1 Cu sites of most cupredoxins, such as Paz [28], Pc [29] and amicyanin [30], are 
typically trigonal pyramidal (Figure 4.1.A) with the Cu ion slightly displaced from the 
N2S equatorial plane in the direction of a Met ligand. The geometry of a T1 Cu site 
varies depending on the residue in the axial position. In stellacyanin (STC), the axial 
ligand is Gln leading to a distorted tetrahedral Cu site [31]. In plantocyanins from lily 
[32] and tomato [33] it is Leu and Val, respectively, thus the T1 Cu sites in those 
proteins are probably three-coordinate. The T1 Cu site of Az contains an additional 
ligand provided by a backbone carbonyl oxygen, resulting in a trigonal bipyramidal 
Cys 
L 
His 
His 
Cys 
L 
His 
His 
Cys 
L 
His 
His 
	   149	  
active site [34]. The T1 Cu site is characterized by a dominant S(Cys)→Cu(II) ligand to 
metal charge transfer (LMCT) transition band at ~ 600 nm and a small hyperfine 
coupling in the parallel region, A||, < 95 × 104 cm-1 [1, 27, 35, 36] (Chapter 1.2.1). 
Studies on engineered, four-coordinate T1 Cu sites with a single Cys ligand have shown 
two additional geometries [1, 23]. A thiolate-containing T2 (S(Cys)-T2) Cu site with a 
tetragonal planar geometry (Figure 4.1.B) is characterized by a S(Cys)→Cu(II) LMCT 
transition band at ~ 400 nm and a large A||, > 130 × 104 cm-1 [1]. A type 1.5 (T1.5) Cu 
site is found when a strong axial ligand moves the Cu ion out of the N2S trigonal plane 
giving a tetrahedral geometry (Figure 4.1.C). The UV-Vis (characterized by two 
S(Cys)→Cu(II) LMCT transition bands at 420 - 450 nm and 540 - 600 nm) and electron 
paramagnetic resonance (EPR) spectra of a T1.5 Cu site are intermediate between those 
of a T1 Cu and a S(Cys)-T2 Cu sites [1].   
 
4.1.1 Design studies of Cu-binding sites 
 
Binding of metal into a non-metalloprotein or a de novo synthesized protein requires 
creation of the optimal coordination environment by introduction of the ligating side 
chains at favorable positions. By protein redesign, Hellinga [23] and Lu et al. [37] 
created T1.5 Cu sites in thioredoxin and superoxide dismutase as scaffolds. A T1.5 Cu 
site was also created within a four helix-bundle systems, a very different tertiary 
structure compared to the β-barrel of cupredoxins [38]. By changing the environment of 
the coordination sphere of this T1.5 Cu site, structurally different CuA and                
S(Cys)-T2 Cu sites have been obtained [39]. Shiga et al. created a T1 Cu site within the 
hydrophobic core of a four-stranded α-helical coiled-coil protein that possesses a vacant 
cavity at the axial position of the Cu-binding site [40, 41]. Changing the axial 
interaction shifted the geometry of this site from trigonal planar towards a distorted 
tetrahedral. Similar, α-helical coiled-coil synthetic model has also been used to design a 
functional T2 Cu center that shows nitrite reductase activity [4].  
Modeling biological Cu sites using copper complexes has been widely studied. 
Kitajama and co-workers reported the X-ray structure of the first model compounds, 
tetrahedral thiolato Cu(II) complexes, which had spectral properties similar to a T1 Cu 
site [42 - 44]. Tolman and co-workers synthesized Cu(II) models of the three-coordinate 
T1 Cu and four-coordinate T1.5 Cu sites [45 - 47]. The three-coordinate N2S(thiolate) 
Cu(II) complex closely mimics the coordination sphere of the trigonal T1 Cu(II) sites of 
fungal laccases and ceruloplasmin. However the A|| value of this site was larger than 
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those for the proteins, whilst the reduction potential was considerably lower [45].        
The length of (thiolate)S-Cu bond has been altered by addition of a thioether ligand 
(N2S(thiolate)S(thioether) Cu(II) complex), leading to a flattened tetrahedral geometry 
of the site, similar to that observed in T1.5 Cu sites (Figure 4.1.C) [46]. Recently, new 
model complexes, characterized by an LMCT transition band at ~ 610- 630 nm, A|| < 
100 × 104 cm-1 and an increased reduction potential (217 - 317 mV) similar to those of 
low-potential T1 Cu sites (for example Az), have been synthesized [48]. 
 
4.1.2 Cupredoxin-like domains as a scaffold for design of Cu-binding centers 
 
The cupredoxin fold is a common motif in metalloproteins and is essential to several 
cellular processes such as respiration, catalysis and metal homeostasis [49, 50]. 
Cupredoxins can occur as either single-domain monomeric proteins [49 - 51] or as 
components of Cu-containing multi-domain proteins (Chapter 1.3). These cupredoxin-
like, metal-binding domains (MBDs) are found in NiRs [52 - 54], MCOs and 
cytochrome c oxidase [55, 56]. The MCOs family includes among others two-domain 
and three-domain laccases [57 - 62], six-domain ceruloplasmin [63], three-domain 
ascorbate oxidase (AO) [64] and Fet3p [65], each containing T1, T2 and T3 Cu sites 
(Chapter 1.3 and 3). 
Several models explaining the evolution of multiple domain Cu-binding proteins 
have been proposed [66 - 69], but most evidence favors that proposed by Nakamura      
et al. [67, 70] (for more details see Chapter 1.3). Trimeric MCOs, in which each 
monomer consists of two cupredoxin-like domains, are considered the key 
intermediates in this model [67]. The authors predicted three types (A, B and C) of the 
two-domain MCOs and classified them according to the location of a T1 Cu site [67]. 
Type A two-domain MCOs contain a T1 Cu site in each domain, whereas type B and 
type C house a T1 Cu site in second (MBD-2) or first (MBD-1) domain, respectively. 
The latter two types are postulated to originate from the type A two-domain MCOs.        
So far, 31 different two-domain MCOs have been identified in genome databases, 
including 3 of type A, 17 of type B and 11 of type C [70], from which only few have 
been isolated and characterised. Small laccase (SLAC) from Streptomyces coelicolor 
[57, 58] belongs to the type B MCOs (Figure 4.2.A and Figure 4.3.A.i), whereas 
mgLAC from metagenome [59], blue copper oxidase (BCO) from Nitrosomonas 
europaea [60] and the unpublished MCO, gdcLAC, from Arthrobacter sp. fb24 (pdb 
file: 3GDC) to the type C. Trimeric NiRs, which contain a T1 Cu site in the MBD-1 
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(Figure 4.2.B and Figure 4.3.A.i), are postulated to have descended either from the type 
C MCOs with concomitant loss of two, inter-domain Cu ions, or from the two-domain 
type Y ancestor (not identified in the genome database [67, 70]), which contains the 
inter-domain T2 Cu site and T1 Cu sites in each domain.  
 
A) 
 
B) 
 
 
Figure 4.2 Representations of the homotrimeric structures of (A) SLAC [58] and (B) 
bNiR [52]. MBD-1 and MBD-2 are shown in orange and green, respectively. The insets 
show the location of the Cu ions in and between MBD-1 and MBD-2 of adjacent 
monomers. The β-sheets of MBD-1 are orange, whereas those of MBD-2 are green. The 
loops, L1 from MBD-1 and L2 from MBD-2 that are involved in T1 Cu binding are 
grey, whilst those that are not are cyan. The T1, T2 and T3 Cu ions are shown as green, 
purple and red spheres, respectively.  
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A) 
 
 
 
B)  
Protein Sequence of the L1 
SLAC D157 H V - - V G T E H H T G G168 I R N – G L173 
bNiR C130 A P E G – M V - - - P W H139 V V S – G M144 
mgLAC C105 H V - - - N V - - - N E H112 V G V R G M118 
 i) 
gdcLAC C144 H Q S – - P L - - - A P H152 I A K – G L157 
   
Protein Sequence of the L2 
SLAC C288 H V Q S H293 S - - - - - - - - D – M G M298 
bNiR N299 H N L I E304 A - - - - - - - - F E L G A310 
mgLAC D253 H V D T H258 V T A G G K H P G - – - G P269 
ii) 
gdcLAC A281 H K T E F286 A - - - - - - - - E – L G W298 
 
Figure 4.3 (A) Schematic representations of the homotrimers and the N- and C-terminal 
cupredoxin-like domains (MBD-1 orange and MBD-2 green) of adjacent monomers of 
SLAC (i) and bNiR (ii) using the same colour scheme as in Figure 4.2. L1 (MBD-1) and 
L2 (MDB-2), which are involved in T1 Cu-binding, are shown as gray boxes, whilst 
loops that are not are cyan. The T1 Cu site (green dot) is located within MBD-2 and 
MDB-1, whilst the potential Cu-binding site (black circle) within MBD-1 (i) and MBD-
2 (ii) of SLAC and bNiR, respectively. The T2 (purple dot) and T2/T3 Cu (purple/red 
dots) sites of bNiR and SLAC are found at the interface of two adjacent monomers.       
(B) Structure-based sequence alignments of L1 (MBD-1, i) and L2 (MBD-2, ii) of 
bNiR, SLAC, mgLAC and gdcLAC with the coordinating residues bold and numbered. 
i) 
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The structure of two-domain trimeric SLAC [58] superposes on the structures of 
mgLAC [59], gdcLAC and bNiR [52] with root-mean-square deviation (RMSD) of       
2.59 Å, 2.07 Å and 2.05 Å, respectively. Three of the four ligands of the T1 Cu site, 
Cys, one His and the axial ligand are situated on a single loop (L1 in mgLAC, gdcLAC 
and bNiR and L2 in SLAC) linking the β-strands (typically β7 - β8), whereas the second 
His ligand, is provided from the core of the protein [71]. The length and the 
composition of the Cu-containing loop varies (Figure 4.3). While in single-domain 
cupredoxins it is rather short (7 to 11 residues) [49], the corresponding loops in            
two-domain MCOs and NiRs are typically longer (11 to 15 residues) [52, 57 - 60, 72]. 
In cupredoxins, the structure of this loop is dictated by length and is independent of 
sequence [5]. Side-chain variations within the loop control surface properties and 
facilitate interaction with a particular protein partner. Comparison of the trimeric 
structures of SLAC, mgLAC (Figure 4.4.A) and bNiR (Figure 4.4.B), as well as the 
overlay of both domains of SLAC (Figure 4.4.C), shows that a T1 Cu site in MBD-1 of 
SLAC is missing, mainly due to the replacement of the potentially Cu-ligating Cys by 
an Asp157. Similarly, at the potential Cu-binding site in the MBD-2 of bNiR (Figure 
4.4.D) and mgSLAC (Figure 4.4.E), a Cys ligand is substituted by Glu and Asp, 
respectively.  
The T2/T3 Cu cluster and the T2 Cu site are placed at the interface between the 
MBD-1 and the MBD-2 of two adjacent monomers of SLAC (Figure 4.2.A and Figure 
4.3.A.i) and bNiR (Figure 4.2.B and Figure 4.3.A.ii), respectively, contributing strongly 
to the stability of the trimer [52, 58]. The T1 and the T2 Cu sites (NiRs) or the T2/3 Cu 
cluster (two-domain MCOs) are 12 - 13 Å apart and are connected by a His(T2)-
Cys(T1) and His(T3)-Cys(T1)-His(T3) motif, respectively, which enable electron 
transfer (ET) between both Cu centers [52, 57 - 60] (Chapter 1.3). The T2/T3 Cu cluster 
is ligated by eight His, which are donated by the two adjacent monomers. At the 
corresponding location, NiRs contain only four His residues, three of which ligate to the 
T2 Cu, whereas the fourth, His249, is not involved in metal ligation.  
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A) B) C) 
   
 D) 
 
E) 
 
 
Figure 4.4 The potential Cu-binding site of SLAC (MBD-1, blue, [58]) superposed on a 
T1 Cu site of (A) mgLAC (MBD-1, magenta, [59]), (B) bNiR (MBD-1, orange, [52]) 
and (C) SLAC (MBD-1, pale cyan). The T1 Cu site of SLAC (MBD-2, pale cyan) 
overlaid on the potential Cu-binding sites of (D) bNiR (MBD-2, orange) and              
(E) mgLAC (MBD-2, magenta). The T1 Cu ions are depicted as green spheres.  
 
4.2 Scope of the chapter 
 
Research presented in this chapter focuses on the design of a T1 Cu site using the 
scaffold of cupredoxin-like domains, MBD-1 and MBD-2, of SLAC and bNiR, 
respectively. Additionally, the possibility of introducing T3 Cus into bNiR (in the 
LacNiR variant) has been investigated. Twenty variants of bNiR and SLAC have been 
prepared, from which fifteen have been isolated, purified and characterized in terms of 
metal content, spectral properties and activity. 
 
4.3 Materials and methods 
 
4.3.1 Cloning of SLAC, bNiR and their variants 
 
The genes encoding for wild type (WT) SLAC from S. coelicolor [73] (Chapter 3.3.1.5, 
SLACtruncated referred to as SLAC in the following sections), and WT bNiR from                
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A. xylosoxidans [74] were used as previously described. The genes encoding for 
qSLAC, tSLAC, A99H_nirSLAC, qNiR and LacNiR were synthesized with Multi 
QuickChange Lightening Mutagenesis Kit (Stratagene), as described in Chapter 5.7.2, 
using templates and the primers listed in Table 4.1. The genes encoding for T1D 
qSLAC, T1D tSLAC, nirSLAC, mgSLAC, T1D nirSLAC, T1D A99H nirSLAC, T1D 
qNiR, T1D azNiR (prepared by Dr. Isabelle Salard), T1D T246H azNiR and Δ252G 
LacNiR were synthesized with QuickChange Mutagenesis Kit (Stratagene), as 
described in Chapter 5.7.2, using templates and the primers listed in Table 4.1. The 
gene encoding for A99H_mgSLAC was amplified by polymerase chain reaction (PCR), 
as described in Chapter 5.7.1, using template and the primers listed in Table 4.1. The 
genes were verified by sequencing both strands. 
 
4.3.2 Expression and purification of proteins 
 
The proteins were expressed in Escherichia coli BL21 (DE3) and purified, as described 
in Chapter 5.10.1 (WT SLAC), Chapter 5.10.2 (SLAC variants) and Chapter 5.10.3 
(WT bNiR and its variants). T1D SLAC [75] was kindly provided by                            
Prof. G.W. Canters. The concentrations of proteins were determined either by using 
extinction coefficients (ε) of 4400 M-1cm-1 at 590 nm (WT SLAC) [73] and                  
5200 M-1cm-1 at 594 nm (WT bNiR) [74] or Bradford assays (Comassie Plus protein 
assay; Thermo Scientific).  
 
4.3.3 Determination of the apparent molecular weight by gel-filtration 
 
The apparent molecular weight (MWapp) of proteins was determined, as described in 
Chapter 5.13.4 using a HiLoad Superdex 200 16/60 (GE Healthcare) gel-filtration 
column in 20 mM tris(hydroxymethyl)aminomethane (Tris) pH 7.5 containing               
200 mM NaCl. When MWapp could not be determined, the trimeric state of the protein 
was determined from the elution volume (Ve) relative to Ve of the control, trimeric 
protein (for example WT SLAC or WT bNiR).  
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Cycle Construct Template Primer sequence 5’ to 3’  Function a 
GTTGGAGTCTCATATGGGGGGCGAGGTGAGACACCTC
AAG 
Cloning, FP 
SLAC_pET22b 
Genomic DNA form S. 
coelicolor 
GTTGGCCATCTCGAGTCAGTGCTCGTGTTCGTGTG Cloning, RP 
0 
bNiR_pET22b b    
CGGTGCCGACGACGTGGCAGTGGTAGTGCCAGTAG D157C c mutation, RP 
tSLAC_pET22b SLAC_pET22b 
ACCGGGCCGTACATGCCGTTGCGGATGTGTCCGGTG 
G168H c and L173M c 
mutations, RP 
mgSLAC_pET22b A99H_mgSLAC_pET22b 
1 
nirSLAC_pET22b A99H_nirSLAC_pET22b 
GATGGACGTGCGGCACAGCCTGCACGTGCA 
TGCACGTGCAGGCTGTGCCGCACGTCCATC 
H99A c mutation, FP 
H99A c mutation, RP 
CGGTGCCGACGACGTGGCAGTGGTAGTGCCAGTAG D157C c mutation, RP 
ACCGGGCCGTACATGCCGTTGCGGATGTGTCCGGTG 
G168H c and L173M c 
mutations. RP 
qSLAC_pET22b SLAC_pET22b 
TGCACGTGCAGGCTGTGCCGCACGTCCATC A99H c mutation, RP 
CTACTGGCACTACCACTGCCACGTCAACGTGAACGAA 
CACGTGGGCGTGCGTGGCATGTACGGCCCGGTGATC 
Loop (mgLAC) 
mutation, FP 
2 
A99H_mgSLAC_ 
pET22b 
qSLAC_pET22b 
GATCACCGGGCCGTACATGCCACGCACGCCCACGTGT 
TCGTTCACGTTGACGTGGCAGTGGTAGTGCCAGTAG 
Loop (mgLAC) 
mutation, RP 
a FP - forward primer, RP - reverse primer. b Used as in [74]. c The SLAClong gene numbering [73] (Chapter 3). 
 
Table 4.1 List of constructs and primers used in this chapter. 
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Cycle Construct Template Primer sequence 5’ to 3’  Function a 
A99H_nirSLAC_ 
pET22b 
qSLAC_pET22b 
CTACTGGCACTACCACTGCCACCCGGAAGGTATGGTGC 
CCTGGCACGTGGTGTCTGGTATGTACGGCCCGGTGATC 
Loop (bNiR) mutation, 
FP 
GCCTACCTGTGCCACAACCTGATCCACGCCTTCGAAC 
N299C and E304H 
mutations, FP 
TTCGAACTGGGCATGGCCGGCCACATCAAG A310M mutation, FP 
2 
qNiR_pET22b bNiR_pET22b 
CAATCGCGACCATCGCCCGCACCTG T246H mutation, FP  
T1D_tSLAC_pET22b tSLAC_pET22b 
T1D_qSLAC_pET22b qSLAC_pET22b 
T1D_mgSLAC_ 
pET22b 
mgSLAC_pET22b 
T1D_nirSLAC_ 
pET22b 
nirSLAC_pET22b 
3 
T1D_A99H_nirSLAC
_pET22b 
A99H_nirSLAC_ 
pET22b 
GTACCACAGCCACGTCCAGAG 
CTCTGGACGTGGCTGTGGTAC 
C288S c mutation, FP 
C288S c mutation, RP 
a FP - forward primer, RP - reverse primer. c The SLAClong gene numbering [73] (Chapter 3). 
 
Table 4.1 List of constructs and primers used in this chapter - continued. 
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Cycle Construct Template Primer sequence 5’ to 3’  Function a 
T1D_bNiR_pGEMT d bNiR_pGEMT 
T1D_qNiR_pET22b qNiR_pET22b 
CCTTCGTCTACCACAGCGCGCCCGAAGGC 
GCCTTCGGGCGCGCTGTGGTAGACGAAGG 
C130S mutation, FP 
C130S mutation, RP 
GGCGTGTATGCCTACCTGTGCACCTTCCCGGGCCATA
GCGCGCTGATGGCCGGCCACATCAAGG 
Loop (Az) mutation, FP 
T1D_azNiR_pET22b d T1D_bNiR_pGEMT 
CCTTGATGTGGCCGGCCATCAGCGCGCTATGGCCCGG
GAAGGTGCACAGGTAGGCATACACGCC 
Loop (Az) mutation, RP 
CAATCGCGACCATCGCCCGCACCTG T246H mutation, FP 
3 
T1D_T246H_azNiR_ 
pET22b 
T1D_azNiR_pET22b 
CAGGTGCGGGCGATGGTCGCGATTG T246H mutation, RP 
GGCGCCGTGGAAGTGGACGTTGTGC D92H mutation, RP 
CATGCCTTCGGGGTGGCAGTGGTAGAC A131H mutation, RP 
CATGGCCGCCGTGCAGGTGCG I251H mutation, RP  
LacNiR_pET22b bNiR_pET22b 
CCTCGATCAGGTTGTGGTTGTGGTAGGCATAC L298H mutation, RP 
CACCTGCACGGCCATGGCGACTGGGTCTG Depletion of G252, FP  
4 
Δ252G_LacNiR_ 
pET22b 
LacNiR_pET22b 
CAGACCCAGTCGCCATGGCCGTGCAGGTG Depletion of G252, RP 
a FP - forward primer, RP - reverse primer. d Designed by Dr. Isabelle Salard. 
 
Table 4.1 List of constructs and primers used in this chapter - continued. 
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4.3.4 Determination of the molecular weight by mass spectrometry 
 
The molecular weight (MW) of proteins was determined by matrix-assisted laser 
desorption ionization time-of-flight mass spectrometry, MALDI-TOF-MS, as described 
in Chapter 5.12.1.  
 
4.3.5 UV-Vis absorption spectroscopy 
 
UV-Vis spectra were acquired at room temperature (RT) on a Perkin Elmer λ 35 
spectrophotometer equipped with a Parkin Elmer PTP-1 peltier, as described in        
Chapter 5.12.2. The ε values of the SLAC and bNiR variants have been estimated from 
the relative absorbance at 280 nm, ~ 360 nm and ~ 590 nm.  
 
4.3.6 Continuous wave electron paramagnetic resonance spectroscopy 
 
Continuous wave (cw) X-band (9.48 GHz) EPR spectra were acquired at ~ 80 K on a 
Bruker EMX EPR spectrometer equipped with an ESR900 cryostat (Oxford 
Instruments), as described in Chapter 5.12.5.  
 
4.3.7 Circular dichroism spectroscopy 
 
Far-UV (190 - 260 nm) and visible (300 - 700 nm) circular dichroism (CD) spectra 
were acquired at 25 °C with Jasco J-810 spectrometer, as described in Chapter 5.12.3. 
The protein concentration ranged from 0.56 to 1.09 mg/mL for the far-UV CD and 11, 
25 and 34 mg/mL for the visible CD measurements of WT SLAC, nirSLAC and T1D 
nirSLAC, respectively. 
 
4.3.8 Metal content determination 
 
The Cu and zinc (Zn) content of purified proteins was determined with a Thermo 
Electron M Series Atomic Absorption Spectrometer (AAS), as described in             
Chapter 5.12.4.  
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4.3.9 Activity measurements 
 
The activity of WT SLAC and its variants was determined spectrophotometrically by 
following the oxidation of 50 mM 2,6-dimethylphenol (2,6-DMP, Appendix A) at       
468 nm (ε468 = 14800 M-1cm-1 [76]) at 21 °C in 0.1 M acetate (pH 5.3 - 5.9), 0.1 M 
phosphate (pH 6.0 - 8.0), 0.1 M Tris (pH 8.0 - 9.0) and 0.1 M carbonate (pH 9.0 - 10.0), 
as previously described [73]. The activity was calculated from the initial rates of 
product formation and expressed as nanomoles of substrate, which is oxidized by one 
mg of the enzyme in one second (10-9 mol×s-1×mg-1). 
 The nitrite reductase activity of WT bNiR and LacNiR was compared by 
measuring the fluorescence intensity changes of reduced N-terminally ATTO 550 
labeled proteins in the presence of nitrite. The procedure for fluorescent labeling of 
proteins is described in Chapter 5.11. The reaction mixtures were prepared in an 
anaerobic chamber (Belle technology, [O2] << 2 ppm) in sealed cuvettes (3 mL) and 
contained equal concentration (150 nM) of LacNiR and WT bNiR in 50 mM phosphate 
pH 7.5. ATTO 550 labeled bNiR and ATTO 550 labeled LacNiR were reduced either 
by sodium ascorbate and phenazine ethosulfate (PES) or 15 µM of dithionite-reduced 
Az from Pseudomonas aeruginosa as described in Chapter 2.3.10. Turnover was 
studied by the addition of anaerobic solution of NaNO2 (66 µM - 5.3 mM). The 
fluorescence intensity of ATTO 550 for the oxidized labeled proteins was determined 
by the addition of an excess of K3[Fe(CN)6]. The emission of ATTO 550 was followed 
at 20 °C at 575 nm using an excitation wavelength of 540 nm.  
 
4.3.10 Crystallization and structure determination 
 
Numerous unsuccessful attempts to crystallize WT SLAC, tSLAC, qSLAC, mgSLAC 
and T1D azNiR were undertaken by using the sitting and/or hanging drop method of 
vapor diffusion at 20 °C. This included the use of buffer/precipitant combinations that 
had previously proven successful for WT SLAC [57], WT bNiR [77] and NIRAMI 
[77], and commercially available solutions.  
Crystals of LacNiR were obtained, as previously described for WT bNiR [77], 
by using the hanging drop vapour diffusion method at 20 °C with a solution of protein    
(1.5 µL, 10 mg/mL) in 5 mM Tris buffer, pH 8.6 mixed with precipitant solution       
(1.5 µL) containing 100 mM Mes pH 6.5, 10 mM ZnSO4×7H2O and 25% PEG-MME 
550, where MME corresponds to monomethyl ether. Crystals formed overnight and 
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were bright blue. Prior to being frozen in liquid nitrogen, a crystal was immersed        
(by Dr. Adriana Badarau) in N-paratone oil as a cryoprotectant. High-resolution 
diffraction data were collected at 100 K at DLS (I03 at 0.9763 Å) The data collection 
and processing, including preliminary structure solution and model building were 
performed by Dr. Arnaud Baslé. The structure was only partially solved using 
molecular replacement with bNiR structure (pdb file: 2VN3) as the search model. 
Secondary Structure Motif (SSM) algorithms implemented in COOT were used to 
generate all superimposed structures and determine the RMSDs for Cα atoms. PyMol 
software was used to visualize the crystal structure [78]. 
 
4.3.11 Creation of structural models of the SLAC variants 
 
Structure modeling was performed using I-TASSER software [79]. The crystal structure 
of WT SLAC (pdb file: 3CG8, [57]) was used as the template for homology modeling 
of tSLAC and qSLAC, the crystal structure of mgLAC (pdb file: 2ZWN, [59]) was used 
as the template for homology modeling of mgSLAC, A99H mgSLAC and                 
T1D mgSLAC, and the structure of WT bNIR (pdb file: 1OE1, [52]) as the template for 
modeling of nirSLAC, T1D nirSLAC and T1D A99H nirSLAC. The template modeling 
(TM) scores and RMSD between the main chain atoms of the modeled structure and the 
template of 0.77 ± 0.10 and 5.3 ± 3.4 Å for tSLAC, 0.74 ± 0.11 and 5.8 ± 3.6 Å for 
qSLAC, 0.74 ± 0.11 and 5.7 ± 3.6 Å for mgSLAC, 0.83 ± 0.08 and 4.4 ± 2.9 Å for 
A99H mgSLAC, 0.82 ± 0.08 and 4.5 ± 3.0 Å for T1D mgSLAC, 0.72 ± 0.11 and         
6.1 ± 3.7 Å for nirSLAC, 0.71 ± 0.11 and 6.1 ± 3.8 Å for T1D nirSLAC and 0.83 ± 0.08 
and 4.3 ± 2.9 Å for T1D A99H nirSLAC, respectively, were calculated. The TM-score 
indicates the difference between the modeled structure and the template by a score 0 to 
1, where 1 indicates a perfect match between two structures. To create trimeric 
structures of variants, the monomeric models were overlaid onto the crystal structure of 
trimeric WT SLAC (pdb file: 3KW8) [58]. PyMol software was used to visualize the 
structural model [78]. 
 
4.3.12 Pulsed electron-electron double resonance measurements 
 
X-band pulsed electron-electron double resonance (PELDOR) measurements were 
performed by Dr. Jessica H. van Wonderen (University of East Anglia). Spectra were 
acquired on a Bruker E680 spectrometer using a Bruker MD5-W1 EPR probehead 
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equipped with an Oxford helium (CF 935) cryostat, as previously described [80], with 
modifications. The microwave pulses were amplified using a 1 kW Traveling Wave 
Tube (TWT) amplifier (Applied Systems Engineering, USA). All EPR experiments 
were carried out at 10 K using 200 µM protein samples (final concentration). WT SLAC 
and mgSLAC were prepared in 10 mM Tris pH 7.5 containing 100 mM NaCl and 50% 
glycerol, whereas T1D mgSLAC in deutarated 10 mM Tris pH 7.5 containing 100 mM 
NaCl and 50% deuterated glycerol.  
The pulse sequence for a four-pulse PELDOR is shown in Figure 4.5. Two 
microwave frequencies, νdetection and νpump, (Δν (νdetection - νpump) of 84 MHz) are used to 
selectively excite two groups of spins, A and B, respectively. The first detection pulse 
(π/2), which is applied at a microwave frequency νdetection and time t = 0, flips A spins to 
the x-y plane where the spin magnetic moments process around the z-axis with different 
angular frequencies. The second detection pulse (π) is applied at time t = τ1 and reverses 
the direction of all the magnetic moments. This two-pulse sequence (π/2-τ1-π) creates    
a Hahn echo at time t = 2τ1. By integrating a Hahn echo signal as a function of the 
magnetic field, the field-swept spectrum is obtained. The third pulse (π, pump pulse) is 
applied at a microwave frequency νpump at t = T and inverts the magnetic moments of B 
spins. The final detection pulse at time t = 2τ1 + τ2 refocuses A spins and creates            
a refocused echo at time t = 2τ1 + 2τ2. Upon inversion of the B spins (the pump pulse), 
the A spins that are coupled with the B spins through dipolar interaction are inverted 
and process in the opposite direction in the x-y plane influencing the intensity of the 
refocused echo [80, 81, 82].     
 
 
 
Figure 4.5 The four-pulse PELDOR experiments. The image is taken from [80]. νdetect 
and νpump - microwave frequencies for selective excitation of two groups of spins; π - 
pulse; τ1, τ2 - pulse separations.  
 
The pulse lengths in a four-pulse PELDOR were 16 ns for π/2 and 32 ns for π. 
The pump pulse lengths were 24 ns (WT SLAC), 30 ns (mgSLAC) and 28 ns           
(T1D mgSLAC) incremented by 16 ns for a total of 160 (WT SLAC), 147 (mgSLAC) 
and 142 (T1D mgSLAC) points in time T. The delays between pulses, τ1, τ2 and τ3, were 
!pump 
!detect 
" " " 2 #1 #2 #2 
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196 ns, 2364 ns and 50 ns for WT SLAC, 200 ns, 2364 ns and 100 ns for mgSLAC and 
140 ns, 2234 ns and 50 ns for T1D mgSLAC, respectively. 2020 (WT SLAC), 10240 
(mgSLAC) and 1400 (T1D mgSLAC) scans with a repetition time of 500 µs, 500 µs and 
20000 µs, respectively, were recorded. 
 
4.4 Results 
 
4.4.1 Creation of the Cu-binding site using SLAC  
 
4.4.1.1 Design cycles of the Cu-binding site within the MBD-1 of SLAC 
 
In the first design cycle (Figure 4.6.A) of a new metal-binding site (MBS), the L1 of 
SLAC (D157HVVGTEHGTGGIRNGL173) has been replaced with the loops involved in 
the T1 Cu-binding of mgLAC (Figure 4.4.A) and WT bNiR (Figure 4.4.B), resulting in 
mgSLAC and nirSLAC, respectively (Table 4.2). Based on the structural resemblance 
between the L1 and L2 of WT SLAC (Figure 4.4.C), the tSLAC variant carrying 
D157C, G168H and L173M point mutations in the L1 has been made (Table 4.2, 
SLAClong gene numbering [73]). All variants from this cycle contain the ligands for a  
T1 Cu site in MBD-2, a T2/T3 Cu cluster at the interface between the MBD-1 and the 
MBD-2, and an MBS in their MBD-1 (MBS-1). In the second design cycle (Figure 
4.6.A), Ala99 (SLAClong gene numbering [73], Chapter 3) in the MBD-1 of tSLAC, 
mgSLAC and nirSLAC has been substituted with His, resulting in the qSLAC, A99H 
mgSLAC and A99H nirSLAC variants. This residue corresponds to the T1 Cu-
coordinating His57 in the MBD-1 of mgLAC, His89 in the MBD-1 of WT bNiR and 
His231 in the MBD-2 of WT SLAC. In the third design cycle (Figure 4.6.A), the C288S 
variants (SLAClong gene numbering [73], Chapter 3) of the proteins from the previous 
cycles, which lack the T1 Cu site (T1D) in MBD-2, have been created, resulting in   
T1D tSLAC, T1D qSLAC, T1D mgSLAC, T1D nirSLAC and T1D A99H nirSLAC. 
The T1D A99H mgSLAC variant was not prepared. 
 
4.4.1.2 Expression and purification of SLAC variants 
 
tSLAC, qSLAC, mgSLAC and nirSLAC were isolated and purified at relatively high 
amounts (~ 20 - 50 mg/L), whilst the expression yield of A99H mgSLAC was 
significantly lower (~ 5 mg/L). A99H nirSLAC was not purified, due to the low 
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expression of the protein. The Ve of proteins (except for A99H mgSLAC) on the        
gel-filtration column correspond to MWapps of 105.9 kDa, 103.8 kDa, 101.5 kDa and 
105.8 kDa, respectively, which are close to the MWapp of WT SLAC (104.3 kDa)     
(Table 4.3). A99H mgSLAC elutes at a Ve lower to that of mgSLAC suggesting that the 
protein aggregates in solution (Table 4.3). The expression levels of proteins from the 
third design cycle were lower than those from the first and second design cycles, but the 
variants (except for T1D qSLAC) were purified in decent amounts (~ 5 - 20 mg/L). 
T1D mgSLAC and T1D nirSLAC elute at a Ve similar to those of mgSLAC and 
nirSLAC (Table 4.3), indicative of the proteins being stable trimers in solution, whereas 
T1D tSLAC and T1D A99H nirSLAC elute at a Ve significantly lower, suggesting that 
these SLAC variants aggregate in solution (Table 4.3). The MALDI-TOF-MS gives the 
MW for the monomer of each protein, which is close to the calculated value (Table 4.4). 
 
4.4.1.3 Activity of SLAC variants with 2,6-DMP 
 
WT SLAC shows typical for laccases, bell-shaped activity pattern with the maximal 
turnover of ~ 80 × 10-9 mol×s-1 of 2,6-DMP per mg of the protein at pH 8.0 (Table 4.5). 
tSLAC and qSLAC are the only variants, which show bell-shaped activity pattern, 
reaching the maximal turnover of ~ 2.0 and 1.0 × 10-9 mol×s-1 of 2,6-DMP, 
respectively, at pH of 5.3 to 5.9 (Table 4.5). mgSLAC, nirSLAC and their T1D variants 
show very little activity with no obvious pH pattern within pH range of 5.3 to 10. 
 
4.4.1.4 Determination of metal content in SLAC variants 
 
AAS quantifies 3.38 ± 0.16 equivalents of Cu per monomer of WT SLAC (Table 4.6), 
which is consistent with the reported values [73]. Low occupancy and absence of the   
T2 Cu has previously been observed in the crystal structure of WT SLAC [57] and other 
laccases [83] and is presumably the reason for having < 4 Cu ions per monomer.       
T1D SLAC contains 2.77 ± 0.08 equivalents of Cu and negligible Zn per monomer 
(Table 4.6), which is also consistent with previous findings [75].  
tSLAC has been isolated with 3.36 ± 0.14 equivalents of Cu per monomer, 
whilst mgSLAC and nirSLAC have decreased Cu occupancy (2.68 ± 0.31 and           
2.91 ± 0.34 equivalents per monomer, respectively) compared to WT protein            
(Table 4.6). The A99H mutation (second design cycle) resulted in qSLAC having 
decreased Cu occupancy compared to tSLAC, but similar to those of mgSLAC and 
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nirSLAC (Table 4.6). Dramatic loss of metal has been observed for A99H mgSLAC, 
which was purified with only 0.85 equivalents of Cu per monomer, and negligible Zn. 
The C288S mutation (third design cycle) resulted in 2.09 ± 0.02 and 2.10 ± 0.07 
equivalents of Cu per monomer for T1D mgSLAC and T1D nirSLAC (Table 4.6) and 
significant increase of Zn content (0.58 ± 0.05 and 1.00 ± 0.12 per monomer 
respectively). T1D tSLAC and T1D A99H nirSLAC hardly bind any metal yielding as 
little as 0.87 and 0.53 equivalents of Cu per monomer, and a negligible amount of Zn 
(Table 4.6). 
 
4.4.1.5 Far -UV CD spectroscopy of SLAC variants 
 
The secondary structure composition of the purified SLAC variants have been estimated 
using far-UV CD spectroscopy and compared to that of WT SLAC (Figure 4.7.A and 
Table 4.7). The far-UV CD spectra of tSLAC (Figure 4.7.B), mgSLAC (Figure 4.7.C) 
and nirSLAC (Figure 4.7.D) resemble that of WT SLAC and consist of three bands at 
around 202 nm (+), 222 nm (−) and 232 nm (+). While the far-UV CD spectrum of 
qSLAC (Figure 4.7.B) is only slightly different to that of WT SLAC, the spectrum of 
A99H mgSLAC (Figure 4.7.C) exhibits a maximum at 192 nm (+) and a minimum at 
218 nm (−) indicative of this protein not folding correctly. The C288S mutation does 
not affect the protein fold (T1D SLAC variant, Figure 4.7.A), which is also the case for 
T1D mgSLAC (Figure 4.7.C) and T1D nirSLAC (Figure 4.7.D). However, the               
far-UV CD spectra of T1D tSLAC (Figure 4.7.B) and T1D A99H nirSLAC               
(Figure 4.7.D) are similar to that of A99H mgSLAC, indicative of these proteins not 
folding correctly. 
The obtained secondary structure compositions (Table 4.7) of WT SLAC, 
tSLAC, mgSLAC, nirSLAC, qSLAC, T1D SLAC, T1D mgSLAC and T1D nirSLAC 
are in relatively good agreement with those calculated from the crystal structure of       
WT SLAC [58]. T1D tSLAC, A99H mgSLAC and T1D A99H nirSLAC show an 
almost 10-fold increase in α-helical content and a lowered percentage of β-strands as 
compared to that of WT SLAC.  
 
4.4.1.6 UV-Vis absorption spectra of SLAC variants 
 
The UV-Vis spectra of WT SLAC (Figures 4.8.A), tSLAC (Figure 4.8.B), qSLAC 
(Figure 4.8.B) and mgSLAC (Figure 4.8.C) are dominated by the              
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S(Cys)π→Cu(II) dx2−y2 LMCT transition band at 590 nm from the T1 Cu(II) site. The 
ratio of the absorbance at 280 nm (due to the presence of Trp, Tyr, Phe and disulfide 
bonds) and 590 nm (A280/A590) for WT SLAC and tSLAC is ~ 13, whilst for mgSLAC 
and qSLAC is ~ 20 - 23 and decreases in the presence of oxidant to ~ 15 - 17               
(Table 4.8). The UV-Vis spectrum of nirSLAC (Figure 4.8.D) is decidedly different and 
does not exhibit an LMCT band at 590 nm. The protein absorbs weakly at 610 nm (with 
a shoulder at ~ 700 nm, Table 4.8) but in the presence of oxidant, this band is shifted 
from 610 nm to 590 nm. This shift and an increase in absorption intensity at ~ 590 nm 
suggest that the spectral features of the T1 Cu site become more dominant over those of 
the introduced MBS-1 (Figure 4.9.A). After removal of an oxidant, the absorbance at 
590 nm of qSLAC, mgSLAC and nirSLAC returns to the value before oxidation.       
A99H mgSLAC hardly absorbs at 590 nm (even in the presence of oxidant), but the 
UV-Vis spectrum shows an intense band at ~ 360 nm, with an A280/A360 ratio of ~ 13.  
The binuclear T3 Cu site of WT SLAC and T1D SLAC gives rise to an intense 
LMCT transition at ~ 330 nm. The 330 nm band is also present in the UV-Vis spectrum 
of tSLAC but not mgSLAC, nirSLAC and qSLAC (Table 4.8). The latter SLAC 
variants exhibit an intense band at ~ 360 nm (an A280/A360 ratio of ~ 23 - 25), 
presumably an LMCT transition from the thiolate (Cys) to the introduced                  
Cu(II)-binding site. The T1D SLAC variants (except for T1D SLAC) absorb strongly at 
~ 360 nm, with an A280/A360 ratio of ~ 30 to 47 (Figure 4.8 and Table 4.8). Additionally 
the T1D mgSLAC (Figure 4.8.C) and T1D nirSLAC (Figure 4.8.D) variants weakly 
absorb at ~ 640 nm. The position and intensity of this band does not change in the 
presence of oxidant.  
 
4.4.1.7 Visible CD spectra of nirSLAC and T1D nirSLAC 
 
The visible CD spectrum of WT SLAC (Figure 4.9.B) is characterized by intense bands 
at 438 nm (22830 cm-1; −) and 540 nm (18520 cm-1; +) and resembles those of small 
blue copper proteins, Pc and STC [84 - 86], and also Fet3p [87] and laccases [84]. By 
comparison the bands at 540 and 438 nm can be assigned as                      
S(Cys)pseudo-σ→Cu(II) dx2−y2 and N(His)π→Cu(II) dx2−y2 LMCT transitions, 
respectively. 
The visible CD spectrum of nirSLAC (Figure 4.9.B) is different to that of WT 
SLAC, and is characterized by an intense band at 360 nm (27778 cm-1, −) and weaker 
bands at 450 nm (22222 cm-1, +), 570 nm (17544 cm-1, +) and 650 nm (15385 cm-1, −). 
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The intensity ratio for the 450 nm and 570 nm bands changes and the 650 nm band is 
shifted towards longer wavelength in the presence of oxidant (Figure 4.9.B), however, 
the spectrum lacks the spectral features typical of WT SLAC. The spectrum of T1D 
nirSLAC (Figure 4.9.B) exhibits only two bands, at 360 nm (−) and 450 nm (+).  
 
4.4.1.8 EPR spectra of SLAC variants 
 
The EPR spectra of tSLAC and WT SLAC are alike and originate from two distinct 
paramagnetic centers (Figure 4.10.A). The T1 and T2 Cu(II) sites demonstrate the axial 
EPR signals with Az values of 77 and 107 × 10-4 cm-1, respectively, which are consistent 
with the reported values for WT [73] and T1D SLAC [75]. The spectra of qSLAC             
(Figure 4.10.A) and mgSLAC (Figure 4.10.B) originate from multiple Cu(II) centers 
but the overlap between EPR signals does not allow for accurate deconvolution. The 
EPR spectrum of nirSLAC (Figure 4.10.C) is different to that of mgSLAC, and 
originates from a single paramagnetic center with an Az of 189 × 10-4 cm-1 (Table 4.9). 
The EPR signal for the T1 Cu site is either absent or of very low intensity suggesting 
that the T1 Cu is either absent or in the Cu(I) form. This is consistent with the lack of 
the LMCT band at 590 nm in the UV-Vis spectrum of nirSLAC in the resting form.  
The EPR spectra of T1D mgSLAC (Figure 4.10.B) and T1D nirSLAC (Figure 
4.10.C) resemble that of nirSLAC giving the Az values of 190 × 10-4 cm-1 and                 
188 × 10-4 cm-1 respectively (Table 4.9). The Az values in the EPR spectra of              
T1D mgSLAC, T1D nirSLAC and nirSLAC are significantly higher then that of the         
T1 Cu sites (< 95 × 10-4 cm-1, [1, 27, 35, 36]) and are similar to that observed for the 
tetragonal S(Cys)-T2 Cu sites (> 130 × 10-4 cm-1, [1]). The EPR spectra of T1D tSLAC 
(Figure 4.10.A) and A99H mgSLAC (Figure 4.10.B) are very similar, but different to 
those of T1D mgSLAC and T1D nirSLAC, and originate from a single paramagnetic 
center with an Az of 160 × 10-4 cm-1 (Table 4.9). The EPR spectrum of T1D A99H 
nirSLAC (Figure 4.10.C) originates from two signals: one with Az of 160 × 10-4 cm-1 
(similar to those of T1D tSLAC and A99H mgSLAC) and second of very low intensity 
with Az of 189 × 10-4 cm-1 (similar to those of nirSLAC, T1D nirSLAC and T1D 
mgSLAC). 
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4.4.1.9 Preliminary studies on the PELDOR of WT SLAC and T1D mgSLAC 
 
The field-swept electron-spin echo (FSE) spectrum of WT SLAC (Figure 4.11.A) is 
similar to that of WT bNiR [80] and is typical of the T1 Cu(II) and the T2 Cu(II) sites. 
The four-pulse ELDOR spectra of WT SLAC and T1D mgSLAC are depicted in       
Figure 4.11.B and Figure 4.12.B, respectively. These spectra are relatively noisy, 
however the time traces are typical of PELDOR spectra after background subtraction 
[80]. The curves were fitted using a distance-domain Tikhonov regularization (thick 
line). Figure 4.11.C and Figure 4.12.C show the frequency domain (thin line) and 
simulated (thick lines) spectra of WT SLAC and T1D mgSLAC, respectively.            
Figure 4.11.D and Figure 4.12.D depict the molecular distances, which were derived 
from weak dipolar interactions between pairs of paramagnetic species. The distances 
determined within WT SLAC are 1.8, 2.2, 2.8, 3.1, 3.4, 4.0 and 4.8 nm, whereas within 
T1D mgSLAC these are 2.1, 2.8, 3.2, 4.0 and 4.8 nm. For comparison, the distances 
obtained from the crystal structure of WT SLAC between the T1 Cu and the T2 Cu are 
shown in Figure 4.11.E. T1D mgSLAC could not be crystallized, therefore, the 
distances between the MBS-1 and the T2 Cu have been calculated from the structural 
model of the protein overlaid on the trimeric structure of WT SLAC (Figure 4.12.E). 
Despite several attempts, it was not possible to obtain the distance distribution between 
the paramagnetic centers in mgSLAC using the PELDOR technique.          
 The Cu-Cu distances of 1.8, 2.2, 2.8 and 3.1 nm for WT SLAC are very close to 
those obtained from the crystal structure [58] (1.67, 2.22, 2.88 and 3.22 nm, 
respectively, Figure 4.11.F). The shortest distance observed in crystal structure,            
1.44 nm, could not be resolved using the PELDOR technique. Three longer distances 
resolved from PELDOR (3.4 nm, 4.0 nm and 4.8 nm) are not observed in the crystal 
structure. Their presence is likely an artifact caused by the very noisy PELDOR 
spectrum. The relative intensity between identified peaks varies, with the most intensive 
peak at 1.8 nm and the least at 3.1 nm. Given that the 1.67 nm peak corresponds to the 
(T1)Cu-(T1)Cu and 3.22 nm to the (T2)Cu-(T2)Cu distances, the intensity ratio directly 
reflects significantly lower occupancy of Cu(II) at the T2 Cu site compared to the          
T1 Cu site. Accordingly, the peaks corresponding to the (T1)Cu-(T2)Cu distances show 
intermediate intensity.   
 Preliminary PELDOR measurements on T1D mgSLAC are highly inconclusive. 
Five Cu-Cu distances have been resolved, from which only two (3.2 and 4.0 nm) are 
close to those estimated from the structure model of T1D mgSLAC (Figure 4.12.F). 
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Possibly, the two distances of 3.22 nm and 3.58 nm between the (T2)Cu-(T2)Cu and 
(MBS-1)Cu-(T2)Cu, respectively, in the structure model of T1D variant, are not 
resolved in PELDOR data and appear as a single peak at 3.2 nm. Likewise, the 
distances of 4.15 nm of (MBS-1)Cu-(T2)Cu and 4.31 nm of (MBS-1)Cu-(MBS-1)Cu 
possibly appear as a single peak at 4.0 nm. Similar lack of resolution has been 
previously reported for PELDOR measurements on WT bNiR (Figure 4.12.F) [80].        
The short distance between the MBS-1 Cu and the T2 Cu sites within the monomer of 
T1D mgSLAC (1.29 nm) is not observed and the presence of remaining three distances 
(2.1, 2.8 and 4.8 nm) can possibly be an artifact, caused by too noisy data and low 
accuracy of data fitting.  
 
4.4.2 Design of the Cu-binding site and the T2/T3 Cu sites using bNiR 
 
4.4.2.1 Design cycles of the Cu-binding sites in bNiR  
 
Attempts to introduce an MBS in the L2 of MBD-2 (N299HNLIEAFELGA310) in bNiR 
were undertaken in parallel with those within MBD-1 of SLAC. The first design cycle, 
which for consistency with the studies on SLAC variants is referred herein as the 
second design cycle (Figure 4.6.B), produced qNiR (Table 4.2), which contains all the 
ligands for the T1 and T2 Cu sites, and an MBS in MBD-2 (MBS-2). The variant carries 
N299C, E304H, A310M point mutations in the L2, and T246H mutations in the core of 
the protein. Thr246 residue corresponds to the T1 Cu-coordinating His89 in the MBD-1 
of WT bNiR, His46 in Az and His231 in the MBD-2 of WT SLAC. 
In the second design cycle (referred herein as the third design cycle, Figure 
4.6.B) T1D qNiR, T1D azNiR and T1D T246H azNiR (T1D azNiR carrying the T246H 
point mutation) that lack the T1 Cu site (C130S mutation) in MBD-1 were prepared.        
In the T1D azNiR and T1D T246H azNiR variants, the L2 has been replaced with the 
T1 Cu-binding loop of Az (C299TFPGH304SALM308) (Table 4.2). The T2 Cu site of T1D 
azNiR and T1D T246H azNiR is coordinated only by two His ligands, as His300, which 
is the third T2 Cu-coordinating ligand, is removed during the replacement of the L2.   
 Based on comparison of the T2 Cu site of bNiR and the T2/T3 Cu cluster of 
laccases, in the third cycle (referred herein as the fourth design cycle, Figure 4.6.B), an 
attempt was made to introduce a T2/T3 Cu site at the interface of the MBD-1 and 
MBD-2 of bNiR. The LacNiR variant of bNiR contains D92H, A131H, I251H and 
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L298H mutations that correspond to His102, His158, His236 and His287 of WT SLAC 
(Table 4.2).   
 
4.4.2.2 Expression and purification of bNiR variants 
 
The qNiR, T1D azNiR and T1D T246H azNiR variants were isolated at relatively large 
amounts (20 - 30 mg/L), whereas the expression level of T1D qNiR was too low to 
enable protein purification (results not shown). qNiR was very unstable and therefore, 
was not characterized. The Ve of T1D azNiR from the gel-filtration column corresponds 
to an MWapp of 111.5 kDa, which is similar to an MWapp of WT bNiR (115.2 kDa) 
(Table 4.3), and is indicative of the protein being a stable trimer in solution.           
MALDI-TOF-MS gives an MW of 36375.5 Da per monomer, which is close to the 
calculated value (Table 4.4). The T1D T246H azNiR variant elutes from the                 
gel-filtration column as two peaks (Table 4.3). The peak eluting at a lower Ve 
corresponds to the trimeric form of the protein, whilst the oligomeric state of the protein 
eluting at a higher Ve, was not estimated. When both fractions were re-applied to the 
gel-filtration column, the heavier form elutes mainly as a trimer, whereas the lighter 
form as a mixture, with the relative amount of forms varying between preparations.         
The T1D T246H azNiR variant was therefore studied in two forms: purified trimer 
(T1D T246H azNiR trimer) and a mixture (T1D T246H azNiR mixture). LacNiR was 
isolated in large amounts (~ 50 mg/L), with a Ve from the gel-filtration column similar 
to that of WT bNiR (Table 4.3), indicative of a stable trimer in solution.                  
MALDI-TOF-MS gives an MW of 36780.5 Da per monomer, which is similar to the 
calculated value (Table 4.4). 
  
4.4.2.3 Determination of metal content in bNiR variants 
 
WT bNiR contains 1.94 ± 0.02 of Cu per monomer (Table 4.6). The metal content in 
T1D azNiR varies between different preparations, yielding 1.52 ± 0.53 of Cu per 
monomer and negligible Zn (Table 4.6). The T1D T246H azNiR trimer and mixture 
were isolated with 1.44 ± 0.01 and 1.96 ± 0.09 of Cu per monomer, respectively, and 
negligible Zn (Table 4.6). For LacNiR, AAS quantifies 2.68 ± 0.15 of Cu per monomer 
and negligible Zn (Table 4.6). All attempts to reconstitute the T2/T3 Cu site of LacNiR 
with Cu(II) were unsuccessful.  
 
	   171	  
4.4.2.4 Far-UV CD spectroscopy of bNiR variants 
 
The far-UV CD spectrum of WT bNiR (Figure 4.13.A) consists of three bands at               
~ 197 nm (+), 216 nm (−) and 226 nm (−). The spectra of T1D azNiR and T246H 
variants (Figure 4.13.A) differ, showing a maximum at 196 nm (+) and the two minima 
at ~ 210 nm (−) and 215 nm (−). The obtained secondary structure composition of           
WT bNiR is in relatively good agreement with that calculated from the structure [52], 
whilst the T1D azNiR and T1D T246H azNiR variants show a significant increase in 
random coil content and a lowered percentage of α-helical and β-strand secondary 
structure compared to the WT protein (Table 4.7). The far-UV CD spectrum of LacNiR 
is comparable to that of WT bNiR (Figure 4.14.A) and the obtained secondary structure 
composition (Table 4.7) is in good agreement with that calculated from the crystal 
structure of LacNiR (Section 4.4.2.7). 
 
4.4.2.5 UV-Vis absorption spectra of bNiR variants 
  
The UV-Vis spectrum of WT bNiR (Figure 4.13.B) is dominated by an intense 
S(Cys)π→Cu(II) dx2−y2 LMCT, and a weak S(Cys)σ→Cu(II) dx2−y2 LMCT transition 
bands at 594 and 470 nm respectively, from the T1 Cu(II) site. The UV-Vis spectrum of 
T1D azNiR (Figure 4.13.B) has an LMCT transition band at ~ 370 nm (A280/A370 ratio 
of ~ 42) and a much weaker band at ~ 573 nm, which intensities do not change upon 
oxidation (Table 4.8). The addition of imidazole as a potential exogenous Cu ligand 
(data not shown), does not affect the intensity and position of the 370 and 573 nm 
bands, however high concentrations of imidazole destabilize T1D azNiR leading to 
precipitation. The UV-Vis spectra of both forms of T1D T246H azNiR (Figure 4.13.B) 
exhibit weak absorption bands at ~ 550 nm, which do not change upon oxidation. Only 
T1D T246H azNiR mixture shows an absorption band at 370 nm exhibiting the 
A280/A370 ratio of ~ 49. The UV-Vis spectrum of LacNiR (Figure 4.14.B) shows an 
intense LMCT band, which is shifted to slightly longer wavelength (600 nm) compared 
to WT bNiR (594 nm) and WT SLAC (590 nm), and its intensity does not change upon 
oxidation. In contrary to WT SLAC, LacNiR hardly absorbs at 330 mm suggesting that 
a T3 Cu(II) site is not present. 
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4.4.2.6 EPR spectra of bNiR variants 
 
The EPR spectrum of WT bNiR (Figure 4.13.C) consists of two EPR signals 
corresponding to the T1 and T2 Cu(II) centers (Table 4.10) [74]. The EPR spectra of the 
T1D azNiR and T1D T246H azNiR variants (Figure 4.13.C) also originate from two 
different EPR signals, one corresponding to the T2 Cu(II) and the other to                    
MBS-2 Cu(II) (Table 4.10). Despite differences in oligomeric state and UV-Vis spectra, 
the EPR spectra of T1D T246H azNiR trimer and mixture are alike and only slightly 
different to that of T1D azNiR (Figure 4.13.C and Table 4.10). The gz values for the        
T2 Cu(II) site of T1D azNiR and both T1D T246H azNiR variants decrease, whilst the 
Az values increase compared to WT bNiR (Table 4.10). This indicates a major change 
in the coordination sphere of the T2 Cu(II) site of the bNiR variants. The MBS-2 Cu(II) 
sites of T1D azNiR and T1D T246H azNiR variants demonstrate EPR signals with 
higher Az values (188 - 206 × 10-4 cm-1) compared to that of the T1 Cu(II) site of WT 
protein (66 × 10-4 cm-1). The EPR spectrum of LacNiR, similar to that of WT bNiR, 
consists of two EPR signals (Figure 4.14.C). The gz and the Az values of the T1 Cu(II) 
site of LacNiR are similar to those of the WT protein, whilst those of the T2 Cu(II) site 
are significantly different (Table 4.10), indicative of a major change in the coordination 
sphere of the T2 Cu site of LacNiR.             
 
4.4.2.7 Crystal structure of LacNiR 
 
LacNiR was crystallized in the presence of 10 mM ZnSO4, using identical conditions to 
those reported for WT bNiR [77]. Soaking the crystals in an excess of CuSO4 resulted 
in decrease in the quality of the diffraction data. The crystal structure of LacNiR was 
determined at 1.75 Å resolution from almost perfectly twinned crystals. Similar to        
WT bNiR, LacNiR crystallizes in space group H3, which, owing to the twinning of the 
crystal, gives the apparent symmetry of space group H32. LacNiR crystallizes as a 
trimer in identical oligomeric arrangement to WT bNiR, with a monomer in the 
asymmetric unit (the trimer is generated by rotational crystallographic symmetry). 
Partial refinement of almost perfectly twinned crystal of LacNiR possibly generates a 
certain inaccuracy in values of bond distances and angles. However, the overall 
structure of LacNiR does not deviate substantially from the structure of WT bNiR. 
Superposition of the Cα atoms of the complete trimer produces an RMSD of 0.65 Å.  
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The coordination environment of the T1 Cu in LacNiR is similar to that found in 
WT bNiR. The positions of His89, His139 and the axial ligand, Met144 are similar, 
however, a small displacement of the thiolate sulfur of Cys130 is observed. The most 
significant alteration in the structure of LacNiR compared to WT bNiR is observed at 
the T2 Cu site (Figure 4.15.A and Figure 4.15.B). The electron density and anomalous 
difference maps (Figure 4.15.A) of this region show a single peak that could be 
attributed to the T2 Cu. There are no other peaks that could be attributed to additional 
Cu ions. However, it is important to note, that diffraction data were collected at a 
wavelength of 0.98 instead of 1.33 Å. Therefore, an anomalous difference map to 
identify the location of any Cu ions in the crystal was generated at lower electron 
contribution to the anomalous signal than in experiment conducted at 1.33 Å.                
The superimposition of the structures of LacNiR and WT SLAC show small 
displacements of the imidazole rings of His92, His94 and His129 of LacNiR              
(Figure 4.15.C). However, a major structural alteration is observed for His251, which 
occupies a dramatically different position of the corresponding residue in WT SLAC 
(Figure 4.15.C). This results in the imidazole ring being shifted much more to the center 
of the active site, possibly preventing Cu from binding. 
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Cycle Protein Mutation 
Expected metal 
binding sites 
WT SLAC  T1 Cu, T2/T3 Cu 
0 
WT bNiR  T1 Cu, T2 Cu 
tSLAC D157HVVGTEHGTGG168IRNGL173 to C157HVVGTEHGTGH168IRNGM173 
mgSLAC D157HVVGTEHGTGG168IRNGL173 to C157HVNVNEH164VGVRGM170 1 
nirSLAC D157HVVGTEHGTGG168IRNGL173 to C157HPEGMVPWH166VVSGM171 
T1 Cu,  
T2/T3 Cu,  
MBS-2 Cu 
qSLAC D157HVVGTEHGTGG168IRNGL173 to C157HVVGTEHGTGH168IRNGM173 and A99H a 
A99H mgSLAC D157HVVGTEHGTGG168IRNGL173 to C157HVNVNEH164VGVRGM170 and A99H a 
A99H nirSLAC D157HVVGTEHGTGG168IRNGL173 to C157HPEGMVPWH166VVSGM171 and A99H a 
T1 Cu,  
T2/T3 Cu,  
MBS-2 Cu 2 
qNiR N299HNLIE304AFELGA310 to C299HNLIH304AFELGM310 and T246H 
T1 Cu, T2 Cu,  
MBS-1 Cu 
a Numbering of the SLAClong gene [73] (Chapter 3). 
 
Table 4.2 Variants of SLAC and bNiR studied in this chapter.  
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Cycle Protein Mutation 
Expected metal 
binding sites 
T1D SLAC C288S b T2/T3 Cu 
T1D tSLAC D157HVVGTEHGTGG168IRNGL173 to C157HVVGTEHGTGH168IRNGM173 and C288S a 
T1D qSLAC D157HVVGTEHGTGG168IRNGL173 to C157HVVGTEHGTGH168IRNGM173, A99H a and C288S a 
T1D mgSLAC D157HVVGTEHGTGG168IRNGL173 to C157HVNVNEH164VGVRGM170 and C288S a 
T1D nirSLAC D157HVVGTEHGTGG168IRNGL173 to C157HPEGMVPWH166VVSGM171 and C288S a 
T1D A99H nirSLAC D157HVVGTEHGTGG168IRNGL173 to C157HPEGMVPWH166VVSGM171, A99H a and C288S a 
T2/T3 Cu,  
MBS-2 Cu 
T1D qNiR N299HNLIE304AFELGA310 to C299HNLIH304AFELGM310, C130S and T246H 
T1D azNiR N299HNLIEAFELGA310 to C112TFPGH117SALM121 and C130S 
3 
T1D T246H azNiR N299HNLIEAFELGA310 to C112TFPGH117SALM121 and C130S and T246H 
T2 Cu,  
MBS-1 Cu 
LacNiR Asp92, Ala131, Ile251 and Leu298 
4 
Δ252G LacNiR Asp92, Ala131, Ile251, Leu298 and Δ252G 
T1 Cu, T2/T3 Cu 
a Numbering of the SLAClong gene [73] (Chapter 3). 
 
Table 4.2 Variants of SLAC and bNiR studied in this chapter - continued.
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Elution volume (Ve), mL 
Cycle Protein 
Protein Control protein 
 MWapp, 
kDa 
Estimated 
oligomeric 
state 
WT SLAC   104.3 Trimer 
0 
WT bNiR   115.2 Trimer 
tSLAC   105.9 Trimer 
mgSLAC   101.5 Trimer 1 
nirSLAC   105.8 Trimer 
qSLAC   103.8 Trimer 
2 
A99H mgSLAC 69.9 72.2 (T1D nirSLAC) a  a 
T1D SLAC a a a Trimer b 
T1D tSLAC 70.1 72.2 (T1D nirSLAC) a a 
T1D mgSLAC 73.1 72.2 (T1D nirSLAC) a Trimer c 
T1D nirSLAC   100.6 Trimer 
T1D A99H 
nirSLAC 
75.4 77.3 (T1D nirSLAC) a a 
T1D azNiR   111.5 Trimer 
75.0 a Trimer c 
3 
T1D T146H 
azNiR 81.0 
74.5 (LacNiR) a a 
4 LacNiR 77.0 76.5 (WT bNiR) a Trimer c 
a Not determined. b Taken from [75]. c Trimeric state was estimated from Ve value 
relative to the Ve of trimeric control protein (shown in brackets).   
 
Table 4.3 Gel-filtration data for purified proteins and calculated apparent molecular 
weights (MWapp). 
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Cycle Protein 
Experimental mass 
(MW), Da 
Theoretical mass 
(MWtheoretical), Da 
WT SLAC 32591.6 32587.0 (− Met) 
0 
WT bNiR 36652.3 36654.8 (+ Met) 
tSLAC 32664.5 32673.2 (− Met) 
mgSLAC 32419.5 32419.0 (− Met) 1 
nirSLAC 32513.4 32534.2 (− Met) 
qSLAC 32736.3 32739.3 (− Met) 
2 
A99H mgSLAC a 32485.0 (− Met) 
T1D tSLAC a 32657.2 (− Met) 
T1D mgSLAC 32400.5 32400.5 (− Met) 
T1D nirSLAC 32519.1 32518.1 (− Met) 
T1D A99H nirSLAC a 32584.2 (− Met) 
T1D azNiR 36374.5 36374.5 (+ Met) 
3 
T1D T146H azNiR a 36410.6 (+ Met) 
5 LacNiR 36780.5 36790.9 (+ Met) 
a Not determined.  
 
Table 4.4 MALDI-TOF-MS data and calculated theoretical masses of purified proteins. 
 
Cycle Protein Optimal pH a  Activity (10-9 mol×s-1×mg-1) 
0 WT SLAC 8.0 77 
tSLAC 5.9 1.9 
mgSLAC 5.3 - 9.5 0.0 - 0.4 1 
nirSLAC 5.3 - 9.5 0.0 - 0.8 
qSLAC 5.3 1.0 
2 
A99H mgSLAC b b 
T1D SLAC 9.0 0.1 
T1D tSLAC b b 
T1D mgSLAC 5.3 - 9.5 0.0 - 0.4 
T1D nirSLAC 5.3 - 9.5 0.0 - 0.1 
3 
T1D A99H nirSLAC b b 
a pH range indicates no optimal pH. b Not determined.  
 
Table 4.5 Activity of the SLAC variants with 50 mM of 2,6-DMP at RT.  
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Experimental 
Cycle Protein 
Theoretical 
Cu/monomer Cu/monomer Zn/monomer 
WT SLAC 4.00 3.38 ± 0.16 Negligible 
0 
WT bNiR 2.00 1.94 ± 0.02 Negligible 
tSLAC 5.00 3.36 ± 0.14 0.07 ± 0.02 
mgSLAC 5.00 2.68 ± 0.31 0.15 ± 0.05 1 
nirSLAC 5.00 2.91 ± 0.34 0.18 ± 0.14 
qSLAC 5.00 2.24 ± 0.21 0.17 ± 0.04 
2 A99H 
mgSLAC 
5.00 0.85 a Negligible a 
T1D SLAC 3.00 2.77 ± 0.08 Negligible 
T1D tSLAC a 4.00 0.87 a Negligible a 
T1D mgSLAC 4.00 2.09 ± 0.02 0.58 ± 0.05 
T1D nirSLAC 4.00 2.10 ± 0.07 1.00 ± 0.12 
T1D A99H 
nirSLAC a 
4.00 0.75 a Negligible a 
T1D azNiR 2.00 1.52 ± 0.53 0.07 ± 0.04 
T1D T246H 
azNiR trimer 
2.00 1.44 ± 0.01 0.08 ± 0.00 
3 
T1D T246H 
azNiR mixture 
2.00 1.96 ± 0.09 0.08 ± 0.01 
4 LacNiR 4.00 2.68 ± 0.15 0.11 ± 0.02 
a Single measurement. 
 
Table 4.6 Cu and Zn quantifications for the purified proteins.  
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Secondary structure, % 
Cycle Protein 
Data 
analazyed a 
Fitting 
NRMSD 
b 
Helix β-sheet Turn 
Random 
coil 
X-ray  6.6 46.5 27.5 19.4 
WT SLAC c 
Far-UV CD 0.034 3.0 47.0 22.0 27.0 
X-ray  12.2 39.6 26.4 21.8 
0 
WT bNiR c 
Far-UV CD 0.040 7.0 41.0 21.0 29.0 
tSLAC Far-UV CD 0.041 3.0 45.0 23.0 30.0 
mgSLAC Far-UV CD 0.039 4.0 44.0 22.0 29.0 1 
nirSLAC Far-UV CD 0.051 3.0 44.0 22.0 29.0 
qSLAC Far-UV CD 0.041 3.0 43.0 24.0 30.0 
2 A99H 
mgSLAC 
Far-UV CD 0.017 30.0 23.0 19.0 28.0 
T1D SLAC Far-UV CD 0.035 3.0 47.0 21.0 27.0 
T1D tSLAC Far-UV CD 0.014 29.0 23.0 20.0 28.0 
T1D mgSLAC Far-UV CD 0.049 3.0 44.0 22.0 30.0 
T1D nirSLAC Far-UV CD 0.049 3.0 46.0 22.0 29.0 
T1D A99H 
nirSLAC 
Far-UV CD 0.016 29.0 22.0 19.0 28.0 
T1D azNiR Far-UV CD 0.039 4.0 33.0 17.0 44.0 
T1D T146H 
azNiR Trimer 
Far-UV CD 0.045 4.0 35.0 18.0 41.0 
3 
T1D T146H 
azNiR Mixture 
Far-UV CD 0.54 4.0 33.0 18.0 44.0 
X-ray  10.4 34.2 28.5 26.9 
4 LacNiR 
Far-UV CD 0.030 11.0 36.0 20.0 31.0 
a In 10 mM phosphate pH 7.0 at 25 °C. b Normalised to 1 root-mean square deviation 
[88] for fitting of the far-UV CD spectra in 190 - 240 nm range using CDSSTR analysis 
method [89], protein reference sets 4 or 7, as implemented by Dichroweb [90]. c The 
structures used were the crystal structures of WT bNiR (pdb code: 1OE1) [52] and WT 
SLAC (pdb code: 3KW8) [58]. 
 
Table 4.7 Comparison of the secondary structure contents determined from available 
structures using STRIDE [91] with those calculated from the far-UV CD spectra using 
Dichroweb [90].  
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Cycle Protein 
λmax(1), nm; 
(εmax(1), M-1cm-1) 
λmax(2), nm; 
(εmax(2), M-1cm-1) 
ε280/ 
εmax(1) 
ε280/ 
εmax(2) 
WT SLAC ~ 330; (3700) 590; (4400) a 15.2 12.5 
0 
WT bNiR 470; (1040) b 594; (5200) b 53.0 10.8 
tSLAC 330; (3200) 590; (4300) 17.0 12.9 
tSLACoxy c d 590; (4400) N/A 12.4 
mgSLAC 360; (2250) 590; (2400) 24.7 22.9 
mgSLACoxy c d 590; (3600) N/A 15.3 
nirSLAC 360; (2500) 610; (700) 22.7 76.4 
1 
nirSLACoxy c d 590; (3000) N/A 18.6 
qSLAC 352; (2170) 590; (2400) 25.5 19.6 
qSLACoxy c d 590; (3200) N/A 17.2 
A99H mgSLAC 360; (4400) 590; (190) 12.6 ~ 290 2 
A99H 
mgSLACoxy c 
d 590; (190) N/A ~ 290 
T1D SLAC 330; (2270) N/A 24.4 N/A 
T1D tSLAC 357; (1700) 590; (80) 33.1 N/A 
T1D mgSLAC 360; (1180) 590; (190) 46.9 ~ 290 
T1D nirSLAC 365; (1850) 637; (200) 30.1 269 
T1D A99H 
nirSLAC 
356; (1200) N/A 45.3 N/A 
T1D azNiR 370; (1300) 573; (350) 42.4 ~ 160 
T1D T146H 
azNiR Trimer 
370; (790) 550; (230) 70.9 ~ 239 
3 
T1D T146H 
azNiR Mixture 
~ 370; (1150) 550; (310) 48.5 ~ 180 
4 LacNiR 470; (1170) 600; (4400) 47.8 12.6 
a Taken from [73]. b Taken from [77]. c In the presence of an excess of [Fe(CN)6]3-.             
d Not determined.  
 
Table 4.8 Comparison of the UV-Vis parameters of purified proteins. 
	   181	  
Protein a 
Parameters b 
WT SLAC tSLAC mgSLAC c nirSLAC qSLAC c A99H mgSLAC 
T1D 
tSLAC 
T1D 
mgSLAC 
T1D 
nirSLAC 
T1D A99H 
nirSLAC d 
gx (T1 Cu) 2.032 2.032 2.032  2.032      
gy (T1Cu) 2.049 2.049 2.049  2.049      
gz (T1Cu) 2.233 2.233 2.233  2.233      
Ax (T1 Cu) 9.3 9.3 9.3  9.3      
Ay (T1 Cu) 9.6 9.6 9.6  9.6      
Az (T1 Cu) 77 77 77  77      
gx (T2 Cu) 2.048 2.034         
gy (T2 Cu) 2.055 2.053         
gz (T2 Cu) 2.362 2.352         
Ax (T2 Cu) 0.0 0.0         
Ay (T2 Cu) 0.0 0.0         
Az (T2 Cu) 107 107         
gx (MBS-2)    2.046  2.026 2.026 2.048 2.046 2.026 
gy (MBS-2)    2.064  2.079 2.079 2.065 2.061 2.079 
gz (MBS-2)    2.247  2.201 2.201 2.252 2.248 2.201 
Ax (MBS-2)    0.0  0.0 0.0 0.0 0.0 0.0 
Ay (MBS-2)    0.0  0.0 0.0 0.0 0.0 0.0 
Az (MBS-2)    189  160 160 190 188 160 
a In 20 mM Tris pH 7.5 containing 200 mM NaCl at ~ 80 K. b The units of the hyperfine coupling constants are 10-4 cm-1. c Signals overlap allows only 
for accurate simulation of the T1 Cu(II) site. d Second, low intensity signal present at gz = 2.252 and Az = 189 × 10-4 cm-1.  
 
Table 4.9 Comparison of the EPR parameters of WT SLAC and the variants made in this study. 
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Protein 
Parameters a 
WT bNiR b LacNiR b T1D azNiR c T1D T246H azNiR trimer c T1D T246H azNiR mixture  c 
gx (T1 Cu) 2.038 2.038    
gy (T1Cu) 2.058 2.058    
gz (T1Cu) 2.221 2.227    
Ax (T1 Cu) 10.3 10.4    
Ay (T1 Cu) 8.3 8.4    
Az (T1 Cu) 66 75    
gx (T2 Cu) 2.017 2.049 2.048 2.058 2.048 
gy (T2 Cu) 2.122 2.127 2.058 2.068 2.058 
gz (T2 Cu) 2.372 2.253 2.266 2.255 2.266 
Ax (T2 Cu) 0.0 0.0 1.0 1.0 1.0 
Ay (T2 Cu) 0.0 0.0 1.0 1.0 1.0 
Az (T2 Cu) 110 142 177 180 177 
gx (MBS-1)   2.019 2.029 2.010 
gy (MBS-1)   2.074 2.063 2.084 
gz (MBS-1)   2.206 2.210 2.206 
Ax (MBS-1)   0.0 0.0 0.0 
Ay (MBS-1)   0.0 0.0 0.0 
Az (MBS-1)   206 188 206 
a The units of the hyperfine coupling constants are 10-4 cm-1. b In 24 mM Tris pH 7.5 plus 40 % glycerol at ~ 80 K. c In 20 mM Tris pH 7.5 containing 
200 mM NaCl at ~ 80 K.   
 
Table 4.10 Comparison of the EPR parameters of WT bNiR and the variants made in this study. 
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A) 
 
B) 
 
 
Figure 4.6 Schemes of the design cycles for the variants of (A) SLAC and (B) bNiR. 
Oval and circle shapes represent MBD-1 and MBD-2, respectively. Blue colours 
represent the two-domain monomer of trimeric proteins. T1, T2, T3, T2/T3 Cus are 
blue, orange, yellow and black dots respectively. MBS-1 and MBS-2 are green dots, 
whilst A99H and T246H mutations at the MBS-1 and MBS-2 are shown as red rings 
around these dots. The proteins that were not prepared are shown in italic.      
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Figure 4.7 Far-UV CD spectra of (A) WT SLAC ( ) and T1D SLAC ( );            
(B) WT SLAC ( ), tSLAC ( ), T1D tSLAC ( ) and qSLAC ( );                    
(C) WT SLAC ( ), mgSLAC ( ), T1D mgSLAC ( ) and A99H mgSLAC          
( ); (D) WT SLAC ( ), nirSLAC ( ), T1D nirSLAC ( ) and T1D A99H 
nirSLAC ( ). The spectra were acquired at 25 °C in 10 mM phosphate at pH 7.0. 
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A) 
 
B) 
 
C) 
 
D) 
 
 
Figure 4.8 UV-Vis absorption spectra of (A) WT SLAC ( ) and T1D SLAC ( ); 
(B) tSLAC ( ), T1D tSLAC ( ) and qSLAC ( ); (C) mgSLAC ( ),             
T1D mgSLAC ( ) and A99H mgSLAC ( ); (D) nirSLAC ( ), T1D nirSLAC             
( ) and T1D A99H nirSLAC ( ). Spectra were acquired at RT in 20 mM Tris        
pH 7.5 containing 200 mM NaCl. 
 
A) 
 
B) 
 
 
Figure 4.9 UV-Vis absorption (A) and visible CD (B) spectra of WT SLAC ( ), 
nirSLAC as isolated ( ), nirSLAC in the presence of an excess of [Fe(CN)6]3- ( ), 
T1D nirSLAC as isolated ( ) and T1D nirSLAC in the presence of an excess of 
[Fe(CN)6]3- ( ). The spectra were acquired in 20 mM Tris pH 7.5 containing              
200 mM NaCl.  
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A) 
 
B) 
 
 C) 
 
 
Figure 4.10 EPR spectra of (A) WT SLAC ( ), tSLAC ( ), qSLAC ( ) and T1D 
tSLAC ( ). (B) WT SLAC ( ), mgSLAC ( ), A99H mgSLAC ( ) and T1D 
mgSLAC ( ). (C) WT SLAC ( ), nirSLAC ( ) and T1D nirSLAC ( ) and 
T1D A99H nirSLAC ( ). The spectra were acquired at ~ 80 K in 20 mM Tris pH 7.5 
containing 200 mM NaCl. 
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A) B) 
         
C) D) 
                 
E) F)  
          
 
Figure 4.11 (A) The FSE spectrum of WT SLAC using a two-pulse echo sequence 
(π/2-τ1-π, Figure 4.5) with a 16 ns 32 ns π-pulse and τ1 = 196 ns. (B) A four-pulse 
PELDOR spectrum ( , after subtraction of an exponential decay) of WT SLAC at 
9.687 GHz, 10 K and τ2 = 2364 ns using the pulse sequence in Figure 4.5, and the fit         
( ) of the spectrum. (C) Frequency domain spectrum ( ) with simulation ( ). 
(D) Distance distribution with peaks at 1.8, 2.2, 2.9, 3.1, 3.4, 4.0 and 4.9 nm and (E) the 
Cu-Cu distances within the WT SLAC trimer [58]. T1, T2 and T3 Cus are green, purple 
and red spheres, respectively. (F) Comparison of the distances obtained from four-pulse 
PELDOR (gray bars) with those from the crystal structure (black bars). Figures (A) - 
(D) prvided by Dr. Jessica H. van Wonderen. 
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A) B) 
       
C) D) 
             
F) 
    
 
E) 
    
 
 
Figure 4.12 (A) The FSE spectrum of T1D mgSLAC using a two-pulse echo sequence 
(π/2-τ1-π, Figure 4.5) with a 16 ns 32 ns π-pulse and τ1 = 140 ns. (B) A four-pulse 
PELDOR spectrum ( , after subtraction of an exponential decay) of T1D mgSLAC at 
9.668 GHz, 10 K and τ2 = 2232 ns using the pulse sequence in Figure 4.5, and the fit           
( ) of the spectrum. (C) Frequency domain spectrum ( ) with simulation ( ). 
(D) Distance distribution with peaks at 2.1, 2.8, 3.2, 4.0 and 4.8 nm. (E) The Cu-Cu 
distances within the trimer of T1D mgSLAC structural model overlaid on the trimeric 
WT SLAC [58]. MBS-1, T2 and T3 Cus are green, purple and red spheres, respectively. 
(F) Comparison of the distances obtained for T1D mgSLAC (i) and WT bNiR (3.07, 
3.40 and 4.22 nm, [80]) from four-pulse PELDOR (gray bars) with those from the 
structural model (T1D mgSLAC) and crystal structure (WT bNiR [52]) (black bars). 
Figures (A) - (D) prvided by Dr. Jessica H. van Wonderen. 
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A) C) 
 
B) 
 
 
 
Figure 4.13 (A) Far-UV CD, (B) UV-Vis absorption and (C) EPR spectra of WT bNiR 
( ), T1D azNiR ( ), T1D T246H azNiR trimer ( ) and T1D azNiR mixture         
( ). The far-UV CD spectra were acquired at 25 °C in 20 mM Tris pH 7.5, the          
UV-Vis spectra at RT in 20 mM Tris pH 7.5 containing 200 mM NaCl and the EPR 
spectra at ~ 80 K in 20 mM Tris pH 7.5 containing 200 mM NaCl.  
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A) C) 
 
B) 
 
 
 
Figure 4.14 (A) Far-UV CD, (B) UV-Vis absorption and (C) EPR spectra of LacNiR       
( ), WT bNiR ( ) and WT SLAC ( ). The far-UV CD spectra were acquired 
at at 25 °C in 10 mM phosphate pH 7.0, the UV-Vis spectra at RT in 20 mM Tris pH 
7.5 and the EPR spectra at ~ 80 K in 24 mM Tris pH 7.5 plus 40 % glycerol (LacNiR 
and WT bNiR) or 20 mM Tris pH 7.5 containing 200 mM NaCl (WT SLAC). 
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     A) 
 
B) C) 
  
 
Figure 4.15 (A) The T2 Cu site of LacNiR superimposed on the 2Fo - Fc electron 
density map (blue) contoured at the 2σ and the anomalous difference map (orange) 
contoured at 5σ level. Overlays of the T2 Cu site of LacNiR (green) on (B) the T2 Cu 
site of WT bNiR (orange) [52] and (C) the T2/T3 Cu cluster of WT SLAC (gray) [58]. 
The T2 Cu is shown as gold, pink and purple spheres in LacNiR, WT bNiR and WT 
SLAC and the T3 Cus are red spheres. 
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4.5 Discussion 
 
4.5.1 Design of Cu sites  
 
Structural comparison between two-domain MCOs and bNiR reveals striking 
similarities suggesting close evolutionary links. However, several features, such as the 
location of the T1 Cu site and the structure of an active center (the T2/T3 Cu cluster in 
MCO and the T2 Cu site in bNiR) imply perhaps a more distant relationship [52, 57, 59, 
60, 67, 69] (Chapter 1.3).  
The SLAC variants (except for tSLAC), which carry mutations in the L1 of 
MBD-1 exhibit an intense LMCT transition band at ~ 360 nm, which is typical of a 
tetragonal S(Cys)-T2 Cu site [1, 18, 92 - 97]. Additionally, mgSLAC and nirSLAC 
variants contain the T1 Cu site, which is characterized by a typical LMCT transition 
band at ~ 590 nm (Chapter 1.2.1). However, this band in the UV-Vis spectrum of 
nirSLAC appears only in the presence of oxidant, indicative of the T1 Cu site in the 
resting state of nirSLAC being in the Cu(I) form. In the resting state, nirSLAC exhibits 
a weak band at ~ 610 nm, suggesting that the introduced MBS-1 site exists as a mixture 
of a tetragonal S(Cys)-T2 Cu and distorted T1 Cu sites. Similar heterogeneity has 
previously been reported for H46G Az, in which the equilibrium between these sites 
changes with the external ligand [15]. However, conversion of the two sites in nirSLAC 
upon addition of imidazole and Cl− was not observed (data not shown). A preliminary 
study on gdcSLAC, with a C157HQSPLAPH165IAKGL170 loop replacing the L1 of 
SLAC (Appendix D), implies the role of an axial Met in binding of S(Cys)-T2 Cu. 
Substitution of Met with Leu affects the spectral properties of the site, as indicated by 
the lowered intensity of the 360 nm band compared to those of mgSLAC and nirSLAC.  
The C288S and C130S mutations in the SLAC and bNiR variants (third design 
cycle) led to the depletion of the T1 Cu sites in these proteins (judged from the 
disappearance of the LMCT transition band at 590 nm in the UV-Vis spectra and 
decrease in a total content of Cu). However, T1D tSLAC does not fold correctly what is 
surprising, as the C288S mutation did not affect the secondary structure composition of 
SLAC (in T1D SLAC) or other variants. The T1D azNiR variant is partially unfolded 
and is significantly less stable than the WT protein. This decreased stability is likely 
caused by the substitution of L2, as depletion of just the T1 Cu site (in C130A variant of 
WT bNiR) has previously shown not to affect the protein’s fold [98]. The T1D variants 
of SLAC (except for T1D SLAC) and bNiR exhibit an intense LMCT band at ~ 360 nm 
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and weak bands at ~ 570 nm (T1D azNiR), ~ 590 nm (T1D tSLAC and T1D mgSLAC) 
or ~ 637 nm (T1D nirSLAC). Similar UV-Vis spectra consisting of ~ 360 nm                    
(ε ~ 2000 M-1cm-1) and weak ~ 550 nm (ε ~ 300 M-1cm-1) bands have been observed for 
the ligand-containing loop peptides of Az [99] and Pc [100], which bind Cu(II) via Cys 
and His, but cannot stabilize a site with T1 Cu properties. Similar spectra have also 
been observed for nitrosocyanin [92], and H117G [11 - 13] and H46G [15] Az.             
The EPR spectra of T1D mgSLAC and T1D nirSLAC exhibit only one paramagnetic 
site, whilst two Cu(II) centers are present in the spectrum of T1D azNR. According to a 
Plumberg-Peisach-Vanngard plot extended for the T1.5 and S(Cys)-T2 Cu(II) sites [13, 
101], which displays a linear relationship between g|| and A|| values for various Cu(II) 
sites, the relation between the gz and Az values for MBS-1 and MBS-2 indicate the 
characteristics of a S(Cys)-T2 Cu(II) site.  
The first design cycle’s mutations in the SLAC and bNiR variants supply only 
the Cys, His and Met ligands on a single loop (L1 and L2) for coordination of the MBS-
1 and MBS-2 Cus. In H46G [15] and H117G [11 - 13] Az water molecules enter the 
coordination shell of the Cu site to compensate for the loss of a His ligand.                    
The resulting Cu site is distorted towards square planar, with a S(Cys) thiolate ligand 
and three nitrogen/oxygen (N/O) donors. Therefore it is possible that the vacant 
coordination position in T1D mgSLAC, T1D nirSLAC and T1D azNiR is occupied 
either by an exogenous ligand (e.g. H2O, OH−), or by N and O donors from the protein 
backbone or nearby side chains. A S(Cys)-T2 Cu site was formed in H117G Az when 
bidentate ligands such as histidine and histamine were added, whereas the addition of 
monodentate ligands such as imidazole and Cl− restored characteristic T1 Cu site 
features [11 - 13]. Histidine does not bind to the Cu(II) in H46G Az, whereas in the 
presence of Cl− and imidazole, the variant tends to form a S(Cys)-T2 Cu site or an 
equilibrium mixture of a T1 and a S(Cys)-T2 Cu species [15]. The addition of either 
imidazole or Cl− did not affect the spectroscopic features of the S(Cys)-T2 Cu sites of 
mgSLAC, nirSLAC and T1D azNiR (data not shown), indicative of either saturation of 
the coordination sphere or no accessibility for external ligands.  
The inclusion of the second His ligand situated in the core of the β-barrel of 
MBD-1 of SLAC and MBD-2 of bNiR (second design cycle) produced proteins, which 
except for qSLAC and T1D T246H azNiR, either did not express or failed to fold 
properly. Despite the additional ligand, the qSLAC and T1D T246H azNiR variants 
posses S(Cys)-T2 Cu sites. Different spectroscopic properties for the two forms of       
T1D T246H azNiR indicate possible flexibility at the S(Cys)-T2 Cu site, a property that 
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has been previously reported for the T1 Cu site of NIRAMI, in which the short 
amicyanin loop replaces L1 of WT bNiR [77]. The presence of two forms of                
T1D T246H azNiR indicates that the amino-acid replacement destabilizes the protein’s 
quaternary structure. Similarly, two forms with different quaternary structure and 
spectral properties were reported for NIRAMI, and L1 was found to be important for 
stabilizing both a functional T1 Cu site and the trimeric arrangement of the enzyme 
[77]. Murphy et al. hypothesized that it is unlikely for the ancestral two-domain 
structures exist as monomers with the functional active sites at the interface of the two 
domains [68]. However, Sato et al. showed that the T1 Cu-binding loop in AZ3A3A 
(the Az variant with 3 introduced Ala residues between the coordinating Cys, His and 
Met in the T1 Cu-binding loop), which only differs in length by one residue to that of 
the WT protein, favors the formation of stable homodimers in solution and a strand 
swapped dimer in the crystal structure with a Cu site at the dimer interface [5].   
Phylogenetic analyses performed by Nakamura et al. [67, 70] indicate that BCO 
[60] is the closest relative to the NiRs, leading to the hypothesis that NiRs might have 
descended from type C two-domain MCOs with concomitant loss of the T3 Cu site (see 
Chapter 1.3). However, the replacement of Asp92, Ala131, Ile251 and Leu298 by His 
residues in bNiR (fourth design cycle) did not result in the incorporation of a T3 Cu site, 
probably as a consequence of the conformation adapted by the side chain of the 
introduced His251. An attempt to enlarge the metal binding pocket by deleting Gly252 
and thus altering the position of the imidazole ring of His251 was not successful, as the 
ΔG252 LacNiR variant expressed very poorly (results not shown). LacNiR shows 
hardly any activity with NO2−, which is not surprising, considering that Asp92, Ala131 
and Ile251 are identified as being catalytically important [52, 102 - 104]. Although 
more detailed analysis is necessary, it is possible that the NiRs appeared before the 
creation of a T2/T3 Cu cluster, evolving from a type Y (containing two T1 Cu sites, one 
in each domain, and the T2 Cu site) rather than a type C ancestor (Chapter 1.3).    
 
4.5.2 Structural models of the Cu sites in SLAC variants 
 
Despite multiple attempts, SLAC and bNiR variants could not be crystallized. 
Assuming that, as in loop chimeras of cupredoxins, the loops replacing L1 and L2 adapt 
a conformation almost identical to those in the native proteins [3, 51], structural models 
of SLAC variants were built using WT SLAC, WT bNiR and mgLAC crystal structures 
as templates. None of the models predicts the tetragonal planar S(Cys)-T2 Cu geometry 
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of MBS-1, and in some cases, the distances between the ligands identified by the 
modeling software (I-TASSER) and the Cu site are too long (~ 5 Å) for these residues 
to be considered as ligands.     
In the structural model of mgSLAC (Figure 4.16.A), the Cu ion is coordinated 
by Cys157, His164, Met170 and a backbone amide N from Ala99. In T1D mgSLAC 
(Figure 4.16.B), the latter is replaced by the backbone amide N from Ser100.                 
The modeled site in the A99H variant has the same ligands as in T1D mgSLAC. 
Therefore, the reasons for incorrect folding of A99H mgSLAC remain unclear.             
The structural model of nirSLAC (Figure 4.16.C) shows that MBS-1 Cu is coordinated 
by Cys157, His164, Met171 and the backbone amide N of Ser100. This model predicts 
a steric hindrance between His164 and Met171, which possibly alters the actual 
structure of the MBS-1 and even T1 Cu sites. The model of T1D nirSLAC                
(Figure 4.16.D) exhibits a different overall structure compared to that of nirSLAC.          
The C-terminal loop (residues 304 - 341) rearranges and Ser100 does not participate in 
binding of Cu ion. Instead, His102 and His104, which are normally ligands to the           
T2 and T3 Cus, respectively, and a backbone carbonyl O from Val103 seem to 
coordinate the Cu site. However, this modeled structure seems unlikely, as such 
coordination would require a significant rearrangement of the protein fold, which does 
not occur (the far-UV CD spectrum is very similar to that of the WT protein).  
The EPR spectrum of T1D mgSLAC indicates the presence of only one 
paramagnetic center (the EPR signal from the T2 Cu(II) was not observed), however, 
preliminary PELDOR experiments predict several Cu(II)-Cu(II) distances (2.1, 2.8, 3.2, 
4.0 and 4.8 nm). This method yields reliably very precise distances in the range of             
~ 1.5 to 8 nm [81, 82] and has successfully been applied in the study of the                
Fe(III)-binding proteins transferrin and lactoferrin [105], a dimeric form of Az [106], 
and WT bNiR [80]. Although the distances between the T1 and the T2 Cus in the 
structural model of T1D mgSLAC and the crystal structure of WT bNiR are similar, 
those estimated using PELDOR differ (Figure 4.12.F, [80]). The creation of a              
S(Cys)-T2 Cu site in all of the SLAC variants results in a concomitant loss of total Cu 
and incorporation of Zn ions. The disappearance of the LMCT band at 330 nm 
(characteristic for the T3 Cu site) from the UV-Vis spectra, suggests that the T2/T3 Cu 
cluster is disrupted in these variants, and therefore the T3 Cu ions are no longer 
antiferromagnetically coupled to give a diamagnetic ground state. Consequently, 
multiple (T3)Cu-(T3)Cu, (T2)Cu-(T3)Cu and (MBS-1)Cu-(T3)Cu distances within a 
trimer ranging from 2.88 to 3.31 nm, 2.92 to 3.35 nm and 3.45 to 4.20 nm                   
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(T1D mgSLAC structural model, Figure 4.12.E), respectively, could be observed. 
Further investigations are necessary to extract more accurate distance distributions 
between the Cu(II) ions, possibly by using a combination of the inversion-recovery 
filter (IRf) technique with PELDOR (IRf PELDOR). This method was successfully 
applied to suppress distances between pairs of like sites in WT bNiR to simplify and the 
distance distributions [80]. 
 
A) 
 
B) 
 
C) 
 
D) 
 
 
Figure 4.16 Structure models of the introduced Cu sites in (A) mgSLAC,                        
(B) T1D mgSLAC, (C) nirSLAC and (D) T1D nirSLAC. Gray dashed lines connect 
ligands to the S(Cys)-T2 Cu site that were identified by I-TASSER software. The Cu of 
mgSLAC and nirSLAC are pink, whilst the Cus in T1D mgSLAC and T1D nirSLAC 
are magenta spheres.  
 
4.5.3 Activity of SLAC variants 
 
The tSLAC variant shows similar to the WT protein spectral features but a significant, 
almost 40-fold, decrease in activity with 2,6-DMP (Table 4.5). Substitution of the L1 in 
SLAC variants creates proteins that are almost inactive. Although WT SLAC has not 
been crystallized in the presence of substrate, the center of the trimer has been 
suggested to contain a shallow substrate-binding pocket [57]. Redesign of this putative 
site in the M198G and M198G/M266A variants resulted in enhanced activity towards 
phenolic substrates [107, 108]. On the other hand, MCO from Streptomyces 
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viridosporus T7A (type B two-domain MCO, Chapter 1.3) was crystallized with 
acetovanillone at the interface of the MBD-1 and MBD-2 within a monomer                
(pdb file: 3TBC). MCO from Amycolatopsis sp. ATCC 39116 (type B two-domain 
MCO, Chapter 1.3) was crystallized with 1-(3,4-dimethoxyphenyl)-2-(2-
methoxyphenoxy)-1,3-dihydroxypropane at the interface of MBD-1 and MBD-2 of each 
neighboring chains of the trimer, above the T2/T3 Cu cluster (pdb file: 3TA4). The L1 
is located relatively far (~ 7 - 10 Å) from the binding site of acetovanillone              
(Figure 4.17.A) but close to the binding site of 1-(3,4-dimethoxyphenyl)-2-(2-
methoxyphenoxy)-1,3-dihydroxypropane (Figure 4.17.B) in these structures. 
Considering that all the SLAC variants that contain the S(Cys)-T2 Cu site (except for 
qSLAC) showed decreased occupancy of Cu (Table 4.6) and almost no activity with 
2,6-DMP (Table 4.5), it is probable that the L1 of WT SLAC is important for stabilizing 
a functional T2/T3 Cu site and interactions with phenolic substrates. 
 
A) 
 
B) 
 
 
Figure 4.17 Cartoon representation of WT SLAC (gray, [58]) overlaid on two-domain 
MCOs from (A) S. viridosporus T7A (teal, pdb file: 3TBC) and (B) Amycolatopsis sp. 
ATCC 39116 (limegreen, pdb file: 3TA4) binding acetovanillone (yellow sticks) and       
1-(3,4-dimethoxyphenyl)-2-(2-methoxyphenoxy)-1,3-dihydroxypropane (green sticks), 
respectively. The L1 of WT SLAC is shown as pink Cα trace. The T1, T2 and T3 Cus of 
WT SLAC are green, purple and red spheres, respectively. The Cus of MCOs from          
S. viridosporus T7A and Amycolatopsis sp. ATCC 39116 are teal and limegreen 
spheres. 
 
4.6 Conclusions 
 
De novo design of Cu-binding sites in proteins or modification of existing sites is of 
special interest for understanding the important features of Cu sites in proteins, but also 
for biotechnological and industrial applications. In the first part of this chapter attempts 
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were made to create a T1 Cu site within the cupredoxin-like domains of WT SLAC and 
WT bNiR that naturally lack a Cu-binding site. This resulted in the introduction of a    
Cu site in MBD-1 and MBD-2 of WT SLAC and WT bNiR, respectively. Spectroscopic 
studies indicate that the Cu in these engineered sites adopts a (distorted) tetragonal                  
S(Cys)-T2 Cu site rather than a T1 Cu site. Construction of a geometrically correct 
primary coordination is not sufficient, as the introduced Cu is ligated by Cys, His, Met, 
and the coordination environment is most likely completed by a backbone carbonyls O 
or amides N, solvent components and side chains of neighboring amino acids. Further 
experiments, particularly resonance Raman spectroscopy measurements are underway 
to establish the coordination and electronic structure of these sites. Design strategy that 
constrain primary and secondary coordination sphere is an objective for future 
experiments.  
 The second part of the work focused on attempts to introduce a T2/T3 Cu cluster 
as found at the monomer-monomer interface in SLAC into the corresponding location 
in bNiR in place of the catalytic T2 Cu site. The electron density of the X-ray             
high-resolution data set of LacNiR shows no evidence that the T3 Cu site, and therefore 
T2/T3 cluster has been introduced.  
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5.1 Buffer solutions 
 
All buffer solutions were prepared using Milli-Q grade water obtained with a Millipore 
Simplicity water purification system with a rated resistivity ≥ 18 MΩcm at room 
temperature (RT).   
Sodium acetate (BDH) was used to buffer protein solutions in the pH range of 
5.2 to 6.0, 2-(N-morpholino)ethanesulphonic (Mes) (Sigma) in the pH range of 6.0 to 
6.5, Tris(hydroxymethyl)aminomethane (Tris) (Sigma) in the pH range of 7.4 to 9.0,    
4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid (Hepes) (VWR) in the pH range of 
7.0 to 8.3 and sodium carbonate (Fisher Scientific) in the range of 9.0 to 10.0. The pH 
was adjusted by addition of either HCl (BDH), NaOH (BDH) or acetic acid (Aldrich), 
in case of sodium acetate buffer. 
Citrate/phosphate (McIlvaine) buffer was used to buffer solutions within the pH 
range of 2.2 to 7.0. Buffers were prepared by mixing stock solutions of 0.2 M dibasic 
sodium phosphate (Na2HPO4, Fluka), and 0.1 M citric acid (BDH) (Table 5.1), and 
diluted as required.  
 
pH Na2HPO4 (mL) Citric acid (mL) 
2.2 1.8 98.2 
2.6 10.8 89.2 
3.0 20.4 79.6 
3.4 28.2 71.8 
3.8 35.4 64.6 
4.0 38.6 61.4 
4.2 41.2 58.8 
4.6 46.6 53.4 
5.0 51.4 48.6 
5.4 55.6 44.4 
5.8 60.6 39.4 
6.2 66.2 33.8 
6.6 72.8 27.2 
7.0 87.2 13.0 
 
Table 5.1 Volumes of 0.2 M Na2HPO4 and 0.1 M citric acid required for preparation of 
100 mL of McIlvaine buffer in the pH range of 2.2 - 7.0 [1]. 
 
Phosphate buffer was used to buffer solutions within the pH range of 6.0 to 8.0. 
Buffers were prepared by mixing stock solutions (Table 5.2) of 1 M dibasic and 
monobasic potassium phosphate K2HPO4 (BDH) and KH2PO4 (Fluka), respectively, 
and diluted as required.  
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pH K2HPO4 (mL) KH2PO4 (mL) 
6.0 13.2 86.8 
6.2 19.2 80.8 
6.4 27.8 72.2 
6.6 38.1 61.9 
6.8 49.7 50.3 
7.0 61.5 38.5 
7.2 71.7 28.3 
7.4 80.2 19.8 
7.6 86.6 13.4 
7.8 90.8 9.2 
8.0 94.0 6.0 
 
Table 5.2 Volumes of 1 M stocks of K2HPO4 and KH2PO4 required for preparation of 
100 mL of 1 M phosphate buffer solutions in the pH range of 6.0 - 8.0 [1]. 
 
5.2 Growth media  
 
All growth media were prepared in deionized water and sterilized by autoclaving at 121 
°C for 30 min. 
 
5.2.1 Luria-Bertani medium 
 
Luria-Bertani (LB) medium consists of 10 g/L tryptone (Melford), 10 g/L NaCl (Sigma) 
and 5 g/L yeast extract (Melford), whilst Low Salt LB medium of 10 g/L tryptone, 5 g/L 
NaCl and 5 g/L yeast extract. The LB-agar and Low Salt LB-agar solid media consist of 
LB and Low Salt LB supplemented with 15 g/L agar (Melford). The media were used to 
grow Escherichia coli strains for molecular cloning and protein expression, typically in 
the presence of an appropriate antibiotic (100 µg/mL ampicillin, 50 µg/mL kanamycin, 
25 µg/mL tetracycline, 34 µg/mL chloramphenicol and 25 µg/mL zeocin)      
 
5.2.2 2×Yeast Extract and Tryptone medium  
 
2×Yeast Extract and Tryptone (2×YT) medium consists of 16 g/L tryptone, 5 g/L NaCl 
and 10 g/L yeast extract. The medium was used for expression of proteins in E. coli 
BL21(DE3) strain in the presence of an appropriate antibiotic.  
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5.2.3 Terrific Broth medium 
 
Terrific Broth (TB) medium consists of 12 g/L Bacto peptone (BD Biosciences), 24 g/L 
yeast extract, 0.4 % (v/v) glycerol (Sigma), 17 mM KH2PO4 and 72 mM K2HPO4.     
The medium was used for high-yield over-expression of proteins in E. coli BL21(DE3) 
in the presence of an appropriate antibiotic.  
 
5.2.4 Yeast Extract Peptone Dextrose, Yeast Extract Peptone Dextrose Sorbitol and 
Yeast Extract Peptone Dextrose Adenine media 
 
Yeast Extract Peptone Dextrose (YPD) medium consists of 10 g/L yeast extract, 20 g/L 
Bacto peptone, 20 g/L dextrose (Melford), and an appropriate antibiotic (100 µg/mL 
zeocin), if necessary. Yeast Extract Peptone Dextrose Sorbitol (YPDS) medium is 
additionally supplemented with 182.2 g/L sorbitol (Melford), whilst Yeast Extract 
Peptone Dextrose Adenine (YPAD) with 0.1 g/L adenine. The YPD-agar, YPDS-agar 
and YPAD-agar solid media are supplemented with 20 g/L agar and 100 µg/mL zeocin, 
if necessary. The media were used for over-expression of Lcc1 in Pichia pastoris X-33 
and Pichia methanolica PMAD11 strains. 
 
5.2.5 Buffered Dextrose Complex and Buffered Methanol Complex media 
 
Buffered Complex (BM-Y) medium consists of 10 g/L yeast extract, 20 g/L              
Bacto peptone, 100 mM phosphate buffer, pH 6.0 (or pH 6.5), 13.4 g/L Yeast Nitrogen 
Base (YNB, Melford) and 400 µg/L biotin (Sigma). Buffered Dextrose Complex 
(BMDY) medium is additionally supplemented with 20 g/L dextrose, whilst Buffered 
Methanol Complex (BMMY) medium with 5 g/L methanol. The media were used for 
over-expression of secreted Lcc1 in P. methanolica PMAD11. 
 
5.2.6 Minimal Dextrose and Minimal Methanol media  
 
Minimal dextrose (MD) and methanol (MtM) solid medium consists of 13.4 g/L YNB, 
400 µg/L biotin and 20 g/L dextrose (MD-agar) or 5 g/L methanol (MtM-agar) 
supplemented with 15 g/L agar. The media were used for growth of P. pastoris X-33 
and P. methanolica PMAD11 strains and selection of Lcc1-expressing transformants. 
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5.2.7 Minimal medium 
 
Minimal medium (MM) consists of 22 g/L dextrose, 1.5 g/L L-asparagin, 0.12 mg/L 
thiamine, 0.06 mg/L HBO3, 0.5 g/L MgSO4×7H2O, 5 mg/L FeCl3×6H2O, 0.2 mg/L 
CuSO4×5H2O, 2.0 mg/L ZnSO4×7H2O, 0.1 mg/L MnSO4×4H2O, 0.04 mg/L 
(NH4)6Mo7O24×4H2O, 1.2 mg/L Ca(NO3)2×4H2O, 0.4 mg/L CoCl2×6H2O, 0.46 g/L 
KH2PO4 and 1.31 g/L K2HPO4×3H2O [2]. The MM-agar consists of MM supplemented 
with 15 g/L agar. The MM and MM-agar were used for growth of Schizophyllum 
commune WT and KS8 strains and over-expression of Lcc1. 
 
5.2.8 Complete medium  
 
Complete medium (CM) consists of 22 g/L dextrose, 2.0 g/L Bacto peptone, 2.0 g/L 
yeast extract, 0.5 g/L MgSO4×7H2O, 0.46 g/L KH2PO4 and 1.31 g/L K2HPO4×3H2O. 
The CM was used for over-expression of Lcc1 in S. commune WT and KS8 strains. 
 
5.2.9 Production medium 
 
Complete medium (PM) consists of 22 g/L dextrose, 1 % ethanol (v/v), 0.12 mg/L 
thiamine, 1.32 g/L (NH4)2SO4, 0.5 g/L MgSO4×7H2O, 5 mg/L FeCl3×6H2O, 0.2 mg/L 
CuSO4×5H2O, 2.0 mg/L ZnSO4×7H2O, 0.1 mg/L MnSO4×4H2O, 0.04 mg/L 
(NH4)6Mo7O24×4H2O, 1.2 mg/L Ca(NO3)2×4H2O and 0.4 mg/L CoCl2×6H2O. The PM 
was used for studies on expression of Lcc1 in S. commune WT and KS8 strains.  
 
5.2.10 Regeneration medium 
 
Regeneration medium (RM) consists of 20 g/L dextrose, 123 g/L MgSO4×7H2O, 2 g/L 
peptone, 2 g/L of yeast extract, 1.85 g/L KH2PO4 and 5.24 g/L K2HPO4×3H2O. The RM 
was used for DNA transformation of S. commune WT and KS8 protoplasts. 
 
5.3 Manipulation of Escherichia coli strains 
 
5.3.1 Strains 
 
E. coli strains (JM101, BL21 (DE3), Rosetta (DE3), BL21 Tuner (DE3), XL1-Blue and 
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XL10-Gold) were maintained either in liquid LB, Low Salt LB, LB-agar and Low Salt 
LB-agar media with an appropriate antibiotic at 4 °C. For long-term storage, the strains 
were maintained as cryo-stocks (at - 80 °C) containing 1.5 mL of pelleted saturated 
culture resuspended in 250 µL of 1 % (w/v) Bacto peptone and 250 µL of 50 % 
glycerol.   
 
5.3.2 Preparation of Escherichia coli competent cells 
 
An isolated colony of E. coli was inoculated in 5 mL of LB media and grown overnight 
at 37 °C with shaking at 200 rpm in an orbital shaker. The overnight culture was diluted 
100-fold into fresh 10 mL of LB and grown for approximately 2 h under the same 
conditions. The cells were centrifuged at 1500 g at 4 °C for 10 min and the pellet was 
resuspended in 1 mL ice-cold sterile buffer containing 85 % (v/v) LB, 10 % (w/v) 
polyethylene glycol (PEG) 8000, 5 % (v/v) dimethyl sulfoxide (Sigma) and 50 mM 
MgCl2, pH 6.5, frozen in liquid nitrogen and stored at - 80 °C [3]. 
 
5.3.3 Transformation in Escherichia coli 
 
Typically 100 µL of competent E. coli cells were incubated with 200 ng of plasmid 
DNA and stored on ice for 20 min. The cells were heat-shocked by incubating them at 
42 °C for 1 min, followed by 2 min incubation on ice. 0.9 mL of LB medium was added 
and the cells were incubated at 37 °C with rotary shaking for ~ 60 min. Typically          
100 µL of the transformed cells was spread on LB-agar (or Low Salt LB-agar) with the 
appropriate antibiotics and incubated overnight at 37 °C. Alternatively, prior to 
deposition, 1 mL of transformed cells was centrifuged at 1500 g at RT for 3 min and the 
cell pellet was resuspended in 100 µL of fresh LB [3].  
 
5.4 Manipulation of Pichia methanolica and Pichia pastoris 
 
5.4.1 Strains 
 
Pichia methanolica PMAD11 and Pichia pastoris X33 strains were kindly provided by 
Dr. Karin Scholtmeijer. For short-time storage, the strains were maintained at 4 °C on 
YPAD-agar (P. methanolica PMAD11) and YPD-agar (P. pastoris X33), respectively, 
whilst for long-term storage, as cryo-stocks (at - 80 °C) containing 1 mL of pelleted 
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overnight culture resuspended in 250 µL of YPAD (P. methanolica PMAD11) or YPD 
(P. pastoris X33) and 250 µL of 30 % sterile glycerol.  
 
5.4.2 Preparation of Pichia methanolica electrocompetent cells 
 
The P. methanolica PMAD11 electrocompetent cells were prepared according to the 
manufacturer’s protocol (Invitrogen). 200 mL of YPAD media was inoculated with the 
overnight culture of PMAD11 strain (starting OD600 ≈ 0.3) and grown for 4 h at 30 °C 
until an OD600 of 0.6 - 1.0 was reached. The cells were centrifuged at RT for 5 min at 
1500 g and the pellet was resuspended in 40 mL of sterile 50 mM phosphate pH 7.5 
containing 25 mM dithiothreitol (DTT). The cell suspension was incubated for 15 min 
at 30 °C, centrifuged for 5 min at 1500 g at 4 °C and washed (three times) with 50 mL 
of ice-cold sterile STM buffer containing 270 mM sucrose, 10 mM Tris pH 7.6 and          
1 mM MgCl2. After pelleting cells for the third time, the cells were resuspended in            
1 mL of ice-cold sterile STM buffer.  
 
5.4.3 Transformation of Pichia methanolica electrocompetent cells 
 
Transformation of Lcc1_pMETαA into P. methanolica PMAD11 strain was conducted 
as previously described [4], with some modifications. Typically 100 µL of competent 
cells were incubated with linearized Lcc1_pMETαA (3 µg) and stored on ice for 2 min 
in the ice-cold sterile 0.2 cm electroporation cuvette (Bio-Rad GenePulser). After 
electroporation, 1 mL of YPAD media (at RT) was added and the mixture was 
incubated for 1 h at 30 °C without shaking. Cells were centrifuged for 3 min at 1500 g 
at RT and resuspended in 100 µL of YNB. 50 µL of cells were spread on MD-agar and 
incubated for 3 - 4 days at 30 °C.  
 
5.4.4 Preparation of Pichia pastoris electrocompetent cells 
 
Electrocompetent P. pastoris X33 cells were prepared according to the manufacturer’s 
protocol (Invitrogen). 500 mL of YPD media was inoculated with 0.5 mL of the 
overnight culture and grown at 30 °C until an OD600 of 1.5 was reached. The cells were 
centrifuged at 1500 g for 5 min at 4 °C and resuspended in 500 mL of ice-cold sterile 
Milli-Q water. The cells were centrifuged again, resuspended in 250 mL of ice-cold 
sterile Milli-Q water, centrifuged again and resuspended in 20 mL of an ice-cold sterile 
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1 M sorbitol. Cells were centrifuged again and the pellet was resuspended in ~ 1 mL of 
ice-cold sterile 1 M sorbitol to the final volume of 1.5 mL. 
 
5.4.5 Transformation of Pichia pastoris electrocompetent cells 
 
Typically, 80 µL of electrocompetent P. pastoris X33 cells were incubated with 
linearized lcc1_pPICZαA (10 µg) and stored on ice for 5 min in the ice-cold sterile        
0.2 cm electroporation cuvette (Bio-Rad GenePulser). After the pulse, 1 mL of ice-cold 
sterile 1 M sorbitol was added. After 2 h of incubation at 30 °C (without shaking), the 
cells were spread on YPDS-agar containing of 100 µg/mL zeocin and incubated for          
3 days at 30 °C.  
 
5.5 Manipulation of Schizophyllum commune  
 
5.5.1 Strains 
 
The S. commune wild type (WT) strain 4-8 [5, 6] and the KS8 thn mutant strain [7, 8] 
were kindly provided by Dr. Karin Scholtmeijer. For short-term storage, the strains 
were maintained on MM-agar at 4 °C. For long-term storage, the strains were 
maintained as cryo-stocks containing 5×5 mm squares of MM-agar grown fungi and 
stored at - 80 °C.   
 
5.5.2 Preparation of protoplasts of Schizophyllum commune 
 
Protoplasts of S. commune WT and KS8 were prepared from mycelial homogenate as 
previously described [9]. The strains were grown on MM-agar for 7 days at 30 °C.          
A quarter of a colony (petri dish, 92 mm diameter×16 mm height) was homogenized 
with a blender (Waring Products, Inc.) in 50 mL of MM, diluted with 100 mL of MM, 
and grown for 24 h at 24 °C with shaking in an orbital shaker at 200 rpm. Cultures were 
homogenized again and grown with additional 50 mL of fresh MM for 16 h at 24 °C 
with shaking in an orbital shaker at 200 rpm. Mycelium was centrifuged for 10 min at 
3500 rpm in a swing rotor and the pellet was washed with 40 mL of sterile 1 M MgSO4. 
The mycelium was centrifuged for additional 15 min at 3500 rpm and the pellet was 
incubated for 4 h at 30 °C at 30 rpm with filter-sterile 50 mL of lysing enzymes mixture 
containing 1.0 mg/mL of Trichoderma harzianum enzymes (Horst) dissolved in 30 mM 
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maleic acid pH 5.8 and 1 M MgSO4. The culture was 2-fold diluted with sterile Milli-Q 
water, incubated for 10 min, and harvested by filtration over nylon miracloth (200 µm 
mesh size, Calbiochem). The flow through was incubated for 10 min with 100 mL of 
sterile 1 M sorbitol and centrifuged for 10 min at 2500 rpm. The pellets were pooled 
and washed twice with 50 mL of sterile 1 M sorbitol and centrifuged for additional          
10 min at 2500 rpm. The pellet was resuspended in 50 mL of sterile 1 M sorbitol, the 
protoplasts were counted and diluted to the number of (2 - 10)×107 protoplasts in 1 mL 
of sterile 1 M sorbitol. 100 µL of sterile 0.5 M CaCl2 was added to each 900 µL aliquot 
of protoplasts. Aliquots of protoplasts were frozen at a cooling rate of 1 °C/min using a 
freezing container Mr. Frosty (Nalagene), and stored at -80 °C. 
 
5.5.3 Transformation of Schizophyllum commune protoplasts 
 
Typically 100 µL of S. commune WT and KS8 protoplasts (fresh or thawed on ice) were 
incubated with ~ 5 µg of purified DNA for 15 min on ice. Subsequently the mixture was 
incubated for 5 min at RT with one volume of freshly prepared 40 % (w/v) PEG4000 in 
10 mM Tris pH 7.0, diluted with 2.5 mL of RM supplemented with 10 µg/mL (WT 
strain) or 25 µg/mL (KS8 strain) of phleomycin and incubated overnight at 25 °C.          
The next day, 7.5 mL of 1 % low-melting point (at 37 °C) agarose in MM containing   
50 µg/mL penicillin, 50 µg/mL streptomycin sulfate, and 8 µg/mL (WT strain) or            
20 µg/mL (KS8 strain) nourseothricin (final concentrations) were added to the 
regenerated protoplasts. The mixture was poured onto MM-agar containing 8 µg/mL 
nourseothricin, and when solidified, the selection plates were incubated at 30 °C for         
3 - 4 days [9]. For a selection of stable transformants, the strains were transferred to a 
MM-agar (without nourseothricin) and incubated at 30 °C for 3 - 4 days.  
 
5.6 Trametes versicolor genomic DNA isolation 
 
Trametes versicolor was grown at RT in 100 mL for 8 days in media containing 10 g/L 
dextrose, 20 g/L KH2PO4, 1.6 g/L Na2HPO4, 264 mg/L CaCl2×H2O, 200 mg/L 
FeSO4×7H2O, 15 mg/L MnSO4×H2O, 20 mg/L ZnSO4×7H2O, 10.0 g/L MgSO4×7H2O, 
40 mg/L CuSO4×5H2O, 550 mg/L adenine, 3.0 g/L α-phenylalanine, 1.0 mg/L thiamine 
and 50.0 g/L asparagine until the surface was fully covered.  
The fungus was frozen in liquid nitrogen and ground to a homogenous paste. 
The ground material was incubated for 1 h at 60 °C with 800 µL of preheated                    
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0.1 M Tris pH 8.0 containing 2 % (w/v) hexadecyltrimethylammonium bromide 
(Sigma), 0.2 % (v/v) β-mercaptoethanol (Aldrich) and 1.4 M NaCl. The material was 
mixed with 400 µL of phenol/chloroform/isoamyl alcohol (25:24:1) and spun down at 
18500 g for 15 min. 600 µL of the water phase was incubated with 10 µL of RNAse 
(Sigma, final concentration 0.3 mg/mL) at 37 °C for 45 min, mixed with 400 µL of 
phenol/chloroform/isoamyl alcohol and spun down at 18500 g for 15 min. 
Subsequently, 600 µL of the water phase was incubated with 400 µL of isopropanol for 
1 h on ice, after which the precipitated DNA was spun down at 18500 g for 5 min.        
The pellet was washed for 45 min in 80 % ethanol, after which the solvent was removed 
and the pellet was left to dry on air for 10 min. The DNA pellet was dissolved in           
Milli-Q water, diluted to the final concentration of 1.0 mg/mL and incubated for 1 h at 
37 °C with 2.5 µL of RNAse.  
 
5.7 Molecular cloning 
 
5.7.1 Polymerase chain reaction 
 
Polymerase chain reactions (PCR) were typically prepared in 0.5 mL eppendorf tubes 
containing around 20 - 50 ng of template DNA, 0.4 mM deoxyribonucleotide 
triphosphates (dNTPs) mix (Promega), 125 ng of forward and reverse DNA primers 
(Sigma-Genosys), 1 µL (2.5 units) of Pfu polymerase (Agilent Technologies), 5 µL of 
10×Pfu buffer made up to 50 µL volume by addition of sterile Milli-Q water. The PCR 
conditions were modified according to the manufacturer’s instructions.  
Alternatively, PCR reactions were carried out using Platinum Pfx DNA 
Polymerase (Invitrogen) according to the manufacturer’s instructions. The reaction 
mixture consisted of 10 - 50 ng of template DNA, 0.3 mM dNTP mixture, 1 mM 
MgSO4, 300 nM of each DNA primer, 0.4 µL (1 unit) of Platinum Pfx polymerase, 5 µL 
of 10×Pfx buffer made up to 50 µL volume by addition of sterile Milli-Q water. 
 
5.7.2 Site-directed mutagenesis 
 
Mutations in plasmid DNA were introduced using a QuickChange Site-Directed 
Mutagenesis Kit (Agilent Technologies), if not stated otherwise. The reaction mixture 
(50 µL) consisted of around 10 - 50 ng template DNA, 0.5 mM dNTP mixture, 125 ng 
of each DNA primer, 1 µL (2.5 units) of Pfu polymerase, 5 µL of 10×Pfu buffer in 
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sterile Milli-Q water. Alternatively, multiple point mutations in plasmid DNA were 
introduced using a QuickChange Lightening Multi Site-Directed Mutagenesis Kit 
(Agilent Technologies). The reaction mixture (25 µL) consisted of ~ 100 ng template 
DNA, 1 µM dNTP mixture, 100 ng of each DNA primer, 1 µL of QuickChange 
Lightening Multi enzyme blend, 0.75 µL QuickSolution, 2.5 µL of 10×QuickChange 
Lightening Multi buffer in sterile Milli-Q water. The conditions for mutant strand 
synthesis reaction were modified according to the manufacturer’s protocol. Prior to 
transformation into XL1-Blue or XL10-Gold competent cells, 1 µL of DpnI restriction 
enzyme (New England BioLabs or Agilent Technologies) was added to digest template 
plasmid DNA. 
 
5.7.3 Extraction of DNA from Escherichia coli 
 
Plasmid DNA was isolated from bacterial cultures using a GenElute Plasmid Mini- and 
Midiprep kit (Sigma) according to the manufacturer’s instructions. DNA for 
transformation in S. commune was isolated using a NucleoBond Xtra Maxi kit 
(Macherey-Nagel) according to the manufacturer’s instructions. The purity of DNA was 
judged by from the relative absorption at 260 nm and 280 nm, where the A260/A280 ratio 
in the range of 1.5 to 1.8 usually indicated a suitably pure DNA with little protein 
contamination. 
 
5.7.4 Digestion of DNA using restriction endonucleases 
 
Plasmid and PCR-amplified DNA was digested using restriction enzymes (New 
England BioLabs) according to the manufacturer’s instructions. Typically, 1 - 3 µg of 
DNA was incubated at 37 °C with the appropriate endonucleases for 1 - 3 h. Prior to 
ligation reaction (Section 5.7.6), the digested DNA was analyzed by agarose gel 
electrophoresis (Section 5.8.1) and purified (Section 5.7.5). 
 
5.7.5 Isolation of DNA from agarose gel 
 
The target bands were excised from the agarose gel using a scalpel and isolated from 
the gel using a GenElute Gel Extraction Kit (Sigma) according to the manufacturer’s 
instructions.      
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5.7.6 DNA ligation 
 
Ligation of the digested with restriction endonucleases vector and insert DNA was 
achieved using a rapid T4 DNA ligase (Fermentas) according to the manufacturer’s 
instructions. Typically, 50 - 100 ng of digested and purified vector was mixed with 
digested and purified DNA insert (using a molar vector to insert ratio of 1:5) in a rapid 
T4 DNA ligase buffer and incubated at RT with a rapid T4 DNA ligase for 30 - 60 min. 
5 - 20 µL of ligation mixture was used for subsequent transformation in E. coli JM101 
competent cells. Successful ligation was verified by the digestion of the ligated plasmid 
with the appropriate restriction endonuclease followed by agarose gel electrophoresis 
(Section 5.8.1) and sequencing of the DNA insert (Section 5.7.7).     
 
5.7.7 DNA sequencing 
 
DNA sequence of amplified and mutated genes in plasmid DNA was verified using 
DNA sequencing service of Backman-Coulter Genomics or GATC Biotech.  
 
5.7.8 Determination of DNA concentration 
 
Concentration of plasmid DNA was determined by measuring the absorption intensity 
at 260 nm and using the relationship that one intensity unit at 260 nm is equal to              
50 µg/mL of double stranded DNA.  
 
5.8 Electrophoresis 
 
5.8.1 Agarose gel electrophoresis 
 
Agarose (1.0 - 2.0 % (w/v), Melford) was dissolved in 50 mL of Tris-Acetate-EDTA 
(TAE) buffer (40 mM Tris pH 8.0, 40 mM acetate and 1 mM 
ethylenediaminetetraacetic acid (EDTA, BDH) by boiling in a microwave. The molten 
agarose was cooled to 50 - 55 °C, poured into a gel cast (BioRad) with 0.1 % (v/v) of        
1 µg/mL ethidium bromide and left to set at RT. Once set, the gel was transferred into a 
gel tank containing TAE buffer and loaded with DNA samples containing DNA loading 
buffer (0.4 % (w/v) bromophenol blue (BDH), 5 % glycerol). A voltage of 120 V was 
applied and electrophoresis was carried out for 30 - 45 min. Lambda DNA (Promega) 
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digested with PstI endonuclease (New England BioLabs) was used as molecular weight 
(MW) marker. Typically, DNA fragments were visualized under UV irradiation 
(BioRad Gel Doc 1000). However, when DNA fragments were required for further 
experiments (e.g. DNA ligation), the agarose gel was illuminated using                         
UV transilluminator (UV Tec). 
 
5.8.2 Sodium dodecyl sulfate-polyacrylamide gel electrophoresis 
 
The expression of proteins was visualized using sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE). The gels consisted of a 5 % acrylamide/bis-
acrylamide stacking gel poured above a layer of 10, 12 and 20 % acrylamide/bis-
acrylamide separation gel with a plastic comb to produce the ridges in the gel.                
The stacking gel consists of 5 % (v/v) acrylamide/bis-acrylamide (BioRad), 125 mM 
Tris pH 6.8, 0.1 % (w/v) sodium dodecyl sulfate (SDS, Sigma), 0.05 % (w/v) 
ammonium persulfate (APS, Aldrich) and 0.1 % (v/v) N,N,N’,N’-tetramethylene 
diamine (TEMED, Aldrich) in dionised water. The separation gel consists of 10 - 20 % 
acrylamide/bis-acrylamide, 375 mM Tris pH 8.8, 0.1 % SDS, 10 % glycerol, 0.05 % 
APS and 0.05 % TEMED in dionised water. Once polymerized, the gel was transferred 
into a Mini-Protein II Cell tank (BioRad) containing SDS-PAGE buffer (25 mM Tris 
pH 8.8, 200 mM glycine (Aldrich) and 0.1 % SDS.  
Protein samples for SDS-PAGE were prepared in cracking buffer containing        
50 mM Tris pH 6.8, 1 % SDS, 15 % glycerol, 2 % β-mercaptoethanol and 0.025 % 
(w/v) bromophenol blue in water. The samples were heated at 100 °C for 5 min. 
Typically 20 µL of protein sample was loaded onto the gel, along with a broad range 
MW marker (6.5 kDa - 200 kDa, BioRad) in cracking buffer or pre-stained Dual Color 
MW marker (10 kDa - 250 kDa, BioRad). 
Electrophoresis was carried out at a constant voltage of 200 V and current of        
~ 60 mA for 60 - 90 min until the dye front reached the bottom of the separation gel. 
Protein bands were visualized by incubating the separation gel in a solution of Instant 
Blue (Expedian).  
 
5.8.3 Western blotting 
 
The expression of Lcc1_cMYC and C452S_Lcc1_cMYC in S. commune KS8 strain 
was verified by immunoblotting. The protein samples were prepared in SDS cracking 
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buffer and loaded (20 µL) onto 20 % SDS PAGE gels or gradient, 4 - 20 % pre-cast 
SDS-PAGE gels (BioRad) along with 5 µL of pre-stained Dual Color MW marker.        
The proteins were electrophoresed at a constant voltage of 200 V until the dye front 
reached the bottom of the gel (Section 5.8.2). Subsequently, the gel was transferred into 
a plastic cast (BioRad), onto a wet blotting card (Sigma) with a foam pad underneath. 
The gel was covered with a pre-wetted Hybond ECL nitrocellulose membrane               
(GE Healthcare), followed by another piece of wet blotting card and a foam pad. Prior 
to assembling, the blotting cards, foam pads and the nitrocellulose membrane were 
thoroughly soaked in transfer buffer (12.5 mM Tris pH 8.8, 100 mM glycine and             
20 % (v/v) methanol). The cast was sealed and placed inside a Mini-Protean II Cell 
(BioRad) containing transfer buffer. The proteins were transferred onto nitrocellulose 
membrane by applying a constant current at 270 mA until all proteins from the               
pre-stained Dual Color MW marker were transferred.  
When protein transfer was completed, the membrane was removed from plastic 
cast and rinsed with TBS buffer (10 mM Tris pH 7.4 and 150 mM NaCl) with               
0.05 % (v/v) Tween 20. The membrane was blocked in 8 % (w/v) skimmed milk in TBS 
and 0.05 % Tween 20 buffer for 60 min with gentle rocking. Subsequently, the blocking 
solution was discarded and the membrane was incubated overnight in 1:1000 diluted 
mouse anti-cMYC primary antibody (Sigma) in 8 % skimmed milk in TBS and 0.05 % 
Tween 20 buffer at 4 °C with gentle rocking.  
The next day the membrane was washed three times with TBS and 0.05 % 
Tween 20 buffer and incubated with 1:5000 diluted rabbit anti-mouse IgG conjugated 
with alkaline phosphatase (AP) secondary antibody (Promega) in 8 % skimmed milk 
solution in TBS and 0.05 % Tween buffer 20 for 60 min at RT with gentle rocking.      
The blocking solution was discarded and the membrane was washed with TBS with 
0.05 % Tween 20, followed by TBS and AP (100 mM Tris, pH 9.5 containing 100 mM 
NaCl and 5 mM MgCl2) buffers. To visualise protein bands, the membrane was 
incubated overnight with 20 mL of AP buffer containing 88 µL of nitroblue tetrazolium 
(NBT, 75 mg/mL in 70 % dimethylformamide, Promega) and 66 µL of 5-bromo-4-
chloro-3-indyl phosphate (BCIP, 50 mg/mL in 100 % dimethylformamide, Promega).  
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5.8.4 Sandwich immunodetection of the Lcc1_cMYC and C452S_Lcc1_cMYC 
variants  
 
S. commune KS8 strains secreting Lcc1_cMYC and C452S_Lcc1_cMYC were selected 
by sandwich immunodetection by Dr. Karin Scholtmeijer. S. commune KS8 strains 
transformed with glcc1_cMYC_pESCT and C452S_glcc1_cMYC_pESCT were grown 
for 3 days at 30 °C on the sterile perforated polycarbonate (PC) membranes (diameter       
~ 7.5 cm, pore size 0.1 µm, Poretics USA) placed on top of MM-agar. The PC 
membranes with colonies were removed from the MM-agar and placed onto 
polyvinylidene difluoride (PVDF) membranes (pre-wetted with methanol and rinsed 
with water) and placed on top of fresh, pre-warmed MM-agar. After incubation for           
2 - 3 h at 30 °C, the PC membranes with colonies were removed and the PVDF 
membranes were allow to dry. The PVDF membrane was wetted with methanol, rinsed 
with water and blocked for 30 min with 5 % (w/v) skimmed milk in PBS (12 mM 
NaH2PO4, 1.76 mM KH2PO4, 2.68 mM KCl and 137 mM NaCl) with 0.1 % (v/v) 
TritonX-100. The blocking solution was discarded and the PVDF membranes were 
incubated with freshly prepared 1:5000 diluted anti-cMYC antibody conjugated with 
AP (Acris SM1863AP) in 5 % skimmed milk solution in PBS, 0.1 % TritonX-100 for       
2 h at RT. The membranes were washed for 5 min with PBS, 0.1 % TritonX-100 
changing the solution twice and then washed once in the AP buffer. The membrane was 
developed by subsequent incubation with 44 µL of NBT and 33 µL of BCIP in 10 mL 
of AP buffer.      
 
5.9 Small scale protein over-expression  
 
5.9.1 Over-expression in Escherichia coli 
 
In order to determine the growing period optimal for protein over-expression, small-
scale expression trials were carried out. Typically, 10 mL of LB containing an 
appropriate antibiotic was inoculated with a single colony of E. coli transformed with 
the expression plasmid and grown overnight at 37 °C, with shaking at 200 rpm in an 
orbital shaker. The next day a 100-fold dilution into 50 mL of LB containing an 
appropriate antibiotic was made and incubated for approximately 2 h, until the OD600 
had reached the required value (typically 0.5 - 1.5). The temperature of the cultures was 
lowered if necessary, the protein expression was induced by the addition of isopropyl  
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β-D-1-thiogalactopyranoside (IPTG). Several growing parameters were optimized, 
including type of E. coli host (BL21 (DE3), BL21 Tuner (DE3) or Rosetta (DE3)), 
duration (6 - 48 h), temperature (4 - 37 °C) of growth, IPTG concentration                     
(0.05 - 1.0 mM), media type (LB, 2×YT and TB), and concentration of Cu(NO3)2               
(0 - 0.2 mM) and proline (0 or 25 mM) (Fluka) in the media.  
Routinely, 4 mL samples of the cultures were collected every few hours 
(typically: 0, 2, 4, 6, 8, 20 h), sonicated and centrifuged for 10 minutes at 5000 g. 50 µL 
samples of sonicated cultures (representing all expressed proteins) and 50 µL of 
supernatant from the spun-down cultures (representing soluble proteins) were taken and 
lysed in SDS-PAGE cracking buffer.  
Proteins from periplasm of E. coli were isolated using an osmotic shock-based 
method. Pellets from 3 mL E. coli cultures were resuspended in 500 µL of the 30 mM 
Tris pH 8.0 containing 1.2 mM EDTA and 20 % (w/v) sucrose, gently shaken for            
10 min at 4 °C and centrifuged at 13000 g for 5 minutes. The pellets were resuspended 
in the ice-cold deionised water, gently shaken at 4 °C for 10 minutes and spun down at 
13000 g for 5 minutes. The pellets were re-suspended in 500 µL of 20 mM Tris pH 8.0, 
sonicated and centrifuged at 4000 g for 15 minutes. The supernatant was subsequently 
centrifuged at 21000 g for 20 minutes and pellets resuspended in 500 µL of 20 mM Tris 
pH 8.0. 50 µL were taken, lysed in SDS-PAGE cracking buffer and analyzed by           
SDS-PAGE electrophoresis to identify the expression level of soluble protein.  
 
5.9.2 Over-expression in Schizophyllum commune 
 
The S. commune WT and KS8 strains containing clcc1_pESCT or glcc1_pESCT were 
grown at 30 °C on the MM-agar for ~ 7 days until the whole surface of perti dish             
(92 mm diameter × 16 mm height) was fully covered. A quarter of the colony was 
homogenized for 15 s with a blender in 50 mL of MM pH 7.0. The liquid standing 
cultures were prepared in the petri dishes (92 mm diameter × 16 mm height) by diluting 
2.5 mL of homogenized colony with 22.5 mL of appropriate media (CM/MM/PM) to 
the final volume of 25 mL. The pH of MM was adjusted to 6.6, 7.0, 7.4 or 8.0. After 
overnight incubation at 30 °C or 23 °C, 0, 1, 2, 3 and 4 mM of Cu(NO3)2 was added        
(1st day of growth). After 6, 9, 12 and 15 days 5 mL of fresh media with an appropriate 
Cu(NO3)2 concentration was added. Samples (1 mL) were taken every 1 - 3 days for 
measurements of Lcc1 activity with 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic 
acid (ABTS).     
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5.10 Large scale protein over-expression and purification 
 
5.10.1 Over-expression and purification of WT SLAC and WT SLAClong in 
Escherichia coli 
 
WT SLAClong and WT SLAC from Streptomyces coelicolor were over-expressed in         
E. coli BL21 (DE3), isolated and purified as previously described [10], with 
modifications. E. coli BL21 (DE3) cells transformed with either SLAC(long)_pET29a 
or SLAC_pET29a were grown in LB containing 100 µg/mL ampicillin at 37 °C with 
shaking at 200 rpm in an orbital shaker until an OD600 of ~ 1.5 was reached. The cells 
were cooled to ~ 20 °C and the protein expression was induced by the addition of            
0.4 mM IPTG. Cells were incubated at 25 °C for a further 20 h before harvesting by 
centrifugation. The cell pellet from 2 L culture was resuspended in 10 mM phosphate 
pH 7.4, sonicated and centrifuged at 35000 g for 30 min. The supernatant was incubated 
overnight at 4 °C with 1 mM Cu(NO3)2 and centrifuged again at 35000 g for 30 min 
prior to loading onto a Diethylaminoethyl (DEAE) Fast Flow Sepharose                        
(GE Healthcare) column (~ 20 cm length, ~ 2.6 cm diameter) equilibrated with               
10 mM phosphate pH 7.4. Bound proteins were eluted with a linear NaCl gradient           
(0 - 0.4 M) in the same buffer. The SLAC-containing fractions (identified by                 
SDS-PAGE) were combined and exchanged into 20 mM Tris pH 7.5 containing              
200 mM NaCl via ultrafiltration (Amicon stirred cell, 30 kDa molecular weight cut off 
(MWCO) membrane). Concentrated protein was further purified on a HiLoad Superdex 
200 16/60 gel filtration column (GE Healthcare) in the same buffer.  
 
5.10.2 Over-expression and purification of SLAC variants 
 
E. coli BL21 (DE3) cells transformed with tSLAC_pET22b, qSLAC_pET22b, 
mgSLAC_pET22b, nirSLAC_pET22b or gdcSLAC_pET22b were grown in 2×YT 
media containing 100 µg/mL ampicillin and 0.2 mM Cu(NO3)2. E. coli BL21 (DE3) 
cells transformed with T1D_tSLAC_pET22b, T1D_qSLAC_pET22b, 
T1D_mgSLAC_pET22b, A99H_mgSLAC_pET22b, T1D_nirSLAC_pET22b, 
A99H_nirSLAC_pET22b, T1D_A99H_nirSLAC_pET22b or 
A99H_gdcSLAC_pET22b were grown in TB media containing 100 µg/mL ampicillin. 
In each case, transformed cells were grown at 37 °C with shaking at 200 rpm in an 
orbital shaker until an OD600 of ~ 1.5 - 2.0 was reached. The cultures were cooled to     
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~ 10 °C, 25 mM proline was added and the protein expression was induced by the 
addition of 1.0 mM IPTG. Cells were incubated at 16 °C for a further 22 h before 
harvesting by centrifugation.  
The cell pellet from 4 L culture was resuspended in 10 mM phosphate pH 7.5, 
sonicated and centrifuged at 35000 g for 30 min. The supernatant was incubated 
overnight at 4 °C with 1 mM Cu(NO3)2 and centrifuged again at 35000 g for 30 min 
prior to loading onto a DEAE Fast Flow Sepharose column (~ 30 cm length, ~ 2.6 cm 
diameter) equilibrated with 10 mM phosphate pH 7.5. Bound protein was eluted with a 
linear NaCl gradient (0 - 0.25 M) in the same buffer. The protein-containing fractions 
(identified by SDS-PAGE) were combined and dialyzed against 20 mM phosphate         
pH 6.8, changing the buffer at least three times. The protein was centrifuged at 35000 g 
for 30 min prior to loading onto a 5 mL HiTrap Q High Performance (HP) column        
(GE Healthcare) equilibrated with 20 mM phosphate pH 6.8. Bound protein was eluted 
with a linear gradient of NaCl (0 - 0.2 M) in the same buffer. The purest,                 
protein-containing fractions (identified by SDS-PAGE) were combined, concentrated 
via ultrafiltration (Amicon ultra 15, 30 kDa MWCO membrane) and exchanged into       
20 mM Tris pH 7.5 containing 200 mM NaCl. Protein was further purified on a HiLoad 
Superdex 200 16/60 gel filtration column in the same buffer.  
 
5.10.3 Over-expression and purification of WT bNiR, M87C bNiR, K329C bNiR 
LacNiR, Δ252G LacNiR, T1D azNiR and T1D T246H azNiR 
 
WT bNiR from Alcaligenes xylosoxidans and its variants were over-expressed in E. coli 
BL21 (DE3) as previously described [11], except for LacNiR, Δ252G LacNiR and 
qNiR, which were grown in the presence of 0.2 mM Cu(NO3)2. 
 WT, M87C and K329C bNiR were isolated and purified as previously described 
[11]. For K329C bNiR the only modification to this method was that the amount of 
streptomycin sulfate used for the precipitation of DNA during purification was lowered 
to 0.3 % (w/v). The cell pellet from 2 L culture of LacNiR, Δ252G LacNiR,                 
T1D azNiR, T1D T246H azNiR and qNiR was resuspended in 20 mM Mes pH 6.0, 
sonicated and centrifuged at 35000 g for 30 min. The supernatant was incubated for 4 h 
at 4 °C with 1 mM (T1D azNiR, T1D T246H azNiR and qNiR) or 2 mM (LacNiR and 
Δ252G LacNiR) Cu(NO3)2. The protein mixture was incubated for additional 2 h at          
4 °C with 0.2 % (T1D azNiR, T1D T246H azNiR and qNiR) or 0.1 % (LacNiR and 
Δ252G LacNiR) of streptomycin sulfate, after which the precipitated DNA was spun 
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down at 35000 g for 30 min prior to loading onto a Sulfopropyl (SP) Fast Flow 
Sepharose column (~ 25 cm length, ~ 2.6 cm diameter) equilibrated with 20 mM          
Mes pH 6.0 (T1D azNiR, T1D T246H azNiR and qNiR) or 10 mM phosphate pH 6.0 
(LacNiR and Δ252G LacNiR). Bound proteins were eluted with a linear gradient of 
NaCl (0 - 0.4 M) in the same buffers. The protein-containing fractions (identified by 
SDS-PAGE) were combined, concentrated via ultrafiltration (Amicon ultra 4, 10 kDa 
MWCO membrane) and exchanged into 20 mM Tris pH 7.5 containing 200 mM NaCl. 
Proteins were further purified on a HiLoad Superdex 200 16/60 gel filtration column in 
the same buffer. 
 
5.10.4 Purification of Laccase A from crude acetone powder from Trametes 
versicolor 
 
Typically 5 g of crude acetone powder from T. versicolor (Fluka, UK) was mixed with 
150 mL of 100 mM phosphate pH 6.0 and stirred at 4 °C for 5 h until all the powder 
was dissolved. The solution was centrifuged at 10000 rpm for 20 min prior to loading 
onto a DEAE Fast Flow Sepharose column (~ 5 cm length, ~ 2.6 cm diameter) 
equilibrated with 100 mM phosphate pH 6.0 containing 100 mM NaCl. The unbound 
greenish-blue fraction was collected and dialyzed against 10 mM phosphate pH 6.0 
changing the buffer at least three times. The solution was centrifuged at 15000 rpm for 
20 min prior to loading onto a DEAE Fast Flow Sepharose column (~ 15 cm length,         
~ 2.6 cm diameter) equilibrated with 10 mM phosphate pH 6.0. The unbound flow 
through was collected (Laccase B) and the bound protein (Laccase A) was eluted with a 
0 - 0.35 M NaCl linear gradient in the same buffer. Fractions from the main peak were 
pooled and exchanged into 10 mM phosphate pH 6.5 (Amicon stirred cell, 30 kDa 
MWCO membrane). The protein was further purified on a DEAE Fast Flow Sepharose 
column (~ 15 cm length, ~ 2.6 cm diameter) equilibrated with 10 mM phosphate           
pH 6.5. The loaded protein was eluted with a 0 - 0.2 M NaCl gradient in the same 
buffer. Fractions with A278/A250 ratios ranging from 11 to 12.8 and A278/A610 ratios of 
16.5 to 18 were combined and the salt was removed by ultrafiltration (Amicon stirred 
cell, 30 kDa MWCO membrane).  
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5.10.5 Bacterial over-expression and purification of Lcc1 
 
5.10.5.1 Refolding of Lcc1 from Escherichia coli BL21 (DE3) inclusion bodies 
 
The Lcc1 protein was slowly refolded from inclusion bodies (IB) using previously 
published procedure [12], with modifications. Two denaturing agents, urea and 
guanidine hydrochloride (Gdn), were used for resolubilization of IB. Typically, ~ 0.4 g 
of IB were incubated at RT in an anaerobic chamber (Belle Technology, [O2] << 2 ppm) 
for ~ 40 min in 20 mL of 6 M urea (or Gdn), 10 mM EDTA and 10 mM DTT in 25 mM 
Tris pH 7.5. Lcc1 was refolded at 4 °C by a 10-fold slow dilution (~ 3.5 mL/h flow rate) 
with 25 mM Tris pH 7.5 supplemented with 0.5 mM EDTA. The protein solution was 
subsequently 10-fold rapidly diluted with 10 mM Tris pH 7.5 and incubated overnight 
with 1.0 mM CuSO4. The proteins were captured using a DEAE Fast Flow Sepharose 
material equilibrated with 25 mM Tris pH 7.5 and eluted with 0.5 M NaCl in the same 
buffer. The protein solution was concentrated and the excess of CuSO4 was removed by 
ultrafiltration (Amicon stirred cell, 30 kDa MWCO membrane). The protein solution 
was further incubated overnight with 2 mM CuSO4 and excess of metal was removed by 
ultrafiltration.    
Lcc1 was fast refolded from IB using previously published procedure [13], with 
modifications. Typically, ~ 0.4 g of IB were incubated at RT in an anaerobic chamber 
for ~ 60 min with 5 mL of 6 M urea (or Gdn), 2 mM DTT and 10, 30 or 50 mM EDTA 
in 10 mM Hepes pH 8.0. Lcc1 was refolded at 4 °C by 50-fold rapid dilution in 10 mM 
Hepes pH 8.0 supplemented with 2 or 5 mM DTT. The protein mixture was dialysed 
against 250 mM ammonium acetate pH 8.0 and further dialysed against the same buffer 
containing different concentrations of CuSO4 (1 - 5 mM). Excess of metal was removed 
by dialysis.  
 
5.10.5.2 Over-expression and purification of soluble Lcc1  
 
E. coli BL21 (DE3) cells transformed with Lcc1_pET29a were grown at 37 °C in LB 
containing 50 µg/mL kanamycin and 0.1 mM Cu(NO3)2 until an OD600 of ~ 1.0 was 
reached. The cells were cooled to ~ 10 °C and 25 mM proline was added. Protein 
expression was induced by the addition of 0.5 mM IPTG and cells were incubated at       
10 °C for an additional 42 h before harvesting by centrifugation. Alternatively, E. coli 
BL21 (DE3) cells transformed with Lcc1_pET22b were grown at 37 °C in LB 
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containing 100 µg/mL ampicillin and 0.1 mM Cu(NO3)2 until an OD600 of ~ 0.8 was 
reached. The cells were cooled to ~ 30 °C and the protein expression was induced by 
the addition of 0.5 mM IPTG. The cells were incubated at 30 °C for an additional 20 h 
before harvesting by centrifugation.  
The cell pellet was resuspended in 20 mM Mes pH 6.0, sonicated and 
centrifuged at 35000 g for 30 min. The supernatant was incubated overnight with           
2.5 mM Cu(NO3)2 at 4 °C. The protein mixture was centrifuged at 35000 g for 30 min 
prior to loading onto a DEAE Fast Flow Sepharose column (~ 15 cm length and              
~ 2.6 cm diameter) equilibrated with 50 mM phosphate pH 6.0 and eluted with a linear 
NaCl gradient (0 - 500 mM) in the same buffer. Fractions containing Lcc1 (identified 
by SDS-PAGE) were combined, exchanged via ultrafiltration (Amicon stirred cell,          
30 kDa MWCO membrane) into 50 mM phosphate pH 6.0 and incubated overnight with 
1 mM Cu(NO3)2.   
 
5.10.5.3 Over-expression and purification of N-terminally fused NusA_Lcc1  
 
E. coli BL21 (DE3) cells transformed with Lcc1_pET44a were grown at 37 °C in LB 
containing 100 µg/mL ampicillin and 0.5 mM Cu(NO3)2 until an OD600 of 1.3 was 
reached. Protein expression was induced by the addition of 0.5 mM IPTG and cells 
were incubated for additional 6 h before harvesting by centrifugation. The cell pellet 
was resuspended in 20 mM phosphate pH 7.4 containing 500 mM NaCl and 30 mM 
imidazole, sonicated and centrifuged at 35000 g for 30 min. The supernatant was loaded 
onto a NiSO4-charged Immobilized Metal Ion Affinity Chromatography (IMAC) 
HiTrap Sepharose HP column (5 mL, GE Healthcare) and eluted with a linear imidazole 
gradient (30 - 225 mM) in 20 mM phosphate pH 7.4 containing 500 mM NaCl. 
Fractions containing NusA_Lcc1 (identified by SDS-PAGE) were combined and 
exchanged via ultrafiltration (Amicon ultra 4, 30 kDa MWCO membrane) into 20 mM 
Tris pH 8.4 containing 150 mM NaCl and 2.5 mM CaCl2. The protein mixture was 
incubated for 7 h at 4 °C with thrombin (1:100 dilution, Sigma) and the enzymatic 
digestion was inhibited with 1 mM 4-(2-aminoethyl)benzenesulfonyl fluoride 
hydrochloride. The protein mixture was exchanged via ultrafiltration (Amicon ultra 4, 
10 kDa MWCO membrane) into 50 mM phosphate pH 6.0 prior to loading onto a 1 mL 
HiTrap SP HP column. The flow through was collected and exchanged into 20 mM Mes 
pH 6.0, and incubated overnight with 1 mM Cu(NO3)2 at 4 °C.   
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5.10.6 Over-expression in Pichia methanolica and purification of Lcc1 
 
Expression of recombinant Lcc1 in P. methanolica PMAD11 strain was performed as 
previously described [14]. The Lcc1 secreting PMAD11 transformant was incubated in 
BMDY media at 30 °C with shaking (300 rpm) until an OD600 of ~ 3.5 was reached. 
Cells were centrifuged at 3000 g for 5 min and the cell pellet was resuspended in a 
BMMY media, pH 6.5 supplemented with 0.2 mM CuSO4. The cultures (500 mL each) 
were incubated at 19 °C with shaking (300 rpm) and 0.8 % (v/v) methanol was added 
daily. After five days of incubation, the cells were harvested by centrifugation at          
10000 g for 10 min and the supernatant was passed through a 0.45 µm filter.  
The supernatant was concentrated (Amicon stirred cell, 30 kDa MWCO 
membrane) and diluted with 20 mM phosphate pH 6.5. The sample was applied onto a 
DEAE Fast Flow Sepharose column (~ 30 cm length, ~ 2.6 cm diameter) equilibrated 
with 20 mM phosphate pH 6.5 and protein was eluted with a 0 - 1.0 M NaCl linear 
gradient in the same buffer. Fractions showing laccase activity with ABTS were pooled 
and exchanged into 20 mM phosphate pH 6.5 containing 200 mM NaCl (Amicon stirred 
cell, 30 kDa MWCO membrane). The concentrated sample (1 mL) was further purified 
on a HiLoad Superdex 75 16/60 column (GE Healthcare) in the same buffer.   
 
5.10.7 Over-expression in Schizophyllum commune and purification of Lcc1  
 
S. commune KS8 strain transformed with gLcc1_pESCT was grown at 30 °C on          
MM-agar (petri dish, 92 mm diameter × 16 mm height) for ~ 7 days until the whole 
surface was covered. A quarter of the colony was blended for 15 s with 50 mL of CM 
pH 7.0. The liquid standing cultures were prepared in the tissue culture flasks with a 
filter cap (Greiner Bio One) by diluting 10 mL of macerated colony with 90 ml of CM 
pH 7.0 to a final volume of 100 mL. After overnight incubation at 30 °C, 2 mM of 
Cu(NO3)2 was added (day 1). After 6 and 9 days of growth 20 mL of fresh CM, pH 7.0 
was added and after 12 days of growth the supernatant was collected and filtered using 
miracloth filters (200 µm mesh size).  
The supernatant was incubated overnight at 4 °C with a DEAE Fast Flow 
Sepharose material equilibrated in 20 mM phosphate pH.7.0. Bound protein was eluted 
with a 0 - 0.4 M NaCl gradient in the same buffer and fractions showing laccase activity 
with ABTS were pooled and dialyzed against 20 mM phosphate pH 6.0 changing buffer 
at least three times. The protein was loaded onto a 5 mL HiTrap Q HP column 
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equilibrated with 20 mM phosphate pH 6.0 and eluted in the linear salt gradient                
(0 - 0.3 M NaCl) in the same buffer. The purest (judged by SDS-PAGE) and the most 
active (with ABTS) fractions were pooled, concentrated by ultrafiltration (Amicon          
ultra 4, 30 kDa MWCO membrane) and NaCl was added to the final concentration of 
200 mM. The protein was further purified using a HiLoad Superdex 75 16/60 column in 
20 mM phosphate pH 6.0 containing 200 mM NaCl.  
 
5.11 Fluorescent labeling of proteins 
 
A) 
 
B) 
 
 
Figure 5.1 Schematic reactions for labeling of (A) amine groups in proteins with an      
N-hydroxysuccinimide (NHS) ester and (B) thiol groups of Cys residues with a 
maleimide derivative of fluorescent dyes (depicted as R). 
 
The proteins were labeled with ATTO fluorescent dyes (ATTO-TEC GmbH,         
Appendix A) at surface-exposed amine groups (including an N-terminus) or at a free 
thiol group of a surface-exposed Cys residue (Figure 5.1) using modified versions of 
published protocols [15, 16] and manufacturer’s recommendation. Conditions, such as 
labeling buffer, label to protein molar ratio, and incubation time and temperature were 
adjusted for each protein.  
For labeling of amine groups, a protein (typically ~ 100 µM) was incubated with 
an N-hydroxysuccinimide (NHS) ester-modified label (0.25 to 10-fold of label to 
protein molar excess) in 100 mM Hepes pH 8.3 or 100 mM phosphate pH 6.0         
(Laccase A and Lcc1) for 30 min to 2 h. For labeling of thiol groups, a protein was 
incubated with a maleimide-modified label (0.5 to 50-fold of label to protein molar 
excess) in 100 mM phosphate pH 7.5 for 30 min to 60 min. Labeling was typically 
performed on ice, except for anaerobic experiments, which were conducted at RT in an 
anaerobic chamber. Unbound dye was removed by single step size-exclusion 
NHS ester derivative Amine group in protein Conjugate (amide bond) 
Maleimide derivative Thiol group in protein Conjugate (tioether bond) 
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chromatography using a desalting PD10 column (GE Healthcare). The dye to protein 
labeling ratios (DOL) was determined according to the manufacturer’s protocol using 
Equation 5.1. Depending on experiment, DOL was kept in the range of 7 to 80 % per 
monomer. 
 
    
€ 
DOL =
Amax
εmax
Aprot
ε prot
⋅ 100% = Amax ⋅ ε prot
Aprot − Amax ⋅ CF280( )⋅ εmax
⋅ 100%       (Equation 5.1),                    
 
where Amax is absorbance intensity at the absorption maximum of a dye, εmax - the 
extinction coefficient of a dye at the absorption maximum Aprot - protein absorbance 
intensity at 280 nm, εprot - the extinction coefficient of the protein at 280 nm and CF280 
is a correction factor.  
 
5.12 Spectroscopy 
 
5.12.1 Determination of the molecular weight of proteins by mass spectrometry 
 
The MWs of proteins were determined by matrix-assisted laser desorption ionization 
time-of-flight mass spectrometry (MALDI-TOF-MS, Voyager - DE STR, Applied 
Biosystems). Spectra were recorded in the positive ion linear mode using a m/z range of 
10000 to 40000 (bNiR and SLAC) or 20000 to 80000 (Lcc1) by Bob Liddell (Pinnacle 
Service, Newcastle University). 
 
5.12.2 UV-Vis absorption spectroscopy 
 
UV-Vis spectra of proteins were acquired on a Parkin-Elmer λ 35 spectrophotometer 
equipped with a Parkin Elmer PTP-1 peltier or on a Varian Cary 50 (Varian Inc., 
Agilent Technologies) spectrophotometer in a range of 200 - 900 nm using a slitwidth 
equivalent to a bandwidth of 1 nm, unless stated otherwise. Measurements were 
conducted using 2 mm or 10 mm path length quartz cuvettes. Activity measurements 
were conducted using a time drive method in which absorption intensity at fixed 
wavelength can be measured over time of experiment. 
For the anaerobic measurements typically the protein samples were prepared in 
septum sealed gas tight 3 mL cuvette in anaerobic chamber. Alternatively, the buffer 
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solution was deoxygenated in the cuvette prior to measurements by equilibrating with 
O2-free Ar ([O2] << 1 ppm) for 45 min before the protein was added. A gentle flow of 
Ar was passed through the head of the cuvette for an additional 15 min.   
 
5.12.3 Circular dichroism spectroscopy 
 
Far-UV (190 - 260 nm) and visible (300 - 700 nm) circular dichroism (CD) spectra of 
proteins were obtained on a Jasco J-810 spectrometer using 2 mm and 10 mm path 
length quartz cuvettes, respectively. The cuvette compartment was maintained at a 
temperature of 25 °C during measurements. 5 (Vis CD) and 10 (Far-UV CD) scans 
were accumulated per sample for both blank and protein spectra.  
 
5.12.4 Atomic absorption spectroscopy 
 
Atomic absorption spectroscopy (AAS) was performed on the M Series Atomic 
Absorption Spectrometer (Thermo Electron Corp.) to determine the Cu and Zn ion 
content of proteins by comparison to a set of calibration standards (Fluka) of known 
concentrations of Cu2+ and Zn2+. Calibration standards of Cu2+ and Zn2+ (0 - 1 ppm) 
were prepared from stock solutions of atomic absorption standards of 987 and             
1005 ppm in 1.2 % (v/v) nitric and 1 % (v/v) hydrochloride acids respectively.             
The intensity of copper absorption was measured at 325.8 nm, whilst of Zn at 213.9 nm. 
 
5.12.5 Electron paramagnetic resonance spectroscopy 
 
Continuous wave (cw) electron paramagnetic resonance (EPR) spectra were acquired at 
the X-band (9.42 GHz) and at temperature between 20 - 80 K using a Bruker EMX EPR 
spectrometer equipped with a TE102 cavity and an ESR900 Cryostat (Oxford 
Instruments) or liquid nitrogen finger dewar. A gentle flow of N2 was passes through to 
avoid condensation in the cavity. Typically, 1 to 8 scans were accumulated per 
spectrum under the conditions of 0.2 mW - 20 mM microwave power, 100 kHz 
modulation frequency and 3 - 5 G modulation amplitude with sweep width of 1000 G or 
1200 G and points resolution of 512, 1024 or 2048, depending on the sample. 
Diphenylpicrylhydrazyl (DPPH) and α,γ-bis-diphenylene-β-phenyl allyl (BDPA) were 
used as external reference compounds. EPR spectra were simulated using either 
SimFonia software (Bruker) or EasySpin [17]. 
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5.12.6 Fluorescence spectroscopy 
 
Fluorescence spectra and time course measurements were performed on a Cary Eclipse 
Fluorescence Spectrophotometer (Varian Inc., Agilent Technologies). Excitation and 
emission band-pass slits were routinely set to 5 nm spectral width and suitable optical 
filters were used both in the excitation and emission paths. The cuvette compartment 
was maintained at a temperature of 20 °C during all measurements. Measurements were 
conducted using 10 mm path length quartz cuvettes, and excitation and emission 
wavelengths appropriate for each fluorescent label. Intrinsic Trp residues were excited 
at 285 nm, whilst emission was monitored at 334 nm.  
For the anaerobic measurements, the protein samples were typically prepared in 
septum sealed gas tight 3 mL cuvette in the anaerobic chamber. Alternatively, the buffer 
solution was deoxygenated in the cuvette prior to measurements by equilibrating with 
O2-free Ar for 45 min before the protein was added. A gentle flow of Ar was passed 
through the head of the cuvette for an additional 15 min.  
The protein’s switching ratio (SR) is defined as the difference between the 
maximum (Fred, fully reduced protein) and the minimum (Foxy, fully oxidized sample) 
fluorescence intensity divided by the maximum value (Equation 5.2).   
 
€ 
SR = Fred − FoxyFred
              (Equation 5.2) 
 
5.13 Chromatography 
 
Ion-exchange, affinity and gel filtration chromatography were used for purification of 
proteins. Gel filtration chromatography was additionally used for analytical purposes to 
determine the apparent MW and oligomeric states of proteins.  
 
5.13.1 Ion-exchange Fast Flow Sepharose columns 
 
DEAE Fast Flow Sepharose column material was used for preparation of anion-
exchange columns for the purification of Laccase A, Lcc1, WT SLAC and their 
variants. SP Fast Flow Sepharose column material was used for preparation of cation-
exchange columns for purification of WT bNiR and its variants.  
	   230	  
Prior to use of column, DEAE or SP Fast Flow Sepharose column material was 
washed with at least 2 L of buffer solution. The pH of the flow-through was checked to 
ensure the equilibration of the material. Proteins were loaded onto DEAE or SP Fast 
Flow Sepharose columns in the same buffer as that used for equilibration of the column 
material. Elution of proteins was achieved by increasing the ionic strength of the buffer 
by providing a linear salt gradient, typically, between 0 and 500 mM NaCl in the same 
buffer as that used for equilibration.  
DEAE and SP Fast Flow Sepharose materials were regenerated according to 
manufacturer’s instructions (GE Healthcare). The column material was washed with         
2 M NaCl (providing contact time of ~ 30 min) to remove bound proteins, followed by 
an excess of Milli-Q water. Subsequently the column material was washed with 0.5 M 
NaOH (providing contact time of ~ 60 min) followed by an excess of Milli-Q water 
until the pH was close to neutral. Columns were run and short-term stored at 4 °C.        
For long-term storage at 4 °C, column material was exchanged into 20 % (v/v) ethanol. 
 
5.13.2 Ion-Exchange HiTrap High Performance columns  
 
HiTrap Q HP and HiTrap SP HP (5 mL) columns attached to an AKTA purifier             
(GE Healthcare) were used in second or final step of purification process. The protein 
was loaded onto the columns in the same buffer as that used for equilibration of the 
column and eluted with an optimized linear salt gradient.  
The columns were typically regenerated by washing with five column volumes 
(CV) of 1 M NaCl, followed by at least five CV of Milli-Q water. Subsequently the 
columns were passed with five CV of 0.5 M NaCl, followed by an excess of Milli-Q 
water until pH was neutral. The columns were stored in 20 % ethanol at RT.  
 
5.13.3 Immobilized metal ion affinity HiTrap Sepharose HP columns 
 
HiTrap IMAC Sepharose HP (5 mL) column attached to an AKTA purifier was used for 
purification of His-tagged proteins (NusA_Lcc1). The column was charged with 0.1 M 
NiSO4 in Milli-Q water following the manufacturer’s instructions. The column was 
equilibrated with a buffer of choice (typically 20 mM phosphate pH 7.4, 0.5 M NaCl 
and 30 mM imidazole) with at least 5 CV prior to protein loading. Elution of proteins 
was achieved by providing a linear imidazole gradient, typically, between 30 and            
500 mM in the same buffer as that used for equilibration. 
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 The immobilized metal ions were stripped off with 20 mM phosphate pH 7.4 
containing 0.5 M NaCl and 50 mM EDTA, washed with 10 CV of 20 mM phosphate 
pH 7.4 containing 0.5 M NaCl and 30 mM imidazole, and 10 CV of Milli-Q water prior 
to recharging a column. The column was typically regenerated with 10 CV of 1.5 M 
NaCl, followed by at least 3 CV of Milli-Q water. Subsequently the column was washed 
with 20 CV of 1 M NaOH followed by 10 CV of Milli-Q water until pH of the flow 
through was neutral. Alternatively, the column was washed with 10 CV of 30 % (v/v) of 
isopropanol followed by 10 CV of Milli-Q water. The columns were stored in 20 % 
ethanol at RT.  
 
5.13.4 Gel-filtration 
 
HiLoad Superdex 75 16/60 and HiLoad Superdex 200 16/60 gel-filtration columns 
attached to an AKTA purifier were used for protein purification, typically in 50 mM 
phosphate pH 6.0 containing 200 mM NaCl or 20 mM Tris pH 7.5 containing 200 mM 
NaCl. Protein injection volumes were less than 2 % of the column volume. Elution of 
proteins (flow rate of 1 mL/min) was typically monitored at 280 nm, 420 nm and              
~ 600 nm at RT.  
The columns were calibrated using a low MW and high MW calibration kits 
(GE Healthcare). HiLoad Superdex 200 16/60 column was calibrated with blue dextran 
(2000 kDa), ferritin (440 kDa), catalase (232 kDa), aldolase (158 kDa), albumin            
(67 kDa), ovalbumin (43 kDa), chymotrypsinogen A (25 kDa) and ribonuclease A     
(13.7 kDa). HiLoad Superdex 75 16/60 column was calibrated with blue dextran         
(2000 kDa), conalbumin (75 kDa), ovalbumin (43 kDa), carbonic anhydrase (29 kDa), 
ribonuclease A (13.7 kDa) and aprotinin (6.5 kDa). 
The columns were typically washed with almost 2 CV of 0.5 M NaOH, followed 
by at least 5 CV of Milli-Q water until pH of the flow through was neutral. The columns 
were stored in 20 % ethanol at RT. 
 
5.14 Ultrafiltration 
 
5.14.1 Amicon Stirred Cell ultrafiltration 
 
An Amicon stirred cell (10 and 200 mL, Amicon) fitted with an appropriate cellulose 
membrane (10 to 30 kDa MWCO, Millipore) was used to concentrate and remove 
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chemicals during the purification of proteins at 4 °C. Exchanging buffer involved 
concentrating the protein solution and then diluting the sample 10-fold in the 
concentrator and repeating this process at least 3 times. A pressure of approximately           
3 - 4 bars supplied from a compressed N2 cylinder (O2-free) was applied during 
operation of the stirred cell.   
 
5.14.2 Centrifugal ultrafiltration 
 
Amicon ultra 4 (4 mL) and 15 (15 mL) (10 kDa and 30 kDa MWCO, Millipore) and 
Vivaspin 500 (5 kDa MWCO, Sartorius) centrifugal concentrators were used to 
concentrate the proteins and remove chemicals through buffer exchange. Exchanging 
buffer and removal of chemicals involved concentrating the protein solution and then 
diluting the sample 5 to 10-fold in the concentrator and repeating this process at least       
5 times. Buffers were typically exchanged at 4 °C, except for experiments conducted at 
RT in the anaerobic chamber. 
 
5.15 Dialysis 
 
5.15.1 Preparation of dialysis tubing 
 
Dialysis tubing (8 kDa and 14 kDa MWCO, Sigma) was prepared by soaking the tubing 
for ~ 60 min in an aqueous solution of 1 % (v/v) acetic acid followed by exchange into 
Milli-Q water. The tubing was soaked in a solution containing 1 mM EDTA and                
1 % (w/v) sodium carbonate and stirred for around 5 minutes. The solution was 
refreshed and the tubing heated up to around 60 °C. The heating process was repeated 
once more with a fresh solution and the dialysis tubing was allowed to cool down to RT 
over a period of 30 min. The dialysis tubing was exchanged into Milli-Q water, heated 
again to around 60 °C, and allowed to cool before storing at 4 °C in Milli-Q water [18].   
 
5.15.2 Dialysis of protein solution 
 
Prior to use, dialysis tubing was washed in an appropriate buffer. Protein solutions were 
sealed in tubing and dialyzed against buffer solution at 4 °C for at least 3 h, with 
stirring. The buffer solution (volume of at least 50-fold sample volume) was typically 
exchanged three times.   
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5.16 Bioinformatics 
 
The alignment of DNA sequences was performed using LALIGN tool from ExPasy 
Bioinformatics Resource Portal using default settings. The theoretical MWs of proteins 
were estimated using Compute pI/Mw tool from ExPasy Bioinformatics Resource 
Portal. Clone Manager (Sci-Ed Software) software was used for design of DNA primers 
and analysis of DNA sequences. The ClustalX software [19] was used to align amino 
acid sequences of proteins using the default settings. Secondary structure composition 
was estimated from crystal structures using STRIDE software [20] and from the far-UV 
CD spectra using Dichroweb software [21]. Structural models were prepared using                
I-TASSER software [22]. The figures of crystal structures of proteins were created 
using PyMol 1.6.0.0 (Schrödinger) [23], whilst structural alignment of proteins was 
performed using Secondary Structure Motif (SSM) algorithms implemented in COOT 
[24]. Figures and data fitting were typically prepared using GraphPad Prism 5 Software. 
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A) 
 
B) 
 
 
Figure A.1 The structures of (A) ATTO 532 and (B) ATTO 590. Structure of ATTO 
647N is not available. 	  
A) 
 
B) 
 	  
Figure A.2 The reaction scheme of (A) 2,2’-azinobis-3-ethylthiazoline-6-sulfonat 
(ABTS) and (B) 2,6-dimethylphenol (2,6-DMP). 
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To investigate the influence of a) dwell time per pixel (bin size), b) time resolution and 
c) the accuracy of τon and τoff determinations on the final result, a series of simulated 
ON/OFF time traces (where “ON” and “OFF” periods correspond to the T1 Cu reduced 
and oxidize, respectively) were constructed and analyzed by Dr. Leandro C. Tabares. 
The simulated time traces were constructed by generating a row of 6×106 data-points 
y(x) in which x is the time and y has a value of 1 or 0. The x-axis was divided into 
increments of 1×10-5 s mimicking a 60 s long trajectory with a resolution of 0.01 ms.  
At the x = 0, y was arbitrarily set to “ON” (y = 1), followed by one “OFF” period (y = 0) 
before another “ON” period was started. While “OFF” periods were fixed to 1000 
points (τoff = 10 ms), the “ON” periods were allowed to last for a time                                
τon = -1×ln(rand)×τred, where rand is a computer generated evenly-distributed random 
number between 0 and 1. In this way the “ON” periods lasted for a random time τon, the 
cumulative distribution of which obeys an exponential decay with a time constant τred 
[1]. Traces were generated in this way for τred = 0.5, 1.0, 3.0, 5.0, 10, 25, 50, 100 and 
200 ms. Subsequently a 60 s, 4 ms-binned simulated trace was treated as in the spot 
measurements, i.e., blocks were extracted and separated by intervals of 800 ms.              
The extracted blocks had subsequent lengths of 20, 36, 44, 52, 52, 52, 52, 52, 44, 36 and 
20 ms. This pattern corresponds with a circular spot with a 12 pixel diameter.                 
The extracted blocks were placed one behind the other to form a continuous time trace. 
For each τred, 100 independent traces were generated to mimic 100 spots. The simulated 
data were used to construct “ON”-time histograms as presented in Figure B.1.A. These 
were fit with single exponentials, the exponential decay constants proving estimates of 
τred. Apart from the procedure described above the full 60 s trajectories with 1 ms 
binning were analyzed. The less extensive simulation mimicking only 50 spots of               
5 pixels diameter with 4 ms binning was also performed (Figure B.1.B). The 
experimental τred values deviate appreciably from the theoretical τred only when the 
latter is much shorter then the observed experimentally dwell time per pixel (1 or 4 ms) 
or much larger than the time windows used for the analysis (20 to 60 ms). The latter 
requirement can be fulfilled as the enzyme rates for NiR are expected to be in the ms 
range [2 - 4].    
To investigate the effect of shape of the spots on the results (Pox distribution and 
τoxy and τred values) the same analysis as presented in Chapter 2 was performed by            
Dr. Leandro C. Tabares but using different shapes for the selected area. Figure B.2 
shows that the use of a whole spot, a rectangular (5×15 pixels) or a square (7×7 pixels) 
area produced similar trends in τoxy and τred values. 
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A) 
 
 
B) τred (ms) a Fit τred (ms) b Fit τred (ms) c Fit τred (ms) d 
 0.5 0.5 1.0 0.9 
 1.0 1.0 1.5 1.5 
 2.5 2.6 3.2 3.2 
 5.0 5.0 5.6 5.7 
 10 10.2 10.5 10.3 
 25 25 27 24 
 50 52 47 50 
 100 112 108 102 
 200 198 178 137 
a τred values used to construct the time traces. b 100 traces, 12 pixels diameter of a spot, 
1 ms bin time. c 100 traces, 12 pixels diameter of a spot, 4 ms bin time. d 50 traces,            
5 pixels diameter of a spot, 4 ms bin time. 
 
Figure B.1 (A) Time histograms for “ON” periods (T1 Cu reduced) extracted from the 
simulated time traces using τred values as specified on the right side of the figure. Lines 
show the fits to single exponential decays. Blue circles: data obtained from 100 
simulated traces, each 60 s long, 1 ms binned, 12 pixel diameter spots; green squares: 
data obtained from 50 simulated traces, each 60 s long, 4 ms binned trace, 12 pixel 
diameter spots; red triangles: 100 spots of 12 pixels diameter. (B) The fitting 
parameters of the “ON”-times histograms extracted from simulated time traces to single 
exponential decays. The dwell time histograms were obtained from 60 s long time 
traces simulated with τred values of 0.5, 1.0, 5.0, 10, 25, 50, 100 and 200 ms.  
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Figure B.2 Effect of the selected spot area on the τon and τoff values for the population 
A (left) and B (right). Blue points: data obtained by analyzing all the pixels within a 
spot with a diameter of 15 pixels. Green points: data obtained by analyzing all the 
pixels within the area of 5×15 pixels around the center of the spot (region 1 on the spot 
at the right, marked with green rectangle). Orange points: data obtained by analyzing 
all the pixels within the area of 7×7 pixels around the center of the spot (region 2, 
marked with orange square).  
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Figure C.1 The comparison of clcc1 and glcc1 sequences. Introns are highlighted in red and single nucleotide mutations in teal. 
 
              10        20        30        40        50        60 
clcc1  GCTATCGGGCCTGTGACCGACCTCACCATCTCTAATGCGGACGTTTCTCCCGACGGCTTC 
       :::::::::::::::::::::::::::::::: ::::::::::::::::::::::::::: 
glcc1  GCTATCGGGCCTGTGACCGACCTCACCATCTCCAATGCGGACGTTTCTCCCGACGGCTTC 
               10        20        30        40        50        60 
 
               70        80        90       100       110       120 
clcc1  ACTCGTGCCGCAGTGCTTGCAAACGGTGTCTTCCCGGGTCCTCTTATCACGGGAAACAAG 
       :::::::::::::::::::::::::: ::::::::::::::::::::::::::::::::: 
glcc1  ACTCGTGCCGCAGTGCTTGCAAACGGCGTCTTCCCGGGTCCTCTTATCACGGGAAACAAG 
               70        80        90       100       110       120 
 
                                                                    
clcc1  G--------------------------------------------------------GCG 
       :                                                        ::: 
glcc1  GTACGTGGCATGCGTTCAGTCTACACCCTACAAGCCTTCTAACTCTTTTACCACAGGGCG 
              130       140       150       160       170       180 
 
          130       140       150       160       170       180     
clcc1  ACAACTTCCAGATCAATGTTGTCGACAACCTCTCTAACGAAACGATGTTGAAGTCGACCT 
       :::::::::::::::::::: ::::::::::::::::::: ::::::::::::::::::: 
glcc1  ACAACTTCCAGATCAATGTTATCGACAACCTCTCTAACGAGACGATGTTGAAGTCGACCT 
              190       200       210       220       230       240 
 
                                                                    
clcc1  CTATC------------------------------------------------------- 
       : :::                                                        
glcc1  CCATCGTATGTGCTTCTACTGTTTCTTAGTCTTGGCAATGGCTCAAGGTCTCCTCCGCAG 
              250       260       270       280       290       300 
 
     190       200       210       220       230       240          
clcc1  CATTGGCACGGCTTCTTCCAGAAGGGTACTAACTGGGCTGATGGAGCTGCCTTCGTCAAC 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
glcc1  CATTGGCACGGCTTCTTCCAGAAGGGTACTAACTGGGCTGATGGAGCTGCCTTCGTCAAC 
              310       320       330       340       350       360 
 
     250       260       270       280       290       300          
clcc1  CAGTGCCCTATCGCGACGGGGAACTCTTTCCTTTACGACTTCACCGCGACGGACCAAGCA 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
glcc1  CAGTGCCCTATCGCGACGGGGAACTCTTTCCTTTACGACTTCACCGCGACGGACCAAGCA 
              370       380       390       400       410       420 
 
     310                                                            
clcc1  GG---------------------------------------------------------- 
       ::                                                           
glcc1  GGTCAGTGCCTGTGGCGCTTATGTTTTCCCGTAATCAGCAGCTAACACTCCGCACCCACA 
              430       440       450       460       470       480 
 
               320       330       340       350       360          
clcc1  --CACCTTCTGGTACCACAGTCACTTGTCTACGCAGTACTGTGATGGTTTGCGGGGCCCG 
         ::::::::::::::::::::::::::::::::::::::: :::::::::::::::::: 
glcc1  GGCACCTTCTGGTACCACAGTCACTTGTCTACGCAGTACTGCGATGGTTTGCGGGGCCCG 
              490       500       510       520       530       540 
 
     370       380       390       400       410       420          
clcc1  ATGGTCGTATACGACCCGAGTGACCCGCATGCGGACCTTTACGACGTCGACGACGAGACC 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
glcc1  ATGGTCGTATACGACCCGAGTGACCCGCATGCGGACCTTTACGACGTCGACGACGAGACC 
              550       560       570       580       590       600 
 
     430       440       450       460       470       480          
clcc1  ACGATCATCACGCTCTCTGATTGGTATCACACCGCCGCTTCGCTCGGTGCTGCCTTCCCG 
       ::::::::::::::::::::::::::::::::::::::::::::::::::::: :::::: 
glcc1  ACGATCATCACGCTCTCTGATTGGTATCACACCGCCGCTTCGCTCGGTGCTGCTTTCCCG 
              610       620       630       640       650       660 
 
                                                            490     
clcc1  -------------------------------------------------------ATTGG 
                                                              ::::: 
glcc1  TAAGTTTGCCCCTGCGCATAGAGTTCGAACCAGATCTAAACGTACTACTTTCAGGATTGG 
              670       680       690       700       710       720 
 
          500       510       520       530       540       550     
clcc1  CTCGGACTCTACCCTGATCAACGGGTTGGGCCGTTTCGCGGGTGGTGACAGCACTGACCT 
       ::::::::::::::: ::::::::::::::::::::::: ::::: :::::::::::::: 
glcc1  CTCGGACTCTACCCTCATCAACGGGTTGGGCCGTTTCGCCGGTGGCGACAGCACTGACCT 
              730       740       750       760       770       780 
 
          560       570       580                                   
clcc1  TGCGGTCATCACTGTTGAGCAGGGCAAGCG------------------------------ 
       :::::::::::: :::::::::::::::::                               
glcc1  TGCGGTCATCACGGTTGAGCAGGGCAAGCGGTGAGTGCTATCCCCTACAGTTGGCACTGT 
              790       800       810       820       830       840 
 
590       600       610       620  
clcc1  -----------------------CTACCGTATGCGTCTTCTCTCGCTGTCTTGCGACCCC 
                              ::::::::::::::::::::::::::::::::::::: 
glcc1  CCCCTTACTGACAGTACTCTCAGCTACCGTATGCGTCTTCTCTCGCTGTCTTGCGACCCC 
              850       860       870       880       890       900 
 
             630       640       650       660       670       680  
clcc1  AACTATGTCTTCTCCATCGACGGCCACAACATGACCATCATCGAGGCCGACGCCGTCAAC 
       ::::::::::::::::::::::: ::::::::::::::::::::::::::::: :::::: 
glcc1  AACTATGTCTTCTCCATCGACGGTCACAACATGACCATCATCGAGGCCGACGCTGTCAAC 
              910       920       930       940       950       960 
 
             690       700       710       720       730       740  
clcc1  CACGAGCCCCTCACGGTCGACTCCATCCAGATCTACGCCGGCCAACGCTACTCCTTCGTT 
       ::::::::::::::::::::::::::::::::::::::::: ::::: :::::::::::  
glcc1  CACGAGCCCCTCACGGTCGACTCCATCCAGATCTACGCCGGACAACGTTACTCCTTCGTC 
             970       980       990      1000      1010      1020 
 
                                                                    
clcc1  -----------------------------------------------------------C 
                                                                  : 
glcc1  GTACGTACTCCGGACAGTCATGATCACGCCCAGCCCGATGCTAACCCGCCTACGCTCAGC 
             1030      1040      1050      1060      1070      1080 
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Figure C.1 The comparison of clcc1 and glcc1 sequences. Introns are highlighted in red and single nucleotide mutations in teal - continued. 
 
            750       760       770       780       790       800   
clcc1  TTACCGCTGACCAGGACATCGACAACTACTTCATCCGTGCCCTGCCCAGCGCCGGTACCA 
       :::: ::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
glcc1  TTACTGCTGACCAGGACATCGACAACTACTTCATCCGTGCCCTGCCCAGCGCCGGTACCA 
             1090      1100      1110      1120      1130      1140 
 
            810       820       830       840       850       860   
clcc1  CCTCGTTCGACGGCGGCATCAACTCGGCTATCCTGCGCTACTCTGGTGCCTCCGAGGTTG 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
glcc1  CCTCGTTCGACGGCGGCATCAACTCGGCTATCCTGCGCTACTCTGGTGCCTCCGAGGTTG 
             1150      1160      1170      1180      1190      1200 
 
            870       880       890       900       910       920   
clcc1  ACCCGACGACCACGGAGACCACGAGCGTCCTCCCCCTCGACGAGGCGAACCTCGTGCCCC 
       ::::::::::::::::::::::::: :::::::::::::::::::::::::::::::::: 
glcc1  ACCCGACGACCACGGAGACCACGAGTGTCCTCCCCCTCGACGAGGCGAACCTCGTGCCCC 
             1210      1220      1230      1240      1250      1260 
         930                                                     
clcc1  TTGACAGCCCCGCTGCT------------------------------------------- 
       :::::::::::::::::                                            
glcc1  TTGACAGCCCCGCTGCTGTACGTTGCATCCTGCACTTGTGAGGAGCGCACATACTAACAC 
             1270      1280      1290      1300      1310      1320 
 
               940       950       960       970       980          
clcc1  ----------CCCGGTGACCCCAACATCGGCGGTGTCGACTACGCGCTGAACTTGGACTT 
                 ::::::::::::::::: :::::::::::::::::::::::::::::::: 
glcc1  GCTGTTGTAGCCCGGTGACCCCAACATTGGCGGTGTCGACTACGCGCTGAACTTGGACTT 
             1330      1340      1350      1360      1370      1380 
 
     990      1000      1010      1020      1030      1040          
clcc1  CAACTTCGATGGCACCAACTTCTTCATCAACGACGTCTCCTTCGTGTCCCCCACTGTCCC 
       ::::::::::::::::::::::::::: ::::::::::::::::: :::::::::::::: 
glcc1  CAACTTCGATGGCACCAACTTCTTCATTAACGACGTCTCCTTCGTATCCCCCACTGTCCC 
             1390      1400      1410      1420      1430      1440 
 
    1050      1060      1070      1080      1090      1100          
clcc1  TGTCCTCCTCCAGATCCTTAGCGGCACCACCTCCGCGGCCGACCTCCTCCCCAGCGGCAG 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
glcc1  TGTCCTCCTCCAGATCCTTAGCGGCACCACCTCCGCGGCCGACCTCCTCCCCAGCGGCAG 
             1450      1460      1470      1480      1490      1500 
 
    1110      1120      1130      1140      1150      1160          
clcc1  TCTCTTCGCCCTCCCGTCCAACTCGACGATCGAGATCTCGTTCCCCATCACCGCGACGAA 
       ::::::::: :::::::::::::::::::::::::::::::::::::::::::::::::: 
glcc1  TCTCTTCGCGCTCCCGTCCAACTCGACGATCGAGATCTCGTTCCCCATCACCGCGACGAA 
             1510      1520      1530      1540      1550      1560 
 
    1170      1180      1190      1200                              
clcc1  CGCGCCCGGCGCGCCGCATCCCTTCCACTTGCACGGT----------------------- 
       :::::::::::::::::::::::::::::::::::::                        
glcc1  CGCGCCCGGCGCGCCGCATCCCTTCCACTTGCACGGTGTACGTGTCCCATCTCATATGCT 
             1570      1580      1590      1600      1610      1620 
 
   
                                   1210      1220      1230         
clcc1  ----------------------------CACACCTTCTCCATCGTTCGTACCGCCGGCAG 
                                   ::::::::::: :::::::::::::::::::: 
glcc1  ACGGAGCTCCACGCTGACCGCCCTATAGCACACCTTCTCTATCGTTCGTACCGCCGGCAG 
             1630      1640      1650      1660      1670      1680 
 
     1240      1250      1260      1270      1280      1290         
clcc1  CACGGATACGAACTTCGTCAACCCCGTCCGCCGCGACGTCGTGAACACCGGTACCGCCGG 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
glcc1  CACGGATACGAACTTCGTCAACCCCGTCCGCCGCGACGTCGTGAACACCGGTACCGCCGG 
             1690      1700      1710      1720      1730      1740 
 
     1300      1310      1320                                       
clcc1  CGACAACGTCACCATTCGCTTCACG----------------------------------- 
       ::::::::::::::: :::::::::                                    
glcc1  CGACAACGTCACCATCCGCTTCACGGTACGCAGCACTCTCCTAACATTCCCACTGTGCGA 
             1750      1760      1770      1780      1790      1800 
 
                               1330      1340      1350      1360   
clcc1  ---------------------ACTGACAACCCCGGCCCCTGGTTCCTCCACTGCCACATC 
                            ::::::::::::::::::::::::::::::::::::::: 
glcc1  TCACTGACTCCTCGCCCACAGACTGACAACCCCGGCCCCTGGTTCCTCCACTGCCACATC 
             1810      1820      1830      1840      1850      1860 
 
           1370      1380      1390      1400      1410      1420   
clcc1  GACTTCCACTTGGAGGCCGGTTTCGCCATCGTCTTCAGCGAGGACACCGCCGACGTCTCG 
       :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: 
glcc1  GACTTCCACTTGGAGGCCGGTTTCGCCATCGTCTTCAGCGAGGACACCGCCGACGTCTCG 
             1870      1880      1890      1900      1910      1920 
 
           1430      1440                                           
clcc1  AACACGACCACCCCCTCGA----------------------------------------- 
       ::::::::::: :::::::                                          
glcc1  AACACGACCACGCCCTCGAGTACGTTGTGCTCCCCTGCCCATCTCCGCGCGCCTGACTAA 
             1930      1940      1950      1960      1970      1980 
 
                            1450      1460      1470      1480      
clcc1  ----------------CTGCTTGGGAAGATCTGTGCCCCACGTACAACGCTCTTGACTCA 
                       :::::::::::::::::::::::::::::::::::::::::::: 
glcc1  CGAGCACCCCTTACAGCTGCTTGGGAAGATCTGTGCCCCACGTACAACGCTCTTGACTCA 
             1990      2000      2010      2020      2030      2040 
 
        1490        
clcc1  TCCGACCTCTAA 
       :::::::::::: 
glcc1  TCCGACCTCTAA 
             2050  
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A) 
 
B) 
 
C) D) 
 
 	  
Figure D.1 (A) Superposition of the T1 Cu site of gdcLAC (green) on the potential 
MBS-1 site of WT SLAC (blue). The T1 Cu is a green sphere. UV-Vis absorption (B), 
far-UV CD (C) and EPR (D) spectra of gdcSLAC ( ), mgSLAC ( ) and               
WT SLAC ( ). The UV-Vis spectra were acquired at RT in 20 mM Tris pH 7.5 
containing 200 mM NaCl, far-UV CD spectra at 25 °C in 20 mM Tris pH 7.5 and EPR 
spectra at ~ 80 K in 20 mM Tris pH 7.5 containing 200 mM NaCl.  
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